"","title","link","pubDate","Site","Lead","Symbol","Company"
"1","Glaxosmithkline plc completes major three-part transaction","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3163959","2015-03-02 02:00:00","Reuters Key Development","Glaxosmithkline plc completes major three-part transaction","GSK"," GlaxoSmithKline"
"2","Sun Pharmaceutical Industries Ltd to buy GlaxoSmithKline Plc Opiates business in Australia","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3164763","2015-03-02 21:48:00","Reuters Key Development","Sun Pharmaceutical Industries Ltd to buy GlaxoSmithKline Plc Opiates business in Australia","GSK"," GlaxoSmithKline"
"3","GlaxoSmithKline Plc sacks 110 China staff in wake of drug bribery case - Reuters","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3168053","2015-03-06 14:07:00","Reuters Key Development","GlaxoSmithKline Plc sacks 110 China staff in wake of drug bribery case - Reuters","GSK"," GlaxoSmithKline"
"4","GlaxoSmithKline Plc intends to sell part holding in Aspen Pharmacare Holdings","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3171328","2015-03-12 11:14:00","Reuters Key Development","GlaxoSmithKline Plc intends to sell part holding in Aspen Pharmacare Holdings","GSK"," GlaxoSmithKline"
"5","GlaxosmithKline Plc completes partial sale of Aspen Pharmacare Holdings Ltd","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3171740","2015-03-13 03:00:00","Reuters Key Development","GlaxosmithKline Plc completes partial sale of Aspen Pharmacare Holdings Ltd","GSK"," GlaxoSmithKline"
"6","GlaxosmithKline Plc and Johnson &amp; Johnson settle U.S. lawsuit over allergy ads - Reuters","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3184358","2015-03-30 22:21:00","Reuters Key Development","GlaxosmithKline Plc and Johnson & Johnson settle U.S. lawsuit over allergy ads - Reuters","GSK"," GlaxoSmithKline"
"7","Glaxosmithkline plc and Theravance announces FDA approval of BREO ELLIPTA for treatment of adults with asthma in the US","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3204592","2015-04-30 15:17:00","Reuters Key Development","Glaxosmithkline plc and Theravance announces FDA approval of BREO ELLIPTA for treatment of adults with asthma in the US","GSK"," GlaxoSmithKline"
"8","Glaxosmithkline PLC declares first interim dividend","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3207140","2015-05-06 07:00:00","Reuters Key Development","Glaxosmithkline PLC declares first interim dividend","GSK"," GlaxoSmithKline"
"9","Glaxosmithkline plc gives FY 2015 EPS below analysts&#39; estimates - Conferance Call","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3208998","2015-05-06 09:30:00","Reuters Key Development","Glaxosmithkline plc gives FY 2015 EPS below analysts' estimates - Conferance Call","GSK"," GlaxoSmithKline"
"10","Perrigo to buy portfolio of OTC brands from Glaxosmithkline","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3223175","2015-06-02 06:27:00","Reuters Key Development","Perrigo to buy portfolio of OTC brands from Glaxosmithkline","GSK"," GlaxoSmithKline"
"11","Avalon Rare Metals Inc and Glaxosmithkline plc Launch Three New Companies with Series A Financing and R&amp;D Support as Part of Ongoing Collaboration","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3229400","2015-06-15 08:00:00","Reuters Key Development","Avalon Rare Metals Inc and Glaxosmithkline plc Launch Three New Companies with Series A Financing and R&D Support as Part of Ongoing Collaboration","GSK"," GlaxoSmithKline"
"12","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3232665","2015-06-22 07:08:00","Reuters Key Development","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","GSK"," GlaxoSmithKline"
"13","GlaxoSmithKline Plc declares dividend","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3254046","2015-07-29 07:00:00","Reuters Key Development","GlaxoSmithKline Plc declares dividend","GSK"," GlaxoSmithKline"
"14","Novartis buys remaining rights to GlaxoSmithKline Plc treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3264458","2015-08-21 01:25:00","Reuters Key Development","Novartis buys remaining rights to GlaxoSmithKline Plc treatment","GSK"," GlaxoSmithKline"
"15","Glaxosmithkline plc and Theravance Inc announces results from the SUMMIT COPD CV survival study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3270960","2015-09-08 14:40:00","Reuters Key Development","Glaxosmithkline plc and Theravance Inc announces results from the SUMMIT COPD CV survival study","GSK"," GlaxoSmithKline"
"16","GlaxoSmithKline plc (ADR), AbbVie Inc: Attractive High-Yield Dividend Pharma ...","http://etfdailynews.com/2015/09/14/glaxosmithkline-plc-adr-abbvie-inc-attractive-high-yield-dividend-pharma-stocks-to-buy/","2015-09-14 12:00:58","ETF Daily News","yield Bob Ciura: The stock market sell-off is painful for investors who own stocks, but the good news is that declining stock prices present new buying opportunities.","GSK"," GlaxoSmithKline"
"17","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3280167","2015-10-01 08:00:00","Reuters Key Development","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","GSK"," GlaxoSmithKline"
"18","Glaxosmithkline plc Nucala receives approval from US FDA","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3296175","2015-11-05 02:00:00","Reuters Key Development","Glaxosmithkline plc Nucala receives approval from US FDA","GSK"," GlaxoSmithKline"
"19","Valneva signs new research and development collaboration with GlaxoSmithKline","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3329606","2016-02-08 01:00:00","Reuters Key Development","Valneva signs new research and development collaboration with GlaxoSmithKline","GSK"," GlaxoSmithKline"
"20","Here is How the US Congress Bill Benefit GlaxoSmithKline plc (ADR), Inovio ...","http://www.businessfinancenews.com/28567-here-is-how-the-us-congress-bill-benefit-glaxosmithkline-plc-adr-inovio-pha/","2016-04-14 12:59:01","Business Finance News","The list includes Sanofi SA (ADR) (NYSE:SNY) , GlaxoSmithKline Plc (ADR) (NYSE:GSK), Inovio Pharmaceuticals Inc. (NASDAQ:INO), and Takeda Pharmaceutical Co Ltd.","GSK"," GlaxoSmithKline"
"21","GSK says its meningitis vaccine achieves study goals","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3374332","2016-05-13 06:15:55","Reuters Key Development","GSK says its meningitis vaccine achieves study goals","GSK"," GlaxoSmithKline"
"22","Glaxosmithkline and Innoviva report positive headline results in Salford Lung study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3380494","2016-05-24 05:54:42","Reuters Key Development","Glaxosmithkline and Innoviva report positive headline results in Salford Lung study","GSK"," GlaxoSmithKline"
"23","GSK says gene therapy for immune disorder meets main goal","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3381235","2016-05-25 05:09:39","Reuters Key Development","GSK says gene therapy for immune disorder meets main goal","GSK"," GlaxoSmithKline"
"24","GlaxoSmithKline plc (ADR) Moves Ahead in COPD Treatment","http://www.businessfinancenews.com/29125-glaxosmithkline-plc-adr-moves-ahead-in-copd-treatment/","2016-05-26 11:40:42","Business Finance News","GlaxoSmithKline's plc (NYSE:GSK) new inhale formulation has shown comprehensive results when compared to the standard of care (SOC) treatment for patients suffering from chronic obstructive pulmonary disease (COPD).","GSK"," GlaxoSmithKline"
"25","GlaxoSmithKline appoints Vivienne Cox to board","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3383144","2016-05-27 09:56:02","Reuters Key Development","GlaxoSmithKline appoints Vivienne Cox to board","GSK"," GlaxoSmithKline"
"26","GSK Wins EU Nod For First Ever Gene Therapy For Children: Significant Victory?","http://www.bidnessetc.com/69728-gsk-wins-eu-nod-gene-therapy-children-significant-victor/","2016-05-31 10:51:53","Bidness ETC","GlaxoSmithKline plc (ADR) (NYSE:GSK) has made its mark yet again in the pharmaceutical industry with its success in getting the European Commission's green signal to sell the world's first ever gene therapy for children.","GSK"," GlaxoSmithKline"
"27","Regulus expands clinical trial collaboration with GSK","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3385271","2016-06-01 08:00:00","Reuters Key Development","Regulus expands clinical trial collaboration with GSK","GSK"," GlaxoSmithKline"
"28","GlaxoSmithkline accelerates filing of COPD triple-therapy drug","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3385696","2016-06-02 02:00:07","Reuters Key Development","GlaxoSmithkline accelerates filing of COPD triple-therapy drug","GSK"," GlaxoSmithKline"
"29","Mylan launches generic rythmol sustained-release capsules","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3385903","2016-06-02 07:00:00","Reuters Key Development","Mylan launches generic rythmol sustained-release capsules","GSK"," GlaxoSmithKline"
"30","GSK rheumatoid arthritis, SLE drug meets late stage study goal","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3388521","2016-06-08 05:38:05","Reuters Key Development","GSK rheumatoid arthritis, SLE drug meets late stage study goal","GSK"," GlaxoSmithKline"
"31","ViiV Healthcare says FDA approves sNDA for dolutegravir","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3389724","2016-06-10 09:10:55","Reuters Key Development","ViiV Healthcare says FDA approves sNDA for dolutegravir","GSK"," GlaxoSmithKline"
"32","GlaxoSmithKline says vaccines chairman Slaoui to retire in 2017","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3390787","2016-06-14 05:58:50","Reuters Key Development","GlaxoSmithKline says vaccines chairman Slaoui to retire in 2017","GSK"," GlaxoSmithKline"
"33","Can GlaxoSmithKline Handle Losing Two Old-Time Execs","http://www.bidnessetc.com/70369-glaxosmithkline-handle-losing-two-oldtime-execs/","2016-06-15 08:13:37","Bidness ETC","GlaxoSmithKline plc (ADR) (NYSE:GSK) is losing some of its long-standing executives at a time when the company is scrambling for a return to profitability.","GSK"," GlaxoSmithKline"
"34","GlaxoSmithKline says lung drug meets late-stage study goals","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3393169","2016-06-20 02:02:24","Reuters Key Development","GlaxoSmithKline says lung drug meets late-stage study goals","GSK"," GlaxoSmithKline"
"35","Why GlaxoSmithKline plc (ADR) (GSK) Stock Is Higher Today","http://investorplace.com/2016/06/glaxosmithkline-gsk-stock/","2016-06-20 13:23:59","Investorplace.com","It found the treatment to be more effective than rival AstraZeneca plc (ADR)'s (AZN) Symbicort. “Triple combination therapy is already a reality for many patients with COPD and is dispensed in multiple inhalers,” Dave Allen, GlaxoSmithKline's head ...","GSK"," GlaxoSmithKline"
"36","GlaxoSmithKline plc (ADR): New COPD Data Positive For Ex-Advair Franchise","http://www.bidnessetc.com/70604-glaxosmithkline-copd-data-positive-exadvair-franchise/","2016-06-21 06:40:57","Bidness ETC","GlaxoSmithKline plc (ADR) (NYSE:GSK) may be well on its way to add another potentially blockbuster respiratory drug to its Ellipta (inhaler) portfolio.","GSK"," GlaxoSmithKline"
"37","Mylan launches generic version of GSK&#39;s avodart capsules","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3395866","2016-06-24 11:44:00","Reuters Key Development","Mylan launches generic version of GSK's avodart capsules","GSK"," GlaxoSmithKline"
"38","Can GlaxoSmithKline plc (ADR) Subsist Advair&#39;s Patent Expiry","http://www.businessfinancenews.com/29424-can-glaxosmithkline-plc-adr-subsist-advairs-patent-expiry/","2016-06-25 08:11:15","Business Finance News","GlaxoSmithKline plc (ADR) (NYSE:GSK) is in dire need of a magical respiratory molecule to patch up the increasing space in its COPD (chronic obstructive pulmonary disease) and asthma portfolio, due to the patent for blockbuster drug Advair approaching ...","GSK"," GlaxoSmithKline"
"39","Brexit: Shockwaves to AstraZeneca, Novartis, GlaxoSmithKline","http://www.businessfinancenews.com/29445-brexit-shockwaves-to-astrazeneca-novartis-glaxosmithkline/","2016-06-27 10:24:47","Business Finance News","The astonishing verdict by the UK people to cut ties with the European Union (EU) has put pharmaceutical companies such as AstraZeneca plc (NYSE:AZN), Novartis, and GlaxoSmithKline in a rollercoaster as the European Medicines Agency (EMA) has to be ...","GSK"," GlaxoSmithKline"
"40","Zika Threat, GlaxoSmithKline plc (ADR) Joins the Race","http://www.businessfinancenews.com/29546-zika-threat-glaxosmithkline-plc-adr-joins-the-race/","2016-07-11 09:30:00","Business Finance News","GlaxoSmithKline plc (NYSE:GSK) has finally stepped forward to work on the development of Zika vaccine in collaboration with National Institutes of Health (NIH).","GSK"," GlaxoSmithKline"
"41","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3406900","2016-07-18 06:16:10","Reuters Key Development","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","GSK"," GlaxoSmithKline"
"42","GlaxoSmithKline and Apple Inc: Medicine Meets Technology","http://www.businessfinancenews.com/29591-glaxosmithkline-and-apple-inc-medicine-meets-technology/","2016-07-18 09:18:45","Business Finance News","Keeping in view the benefits of the kit, GlaxoSmithKline plc (NYSE:GSK) and Purdue Pharma want to get their hands on it and make the best of it while having it on board.","GSK"," GlaxoSmithKline"
"43","GlaxoSmithKline ships 2016-17 seasonal influenza vaccines for US market","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3408521","2016-07-20 15:51:00","Reuters Key Development","GlaxoSmithKline ships 2016-17 seasonal influenza vaccines for US market","GSK"," GlaxoSmithKline"
"44","GlaxoSmithKline plc (ADR) Earning Release; Here&#39;s What to Expect","http://www.businessfinancenews.com/29664-glaxosmithkline-plc-adr-earning-release-heres-what-to-expect/","2016-07-26 10:11:07","Business Finance News","The UK-based pharmaceutical company, GlaxoSmithKline plc (ADR) (NYSE:GSK), is expected to announce second quarter (2Q) earnings result on July 27.","GSK"," GlaxoSmithKline"
"45","GSK CEO: UK competitive post-Brexit but questions over drug regulation, science","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3412627","2016-07-27 07:00:00","Reuters Key Development","GSK CEO: UK competitive post-Brexit but questions over drug regulation, science","GSK"," GlaxoSmithKline"
"46","GlaxoSmithKline plc Beats on Revenue; Invests in New Respiratory Drug","http://www.bidnessetc.com/71732-glaxosmithkline-beats-revenue-invests-respiratory-drug/","2016-07-27 09:21:52","Bidness ETC","GlaxoSmithKline plc. (ADR) (NYSE:GSK) purchased global rights to an early-stage respiratory drug from Johnson & Johnson (NYSE:JNJ) for up to $230 million, or 175 million pounds, today.","GSK"," GlaxoSmithKline"
"47","Vectura initiates legal proceedings against GSK in the U.S.","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3412881","2016-07-27 12:19:40","Reuters Key Development","Vectura initiates legal proceedings against GSK in the U.S.","GSK"," GlaxoSmithKline"
"48","GlaxoSmithKline plc (ADR) Picks Alphabet Inc for Bioelectronic Medicine","http://www.businessfinancenews.com/29709-glaxosmithkline-plc-adr-picks-alphabet-inc-for-bioelectronic-medicine/","2016-08-01 12:07:30","Business Finance News","GlaxoSmithKline Plc (ADR) (NYSE:GSK) and Alphabet Inc.'s (NASDAQ:GOOGL) life-sciences business, Verily Life Sciences, agreed to the creation of a new entity, called Galvani Bioelectronics, for the research and development (R&D) of Bioelectronic ...","GSK"," GlaxoSmithKline"
"49","Gsk Consumer Healthcare says FDA approved Flonase Sensimist allergy relief as OTC treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3418121","2016-08-03 08:03:00","Reuters Key Development","Gsk Consumer Healthcare says FDA approved Flonase Sensimist allergy relief as OTC treatment","GSK"," GlaxoSmithKline"
"50","Zika Threat: GlaxoSmithKline plc (GSK), Inovio Pharmaceuticals Inc (INO ...","http://www.thecountrycaller.com/52412-zika-threat-glaxosmithkline-plc-gsk-inovio-pharmaceuticals-inc-ino-sanofi-sa-sny-what-are-the-options","2016-08-09 14:33:45","TCC","The threat of Zika virus has opened a new window for the pharmaceutical companies to enter into a lucrative market of vaccine production.","GSK"," GlaxoSmithKline"
"51","GlaxoSmithKline plc (NYSE:GSK) Offers Money Back Guarantees on Rare ...","http://www.thecountrycaller.com/66019-glaxosmithkline-plc-adr-gsk-offers-money-back-guarantees-on-rare-pathological-ailments","2016-08-15 11:00:00","TCC","Multiple companies around the globe are now offering the option of money back guarantees to expand the exposure of their costly therapies.","GSK"," GlaxoSmithKline"
"52","GlaxoSmithKline plc (ADR) (NYSE:GSK) Survive From New Respiratory Molecule ...","http://www.thecountrycaller.com/50021-will-glaxosmithkline-gsk-survive-from-new-respiratory-molecule-induction/","2016-08-15 11:33:45","TCC","GlaxoSmithKline's plc (ADR) (NYSE:GSK) respiratory franchise is going through a tough time due to fierce competition after the patent expiration of the company's blockbuster drugs and with the induction of generics in the therapeutic market.","GSK"," GlaxoSmithKline"
"53","Gilead Sciences, Inc: How Troubling is GSK&#39;s Game-Changing HIV Attempt?","http://www.bidnessetc.com/72767-gilead-sciences-troubling-gsks-gamechanging-hiv-attempt/","2016-08-30 11:40:48","Bidness ETC","Gilead Sciences, Inc. (NASDAQ:GILD) has tied all hopes with its legacy HIV business now that its core franchise of hepatitis C medicines is flagging.","GSK"," GlaxoSmithKline"
"54","GSK Consumer Healthcare announces Flonase allergy relief for OTC use in Canada","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3435725","2016-08-31 17:09:00","Reuters Key Development","GSK Consumer Healthcare announces Flonase allergy relief for OTC use in Canada","GSK"," GlaxoSmithKline"
"55","DR. Reddy&#39;s laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3436850","2016-09-02 11:32:00","Reuters Key Development","DR. Reddy's laboratories says launch of Bupropion HCL extended-release tablets, USP (sr) in U.S. market","GSK"," GlaxoSmithKline"
"56","GlaxoSmithKline sees positive results from COPD Salford Lung study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3437026","2016-09-05 02:00:06","Reuters Key Development","GlaxoSmithKline sees positive results from COPD Salford Lung study","GSK"," GlaxoSmithKline"
"57","GSK presents positive results from phase III FULFIL study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3437818","2016-09-06 09:45:00","Reuters Key Development","GSK presents positive results from phase III FULFIL study","GSK"," GlaxoSmithKline"
"58","GlaxoSmithKline plc (ADR) Headed For Steady Double-Digit Growth?","http://www.bidnessetc.com/72963-glaxosmithkline-headed-steady-doubledigit-growth/","2016-09-09 10:56:40","Bidness ETC","Having faced turmoil following back-to-back patent expiries of blockbusters, GlaxoSmithKline plc (ADR) (NYSE:GSK) seems to be heading for a turnaround with strong growth stemming from new drugs and the solid HIV and vaccines businesses.","GSK"," GlaxoSmithKline"
"59","Will GlaxoSmithKline plc (ADR) (GSK) Exhibit Growth After Patent Cliff?","http://www.thecountrycaller.com/71245-will-glaxosmithkline-plc-adr-gsk-exhibit-growth-after-patent-cliff","2016-09-10 08:00:00","TCC","Majority of the investors are skeptical about the future prospects of GlaxoSmithKline plc (ADR) (NYSE:GSK) due to its performance in 2015, as it was hit hard by the patent cliff.","GSK"," GlaxoSmithKline"
"60","Aspen Pharma to buy almost entire of GSK&#39;s anaesthetics portfolio","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3439698","2016-09-12 03:00:22","Reuters Key Development","Aspen Pharma to buy almost entire of GSK's anaesthetics portfolio","GSK"," GlaxoSmithKline"
"61","GSK appoints Emma Walmsley as new CEO","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3442740","2016-09-20 02:00:08","Reuters Key Development","GSK appoints Emma Walmsley as new CEO","GSK"," GlaxoSmithKline"
"62","Medecins Sans Frontieres Happy with GlaxoSmithKline plc (ADR) (NYSE:GSK) Price ...","http://marketexclusive.com/medecins-sans-frontieres-happy-glaxosmithkline-price-reduction-synflorix/32571/","2016-09-20 09:23:56","Market Exclusive","Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline plc (ADR)(NYSE:GSK) have yielded fruit. The British drugmaker says that it will lower the price of Synflorix, ...","GSK"," GlaxoSmithKline"
"63","GSK files regulatory submissions in U.S. and Europe for lupus drug","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3444496","2016-09-23 04:44:14","Reuters Key Development","GSK files regulatory submissions in U.S. and Europe for lupus drug","GSK"," GlaxoSmithKline"
"64","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3444643","2016-09-23 08:00:00","Reuters Key Development","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","GSK"," GlaxoSmithKline"
"65","GlaxoSmithKline plc (ADR) (GSK) Steps ahead in Lupus Treatment","http://smartstocknews.com/48211-glaxosmithkline-plc-adr-gsk-steps-ahead-in-lupus-treatment/","2016-09-27 12:16:09","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","GlaxoSmithKline plc (ADR) (NYSE:GSK) submitted its subcutaneous drug, Benlysta, indicated for the management and treatment of lupus for approval in the US and EU before the respective regulatory agencies.","GSK"," GlaxoSmithKline"
"66","GSK, Oncodesign announce agreement for Oncodesign&#39;s Acquisition of GSK&#39;s Research Centre in France","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446090","2016-09-28 01:30:00","Reuters Key Development","GSK, Oncodesign announce agreement for Oncodesign's Acquisition of GSK's Research Centre in France","GSK"," GlaxoSmithKline"
"67","Oncodesign to buy François Hyafil research centre from GSK","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446085","2016-09-28 01:30:00","Reuters Key Development","Oncodesign to buy François Hyafil research centre from GSK","GSK"," GlaxoSmithKline"
"68","GSK says to sell remaining stake in Aspen Pharmacare","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446530","2016-09-28 11:19:59","Reuters Key Development","GSK says to sell remaining stake in Aspen Pharmacare","GSK"," GlaxoSmithKline"
"69","GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446845","2016-09-29 02:54:38","Reuters Key Development","GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale","GSK"," GlaxoSmithKline"
"70","Aspen Pharmacare says GSK sells remaining stake in co","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3446847","2016-09-29 03:05:09","Reuters Key Development","Aspen Pharmacare says GSK sells remaining stake in co","GSK"," GlaxoSmithKline"
"71","GlaxoSmithKline appoints new consumer healthcare CEO","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3447064","2016-09-29 07:40:19","Reuters Key Development","GlaxoSmithKline appoints new consumer healthcare CEO","GSK"," GlaxoSmithKline"
"72","Glaxo to pay $20 mln to resolve SEC charges&lt;GSK.L&gt;","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3448139","2016-09-30 14:15:05","Reuters Key Development","Glaxo to pay $20 mln to resolve SEC charges<GSK.L>","GSK"," GlaxoSmithKline"
"73","GSK submits U.S. application for Shingles vaccine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3458737","2016-10-24 02:00:06","Reuters Key Development","GSK submits U.S. application for Shingles vaccine","GSK"," GlaxoSmithKline"
"74","GlaxoSmithKline plc (ADR) (GSK) Seeks FDA Approval for New Shingles Vaccine","http://investorplace.com/2016/10/glaxosmithkline-shingles-shingrix-gsk/","2016-10-24 12:41:15","Investorplace.com","GlaxoSmithKline plc (ADR) (NYSE:GSK), a healthcare company, is seeking approval from the U.S. Food and Drug Administration for a shingles vaccine.","GSK"," GlaxoSmithKline"
"75","GlaxoSmithKline plc (ADR) (GSK) Q3 Earnings: What Merrill Lynch Expects","http://smartstocknews.com/57462-glaxosmithkline-plc-adr-gsk-q3-earnings-what-merrill-lynch-expects/","2016-10-24 12:50:22","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","GlaxoSmithKline plc (ADR) (NYSE:GSK) is slated to report third-quarter financial results for fiscal year 2016 on Wednesday, October 26.","GSK"," GlaxoSmithKline"
"76","Fimbrion, GSK to develop novel antibacterial therapy for UTIs","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3460547","2016-10-25 09:45:00","Reuters Key Development","Fimbrion, GSK to develop novel antibacterial therapy for UTIs","GSK"," GlaxoSmithKline"
"77","GlaxoSmithKline plc (ADR) (NYSE:GSK) Teams Up With Fimbrion Therapeutics, Inc.","http://marketexclusive.com/glaxosmithkline-plc-adr-nysegsk-teams-fimbrion-therapeutics-inc/35047/","2016-10-26 07:04:55","Market Exclusive","Under the partnership, the two companies will mainly work on a joint project between GSK Discovery Partnerships with Academia (DPAc) and Fimbrion Therapeutics.","GSK"," GlaxoSmithKline"
"78","GSK CEO says weak pound hasn&#39;t impacted company&#39;s UK pricing","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3461487","2016-10-26 07:15:00","Reuters Key Development","GSK CEO says weak pound hasn't impacted company's UK pricing","GSK"," GlaxoSmithKline"
"79","GlaxoSmithKline plc (ADR) (NYSE:GSK) Steps Ahead in Vaccine Combination","http://smartstocknews.com/43796-glaxosmithkline-plc-adr-gsk-steps-ahead-in-vaccine-combination/","2016-11-01 08:21:57","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","GSK's Shingrix belongs to the non-live recombinant category indicated for the prevention of shingles in a very minimal side effect profile.","GSK"," GlaxoSmithKline"
"80","GSK gets European nod for Boostrix vaccine label changes","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3466965","2016-11-01 09:06:37","Reuters Key Development","GSK gets European nod for Boostrix vaccine label changes","GSK"," GlaxoSmithKline"
"81","GSK Stock: GlaxoSmithKline PLC Is a High-Dividend Stock","https://www.incomeinvestors.com/gsk-stock-glaxosmithkline-plc-high-dividend-stock/8252/","2016-11-12 07:03:41","Income Investors","One sector that is known for large gross margins is the healthcare sector. Typically, high-gross-margin businesses are not looked at by dividend investors, the reason being that there is often no dividend.","GSK"," GlaxoSmithKline"
"82","GSK files regulatory submission in U.S. for COPD treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3481804","2016-11-21 02:11:35","Reuters Key Development","GSK files regulatory submission in U.S. for COPD treatment","GSK"," GlaxoSmithKline"
"83","GSK files regulatory submission of candidate vaccine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3482055","2016-11-21 06:30:00","Reuters Key Development","GSK files regulatory submission of candidate vaccine","GSK"," GlaxoSmithKline"
"84","GSK files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with COPD","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3482101","2016-11-21 07:00:00","Reuters Key Development","GSK files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with COPD","GSK"," GlaxoSmithKline"
"85","GSK receives FDA approval for expanded indication for flulaval® quadrivalent (influenza vaccine) for infants 6 months and older","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3482145","2016-11-21 08:28:00","Reuters Key Development","GSK receives FDA approval for expanded indication for flulaval® quadrivalent (influenza vaccine) for infants 6 months and older","GSK"," GlaxoSmithKline"
"86","Here&#39;s Our Take On Theravance Biopharma Inc (NASDAQ:TBPH) and GlaxoSmithKline ...","https://marketexclusive.com/heres-take-theravance-biopharma-inc-nasdaqtbph-glaxosmithkline-plc-adr-nysegsks-latest-submission/40401/","2016-11-22 06:03:45","Market Exclusive","The current SOC is another Glaxo drug, a double therapy of salmeterol and fluticasone, called Advair. It's been a huge earner for the company, but there's increasing pressure on its market share from companies like AstraZeneca plc (ADR) (NYSE:AZN), ...","GSK"," GlaxoSmithKline"
"87","GSK&#39;s Mepolizumab meets endpoints in phase 3 EGPA study","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3483295","2016-11-23 02:05:26","Reuters Key Development","GSK's Mepolizumab meets endpoints in phase 3 EGPA study","GSK"," GlaxoSmithKline"
"88","GlaxoSmithKline submits marketing application for shingles vaccine to EMA","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3485182","2016-11-25 08:35:13","Reuters Key Development","GlaxoSmithKline submits marketing application for shingles vaccine to EMA","GSK"," GlaxoSmithKline"
"89","GSK&#39;s lung drug gains approval in Japan","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3488725","2016-12-02 02:01:39","Reuters Key Development","GSK's lung drug gains approval in Japan","GSK"," GlaxoSmithKline"
"90","GSK applies for EU marketing nod for COPD drug cocktail","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3489268","2016-12-02 09:15:00","Reuters Key Development","GSK applies for EU marketing nod for COPD drug cocktail","GSK"," GlaxoSmithKline"
"91","GSK files EU submission for closed triple combination therapy for patients with COPD","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3489299","2016-12-02 10:12:32","Reuters Key Development","GSK files EU submission for closed triple combination therapy for patients with COPD","GSK"," GlaxoSmithKline"
"92","Analyst Insights on Price Target Estimates: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2016/12/03/analyst-insights-on-price-target-estimates-glaxosmithkline-plc-adr-nysegsk/","2016-12-03 08:30:00","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) soared 0.72% during previous trade, a total of 3.91M shares exchanged hands compared with its average trading volume of 4.48M shares whereas its relative volume is 1.10.","GSK"," GlaxoSmithKline"
"93","GSK submits regulatory application in Japan for belimumab","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3494065","2016-12-13 04:21:10","Reuters Key Development","GSK submits regulatory application in Japan for belimumab","GSK"," GlaxoSmithKline"
"94","GlaxoSmithKline plc&#39;s (ADR) (NYSE:GSK) Opens Its First Fully Dedicated ...","https://marketexclusive.com/glaxosmithkline-plcs-adr-nysegsk-opens-first-fully-dedicated-vaccines-rd-center-rockville/46670/","2016-12-15 09:17:10","Market Exclusive","GlaxoSmithKline plc (ADR) (NYSE:GSK) is celebrating another milestone; the opening of its newest global vaccines R&D center in Rockville, Maryland.","GSK"," GlaxoSmithKline"
"95","GSK announces start of phase III trails for asthma therapy","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3497319","2016-12-19 04:32:43","Reuters Key Development","GSK announces start of phase III trails for asthma therapy","GSK"," GlaxoSmithKline"
"96","GSK&#39;s Viiv announces positive results from initial HIV phase III studies","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3497917","2016-12-20 02:00:10","Reuters Key Development","GSK's Viiv announces positive results from initial HIV phase III studies","GSK"," GlaxoSmithKline"
"97","GlaxoSmithKline PLC (ADR) (GSK) Phase 3 Trials Looks Positive: Will Gilead ...","http://www.insidermonkey.com/blog/glaxosmithkline-plc-adr-gsk-phase-3-trials-looks-positive-will-gilead-sciences-inc-gild-endure-512585/","2016-12-21 13:22:30","Insider Monkey (blog)","Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.","GSK"," GlaxoSmithKline"
"98","Analysts Weigh in on: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2016/12/23/analysts-weigh-in-on-glaxosmithkline-plc-adr-nysegsk/","2016-12-23 08:41:15","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) soared 0.39% during previous trade, a total of 3.43M shares exchanged hands compared with its average trading volume of 4.53M shares whereas its relative volume is 1.10.","GSK"," GlaxoSmithKline"
"99","NeRRe, A GlaxoSmithKline PLC (ADR) (GSK) Spinout Raises £23 Million For NK ...","http://www.insidermonkey.com/blog/nerre-a-glaxosmithkline-plc-adr-gsk-spinout-raises-23-million-for-nk-antagonists-514967/","2017-01-06 10:56:15","Insider Monkey (blog)","NeRRe Therapeutics, which is a GlaxoSmithKline PLC (ADR) (NYSE:GSK) spinout, has raised £23 million ($28 million) in a Series B financing round.","GSK"," GlaxoSmithKline"
"100","Adaptimmune says confirms GSK nomination of second adaptimmune target under strategic multi-target collaboration","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3505807","2017-01-09 08:01:00","Reuters Key Development","Adaptimmune says confirms GSK nomination of second adaptimmune target under strategic multi-target collaboration","GSK"," GlaxoSmithKline"
"101","JD.Com Inc (ADR) (NASDAQ:JD) &amp; GlaxoSmithKline plc (ADR) (NYSE:GSK) News Recap","http://www.newsismoney.com/2017/01/10/jd-com-inc-adr-nasdaqjd-glaxosmithkline-plc-adr-nysegsk-news-recap/","2017-01-10 09:26:15","Money News","On Monday, Shares of JD.Com Inc (ADR) (NASDAQ:JD) lost -0.04% to $26.26. The share price is trading in a range of $26.14 - 26.95.","GSK"," GlaxoSmithKline"
"102","Notable Runners Biocept Inc (NASDAQ:BIOC), GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://wallstrt24.com/notable-runners-biocept-inc-nasdaqbioc-glaxosmithkline-plc-adr-nysegsk/2426309/","2017-01-13 09:48:45","Wall Street 24","Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) declined -0.10% to $39.01. Stock exchanged hands with the total volume of 4.24 Million shares, as contrast to its average volume of 3.88 Million shares.","GSK"," GlaxoSmithKline"
"103","GSK&#39;s pharmaceuticals president Abbas Hussain to leave in 2017","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3510711","2017-01-19 02:05:58","Reuters Key Development","GSK's pharmaceuticals president Abbas Hussain to leave in 2017","GSK"," GlaxoSmithKline"
"104","GlaxoSmithKline appoints Luke Miels President, Global Pharma","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3510721","2017-01-19 02:09:25","Reuters Key Development","GlaxoSmithKline appoints Luke Miels President, Global Pharma","GSK"," GlaxoSmithKline"
"105","Synergy Pharmaceuticals Inc (NASDAQ:SGYP) &amp; GlaxoSmithKline plc (ADR) (NYSE ...","http://www.newsismoney.com/2017/01/24/synergy-pharmaceuticals-inc-nasdaqsgyp-glaxosmithkline-plc-adr-nysegsk-worth-watching-stocks/","2017-01-24 08:18:45","Money News","On Monday, Shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) lost -2.54% to $5.76. The share price is trading in a range of $5.53 - 5.93.","GSK"," GlaxoSmithKline"
"106","Zacks Investment Research announced GlaxoSmithKline plc (ADR) (NYSE:GSK ...","http://breakingfinancenews.com/investing/zacks-investment-research-announced-glaxosmithkline-plc-adr-nysegsk-bumping-its-target-to-44-00-earlier-today/163312/","2017-01-25 10:45:00","Breaking Finance News","Boasting a price of $38.84, GlaxoSmithKline plc (ADR) (NYSE:GSK) traded 0.25% higher on the day. The last closing price is down -6.13% from the 200-day moving average, compared to the S&P 500 which has decreased -0.05% over the same time.","GSK"," GlaxoSmithKline"
"107","Analysts Rating Stocks Watch List: Endo International plc – Ordinary Shares ...","http://www.newsismoney.com/2017/01/26/analysts-rating-stocks-watch-list-endo-international-plc-ordinary-shares-nasdaqendp-glaxosmithkline-plc-adr-nysegsk/","2017-01-26 09:37:30","Money News","Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) inclined 0.39% to $38.88. The share price of the stock plunged -2.87% for the year.","GSK"," GlaxoSmithKline"
"108","EMA recommends approval of two biosimilars from Amgen","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3516643","2017-01-27 07:21:30","Reuters Key Development","EMA recommends approval of two biosimilars from Amgen","GSK"," GlaxoSmithKline"
"109","AES Corp (NYSE:AES) &amp; GlaxoSmithKline plc (ADR) (NYSE:GSK) News Buzz","http://www.newsismoney.com/2017/01/30/aes-corp-nyseaes-glaxosmithkline-plc-adr-nysegsk-news-buzz/","2017-01-30 09:26:15","Money News","Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) declined -0.23% to $38.73. The share price of the stock plunged -3.25% for the year.","GSK"," GlaxoSmithKline"
"110","Analysts Keeping an Eye on: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2017/02/01/analysts-keeping-an-eye-on-glaxosmithkline-plc-adr-nysegsk/","2017-02-01 08:41:15","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) soared 0.79% during previous trade, a total of 3.49M shares exchanged hands compared with its average trading volume of 3.42M shares whereas its relative volume is 0.88.","GSK"," GlaxoSmithKline"
"111","Advair, Armonair From Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA ...","https://marketexclusive.com/advair-armonair-teva-pharmaceutical-industries-ltd-adr-nyseteva-gets-approval-fda/70897/","2017-02-02 09:26:15","Market Exclusive","Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S.","GSK"," GlaxoSmithKline"
"112","Pernix Therapeutics provides update on arbitration","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3520428","2017-02-03 08:00:00","Reuters Key Development","Pernix Therapeutics provides update on arbitration","GSK"," GlaxoSmithKline"
"113","2 Notable Runners GlaxoSmithKline plc (ADR) (NYSE:GSK), Clorox Co (NYSE:CLX)","http://wallstrt24.com/2-notable-runners-glaxosmithkline-plc-adr-nysegsk-clorox-co-nyseclx/2428815/","2017-02-06 07:43:55","Wall Street 24","On Friday, GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened its trade at $39.29 and after floating in a range of $39.24 to $39.41, settled at $39.32.","GSK"," GlaxoSmithKline"
"114","Stock Price of GlaxoSmithKline PLC (GSK) Increases 1.52%","https://www.morningoutlook.com/02-06-2017/stock-price-of-glaxosmithkline-plc-gsk-increases-1-52/","2017-02-06 09:41:33","Morning Outlook","GlaxoSmithKline plc (ADR) Last issued its quarterly earnings results on Feb 3, 2016. The company reported $0.18 EPS for the quarter.","GSK"," GlaxoSmithKline"
"115","Pernix Therapeutics Holdings Inc (NASDAQ:PTX) Just Made Itself A Lot More ...","https://www.insiderfinancial.com/pernix-therapeutics-holdings-inc-nasdaqptx-just-made-itself-a-lot-more-attractive-as-a-buyout-target/119438/","2017-02-07 01:55:11","Insider Financial","Anyway, Pernix has been in a long standing legal dispute with biotech giant GlaxoSmithKline plc (ADR) (NYSE:GSK) over Treximet.","GSK"," GlaxoSmithKline"
"116","The FDA Accepts Keytruda From Merck &amp; Co., Inc. (NYSE:MRK) For Bladder Cancer","https://marketexclusive.com/fda-accepts-keytruda-merck-co-inc-nysemrk-bladder-cancer/71240/","2017-02-07 09:48:45","Market Exclusive","In doing this, the company has gone a step further to establish collaborations with the likes of Amgen, Inc.(NASDAQ:AMGN), GlaxoSmithKline plc (ADR)(NYSE:GSK), and Pfizer Inc.(NYSE:PFE). Meanwhile, Merck's stock closed at $64.94 an increase of $0.65 ...","GSK"," GlaxoSmithKline"
"117","Earnings Scheduled For February 8, 2017","https://www.benzinga.com/news/earnings/17/02/9009954/earnings-scheduled-for-february-8-2017","2017-02-08 04:41:34","Benzinga","GlaxoSmithKline plc (ADR) (NYSE: GSK) is projected to report its quarterly earnings at $0.63 per share on revenue of $9.26 billion.","GSK"," GlaxoSmithKline"
"118","GSK says launched flonase sensimist allergy relief nationwide","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3522863","2017-02-08 07:00:00","Reuters Key Development","GSK says launched flonase sensimist allergy relief nationwide","GSK"," GlaxoSmithKline"
"119","New GSK CEO likely to give strategy update in H2 2017","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3522879","2017-02-08 07:45:00","Reuters Key Development","New GSK CEO likely to give strategy update in H2 2017","GSK"," GlaxoSmithKline"
"120","Analysts Rating Stocks Update: Visa Inc (NYSE:V) &amp; GlaxoSmithKline plc (ADR ...","http://www.newsismoney.com/2017/02/09/analysts-rating-stocks-update-visa-inc-nysev-glaxosmithkline-plc-adr-nysegsk/","2017-02-09 09:48:45","Money News","Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) inclined 0.73% to $39.75. The share price of the stock plunged -2.48% for the year.","GSK"," GlaxoSmithKline"
"121","2 Stocks in Focus Glu Mobile Inc. (NASDAQ:GLUU), GlaxoSmithKline plc (ADR ...","http://wsbreakingnews.com/2-stocks-in-focus-glu-mobile-inc-nasdaqgluu-glaxosmithkline-plc-adr-nysegsk/5256085/","2017-02-10 08:52:30","Financial Breaking News","On Thursday, Glu Mobile Inc. (NASDAQ:GLUU) stock opened its trade at $2.25 and after floating in a range of $2.06 to $2.26, settled at $2.18.","GSK"," GlaxoSmithKline"
"122","Stock Price of GlaxoSmithKline PLC (GSK) Increases 2.44%","https://www.morningoutlook.com/02-13-2017/stock-price-of-glaxosmithkline-plc-gsk-increases-2-44/","2017-02-13 03:38:24","Morning Outlook","GlaxoSmithKline plc (ADR) Last issued its quarterly earnings results on Feb 3, 2016. The company reported $0.18 EPS for the quarter.","GSK"," GlaxoSmithKline"
"123","Today&#39;s Watch List: Nokia Corporation (ADR) (NYSE:NOK), Gilead Sciences Inc ...","http://www.benchmarkmonitor.com/2017/02/13/todays-watch-list-nokia-corporation-adr-nysenok-gilead-sciences-inc-nasdaqgild/","2017-02-13 05:41:15","Benchmark Monitor","Gilead Sciences Inc. (NASDAQ:GILD) will face off against GlaxoSmithKline PLC (GSK) next week when companies reveal dueling clinical results of their competing HIV drugs at an HIV conference in Seattle, Washington.","GSK"," GlaxoSmithKline"
"124","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3526432","2017-02-13 18:55:53","Reuters Key Development","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","GSK"," GlaxoSmithKline"
"125","GSK announces positive final stage results for two-drug HIV treatment","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3526688","2017-02-14 02:00:05","Reuters Key Development","GSK announces positive final stage results for two-drug HIV treatment","GSK"," GlaxoSmithKline"
"126","GlaxoSmithKline plc (ADR)(NYSE:GSK) Two-Drug Cocktail Aims Decrease HIV ...","https://marketexclusive.com/glaxosmithkline-plc-adrnysegsk-two-drug-cocktail-aims-decrease-hiv-patient-pill-intake/72056/","2017-02-14 07:00:54","Market Exclusive","Data from a Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle revealed that 95% of patients who switched over to the new cocktail had their virus restrained to unnoticeable levels.","GSK"," GlaxoSmithKline"
"127","Novartis AG (NYSE:NVS) Greater Use Of Technology In Transforming Medical Education","https://marketexclusive.com/glaxosmithkline-plc-nysegsks-two-drug-cocktail-aim-reduce-number-pills-hiv-patients-take-daily/72033/","2017-02-14 07:11:15","Market Exclusive","Many pharmaceutical companies have been seeking to change their methods of reaching healthcare professionals with the likes of GlaxoSmithKline plc (ADR)(NYSE:GSK) and Pfizer Inc. (NYSE:PFE) engaging in webinars. However, Novartis has chosen to ...","GSK"," GlaxoSmithKline"
"128","Bank of America ML Didn&#39;t Change HIV Estimates for GlaxoSmithKline plc (ADR) (GSK)","http://smartstocknews.com/37721-bank-of-america-ml-didnt-change-hiv-estimates-for-glaxosmithkline-plc-adr-gsk/","2017-02-14 12:24:19","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Gilead reported PII data for bictegravir (potential competitor to GlaxoSmithKline plc's (ADR) (NYSE:GSK) integrase inhibitor Tivicay), at the CROI HIV conference, that, as expected shows similarly strong efficacy to GlaxoSmithKline plc's (ADR) (NYSE ...","GSK"," GlaxoSmithKline"
"129","Tuesday&#39;s Vital Data: Tesla Inc (TSLA), Gilead Sciences, Inc. (GILD) and ...","http://www.nasdaq.com/article/tuesdays-vital-data-tesla-inc-tsla-gilead-sciences-inc-gild-and-microsoft-corporation-msft-cm747856","2017-02-14 14:20:22","Nasdaq","The company said that its HIV treatment, Bictegravir, delivered 97% virus suppression, which is just as effective as the leading HIV treatment made by GlaxoSmithKline Plc (ADR) (NYSE: GSK ). Furthermore, there were no cases of emerging resistance and ...","GSK"," GlaxoSmithKline"
"130","Dysfunction, Heartbreak And Love: 11 Most Interesting Corporate Couples","https://www.benzinga.com/news/17/02/9047553/dysfunction-heartbreak-and-love-11-most-interesting-corporate-couples","2017-02-14 17:30:00","Benzinga","Back in 2000, Glaxo Wellcome PLC and SmithKline Beecham sealed the $75.7 billion deal and, as a team, took the name GlaxoSmithKline plc (ADR) (NYSE: GSK). Their union followed a brief period of tension - what was described as a “bitter power ...","GSK"," GlaxoSmithKline"
"131","Scorpio Tankers Inc. (NYSE:STNG) &amp; GlaxoSmithKline plc (ADR) (NYSE:GSK) Stocks ...","http://www.journalfinance.net/2017/02/scorpio-tankers-inc-nysestng-glaxosmithkline-plc-adr-nysegsk-stocks-buzz/","2017-02-16 08:46:05","Daily News Journal (press release)","The stock appeared -29.13% below its 52-week highs and is up 13.66% for the last five trades. Shares of GlaxoSmithKline plc (ADR) (NYSE:GSK) inclined 1.15% to $40.57. The share price of the stock surged 2.04% for the year. Analysts give GSK a mean ...","GSK"," GlaxoSmithKline"
"132","European ADRs Edge Higher as Pharma Stocks See Mixed Fortunes","http://www.nasdaq.com/article/european-adrs-edge-higher-as-pharma-stocks-see-mixed-fortunes-cm748943","2017-02-16 10:55:28","Nasdaq","American depository receipts of European stocks were 0.3% higher at 125.07 on the Bank of New York Mellon Europe ADR Index on Thursday morning.","GSK"," GlaxoSmithKline"
"133","Dividend Growth of GlaxoSmithKline PLC(GSK)","http://www.tradecalls.org/2017-02-17-dividend-growth-of-glaxosmithkline-plcgsk","2017-02-17 04:33:45","Trade Calls","Currently the company Insiders own 10% of GlaxoSmithKline PLC shares according to the proxy statements. Institutional Investors own 8.41% of GlaxoSmithKline PLC shares.","GSK"," GlaxoSmithKline"
"134","10 High-Dividend Bank Stocks to Invest Into in 2017","https://www.incomeinvestors.com/10-high-dividend-bank-stocks-to-invest-into-in-2017/14865/","2017-02-17 10:56:38","Income Investors","Greenhill sees a lot of repeat business from companies that are considered global players, such as GlaxoSmithKline plc (ADR) (NYSE:GSK) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). There is no company that accounts for more than 10% ...","GSK"," GlaxoSmithKline"
"135","Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is Turning Around","http://investorplace.com/2017/02/teva-pharmaceutical-industries-ltd-adr-teva-turning-around/","2017-02-17 11:18:45","Investorplace.com","TEVA also announced that it has two new asthma drugs on the market that will be direct competitors to GlaxoSmithKline plc (ADR)'s (NYSE:GSK) Advair. According to Fierce Biotech, Advair is a blockbuster, bringing in more than $2.3 billion in sales for 2016.","GSK"," GlaxoSmithKline"
"136","2 Stocks to Watch For GlaxoSmithKline plc (ADR) (NYSE:GSK), Community Health ...","http://www.journalfinance.net/2017/02/2-stocks-to-watch-for-glaxosmithkline-plc-adr-nysegsk-community-health-systems-nysecyh/","2017-02-20 10:15:36","Daily News Journal (press release)","On Friday, GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened its trade at $41.02 and after floating in a range of $40.88 to $41.34, settled at $41.34.","GSK"," GlaxoSmithKline"
"137","Large Outflow of Money Witnessed in GlaxoSmithKline PLC","http://www.moneyflowtrends.com/2017-02-22-large-outflow-of-money-witnessed-in-glaxosmithkline-plc","2017-02-22 08:19:28","Money Flow Index & Trends","GlaxoSmithKline plc (ADR) Last issued its quarterly earnings results on Feb 3, 2016. The company reported $0.18 EPS for the quarter.","GSK"," GlaxoSmithKline"
"138","Insights On Trending Stocks – GlaxoSmithKline plc (ADR) (NYSE:GSK), Level 3 ...","http://www.wallstreetnews24.com/insights-on-trending-stocks-glaxosmithkline-plc-adr-nysegsk-level-3-communications-inc-nyselvlt/","2017-02-22 09:22:40","Wall Street Times (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) traded at a yearly high level of $45.58 during the last trading session. The last session's volume of 5.97 million shares was higher than its average volume of 3.71 million shares.","GSK"," GlaxoSmithKline"
"139","Analyst Reviews on Overbuying: GlaxoSmithKline plc (ADR) (NYSE:GSK)","http://postregistrar.com/2017/02/22/analyst-reviews-on-overbuying-glaxosmithkline-plc-adr-nysegsk/","2017-02-22 09:48:45","Post Registrar","GlaxoSmithKline plc (ADR) (NYSE:GSK) share price plunged -0.02% or -0.01 points to reach at $41.63 during previous trading session.","GSK"," GlaxoSmithKline"
"140","GSK reports positive results in study for controlled asthma","http://www.reuters.com/finance/stocks/GSK/key-developments/article/3533893","2017-02-23 04:46:39","Reuters Key Development","GSK reports positive results in study for controlled asthma","GSK"," GlaxoSmithKline"
"141","Active Stock News – GlaxoSmithKline plc (ADR) (NYSE:GSK), Michael Kors ...","http://www.wallstreetnews24.com/active-stock-news-glaxosmithkline-plc-adr-nysegsk-michael-kors-holdings-ltd-nysekors/","2017-02-23 06:50:30","Wall Street Times (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) traded at a yearly high level of $45.58 during the last trading session. The last session's volume of 3.78 million shares was lower than its average volume of 3.82 million shares.","GSK"," GlaxoSmithKline"
"142","ArcelorMittal (NYSE:MT) and Votorantim to merge their long steel operations in ...","http://www.benchmarkmonitor.com/2017/02/24/arcelormittal-nysemt-and-votorantim-to-merge-their-long-steel-operations-in-brazil/","2017-02-24 09:15:00","Benchmark Monitor","ArcelorMittal SA (ADR) (NYSE:MT) and Votorantim SA said on Thursday they will merge their long steel operations in Brazil, creating a company with a combined production capacity of 5.4 million tonnes of rolled steel per year.","GSK"," GlaxoSmithKline"
"143","Cloud Peak Energy Inc. (NYSE:CLD) &amp; GlaxoSmithKline plc (ADR) (NYSE:GSK) Worth ...","http://www.journalfinance.net/2017/02/cloud-peak-energy-inc-nysecld-glaxosmithkline-plc-adr-nysegsk-worth-watching-stocks/","2017-02-24 10:00:00","Daily News Journal (press release)","On Thursday, Shares of Cloud Peak Energy Inc. (NYSE:CLD) lost -9.68% to $5.13. The share price is trading in a range of $5.04 - 5.40.","GSK"," GlaxoSmithKline"
"144","What The Latest Ruling Means For Pernix Therapeutics Holdings Inc (NASDAQ:PTX)","https://www.insiderfinancial.com/what-the-latest-ruling-means-for-pernix-therapeutics-holdings-inc-nasdaqptx/119770/","2017-02-24 13:45:00","Insider Financial","The driver behind our turning our attention to Pernix was a then just-reported litigation outcome, detailing the conclusion of a long standing dispute between Pernix and big pharma incumbent, GlaxoSmithKline plc (ADR) (NYSE:GSK) over a drug called ...","GSK"," GlaxoSmithKline"
"145","Hot Action in 2 Stocks – GlaxoSmithKline plc (ADR) (NYSE:GSK), Alexion ...","http://www.wallstreetnews24.com/hot-action-in-2-stocks-glaxosmithkline-plc-adr-nysegsk-alexion-pharmaceuticals-inc-nasdaqalxn/","2017-02-27 10:22:30","Wall Street Times (press release)","GlaxoSmithKline plc (ADR) (NYSE:GSK) traded at a yearly high level of $45.58 during the last trading session. The last session's volume of 3.20 million shares was lower than its average volume of 3.73 million shares.","GSK"," GlaxoSmithKline"
"146","AstraZeneca PLC announces acquisition of rights to Actavis PLC portfolio","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3164962","2015-03-03 02:05:00","Reuters Key Development","AstraZeneca PLC announces acquisition of rights to Actavis PLC portfolio","AZN","AstraZeneca"
"147","AstraZeneca PLC gives FY 2015 guidance","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3198728","2015-03-06 01:00:00","Reuters Key Development","AstraZeneca PLC gives FY 2015 guidance","AZN","AstraZeneca"
"148","AstraZeneca PLC announces BRILINTA PEGASUS-TIMI 54 STUDY","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3172654","2015-03-16 03:00:00","Reuters Key Development","AstraZeneca PLC announces BRILINTA PEGASUS-TIMI 54 STUDY","AZN","AstraZeneca"
"149","AstraZeneca PLC announces positive phase III results for PT003 in COPD","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3174553","2015-03-18 03:14:00","Reuters Key Development","AstraZeneca PLC announces positive phase III results for PT003 in COPD","AZN","AstraZeneca"
"150","AstraZeneca PLC announces collaboration with Daiichi Sankyo Inc","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3175445","2015-03-19 03:01:00","Reuters Key Development","AstraZeneca PLC announces collaboration with Daiichi Sankyo Inc","AZN","AstraZeneca"
"151","PatientsLikeMe and AstraZeneca PLC announces global research collaboration","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3191207","2015-04-13 08:00:00","Reuters Key Development","PatientsLikeMe and AstraZeneca PLC announces global research collaboration","AZN","AstraZeneca"
"152","AstraZeneca PLC announces tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3192426","2015-04-15 02:02:00","Reuters Key Development","AstraZeneca PLC announces tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma","AZN","AstraZeneca"
"153","AstraZeneca PLC&#39;s Medimmune and Immunocore announces new collaboration to conduct immuno-oncology combination trials in melanoma","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3193219","2015-04-16 02:02:00","Reuters Key Development","AstraZeneca PLC's Medimmune and Immunocore announces new collaboration to conduct immuno-oncology combination trials in melanoma","AZN","AstraZeneca"
"154","AstraZeneca PLC announces selumetinib granted orphan drug designation by FDA","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3194031","2015-04-17 02:00:00","Reuters Key Development","AstraZeneca PLC announces selumetinib granted orphan drug designation by FDA","AZN","AstraZeneca"
"155","Bina Technologies and AstraZeneca announce collaborative agreement for global deployment of Bina&#39;s genomic management solution","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3196182","2015-04-21 07:00:00","Reuters Key Development","Bina Technologies and AstraZeneca announce collaborative agreement for global deployment of Bina's genomic management solution","AZN","AstraZeneca"
"156","AstraZeneca PLC and Innate to collaborate in immuno-oncology","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3198703","2015-04-24 02:00:00","Reuters Key Development","AstraZeneca PLC and Innate to collaborate in immuno-oncology","AZN","AstraZeneca"
"157","AstraZeneca PLC reaffirms FY 2015 guidance","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3198735","2015-04-24 02:00:00","Reuters Key Development","AstraZeneca PLC reaffirms FY 2015 guidance","AZN","AstraZeneca"
"158","AstraZeneca PLC announces positive phase III results for two antibiotics, zinforo and investigational ceftazidime-avibactam","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3200305","2015-04-27 05:00:00","Reuters Key Development","AstraZeneca PLC announces positive phase III results for two antibiotics, zinforo and investigational ceftazidime-avibactam","AZN","AstraZeneca"
"159","AstraZeneca to invest in biologics manufacturing facility in Sweden","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3214330","2015-05-18 04:30:00","Reuters Key Development","AstraZeneca to invest in biologics manufacturing facility in Sweden","AZN","AstraZeneca"
"160","AstraZeneca to collaborate with Lilly on solid tumours clinical trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3221371","2015-05-29 02:00:00","Reuters Key Development","AstraZeneca to collaborate with Lilly on solid tumours clinical trial","AZN","AstraZeneca"
"161","AstraZeneca PLC announces phase III results for lesinurad in combination with febuxostat in tophaceous gout patients","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3228953","2015-06-13 09:00:00","Reuters Key Development","AstraZeneca PLC announces phase III results for lesinurad in combination with febuxostat in tophaceous gout patients","AZN","AstraZeneca"
"162","AstraZeneca to collaborate with the University of Michigan","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3230442","2015-06-17 02:02:00","Reuters Key Development","AstraZeneca to collaborate with the University of Michigan","AZN","AstraZeneca"
"163","Clearance of Innate Pharma co-development with AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3241014","2015-07-07 01:04:00","Reuters Key Development","Clearance of Innate Pharma co-development with AstraZeneca","AZN","AstraZeneca"
"164","AstraZeneca PLC not importing enough of diabetes drug: Lee Pharma - Business Standard","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3242172","2015-07-07 20:00:00","Reuters Key Development","AstraZeneca PLC not importing enough of diabetes drug: Lee Pharma - Business Standard","AZN","AstraZeneca"
"165","AstraZeneca gets US FDA approval for IRESSA (gefitinib) tablets","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3243762","2015-07-13 14:27:00","Reuters Key Development","AstraZeneca gets US FDA approval for IRESSA (gefitinib) tablets","AZN","AstraZeneca"
"166","AstraZeneca PLC enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3245602","2015-07-16 02:05:00","Reuters Key Development","AstraZeneca PLC enters option agreement with Kyowa Hakko Kirin for commercialisation of benralizumab in Japan","AZN","AstraZeneca"
"167","Astrazeneca PLC AZ completes agreement with Tillotts for Entocort","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3246330","2015-07-17 02:05:00","Reuters Key Development","Astrazeneca PLC AZ completes agreement with Tillotts for Entocort","AZN","AstraZeneca"
"168","AstraZeneca PLC recommends an unchanged first interim dividend of $0.90","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3252843","2015-07-30 02:03:00","Reuters Key Development","AstraZeneca PLC recommends an unchanged first interim dividend of $0.90","AZN","AstraZeneca"
"169","Isis Pharmaceuticals Inc and AstraZeneca to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3254727","2015-08-03 02:00:00","Reuters Key Development","Isis Pharmaceuticals Inc and AstraZeneca to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases","AZN","AstraZeneca"
"170","AstraZeneca Plc&#39;s Medimmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3256450","2015-08-05 02:03:00","Reuters Key Development","AstraZeneca Plc's Medimmune and Mirati Therapeutics partner on immuno-oncology combination in lung cancer","AZN","AstraZeneca"
"171","AstraZeneca Plc&#39;s Medimmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3258934","2015-08-10 03:01:00","Reuters Key Development","AstraZeneca Plc's Medimmune enters into strategic cancer vaccine collaboration and license agreement with Inovio Pharmaceuticals","AZN","AstraZeneca"
"172","AstraZeneca PLC and Valeant to partner on brodalumab","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3268280","2015-09-01 02:04:00","Reuters Key Development","AstraZeneca PLC and Valeant to partner on brodalumab","AZN","AstraZeneca"
"173","AstraZeneca enters license agreement with Daiichi Sankyo","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3269173","2015-09-02 03:10:00","Reuters Key Development","AstraZeneca enters license agreement with Daiichi Sankyo","AZN","AstraZeneca"
"174","AstraZeneca PLC US FDA approves expanded indication for brilinta","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3269828","2015-09-04 03:00:00","Reuters Key Development","AstraZeneca PLC US FDA approves expanded indication for brilinta","AZN","AstraZeneca"
"175","AstraZeneca to invest in oncology bioinformatics collaboration-Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3270721","2015-09-08 02:28:00","Reuters Key Development","AstraZeneca to invest in oncology bioinformatics collaboration-Reuters","AZN","AstraZeneca"
"176","AstraZeneca buys manufacturing facility in U.S. from Amgen-Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3272378","2015-09-11 02:04:00","Reuters Key Development","AstraZeneca buys manufacturing facility in U.S. from Amgen-Reuters","AZN","AstraZeneca"
"177","AstraZeneca PLC diabetes drug combination faces delay after FDA rebuff - Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3287427","2015-10-15 20:00:00","Reuters Key Development","AstraZeneca PLC diabetes drug combination faces delay after FDA rebuff - Reuters","AZN","AstraZeneca"
"178","AstraZeneca PLC opens new $224 mln drug factory in Russia - Reuters","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3287484","2015-10-19 20:00:00","Reuters Key Development","AstraZeneca PLC opens new $224 mln drug factory in Russia - Reuters","AZN","AstraZeneca"
"179","Igenica Biotherapeutics enters into a strategic oncology research agreement with AstraZeneca PLC&#39;s MedImmune","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3291764","2015-10-28 08:30:00","Reuters Key Development","Igenica Biotherapeutics enters into a strategic oncology research agreement with AstraZeneca PLC's MedImmune","AZN","AstraZeneca"
"180","AstraZeneca PLC presents positive update on Lesinurad Renal Data in Gout Patients","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3297663","2015-11-09 08:00:00","Reuters Key Development","AstraZeneca PLC presents positive update on Lesinurad Renal Data in Gout Patients","AZN","AstraZeneca"
"181","Celgene in Collaboration with AstraZeneca Announce Initiation of Fusion Clinical Development Program in Immuno-Oncology","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3307881","2015-12-07 07:30:00","Reuters Key Development","Celgene in Collaboration with AstraZeneca Announce Initiation of Fusion Clinical Development Program in Immuno-Oncology","AZN","AstraZeneca"
"182","AstraZeneca PLC completes acquisition of ZS Pharma","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3314152","2015-12-16 19:00:00","Reuters Key Development","AstraZeneca PLC completes acquisition of ZS Pharma","AZN","AstraZeneca"
"183","AstraZeneca PLC and Moderna Therapeutics announce new collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics(tm)","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3319162","2016-01-11 06:59:00","Reuters Key Development","AstraZeneca PLC and Moderna Therapeutics announce new collaboration to Co-Develop and Co-Commercialize Immuno-Oncology mRNA Therapeutics(tm)","AZN","AstraZeneca"
"184","Incyte Corp and AstraZeneca Inc announce new lung cancer clinical trial collaboration","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3319165","2016-01-11 07:00:00","Reuters Key Development","Incyte Corp and AstraZeneca Inc announce new lung cancer clinical trial collaboration","AZN","AstraZeneca"
"185","AstraZeneca says US FDA grants Lynparza BTD for prostate cancer<U+200D><U+200B>","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3325224","2016-01-28 02:03:00","Reuters Key Development","AstraZeneca says US FDA grants Lynparza BTD for prostate cancer<U+200D><U+200B>","AZN","AstraZeneca"
"186","AstraZeneca PLC says Zurampic approved in EU for gout patients","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3333082","2016-02-19 02:00:00","Reuters Key Development","AstraZeneca PLC says Zurampic approved in EU for gout patients","AZN","AstraZeneca"
"187","AstraZeneca enters licensing deal with China Medical System","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3336612","2016-02-29 02:59:00","Reuters Key Development","AstraZeneca enters licensing deal with China Medical System","AZN","AstraZeneca"
"188","AstraZeneca to sell rights for constipation drug in Europe","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3337216","2016-02-29 19:00:00","Reuters Key Development","AstraZeneca to sell rights for constipation drug in Europe","AZN","AstraZeneca"
"189","AstraZeneca says FDA approves new indication for FASLODEX","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3338283","2016-03-02 18:57:00","Reuters Key Development","AstraZeneca says FDA approves new indication for FASLODEX","AZN","AstraZeneca"
"190","AstraZeneca acquires rights to Orexo OX-CLI project","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3344365","2016-03-17 03:00:00","Reuters Key Development","AstraZeneca acquires rights to Orexo OX-CLI project","AZN","AstraZeneca"
"191","AstraZeneca says launches and prices 2.2 bln euro of bonds","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3369333","2016-05-09 12:35:02","Reuters Key Development","AstraZeneca says launches and prices 2.2 bln euro of bonds","AZN","AstraZeneca"
"192","Weekly Biotech Report Part I – FDA To Decide On AstraZeneca plc (ADR) (NYSE ...","http://marketexclusive.com/weekly-biotech-report-part-astrazeneca-plc-adr-nyseazn-zs-9/6758/","2016-05-16 09:23:11","Market Exclusive","On May 26th, the FDA will issue its final decision on AstraZeneca PLC (ADR) (NYSE:AZN) drug ZS-9 for hyperkalemia, a condition that is caused by too much potassium in blood serum.","AZN","AstraZeneca"
"193","AstraZeneca receives complete response letter from U.S. FDA for sodium zirconium cyclosilicate","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3382659","2016-05-27 02:00:47","Reuters Key Development","AstraZeneca receives complete response letter from U.S. FDA for sodium zirconium cyclosilicate","AZN","AstraZeneca"
"194","AstraZeneca announces positive results in breast cancer trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3382656","2016-05-27 02:03:02","Reuters Key Development","AstraZeneca announces positive results in breast cancer trial","AZN","AstraZeneca"
"195","EU health agency recommends approval of new hepatitis C drugs","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3382994","2016-05-27 07:21:42","Reuters Key Development","EU health agency recommends approval of new hepatitis C drugs","AZN","AstraZeneca"
"196","Adherium says Astrazeneca will use its Smartinhaler platform in US clinical study&lt;ADR.AX&gt;&lt;AZN.L&gt;","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3390450","2016-06-13 18:16:55","Reuters Key Development","Adherium says Astrazeneca will use its Smartinhaler platform in US clinical study<ADR.AX><AZN.L>","AZN","AstraZeneca"
"197","AstraZeneca confirms CDC interim recommendation on flu vaccine","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3394966","2016-06-23 02:00:08","Reuters Key Development","AstraZeneca confirms CDC interim recommendation on flu vaccine","AZN","AstraZeneca"
"198","AstraZeneca says life sciences competitivess, drug access key after Brexit","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3395524","2016-06-24 02:00:06","Reuters Key Development","AstraZeneca says life sciences competitivess, drug access key after Brexit","AZN","AstraZeneca"
"199","Can Orphan Drug Act Ameliorate AstraZeneca plc (ADR) to Protect Crestor Patent","http://www.businessfinancenews.com/29464-can-orphan-drug-act-ameliorate-astrazeneca-plc-adr-to-protect-crestor-paten/","2016-06-28 11:45:00","Business Finance News","AstraZeneca plc (NYSE:AZN) is of the opinion that Food and Drug Administration (FDA) is to hold up the approval of Crestor's generics till 2023.","AZN","AstraZeneca"
"200","U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3397191","2016-06-28 13:57:18","Reuters Key Development","U.S. FDA says continues to find benefits of flumist quadrivalent outweigh any potential risks","AZN","AstraZeneca"
"201","Valeant Pharmaceuticals announces new licensing arrangement for Brodalumab in Europe","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3399039","2016-07-01 02:00:00","Reuters Key Development","Valeant Pharmaceuticals announces new licensing arrangement for Brodalumab in Europe","AZN","AstraZeneca"
"202","AstraZeneca plc (ADR) and Valeant Pharmaceuticals Intl Inc (VRX) Ended ...","http://www.businessfinancenews.com/29494-astrazeneca-plc-adr-and-valeant-pharmaceuticals-intl-inc-ended-dermatology/","2016-07-01 09:57:20","Business Finance News","AstraZeneca plc (NYSE:AZN) has sacked its brodalumab's European license from Valeant Pharmaceuticals International Inc. (NYSE:VRX) for the development and commercialization of the drug.","AZN","AstraZeneca"
"203","Fibrogen announces receipt of $62 million license payment from Astrazeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3402497","2016-07-08 04:00:00","Reuters Key Development","Fibrogen announces receipt of $62 million license payment from Astrazeneca","AZN","AstraZeneca"
"204","AstraZeneca plc (ADR) Hits the Right Spot, At the Right Time","http://www.businessfinancenews.com/29536-astrazeneca-plc-adr-hits-the-right-spot-at-the-right-time/","2016-07-08 11:33:45","Business Finance News","AstraZeneca plc (NYSE:AZN) and FibroGen, Inc. (NASDAQ:FGEN) have extended their mutual 2013 collaboration deal for the development and commercialization of their investigational molecule roxadustat (FG-4592) in the US and certain other territories for ...","AZN","AstraZeneca"
"205","Astrazeneca&#39;s lung cancer drug meets primary endpoint in late-stage trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3406735","2016-07-18 02:00:08","Reuters Key Development","Astrazeneca's lung cancer drug meets primary endpoint in late-stage trial","AZN","AstraZeneca"
"206","AstraZeneca says new diabetes treatment gets European approval","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3407752","2016-07-19 09:15:02","Reuters Key Development","AstraZeneca says new diabetes treatment gets European approval","AZN","AstraZeneca"
"207","AstraZeneca plc Lost the Battle, What&#39;s Next!","http://www.businessfinancenews.com/29622-astrazeneca-plc-adr-lost-the-battle-whats-next/","2016-07-21 12:53:06","Business Finance News","AstraZeneca plc (NYSE:AZN) has failed to get an extension in Crestor's patent case after a federal judge's decision surfaced, who denied the company's bid for a restraining order.","AZN","AstraZeneca"
"208","Astrazeneca and Moderna files first clinical trial application in RNA therapeutics","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3411568","2016-07-26 07:00:00","Reuters Key Development","Astrazeneca and Moderna files first clinical trial application in RNA therapeutics","AZN","AstraZeneca"
"209","Can Novartis AG Acquire AstraZeneca plc?","http://www.bidnessetc.com/71816-novartis-ag-acquire-astrazeneca/","2016-07-29 09:30:56","Bidness ETC","AstraZeneca plc (ADR) (NYSE:AZN) shares spiked up in Thursday's trade after market buzzed with speculation that the UK-based pharma giant may attract takeover interest from the Swiss company, Novartis AG.","AZN","AstraZeneca"
"210","Hutchison China, AstraZeneca amend savolitinib co-development agreement","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3415923","2016-08-01 02:21:58","Reuters Key Development","Hutchison China, AstraZeneca amend savolitinib co-development agreement","AZN","AstraZeneca"
"211","AstraZeneca plc (ADR): What Are the Future Prospects?","http://www.businessfinancenews.com/29703-astrazeneca-plc-adr-what-are-the-future-prospects/","2016-08-01 06:07:30","Business Finance News","AstraZeneca plc (NYSE:AZN) CEO Pascal Soriot recently mentioned that the company plans to boost sales to $41 billion by calendar year 2023 (CY23).","AZN","AstraZeneca"
"212","AstraZeneca says increased Moderna stake to 9 pct","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3423432","2016-08-10 09:41:39","Reuters Key Development","AstraZeneca says increased Moderna stake to 9 pct","AZN","AstraZeneca"
"213","AstraZeneca plc (ADR) Stock Open to Further Upside; Here&#39;s Why","http://www.bidnessetc.com/72232-astrazeneca-stock-further-upside/","2016-08-13 10:01:18","Bidness ETC","AstraZeneca plc (ADR) (NYSE:AZN) has surged over 35% on the London stock exchange since mid-June, despite being expected to have a disappointing year due to patent expirations of some best-selling drugs.","AZN","AstraZeneca"
"214","AstraZeneca plc (ADR) (AZN) Got Breakthrough In The UK Market","http://www.thecountrycaller.com/37057-astrazeneca-plc-adr-azn-got-breakthrough-in-the-uk-market","2016-08-15 07:37:30","TCC","AstraZeneca plc (ADR) (NYSE:AZN) has huge expectations with its blood thinner drug Brilinta (ticagrelor) to generate revenue in the years to come.","AZN","AstraZeneca"
"215","Adherium to provide Smartinhalers to Astrazeneca Australia","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3427269","2016-08-16 07:00:00","Reuters Key Development","Adherium to provide Smartinhalers to Astrazeneca Australia","AZN","AstraZeneca"
"216","AstraZeneca plc (ADR) (NYSE:AZN) Cope with the Future Challenges?","http://www.thecountrycaller.com/52950-will-astrazeneca-plc-adr-anz-cope-with-the-future-challenges","2016-08-16 08:33:45","TCC","AstraZeneca's plc (ADR) (NYSE:AZN) is increasing its pace on multiple aspects to enhance its revenue in order to compete with the launching of generics and biosimilars in different therapeutic markets.","AZN","AstraZeneca"
"217","Lilly and Astrazeneca receive FDA fast track designation for AZD3293","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3430135","2016-08-22 06:00:00","Reuters Key Development","Lilly and Astrazeneca receive FDA fast track designation for AZD3293","AZN","AstraZeneca"
"218","AstraZeneca, Lilly receive FDA fast track designation for AZD3293","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3430162","2016-08-22 06:03:51","Reuters Key Development","AstraZeneca, Lilly receive FDA fast track designation for AZD3293","AZN","AstraZeneca"
"219","PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)&#39;s Antibiotic Business","http://investorplace.com/2016/08/pfizer-astrazeneca-antibiotic-pfe-azn/","2016-08-24 10:37:30","Investorplace.com","Pfizer Inc. (NYSE:PFE) has announced that it will be acquiring part of AstraZeneca plc (ADR)'s (NYSE:AZN) antibiotic business.","AZN","AstraZeneca"
"220","Will AstraZeneca plc (ADR) Survive Crestor Patent Expiration?","http://www.bidnessetc.com/72678-astrazeneca-survive-crestor-patent-expiration/","2016-08-26 14:36:51","Bidness ETC","AstraZeneca plc (ADR) (NYSE:AZN) is facing revenue decline as the patent for its blockbuster drug Crestor expired last month.","AZN","AstraZeneca"
"221","AstraZeneca plc (ADR) (AZN) Stock Upgraded to Buy: Argus","http://www.thecountrycaller.com/50479-astrazeneca-plc-adr-azn-stock-upgraded-to-buy-argus","2016-08-29 13:26:15","TCC","Biopharmaceutical company AstraZeneca plc (ADR) (NYSE:AZN) stock rating has been upgraded from Hold to Buy, along with a Price Target of $38.00, by sell side firm Argus.","AZN","AstraZeneca"
"222","AstraZeneca announces results from SYMBICORT study","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3435716","2016-08-31 17:00:00","Reuters Key Development","AstraZeneca announces results from SYMBICORT study","AZN","AstraZeneca"
"223","Astrazeneca completes Aspen agreement","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3435911","2016-09-01 02:00:10","Reuters Key Development","Astrazeneca completes Aspen agreement","AZN","AstraZeneca"
"224","Aspen Pharmacare to buy exclusive rights to commercialise AstraZeneca&#39;s anaesthetics portfolio","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3435884","2016-09-01 02:00:46","Reuters Key Development","Aspen Pharmacare to buy exclusive rights to commercialise AstraZeneca's anaesthetics portfolio","AZN","AstraZeneca"
"225","Astrazeneca says asthma drug shows positive results in phase III trials","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3437011","2016-09-05 01:05:13","Reuters Key Development","Astrazeneca says asthma drug shows positive results in phase III trials","AZN","AstraZeneca"
"226","AstraZeneca plc (ADR): Why the Future Is Promising","http://www.bidnessetc.com/72970-astrazeneca-future-promising/","2016-09-09 12:30:00","Bidness ETC","AstraZeneca plc (ADR) (NYSE:AZN) has been facing a revenue decline after losing patent protection on its blockbuster drugs, Nexium and Crestor, recently.","AZN","AstraZeneca"
"227","Astrazeneca says to withdraw EU marketing application for cancer drug","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3443478","2016-09-21 06:11:25","Reuters Key Development","Astrazeneca says to withdraw EU marketing application for cancer drug","AZN","AstraZeneca"
"228","FDA approves Astrazeneca&#39;s blood-based companion diagnostic for Tagrisso (osimertinib)","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3447053","2016-09-29 07:25:17","Reuters Key Development","FDA approves Astrazeneca's blood-based companion diagnostic for Tagrisso (osimertinib)","AZN","AstraZeneca"
"229","Allergan Plc enters licensing agreement with Astrazeneca for worldwide rights to Medi2070","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3448322","2016-10-03 02:00:00","Reuters Key Development","Allergan Plc enters licensing agreement with Astrazeneca for worldwide rights to Medi2070","AZN","AstraZeneca"
"230","AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3448959","2016-10-04 03:21:55","Reuters Key Development","AstraZeneca exec: $3.5 bln Brilinta sales goal no longer attainable","AZN","AstraZeneca"
"231","Insmed announces worldwide license agreement with AstraZeneca for oral DPP1 inhibitor","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3449534","2016-10-05 06:55:00","Reuters Key Development","Insmed announces worldwide license agreement with AstraZeneca for oral DPP1 inhibitor","AZN","AstraZeneca"
"232","Here&#39;s Why AstraZeneca plc (ADR) (AZN) is Trimming its Drug Pipeline","http://smartstocknews.com/34064-heres-why-astrazeneca-plc-adr-azn-is-trimming-its-drug-pipeline/","2016-10-06 10:51:23","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca PLC (ADR) (NYSE:AZN) is working on the idea of investing more in oncological ailments. In order to accomplish the task, it is handing over its molecules to other companies.","AZN","AstraZeneca"
"233","3 Big Stock Charts: Chesapeake Energy Corporation (CHK), AstraZeneca plc (ADR ...","http://investorplace.com/2016/10/3-big-stock-charts-chesapeake-energy-corporation-chk-astrazeneca-plc-adr-azn-and-groupon-inc-grpn/","2016-10-07 09:52:30","Investorplace.com","The market will spend much of this Friday digesting the latest jobs report and its implications on the upcoming interest rate decision.","AZN","AstraZeneca"
"234","Wil AstraZeneca plc (ADR) (AZN) Compete in Lung Cancer Treatment?","http://www.voiceobserver.com/90091-wil-astrazeneca-plc-adr-azn-compete-in-lung-cancer-treatment/","2016-10-10 08:45:00","The Voice Observer","AstraZeneca Plc (ADR) (NYSE:AZN) is working on the research and development (R&D) of oncology molecules, keeping in view the prospects of the pharmaceutical arena.","AZN","AstraZeneca"
"235","Allergan says FDA accepts supplemental new drug application for avycaz","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3451804","2016-10-11 08:01:00","Reuters Key Development","Allergan says FDA accepts supplemental new drug application for avycaz","AZN","AstraZeneca"
"236","Synairgen says AstraZeneca decided to stop phase IIa AZD9412 trial","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3452249","2016-10-12 02:00:16","Reuters Key Development","Synairgen says AstraZeneca decided to stop phase IIa AZD9412 trial","AZN","AstraZeneca"
"237","FDA accepts AstraZeneca&#39;s new Hyperkalaemia drug application for review","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3455613","2016-10-18 02:00:10","Reuters Key Development","FDA accepts AstraZeneca's new Hyperkalaemia drug application for review","AZN","AstraZeneca"
"238","AstraZeneca plc (ADR) (NYSE:AZN): Merrill Lynch Lowers Estimates, Reiterates Buy","http://smartstocknews.com/50712-astrazeneca-plc-adr-nyseazn-merrill-lynch-lowers-estimates-reiterates-buy/","2016-10-21 11:48:29","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca plc (ADR) (NYSE:AZN) is scheduled to report its third-quarter earnings data on November 10. Merrill Lynch analyst Sachin Jain and team reiterated a Buy rating on the company's stock ahead of the results while lowering their earnings ...","AZN","AstraZeneca"
"239","AstraZeneca says Lynparza late-stage study succeeds","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3461031","2016-10-26 02:00:05","Reuters Key Development","AstraZeneca says Lynparza late-stage study succeeds","AZN","AstraZeneca"
"240","AstraZeneca plc (ADR) (AZN) Is Up Against Tesaro For Expanded US Ovarian ...","http://smartstocknews.com/24417-astrazeneca-plc-adr-azn-is-up-against-tesaro-for-expanded-us-ovarian-cancer-market/","2016-10-26 12:31:14","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca plc (ADR) (NYSE:AZN) reported positive headline data on Wednesday for its Phase 3 'Solo2' trial, testing the PARP inhibitor Lynparza as a maintenance therapy in second-line, platinum-sensitive, BRCA-mutated ovarian cancer.","AZN","AstraZeneca"
"241","AstraZeneca says FDA puts partial hold on patient enrolment for head and neck cancer trials","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3463296","2016-10-27 11:51:26","Reuters Key Development","AstraZeneca says FDA puts partial hold on patient enrolment for head and neck cancer trials","AZN","AstraZeneca"
"242","AstraZeneca Canada announces Lynparza trial results","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3466870","2016-11-01 08:00:00","Reuters Key Development","AstraZeneca Canada announces Lynparza trial results","AZN","AstraZeneca"
"243","Earnings Whispers: AstraZeneca plc (ADR) (AZN) &amp; Himax Technologies, Inc. (ADR ...","http://www.thecountrycaller.com/21067-earnings-whispers-astrazeneca-plc-adr-azn--himax-technologies-inc-adr-himx","2016-11-09 11:41:15","TCC","AstraZeneca plc (ADR) (NYSE:AZN) and Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) are set to report their third quarter of fiscal year 2016 (3QFY16) financial results before the opening bell on Thursday.","AZN","AstraZeneca"
"244","AstraZeneca CEO: drug price pressure won&#39;t go away under Trump","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3474648","2016-11-10 05:04:31","Reuters Key Development","AstraZeneca CEO: drug price pressure won't go away under Trump","AZN","AstraZeneca"
"245","Takeover Talk Inspires AstraZeneca plc (AZN) Option Bulls","http://www.schaeffersresearch.com/content/options/2016/11/11/takeover-talk-inspires-astrazeneca-plc-azn-option-bulls","2016-11-11 13:45:16","Schaeffers Research (blog)","AstraZeneca plc (ADR) (NYSE:AZN) stock volume is surging today, running in the 98th percentile of its annual range, as rumors swirl that fellow drugmaker Novartis AG (ADR) (NYSE:NVS) is considering buying the company.","AZN","AstraZeneca"
"246","Novartis AG (NVS) May Fancy AstraZeneca plc (AZN) for Takoever: Reports","http://smartstocknews.com/56404-novartis-ag-nvs-may-fancy-astrazeneca-plc-azn-for-takoever-reports/","2016-11-12 09:48:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","The American depository receipts of AstraZeneca plc (ADR) (NYSE:AZN) traded up over 1% on the New York exchange Friday, after a report suggested that the company may attract a takeover interest from Novartis AG (ADR) (NYSE:NVS).","AZN","AstraZeneca"
"247","Emerging Markets: Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) Leading the ...","http://smartstocknews.com/65935-emerging-markets-pfizer-inc-pfe-astrazeneca-plc-adr-azn-leading-the-pharmaceutical-arena/","2016-11-21 08:30:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Giant pharma companies such as Pfizer Inc (NYSE:PFE) and others are working diligently on emerging markets to expand their drug portfolios.","AZN","AstraZeneca"
"248","Analyst Upgrades: Apple Inc., AstraZeneca plc, and Ctrip.com International, Ltd.","http://www.schaeffersresearch.com/content/news/2016/11/25/analyst-upgrades-apple-inc-astrazeneca-plc-and-ctrip-com-international-ltd","2016-11-25 09:15:00","Schaeffers Research (blog)","Analysts are weighing in on iPhone maker Apple Inc. (NASDAQ:AAPL), drugmaker AstraZeneca plc (ADR) (NYSE:AZN), and online travel stock Ctrip.","AZN","AstraZeneca"
"249","AstraZeneca PLC (ADR) (AZN) Relocating Jobs At UK Division","http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-relocating-jobs-at-u-k-division-499733/","2016-12-06 09:48:45","Insider Monkey (blog)","AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation.","AZN","AstraZeneca"
"250","Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer&#39;s treatment","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3492833","2016-12-09 07:00:00","Reuters Key Development","Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer's treatment","AZN","AstraZeneca"
"251","Analyst Upgrades: Biogen Inc, AstraZeneca plc, and Broadcom Ltd","http://www.schaeffersresearch.com/content/news/2016/12/09/analyst-upgrades-biogen-inc-astrazeneca-plc-and-broadcom-ltd","2016-12-09 09:29:03","Schaeffers Research (blog)","Analysts are weighing in on drug stocks Biogen Inc (NASDAQ:BIIB) and AstraZeneca plc (ADR) (NYSE:AZN), as well as Apple Inc. (NASDAQ:AAPL) supplier Broadcom Ltd (NASDAQ:AVGO).","AZN","AstraZeneca"
"252","Astrazeneca says durvalumab gets FDA’s priority review status in bladder cancer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3492973","2016-12-09 10:05:42","Reuters Key Development","Astrazeneca says durvalumab gets FDA’s priority review status in bladder cancer","AZN","AstraZeneca"
"253","Analyst Insights on Share&#39;s Rating and Recommendations: AstraZeneca plc (ADR ...","http://postregistrar.com/2016/12/10/analyst-insights-on-shares-rating-and-recommendations-astrazeneca-plc-adr-nyseazn/","2016-12-10 10:00:00","Post Registrar","AstraZeneca plc (ADR) (NYSE:AZN) rose 3.39% during previous trade. Leerink Partners issued rating on the stock of AstraZeneca plc (ADR) (NYSE:AZN) in a research note issued to investors on Dec-09-16, the stock received “Upgrade” rating from Mkt ...","AZN","AstraZeneca"
"254","Knight Therapeutics announces exclusive license agreement with AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3495775","2016-12-15 07:30:00","Reuters Key Development","Knight Therapeutics announces exclusive license agreement with AstraZeneca","AZN","AstraZeneca"
"255","Almirall receives $30 million in milestone payment from Astrazeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3496499","2016-12-16 04:35:36","Reuters Key Development","Almirall receives $30 million in milestone payment from Astrazeneca","AZN","AstraZeneca"
"256","Ionis earns $28 mln from Astrazeneca for drug to treat cancer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3496622","2016-12-16 07:29:44","Reuters Key Development","Ionis earns $28 mln from Astrazeneca for drug to treat cancer","AZN","AstraZeneca"
"257","AstraZeneca completes sale of antibiotics business to Pfizer","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3500067","2016-12-23 02:00:05","Reuters Key Development","AstraZeneca completes sale of antibiotics business to Pfizer","AZN","AstraZeneca"
"258","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3500132","2016-12-23 02:05:00","Reuters Key Development","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","AZN","AstraZeneca"
"259","AstraZeneca plc (AZN): What does the Future Hold?","http://smartstocknews.com/59771-astrazeneca-plc-azn-what-does-the-future-hold/","2017-01-03 08:38:46","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","AstraZeneca plc (ADR) (NYSE:AZN) has faced various ups and downs in the financial year (FY2016) concerning patent cliff side effects.","AZN","AstraZeneca"
"260","AstraZeneca plc (ADR) (AZN): Merill Lynch Analysts view on MYSTIC","http://smartstocknews.com/34920-astrazeneca-plc-adr-azn-merill-lynch-analysts-view-on-mystic/","2017-01-04 12:21:29","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Questions have mainly revolved around trial layout, with much discussion of just how to interpret AstraZeneca plc (ADR) (NYSE:AZN) comments through its roadshow in late 16. In ML's view, AZN's R&D call 15th December went a long way to answering ...","AZN","AstraZeneca"
"261","Bristol-Myers Squibb Co (BMY) Could Benefit From AstraZeneca plc (ADR) (AZN ...","http://www.thecountrycaller.com/40685-bristol-myers-squibb-co-bmy-could-benefit-from-astrazeneca-plc-adr-azn-mystic","2017-01-18 12:03:45","TCC","BMO Capital weighed in on AstraZeneca plc (ADR) (NYSE:AZN) recently following the announcement of refined endpoint for Phase III Mystic trial and the delay in immuno-oncology combination data.","AZN","AstraZeneca"
"262","GlaxoSmithKline appoints Luke Miels President, Global Pharma","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3510720","2017-01-19 02:09:25","Reuters Key Development","GlaxoSmithKline appoints Luke Miels President, Global Pharma","AZN","AstraZeneca"
"263","Delcath Systems, Inc. (NASDAQ:DCTH) &amp; AstraZeneca plc (ADR) (NYSE:AZN) News Recap","http://www.newsismoney.com/2017/01/19/delcath-systems-inc-nasdaqdcth-astrazeneca-plc-adr-nyseazn-news-recap/","2017-01-19 09:48:45","Money News","On Wednesday, Shares of Delcath Systems, Inc. (NASDAQ:DCTH) lost -11.96% to $0.409. The share price is trading in a range of $0.40 - 0.70.","AZN","AstraZeneca"
"264","AstraZeneca says asthma drug granted paediatric exclusivity in U.S.","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3515704","2017-01-26 05:00:03","Reuters Key Development","AstraZeneca says asthma drug granted paediatric exclusivity in U.S.","AZN","AstraZeneca"
"265","Week Ahead: Apple Inc. (NASDAQ:AAPL), Amazon.com, Inc. (NASDAQ:FB), Facebook ...","https://stockmarketdaily.co/2017/01/30/week-ahead-apple-inc-nasdaqaapl-amazon-com-inc-nasdaqfb-facebook-inc-nasdaqfb-under-armour-inc-nseua-and-alteria-group-inc-nysemo-to-report-their-earnings-this-week/","2017-01-30 06:09:36","Stock Market Daily","AstraZeneca PLC (ADR) (NYSE:AZN) is planning to release its results on Thursday before the bell. Analysts see the company reporting EPS of $1.17.","AZN","AstraZeneca"
"266","Clovis Oncology Inc&#39;s (NASDAQ:CLVS) Ovarian Cancer Drug Faces Stiff ...","https://marketexclusive.com/clovis-oncology-incs-nasdaqclvs-ovarian-cancer-drug-faces-stiff-competition-astrazeneca-plc-adrnyseazn-tesaro-incnasdaqtsro/70660/","2017-01-31 08:52:30","Market Exclusive","Trials of rival drugs from AstraZeneca plc (ADR)(NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ:CLVS).","AZN","AstraZeneca"
"267","AstraZeneca plc (ADR) (NYSE:AZN) &amp; PepsiCo, Inc. (NYSE:PEP) Stocks in the ...","http://www.newsismoney.com/2017/01/31/astrazeneca-plc-adr-nyseazn-pepsico-inc-nysepep-stocks-in-the-spotlight/","2017-01-31 09:03:45","Money News","On Monday, Shares of AstraZeneca plc (ADR) (NYSE:AZN) gained 0.15% to $27.09. The share price is trading in a range of $26.94 - 27.10.","AZN","AstraZeneca"
"268","2 Drug Stocks in Danger Next Month","http://www.schaeffersresearch.com/content/analysis/2017/01/31/2-drug-stocks-in-danger-next-month","2017-01-31 14:52:30","Schaeffers Research (blog)","February can be a tough time for the broad market. While we previously highlighted stocks that tend to outperform during the second month of the year, we'll now take a look at specific names that have historically underperformed.","AZN","AstraZeneca"
"269","AstraZeneca CEO says MYSTIC cancer drug trial &quot;not binary&quot;","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3519508","2017-02-02 02:41:35","Reuters Key Development","AstraZeneca CEO says MYSTIC cancer drug trial ""not binary""","AZN","AstraZeneca"
"270","Earnings Scheduled For February 2, 2017","https://www.benzinga.com/news/earnings/17/02/8983671/earnings-scheduled-for-february-2-2017","2017-02-02 05:01:18","Benzinga","AstraZeneca plc (ADR) (NYSE: AZN) is projected to report its quarterly earnings at $0.59 per share on revenue of $5.55 billion.","AZN","AstraZeneca"
"271","AstraZeneca plc (ADR) (AZN) Releases Earnings Results, Beats Expectations By ...","https://www.highlandmirror.com/2017-02-02-astrazeneca-plc-adr-azn-releases-earnings-results-beats-expectations-by-0-03-eps","2017-02-02 05:41:15","Highland Mirror","AstraZeneca plc (ADR) (AZN) announced its most recent quarterly financial results on Thursday, Feb-2-2017. AZN said it had a profit of $1.21 Earnings per Share for the quarter.","AZN","AstraZeneca"
"272","Amazon.com, Inc. (NASDAQ:AMZN), Amgen, Inc. (NASDAQ:AMGN), GoPro Inc (NASDAQ ...","https://stockmarketdaily.co/2017/02/02/amazon-com-inc-nasdaqamzn-amgen-inc-nasdaqamgn-gopro-inc-nasdaqgpro-merck-co-in-nysemrk-and-visa-inc-nysev-to-announce-their-results/","2017-02-02 06:02:47","Stock Market Daily","AstraZeneca PLC (ADR) (NYSE:AZN) would announce its results before the bell. Analysts see the company delivering EPS of $1.13.","AZN","AstraZeneca"
"273","Stocks To Watch: Facebook Inc (NASDAQ:FB), Shutterfly, Inc. (NASDAQ:SFLY ...","https://stockmarketdaily.co/2017/02/02/stocks-to-watch-facebook-inc-nasdaqfb-shutterfly-inc-nasdaqsfly-cirrus-logic-inc-nasdaqcrus-tractor-supply-company-nasdaqtsco-and-few-more/","2017-02-02 06:06:07","Stock Market Daily","Street expects an EPS of 46 cents. AstraZeneca PLC (ADR) (NYSE:AZN) will announce its results before market opens. Analysts are looking for an EPS of $1.13.","AZN","AstraZeneca"
"274","Stock News AstraZeneca plc (ADR) (NYSE:AZN), Synchrony Financial (NYSE:SYF)","http://wallstrt24.com/stock-news-astrazeneca-plc-adr-nyseazn-synchrony-financial-nysesyf/2428607/","2017-02-02 08:52:30","Wall Street 24","On Wednesday, AstraZeneca plc (ADR) (NYSE:AZN) stock opened its trade at $27.32 and after floating in a range of $27.23 to $27.76, settled at $27.76.","AZN","AstraZeneca"
"275","Pharma stocks to watch: Merck &amp; Co., Inc. (NYSE: MRK) and AstraZeneca plc (ADR ...","http://fxdailyreport.com/pharma-stocks-watch-merck-co-inc-nyse-mrk-astrazeneca-plc-adrnyse-azn/","2017-02-02 12:26:15","FX Daily Report","AstraZeneca plc (ADR)(NYSE:AZN) stock opened on a weak note on February 2nd, 2017 impacted by the lower than estimated results.","AZN","AstraZeneca"
"276","Stocks Under Consideration AstraZeneca plc (ADR) (NYSE:AZN), Bank of New York ...","http://wallstrt24.com/stocks-under-consideration-astrazeneca-plc-adr-nyseazn-bank-of-new-york-mellon-corp-nysebk/2428654/","2017-02-03 08:52:30","Wall Street 24","On Thursday, AstraZeneca plc (ADR) (NYSE:AZN) stock opened its trade at $27.01 and after floating in a range of $26.98 to $27.58, settled at $27.56.","AZN","AstraZeneca"
"277","FDA Watch: February&#39;s Notable PDUFA Dates","https://www.benzinga.com/general/biotech/17/02/8998815/fda-watch-februarys-notable-pdufa-dates","2017-02-06 14:43:20","Benzinga","Valeant bought Brodalumab from AstraZeneca plc (ADR) (NYSE: AZN) for a throw-away price of $100 million in upfront payment, $170 million in pre-launch milestones and $175 million in sales bonuses.","AZN","AstraZeneca"
"278","ACADIA Pharmaceuticals (ACAD) Buyout: Why The AstraZeneca (AZN) Rumor Matters","https://bnlfinance.com/2017/02/06/acadia-pharmaceuticals-acad-buyout-why-the-astrazeneca-azn-rumor-matters/","2017-02-06 18:03:45","BNL Finance (press release) (registration) (blog)","ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) continued its move higher on Monday, giving ACAD stock gains of 30% so far this year. The gains reflect optimism that recent buyout rumors with AstraZeneca plc (ADR) (NYSE:AZN) might actually be true.","AZN","AstraZeneca"
"279","AstraZeneca plc (ADR) (NYSE:AZN) &amp; Xylem Inc (NYSE:XYL) Worth Watching Stocks","http://www.newsismoney.com/2017/02/07/astrazeneca-plc-adr-nyseazn-xylem-inc-nysexyl-worth-watching-stocks/","2017-02-07 08:30:00","Money News","On Monday, Shares of AstraZeneca plc (ADR) (NYSE:AZN) gained 0.61% to $28.09. The share price is trading in a range of $27.71 - 28.10.","AZN","AstraZeneca"
"280","Shares of Astrazeneca PLC (AZN) Sees Large Outflow of Money","https://www.highlandmirror.com/2017-02-08-shares-of-astrazeneca-plc-azn-sees-large-outflow-of-money-2","2017-02-08 04:11:15","Highland Mirror","Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.AstraZeneca plc (ADR) was Upgraded by Leerink Partners to Outperform on Dec 9, 2016. AstraZeneca plc (ADR) was Upgraded by ...","AZN","AstraZeneca"
"281","AstraZeneca plc (ADR) (NYSE:AZN) &amp; Lam Research Corporation (NASDAQ:LRCX ...","http://www.newsismoney.com/2017/02/08/astrazeneca-plc-adr-nyseazn-lam-research-corporation-nasdaqlrcx-traders-recap/","2017-02-08 11:30:00","Money News","On Tuesday, Shares of AstraZeneca plc (ADR) (NYSE:AZN) gained 0.61% to $28.26. The share price is trading in a range of $28.09 - 28.30.","AZN","AstraZeneca"
"282","Atossa Genetics Inc (NASDAQ:ATOS) Should Continue To Run This Quarter","https://www.insiderfinancial.com/atossa-genetics-inc-nasdaqatos-should-continue-to-run-this-quarter/119533/","2017-02-09 09:03:45","Insider Financial","The active compound is already approved and marketed by AstraZeneca plc (ADR) (NYSE:AZN), but Atossa is trying to improve on the delivery to - in turn - improve on efficacy in a breast cancer indication, and therein lies the majority of its current ...","AZN","AstraZeneca"
"283","TapImmune Inc (NASDAQ:TPIV) Could Be About To Run… Finally.","https://www.insiderfinancial.com/tapimmune-inc-nasdaqtpiv-could-be-about-to-run-finally/119600/","2017-02-14 13:22:30","Insider Financial","There is a collaboration with pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN) being conducted at the world-famous Memorial Sloan-Kettering Institute that is investigating the impact of including TPIV200 as a combination with AstraZeneca's ...","AZN","AstraZeneca"
"284","Impact of Brokerage Rating on Astrazeneca PLC(AZN)","https://www.highlandmirror.com/2017-02-15-impact-of-brokerage-rating-on-astrazeneca-plcazn","2017-02-15 05:30:00","Highland Mirror","Many Astrazeneca PLC(AZN) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.","AZN","AstraZeneca"
"285","China MediTech And AstraZeneca PLC (ADR) (AZN) To Present Savolitinib Phase II ...","http://www.insidermonkey.com/blog/china-meditech-and-astrazeneca-plc-adr-azn-to-present-savolitinib-phase-ii-results-at-the-genitourinary-cancers-symposium-2017-559096/","2017-02-15 10:00:00","Insider Monkey (blog)","Hutchison China MediTech Limited and AstraZeneca plc (ADR) (NYSE:AZN) are to present data from their phase II clinical trials of Savolitinib, at the upcoming 2017 Genitourinary Cancers Symposium.","AZN","AstraZeneca"
"286","Price Bump From M&amp;A Rumors Earns Acadia A Vetr Downgrade","https://www.benzinga.com/general/biotech/17/02/9055984/price-bump-from-m-a-rumors-earns-acadia-a-vetr-downgrade","2017-02-15 16:56:15","Benzinga","Share price in Acadia spiked over 8.5 percent Tuesday on rumors the biotech company was approached by AstraZeneca plc (ADR) (NYSE: AZN) considering a possible acquisition. The rumor remains unconfirmed, but ACADIA remained steady the next day ...","AZN","AstraZeneca"
"287","Why Zosano Pharma Corp (NASDAQ:ZSAN) Jumped Over 41%?","http://www.financialstrend.com/why-zosano-pharma-corp-nasdaqzsan-jumped-over-41-25758.html","2017-02-16 07:00:00","FinancialsTrend","Thinly traded stock Zosano Pharma Corp (NASDAQ:ZSAN) was up over 41% in last trading session on strong volume in anticipation to its announcement of successful report from a Phase III clinical study, ZOTRIP, evaluating lead product candidate “M207” for ...","AZN","AstraZeneca"
"288","Astrazeneca says will get $130 mln as milestone payment after Brodalumab approval","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3529441","2017-02-16 07:01:01","Reuters Key Development","Astrazeneca says will get $130 mln as milestone payment after Brodalumab approval","AZN","AstraZeneca"
"289","After Merck Stops Study, What Remains Of The Alzheimer&#39;s Drug Pipeline?","https://www.benzinga.com/general/biotech/17/02/9061803/after-merck-stops-study-what-remains-of-the-alzheimers-drug-pipeline","2017-02-16 16:14:59","Benzinga","In collaboration with AstraZeneca plc (ADR) (NYSE: AZN), Eli Lilly is still exploring the use of a beta secretase enzyme (BACE) inhibitor to clear amyloid plaque deposits in the brain (which most believe is the cause of AD).","AZN","AstraZeneca"
"290","Dividend Growth of Astrazeneca PLC(AZN)","https://www.tradecalls.org/2017-02-17-dividend-growth-of-astrazeneca-plcazn","2017-02-17 04:33:45","Trade Calls","Institutional Investors own 12.9% of Astrazeneca PLC shares. Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.","AZN","AstraZeneca"
"291","Presidents Day May Be Bad News For Align Technology, AstraZeneca Shares","http://www.schaeffersresearch.com/content/analysis/2017/02/17/presidents-day-may-be-bad-news-for-align-technology-astrazeneca-shares","2017-02-17 11:07:30","Schaeffers Research (blog)","Meanwhile, we have our eye on two healthcare stocks from the list: Align Technology, Inc. (NASDAQ:ALGN) and AstraZeneca plc (ADR) (NYSE:AZN). As we'll explore below, options traders have been taking wildly different approaches to shares of ALGN and ...","AZN","AstraZeneca"
"292","Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still in Trouble","http://investorplace.com/2017/02/why-valeant-pharmaceuticals-intl-inc-vrx-stock-still-trouble/","2017-02-17 11:20:18","Investorplace.com","... the other novel biologics (Taltz, Cosentyx, Stelara) have similar restrictions to access.” Throw in the fact that Valeant will be splitting any Siliq revenue with AstraZeneca plc (ADR) (NYSE:AZN), and what you're left with is something less than ...","AZN","AstraZeneca"
"293","Peregrine Pharmaceuticals (NASDAQ:PPHM)&#39;s Run Validates Our Thesis","https://www.insiderfinancial.com/peregrine-pharmaceuticals-nasdaqpphms-run-validates-our-thesis/119677/","2017-02-21 00:02:54","Insider Financial","A host of big name pharmas are pushing ovarian cancer assets through various stages of the development pathway - AstraZeneca plc (ADR)(NYSE:AZN), Clovis Oncology Inc(NASDAQ:CLVS), TESARO Inc(NASDAQ:TSRO) - as are some smaller, but ...","AZN","AstraZeneca"
"294","Bristol-Myers Squibb Co (NYSE:BMY), Merck &amp; Co., Inc. (NYSE:MRK), And Other ...","https://marketexclusive.com/bristol-myers-squibb-co-nysebmy-merck-co-inc-nysemrk-pharmaceutical-firms-targeting-o-segment/73421/","2017-02-21 06:03:45","Market Exclusive","In addition to the treatments that have already been approved, numerous trials are being conducted by pharmaceutical firms such as Incyte Corporation (NASDAQ:INCY) and AstraZeneca plc (ADR) (NYSE:AZN) for drugs designed for the treatment of cancers ...","AZN","AstraZeneca"
"295","Stocks to Keep Your Eyes on -Exelixis, Inc. (NASDAQ:EXEL), AstraZeneca plc ...","http://www.journalfinance.net/2017/02/stocks-to-keep-your-eyes-on-exelixis-inc-nasdaqexel-astrazeneca-plc-adr-nyseazn/","2017-02-21 08:29:04","Daily News Journal (press release)","AstraZeneca plc (ADR) (NYSE:AZN) shares moved to $29.16 after opening the day at $29.16, on Friday. The stock floated in a price range of $28.93 to $29.27, with market capitalization of $73.61B.","AZN","AstraZeneca"
"296","Analyst: Buy AstraZeneca On The Turnaround Story","https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9076198/analyst-buy-astrazeneca-on-the-turnaround-story","2017-02-22 07:22:30","Benzinga","Following AstraZeneca plc (ADR) (NYSE: AZN)'s strong start to 2017, including a positive data report for breast cancer treatment Lynparza, investors await a barrage of news highlighting significant findings and potential approvals for various portfolio ...","AZN","AstraZeneca"
"297","Stock&#39;s Buzzers AstraZeneca plc (ADR) (NYSE:AZN), Telefonica Brasil SA (ADR ...","http://www.journalfinance.net/2017/02/stocks-buzzers-astrazeneca-plc-adr-nyseazn-telefonica-brasil-sa-adr-nyseviv/","2017-02-22 09:10:53","Daily News Journal (press release)","On Tuesday, AstraZeneca plc (ADR) (NYSE:AZN) stock opened its trade at $28.98 and after floating in a range of $28.87 to $29.13, settled at $29.01.","AZN","AstraZeneca"
"298","Forward Earnings Estimate of Astrazeneca PLC(AZN)","https://www.highlandmirror.com/2017-02-23-forward-earnings-estimate-of-astrazeneca-plcazn","2017-02-23 04:56:15","Highland Mirror","Astrazeneca PLC has received $0.32 as the consensus Earnings Estimate for the Quarter ending on Mar 2017 ,According to the estimate provided by 1 Financial Advisor in the Stock Trading Firms.","AZN","AstraZeneca"
"299","News Buzz AstraZeneca plc (ADR) (NYSE:AZN), Baozun Inc (ADR) (NASDAQ:BZUN)","http://www.journalfinance.net/2017/02/news-buzz-astrazeneca-plc-adr-nyseazn-baozun-inc-adr-nasdaqbzun/","2017-02-23 09:26:15","Daily News Journal (press release)","On Wednesday, AstraZeneca plc (ADR) (NYSE:AZN) stock opened its trade at $28.62 and after floating in a range of $28.61 to $28.98, settled at $28.92.","AZN","AstraZeneca"
"300","Siliq Won&#39;t Bring Valeant Pharmaceuticals Intl Inc (VRX) Stock Back to Life","http://investorplace.com/2017/02/valeant-valeant-stock-vrx-vrx-stock/","2017-02-23 14:06:59","Investorplace.com","Co-developers Amgen, Inc. (NASDAQ:AMGN) and AstraZeneca Plc (ADR) (NYSE:AZN) both essentially pulled the plug on the drug, and AstraZeneca sold the rights to Valeant for $100 million in 2015.","AZN","AstraZeneca"
"301","EU regulator recommends condition approval of Shire&#39;s chronic hypoparathyroidism medicine","http://www.reuters.com/finance/stocks/AZN/key-developments/article/3535218","2017-02-24 07:00:00","Reuters Key Development","EU regulator recommends condition approval of Shire's chronic hypoparathyroidism medicine","AZN","AstraZeneca"
"302","Momentum Stocks AstraZeneca plc (ADR) (NYSE:AZN), Communications Sales ...","http://www.journalfinance.net/2017/02/momentum-stocks-astrazeneca-plc-adr-nyseazn-communications-sales-leasing-inc-nasdaqcsal/","2017-02-24 08:49:13","Daily News Journal (press release)","On Thursday, AstraZeneca plc (ADR) (NYSE:AZN) stock opened its trade at $29.24 and after floating in a range of $29.22 to $29.63, settled at $29.51.","AZN","AstraZeneca"
"303","Carl Icahn&#39;s Track Record In Big Pharma","https://www.benzinga.com/general/biotech/17/02/9084990/carl-icahns-track-record-in-big-pharma","2017-02-24 09:37:30","Benzinga","MEDIMMUNE, LLC, which was sold to AstraZeneca plc (ADR) (NYSE: AZN). Amylin Pharmaceuticals LLC (NASDAQ: AMLN), which was acquired by Bristol-Myers Squibb in 2012.","AZN","AstraZeneca"
"304","Stock Price of Astrazeneca PLC (AZN) Increases 0.65%","http://www.moneyflowtrends.com/2017-02-27-stock-price-of-astrazeneca-plc-azn-increases-0-65","2017-02-27 00:08:22","Money Flow Index & Trends","Institutional Investors own 12.41% of Astrazeneca PLC shares. Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.","AZN","AstraZeneca"
"305","Big Movers in the Stock Market- AstraZeneca plc (ADR) (NYSE:AZN), Convergys ...","http://www.wallstreetnews24.com/big-movers-in-the-stock-market-astrazeneca-plc-adr-nyseazn-convergys-corp-nysecvg/","2017-02-27 08:56:25","Wall Street Times (press release)","AstraZeneca plc (ADR) (NYSE:AZN) traded at a yearly high level of $35.04 during the last trading session. The last session's volume of 3.53 million shares was lower than its average volume of 6.76 million shares.","AZN","AstraZeneca"
"306","Gilead Sciences submits new drug application to FDA","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3188425","2015-04-07 17:56:00","Reuters Key Development","Gilead Sciences submits new drug application to FDA","GILD"," Gilead"
"307","Gilead Sciences Inc announces data for investigational, all-oral, pan-genotypic three-drug regimen of sofosbuvir, GS-5816 and GS-9857 for chronic hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3197585","2015-04-23 01:00:00","Reuters Key Development","Gilead Sciences Inc announces data for investigational, all-oral, pan-genotypic three-drug regimen of sofosbuvir, GS-5816 and GS-9857 for chronic hepatitis C","GILD"," Gilead"
"308","Gilead Sciences Inc raises FY 2015 product sales guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3204618","2015-04-30 16:01:00","Reuters Key Development","Gilead Sciences Inc raises FY 2015 product sales guidance","GILD"," Gilead"
"309","Gilead Sciences Inc declares quarterly cash dividend","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3204599","2015-04-30 16:02:00","Reuters Key Development","Gilead Sciences Inc declares quarterly cash dividend","GILD"," Gilead"
"310","Gilead Sciences acquires EpiTherapeutics","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3207223","2015-05-06 08:30:00","Reuters Key Development","Gilead Sciences acquires EpiTherapeutics","GILD"," Gilead"
"311","China rejects Gilead Sciences Inc&#39;s hepatitis C drug patent -advocacy group - Reuters","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3232224","2015-06-18 20:00:00","Reuters Key Development","China rejects Gilead Sciences Inc's hepatitis C drug patent -advocacy group - Reuters","GILD"," Gilead"
"312","Gilead Sciences Inc submits new drug application to U.S. FDA for single tablet regimen for HIV containing rilpivirine","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3238458","2015-07-01 16:30:00","Reuters Key Development","Gilead Sciences Inc submits new drug application to U.S. FDA for single tablet regimen for HIV containing rilpivirine","GILD"," Gilead"
"313","Gilead Sciences Inc raises FY 2015 product sales guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3251798","2015-07-28 16:01:00","Reuters Key Development","Gilead Sciences Inc raises FY 2015 product sales guidance","GILD"," Gilead"
"314","Gilead Sciences declares cash dividend","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3251807","2015-07-28 16:02:00","Reuters Key Development","Gilead Sciences declares cash dividend","GILD"," Gilead"
"315","Gilead Sciences prices $10 billion of senior unsecured notes","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3271546","2015-09-09 20:57:00","Reuters Key Development","Gilead Sciences prices $10 billion of senior unsecured notes","GILD"," Gilead"
"316","European CHMP adopts positive opinion for Gilead Inc&#39;s single tablet regimen Genvoya","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3277669","2015-09-25 07:33:00","Reuters Key Development","European CHMP adopts positive opinion for Gilead Inc's single tablet regimen Genvoya","GILD"," Gilead"
"317","Gilead Sciences Inc says FDA approves new treatment combination of Gilead&#39;s pulmonary arterial hypertension drug","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3280778","2015-10-02 18:19:00","Reuters Key Development","Gilead Sciences Inc says FDA approves new treatment combination of Gilead's pulmonary arterial hypertension drug","GILD"," Gilead"
"318","Gilead Sciences Inc announces Phase 3 results for Genvoya","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3288636","2015-10-22 07:33:00","Reuters Key Development","Gilead Sciences Inc announces Phase 3 results for Genvoya","GILD"," Gilead"
"319","Gilead Sciences Inc raises FY 2015 product sales guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3291069","2015-10-27 16:00:00","Reuters Key Development","Gilead Sciences Inc raises FY 2015 product sales guidance","GILD"," Gilead"
"320","Gilead Sciences Inc submits NDA to U.S. FDA for fixed-dose combination of sofosbuvir/velpatasvir for treatment of all six genotypes of hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3291992","2015-10-28 17:52:00","Reuters Key Development","Gilead Sciences Inc submits NDA to U.S. FDA for fixed-dose combination of sofosbuvir/velpatasvir for treatment of all six genotypes of hepatitis C","GILD"," Gilead"
"321","Gilead Sciences and WuXi PharmaTech announce collaboration for dedicated analytical and stability testing facility","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3293221","2015-10-29 22:00:00","Reuters Key Development","Gilead Sciences and WuXi PharmaTech announce collaboration for dedicated analytical and stability testing facility","GILD"," Gilead"
"322","Gilead Sciences, Inc says U.S. FDA approves it&#39;s single tablet regimen Genvoya for treatment of HIV-1 infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3296563","2015-11-05 12:47:00","Reuters Key Development","Gilead Sciences, Inc says U.S. FDA approves it's single tablet regimen Genvoya for treatment of HIV-1 infection","GILD"," Gilead"
"323","Gilead Sciences Inc announces top-line results from two phase 3 studies evaluating tenofovir alafenamide","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3317720","2016-01-05 08:30:00","Reuters Key Development","Gilead Sciences Inc announces top-line results from two phase 3 studies evaluating tenofovir alafenamide","GILD"," Gilead"
"324","Gilead Sciences Inc submits new drug application for the treatment of chronic hepatitis B","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3319660","2016-01-12 08:30:00","Reuters Key Development","Gilead Sciences Inc submits new drug application for the treatment of chronic hepatitis B","GILD"," Gilead"
"325","Gilead and Galapagos global partnership cleared by U.S. Federal Trade Commission; Gilead to make equity investment in Galapagos","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3320019","2016-01-13 01:42:00","Reuters Key Development","Gilead and Galapagos global partnership cleared by U.S. Federal Trade Commission; Gilead to make equity investment in Galapagos","GILD"," Gilead"
"326","Gilead holds 14.75% of Galapagos shares<U+200B>","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3323408","2016-01-25 01:30:00","Reuters Key Development","Gilead holds 14.75% of Galapagos shares<U+200B>","GILD"," Gilead"
"327","Gilead Sciences Inc&#39;s John C. Martin to assume role of Executive Chairman of the Board","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3326041","2016-01-29 08:00:00","Reuters Key Development","Gilead Sciences Inc's John C. Martin to assume role of Executive Chairman of the Board","GILD"," Gilead"
"328","Gilead Sciences announces declaration of Q1 cash dividend and increases to shareholder return programs","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3327627","2016-02-02 16:01:00","Reuters Key Development","Gilead Sciences announces declaration of Q1 cash dividend and increases to shareholder return programs","GILD"," Gilead"
"329","Gilead Sciences says FDA approves two supplemental indications for Harvoni in chronic Hep C patients","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3332038","2016-02-16 08:30:00","Reuters Key Development","Gilead Sciences says FDA approves two supplemental indications for Harvoni in chronic Hep C patients","GILD"," Gilead"
"330","Gilead Sciences Inc says FDA approves Descovy","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3352851","2016-04-04 14:57:00","Reuters Key Development","Gilead Sciences Inc says FDA approves Descovy","GILD"," Gilead"
"331","Gilead Sciences Inc reiterates FY 2016 guidance","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3365729","2016-04-28 16:01:00","Reuters Key Development","Gilead Sciences Inc reiterates FY 2016 guidance","GILD"," Gilead"
"332","Gilead Sciences, Inc announces quarterly dividend","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3364854","2016-04-28 16:02:00","Reuters Key Development","Gilead Sciences, Inc announces quarterly dividend","GILD"," Gilead"
"333","Galapagos listing of existing shares on Euronext Brussels &amp; Amsterdam","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3376436","2016-05-17 01:05:41","Reuters Key Development","Galapagos listing of existing shares on Euronext Brussels & Amsterdam","GILD"," Gilead"
"334","Galapagos says completed end-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3380837","2016-05-24 16:09:45","Reuters Key Development","Galapagos says completed end-of-Phase 2 FDA and EMA consultations in rheumatoid arthritis","GILD"," Gilead"
"335","Gilead Sciences appoints Kevin Young as COO","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3380848","2016-05-24 16:30:00","Reuters Key Development","Gilead Sciences appoints Kevin Young as COO","GILD"," Gilead"
"336","Gilead says European Commission grants marketing authorization for Odefsey®","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3395263","2016-06-23 07:53:00","Reuters Key Development","Gilead says European Commission grants marketing authorization for Odefsey®","GILD"," Gilead"
"337","Diplomat Pharmacy says to dispense epclusa for treatment of chronic Hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3397233","2016-06-28 16:30:00","Reuters Key Development","Diplomat Pharmacy says to dispense epclusa for treatment of chronic Hepatitis C","GILD"," Gilead"
"338","Ligand enters into Omniab platform license agreement with Gilead Sciences","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3402421","2016-07-08 09:00:00","Reuters Key Development","Ligand enters into Omniab platform license agreement with Gilead Sciences","GILD"," Gilead"
"339","Gilead&#39;s Odefsey meets primary objective in phase 3B studies","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3409438","2016-07-21 16:30:00","Reuters Key Development","Gilead's Odefsey meets primary objective in phase 3B studies","GILD"," Gilead"
"340","EMA adopts positive opinion on expanded approval of Gilead&#39;s HIV drug, Truvada","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3410011","2016-07-22 07:17:00","Reuters Key Development","EMA adopts positive opinion on expanded approval of Gilead's HIV drug, Truvada","GILD"," Gilead"
"341","Gilead Sciences Q2 non-GAAP earnings per share $3.08","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3410919","2016-07-25 16:08:00","Reuters Key Development","Gilead Sciences Q2 non-GAAP earnings per share $3.08","GILD"," Gilead"
"342","Gilead Sciences sets qtrly dividend of $0.47 per share","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3410920","2016-07-25 16:10:00","Reuters Key Development","Gilead Sciences sets qtrly dividend of $0.47 per share","GILD"," Gilead"
"343","BRIEF-Massachusetts attorney general&#39;s office notifies Gilead of decision to suspend co&#39;s obligations under CID until further notice","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3420629","2016-08-05 17:05:06","Reuters Key Development","BRIEF-Massachusetts attorney general's office notifies Gilead of decision to suspend co's obligations under CID until further notice","GILD"," Gilead"
"344","Genmab enters commercial license agreement with Gilead for DuoBody(R)Technology","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3423528","2016-08-10 13:07:11","Reuters Key Development","Genmab enters commercial license agreement with Gilead for DuoBody(R)Technology","GILD"," Gilead"
"345","Gilead Sciences prices $5 bln of senior unsecured notes","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3441667","2016-09-15 22:01:00","Reuters Key Development","Gilead Sciences prices $5 bln of senior unsecured notes","GILD"," Gilead"
"346","Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3443702","2016-09-21 17:00:00","Reuters Key Development","Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis","GILD"," Gilead"
"347","Gilead sciences, WHO announce 5-year visceral leishmaniasis collaboration","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3445934","2016-09-27 16:05:00","Reuters Key Development","Gilead sciences, WHO announce 5-year visceral leishmaniasis collaboration","GILD"," Gilead"
"348","Galapagos Q3 net result turns to 8.1 mln euro profit","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3463978","2016-10-28 01:55:18","Reuters Key Development","Galapagos Q3 net result turns to 8.1 mln euro profit","GILD"," Gilead"
"349","Gilead Q3 earnings per share $2.49","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3467065","2016-11-01 16:01:00","Reuters Key Development","Gilead Q3 earnings per share $2.49","GILD"," Gilead"
"350","Gilead - data for combination of selonsertib, gs-9674 in rodent model of advanced fibrosis resulted in greater anti-fibrotic activity than either agent alone","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3478118","2016-11-14 16:30:00","Reuters Key Development","Gilead - data for combination of selonsertib, gs-9674 in rodent model of advanced fibrosis resulted in greater anti-fibrotic activity than either agent alone","GILD"," Gilead"
"351","GlobeImmune announces updates","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3481082","2016-11-17 17:49:06","Reuters Key Development","GlobeImmune announces updates","GILD"," Gilead"
"352","EMA says patients treated with direct-acting antivirals for hepatitis C may be at risk of hepatitis B re-activation","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3489298","2016-12-02 10:06:49","Reuters Key Development","EMA says patients treated with direct-acting antivirals for hepatitis C may be at risk of hepatitis B re-activation","GILD"," Gilead"
"353","Gilead Sciences submits new drug application to U.S. FDA for Hepatitis C","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3492215","2016-12-08 08:11:00","Reuters Key Development","Gilead Sciences submits new drug application to U.S. FDA for Hepatitis C","GILD"," Gilead"
"354","Gilead says Japan&#39;s Ministry of Health, Labour and Welfare approves co&#39;s Vemlidy for patients with chronic Hepatitis B virus infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3497125","2016-12-19 02:03:00","Reuters Key Development","Gilead says Japan's Ministry of Health, Labour and Welfare approves co's Vemlidy for patients with chronic Hepatitis B virus infection","GILD"," Gilead"
"355","Gilead COO says slowdown in patients starting hep C therapies to continue in 2017","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3505956","2017-01-09 14:40:00","Reuters Key Development","Gilead COO says slowdown in patients starting hep C therapies to continue in 2017","GILD"," Gilead"
"356","Will Gilead Sciences End Up Like Valeant Pharmaceuticals?","http://seekingalpha.com/article/4040607-will-gilead-sciences-end-like-valeant-pharmaceuticals","2017-01-30 09:25:19","Seeking Alpha","Answers a question from a Client, who wonders if Gilead Sciences will end up like Valeant Pharmaceuticals. A comparative quantitative analysis using a unique free cash flow ratio.","GILD"," Gilead"
"357","3 Critical Things to Watch in Gilead Sciences&#39; Q4 Results","https://www.fool.com/investing/2017/01/31/3-things-to-watch-in-gilead-sciences-q4-results.aspx","2017-01-31 15:37:30","Motley Fool","Gilead Sciences' (NASDAQ:GILD) shareholders anxiously await February 7 to arrive. That's the day the big biotech announces its fourth-quarter results.","GILD"," Gilead"
"358","What Filgotinib Could Mean For Gilead&#39;s Future","http://seekingalpha.com/article/4041435-filgotinib-mean-gileads-future","2017-02-01 09:19:44","Seeking Alpha","These discussions are based, in part, on the fact that it is always difficult to evaluate, let alone value, a biotech company's pipeline. The pipeline is the key component of the future of any biotech. That pipeline can be filled by internal R&D, but ...","GILD"," Gilead"
"359","Benedict Financial Advisors Inc Buys Gilead Sciences, LyondellBasell ...","http://www.gurufocus.com/news/478910/benedict-financial-advisors-inc-buys-gilead-sciences-lyondellbasell-industries-nv-wisdomtree-high-dividend-fund-sells-siemens-ag-wells-fargo-advansix","2017-02-01 14:41:15","GuruFocus.com","Atlanta, GA, based Investment company Benedict Financial Advisors Inc buys Gilead Sciences, LyondellBasell Industries NV, WisdomTree High Dividend Fund, Phillips 66, American Express, TransCanada, C.H.","GILD"," Gilead"
"360","Earnings Preview: What To Expect From Gilead On Tuesday","http://www.forbes.com/sites/adamsarhan/2017/02/02/earnings-preview-what-to-expect-from-gilead-on-tuesday/","2017-02-02 07:19:55","Forbes","Gilead Sciences, Inc., incorporated on June 22, 1987, is a research-based biopharmaceutical company. The Company focuses on the discovery, development and commercialization of medicines in areas of unmet medical need.","GILD"," Gilead"
"361","The Case for and Against Gilead Sciences Inc (NASDAQ:GILD)","http://stocknewsjournal.com/2017/02/02/the-case-for-and-against-gilead-sciences-inc-nasdaqgild/","2017-02-02 09:37:30","StockNewsJournal","Gilead Sciences Inc. (GILD) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $72.82, up from yesterday's close by 0.51%.","GILD"," Gilead"
"362","3 Crucial Questions Gilead Sciences Should Answer Tuesday","https://www.fool.com/investing/2017/02/05/3-crucial-questions-gilead-sciences-should-answer.aspx","2017-02-05 08:18:45","Motley Fool","Gilead's worldwide HCV sales plummeted by 31% year over year last quarter, as lower patient starts ","GILD"," Gilead"
"363","Grisanti Capital Management LLC Buys Citigroup, DaVita, Gilead Sciences, Sells ...","http://www.gurufocus.com/news/480413/grisanti-capital-management-llc-buys-citigroup-davita-gilead-sciences-sells-cognizant-technology-solutions-medtronic-plc-allergan-plc","2017-02-06 12:37:30","GuruFocus.com","New York, NY, based Investment company Grisanti Capital Management LLC buys Citigroup, DaVita, Gilead Sciences, Skyworks Solutions, Wells Fargo, Nike, Viacom, Schlumberger, Visa, AmeriGas Partners LP, sells Cognizant Technology Solutions, ...","GILD"," Gilead"
"364","All eyes will be on Gilead&#39;s hepatitis C franchise as it reports fourth ...","http://www.marketwatch.com/story/all-eyes-will-be-on-gileads-hepatitis-c-franchise-as-it-reports-fourth-quarter-earnings-2017-02-06","2017-02-06 16:35:00","MarketWatch","Gilead Sciences Inc. first became notorious in 2014 for the high price of its hepatitis C drug Sovaldi: More than $80,000 for a course of treatment.","GILD"," Gilead"
"365","Form 4 GILEAD SCIENCES INC For: Feb 02 Filed by: Alton Gregg H","http://www.streetinsider.com/SEC+Filings/Form+4+GILEAD+SCIENCES+INC+For%3A+Feb+02+Filed+by%3A+Alton+Gregg+H/12504515.html","2017-02-06 20:52:30","StreetInsider.com","Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. Alton Gregg H. (Last), (First), (Middle). GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE. (Street) ...","GILD"," Gilead"
"366","Some Risk Relief For Gilead Longs","http://seekingalpha.com/article/4043388-risk-relief-gilead-longs","2017-02-07 12:15:00","Seeking Alpha","As Friedrich Research noted recently, investing in Gilead and other biotechs involves more risk than investing in stocks in other industries.","GILD"," Gilead"
"367","Earnings Reaction History: Gilead Sciences Inc., 63.6% Follow-Through ...","http://www.nasdaq.com/article/earnings-reaction-history-gilead-sciences-inc-636-follow-through-indicator-40-sensitive-cm744415","2017-02-07 13:33:45","Nasdaq","Gilead Sciences Inc. ( GILD ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement ...","GILD"," Gilead"
"368","Gilead Sciences reports Q4 earnings per share $2.34","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3522142","2017-02-07 16:01:00","Reuters Key Development","Gilead Sciences reports Q4 earnings per share $2.34","GILD"," Gilead"
"369","Gilead Sciences sets quarterly dividend of $0.52 per share","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3522141","2017-02-07 16:02:00","Reuters Key Development","Gilead Sciences sets quarterly dividend of $0.52 per share","GILD"," Gilead"
"370","Gilead Sciences Inc. Reports Q4 Earnings Decline and Worsening Outlook for 2017","https://www.fool.com/investing/2017/02/07/gilead-sciences-inc-reports-q4-earnings-decline-an.aspx","2017-02-07 18:37:30","Motley Fool","Anyone who follows Gilead Sciences was probably most interested in the company's hepatitis C virus (HCV) franchise performance in the fourth quarter.","GILD"," Gilead"
"371","Gilead: Dreadful Guidance Inspires Fear","http://seekingalpha.com/article/4043587-gilead-dreadful-guidance-inspires-fear","2017-02-07 19:53:52","Seeking Alpha","However, guidance is dreadful vs. estimates with FY17 revenue guided to be around $22.5-24.5b vs. estimates around $28b. After adjusting the DCF model I showed in a previous article, the stock is naturally less attractive, but downside risk is still ...","GILD"," Gilead"
"372","Gilead Sciences (GILD) Q4 2016 Results - Earnings Call Transcript","http://seekingalpha.com/article/4043634-gilead-sciences-gild-q4-2016-results-earnings-call-transcript","2017-02-07 22:48:52","Seeking Alpha","Non-GAAP financial measures will be used to help you understand the company's underlying business performance. The GAAP to non-GAAP reconciliations are provided in the earnings press release as well as on the Gilead website. I will now turn the call ...","GILD"," Gilead"
"373","New leadership for Gilead Sciences Canada, Inc.","http://finance.yahoo.com/news/leadership-gilead-sciences-canada-inc-132200316.html","2017-02-08 08:29:28","Yahoo Finance","8, 2017 /CNW/ - Kennet Brysting has been appointed General Manager of Gilead Sciences Canada, Inc., assuming leadership of Gilead's sixth-largest market.","GILD"," Gilead"
"374","Spot Trading LLC Buys Gilead Sciences, Allergan PLC, Bristol-Myers Squibb ...","http://www.nasdaq.com/article/spot-trading-llc-buys-gilead-sciences-allergan-plc-bristol-myers-squibb-company-sells-spdr-cm744907","2017-02-08 09:03:45","Nasdaq","Spot Trading L.L.C initiated holdings in Gilead Sciences Inc. The purchase prices were between $71.61 and $78.47, with an estimated average price of $74.33.","GILD"," Gilead"
"375","Buffalo Wild Wings, Gilead Sciences, Vertex Pharmaceuticals Downgraded","http://www.schaeffersresearch.com/content/news/2017/02/08/buffalo-wild-wings-gilead-sciences-vertex-pharmaceuticals-downgraded","2017-02-08 09:48:45","Schaeffers Research (blog)","Analysts are weighing in on sports bar Buffalo Wild Wings (NASDAQ:BWLD), as well as drug stocks Gilead Sciences, Inc. (NASDAQ:GILD) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Here's a quick roundup of today's bearish brokerage notes on ...","GILD"," Gilead"
"376","Martin Shkreli: I Would Buy Gilead Shares","https://www.benzinga.com/general/biotech/17/02/9011449/martin-shkreli-i-would-buy-gilead-shares","2017-02-08 10:00:00","Benzinga","Investors may not have been thrilled with Gilead Sciences, Inc. (NASDAQ: GILD)'s fourth-quarter report, but Martin Shkreli was ecstatic.","GILD"," Gilead"
"377","Gilead Sciences &amp; Bristol Myers: Two Wrongs Make a Right?","http://blogs.barrons.com/stockstowatchtoday/2017/02/08/gilead-sciences-bristol-myers-two-wrongs-make-a-right/","2017-02-08 10:17:54","Barron's (blog)","Plans to Get out of Value Trap. Gilead repurchased $1bn of shares in 4Q'16, sticking to its plan of pausing on buyback to prepare for acquisitions.","GILD"," Gilead"
"378","3 Big Stock Charts for Wednesday: Gilead Sciences, Inc. (GILD), AK Steel ...","http://investorplace.com/2017/02/3-big-stock-charts-for-wednesday-gilead-sciences-inc-gild-ak-steel-holding-corporation-aks-and-sysco-corporation-syy/","2017-02-08 10:56:15","Investorplace.com","The markets are starting to split again as the earnings traders are driving a wedge between the correlation that investors like to see growth with a bull market.","GILD"," Gilead"
"379","Wednesday&#39;s Market Insights: DryShips Inc. (DRYS), Gilead Sciences, Inc. (GILD ...","https://www.smarteranalyst.com/2017/02/08/wednesdays-market-insights-dryships-inc-drys-gilead-sciences-inc-gild-galena-biopharma-gale/","2017-02-08 12:05:13","Smarter Analyst","Gilead Sciences, Inc. (NASDAQ:GILD) are trading down by 9% after the healthcare giant announced guidance for the year far below Wall Street's previous expectations.","GILD"," Gilead"
"380","Gilead Bombs - Analysis","http://seekingalpha.com/article/4043878-gilead-bombs-analysis","2017-02-08 13:33:45","Seeking Alpha","Jeremiah was generally a gloomy guy, it would seem, and choosing the name Gilead Sciences for a stock was an interesting decision.","GILD"," Gilead"
"381","Gilead Sciences, Fitbit Plunge into Wednesday&#39;s 52-Week Low Club","http://247wallst.com/investing/2017/02/08/gilead-sciences-fitbit-plunge-into-wednesdays-52-week-low-club/","2017-02-08 16:08:24","24/7 Wall St.","Gilead Sciences Inc. (NASDAQ: GILD) dropped about 10% Wednesday to post a new 52-week low of $65.75 after closing Tuesday at $73.13.","GILD"," Gilead"
"382","Gilead execs receive hefty bonuses for 2016 performance","http://seekingalpha.com/news/3241702-gilead-execs-receive-hefty-bonuses-2016-performance","2017-02-08 16:23:30","Seeking Alpha","In a regulatory filing, Gilead Sciences (NASDAQ:GILD) discloses the 2016 bonuses for senior executives and base salaries for this year.","GILD"," Gilead"
"383","Gilead Sciences and Container Store skid; Nordstrom climbs","https://www.washingtonpost.com/business/gilead-sciences-and-container-store-skid-nordstrom-climbs/2017/02/08/1f053248-ee49-11e6-a100-fdaaf400369a_story.html","2017-02-08 16:55:34","Washington Post","Nordstrom Inc., up $1.75 to $44.53. After initially slipping, the stock recovered after President Donald Trump criticized the retailer for treating his daughter “so unfairly.","GILD"," Gilead"
"384","Why Gilead Sciences, Zillow Group, and Parsley Energy Slumped Today","https://www.fool.com/investing/2017/02/08/why-gilead-sciences-zillow-group-and-parsley-energ.aspx","2017-02-08 16:56:12","Motley Fool","Despite the relatively neutral performance from the market today, some stocks fell sharply, and Gilead Sciences (NASDAQ:GILD), Zillow Group (NASDAQ:Z) (NASDAQ:ZG), and Parsley Energy (NYSE:PE) were among the worst performers on the day.","GILD"," Gilead"
"385","Gilead: A Technical Perspective","http://seekingalpha.com/article/4044356-gilead-technical-perspective","2017-02-09 11:52:30","Seeking Alpha","Gilead (NASDAQ:GILD) reported earnings on February 7th, and despite beating estimates on both the top and bottom line, it tanked.","GILD"," Gilead"
"386","Gilead, GlaxoSmithKline Race for HIV Cure (GILD,GSK)","http://www.investopedia.com/news/gilead-glaxosmithkline-race-hiv-cure-gildgsk/","2017-02-09 13:16:18","Investopedia","Gilead Sciences Inc. (GILD) will face off against GlaxoSmithKline PLC (GSK) next week when companies reveal dueling clinical results of their competing HIV drugs at an HIV conference in Seattle, Washington.","GILD"," Gilead"
"387","Gilead Could Go Lower","http://seekingalpha.com/article/4044637-gilead-go-lower","2017-02-09 21:26:15","Seeking Alpha","Since the 3rd of November last, Gilead's returns have been dismal compared to the Biotechnology Index ETF (NASDAQ:IBB) and also Pfizer Inc.(NYSE:PFE), which is a bellwether stock in this sector. Again, it wasn't necessarily the company's fourth-quarter ...","GILD"," Gilead"
"388","Gilead Sciences, Inc. (NASDAQ:GILD), GlaxoSmithKline Plc (NYSE:GSK) Battle ...","https://marketexclusive.com/gilead-sciences-inc-nasdaqgild-glaxosmithkline-plc-nysegsk-battle-head-hiv-treatment/71599/","2017-02-10 09:37:30","Market Exclusive","Gilead Sciences, Inc. (NASDAQ:GILD) and GlaxoSmithKline Plc (NYSE:GSK) will battle head-on in a coming HIV/AIDS conference to reveal clinical test trial results for HIV treatment.","GILD"," Gilead"
"389","Gilead&#39;s travails good for biotech says JPMorgan&#39;s Kasimov","http://seekingalpha.com/news/3242568-gileads-travails-good-biotech-says-jpmorgans-kasimov","2017-02-10 11:18:44","Seeking Alpha","Gilead Sciences' (GILD +1.3%) recent plunge after releasing disappointing guidance appears to be a plus for biotech says Barron's Ben Levisohn.","GILD"," Gilead"
"390","Gilead Sciences Will More Than Survive 2017","http://seekingalpha.com/article/4044896-gilead-sciences-will-survive-2017","2017-02-10 12:48:45","Seeking Alpha","Gilead Sciences (NASDAQ: GILD) investors had some reason to celebrate when the biotech company reported fourth quarter and full year earnings on Tuesday.","GILD"," Gilead"
"391","Holowesko Partners Ltd. Buys Wells Fargo, Gilead Sciences, PulteGroup, Sells ...","http://www.nasdaq.com/article/holowesko-partners-ltd-buys-wells-fargo-gilead-sciences-pultegroup-sells-citizens-financial-cm746504","2017-02-10 15:15:00","Nasdaq","Holowesko Partners Ltd. added to the holdings in Gilead Sciences Inc by 100.38%. The purchase prices were between $71.61 and $78.47, with an estimated average price of $74.33.","GILD"," Gilead"
"392","Better Buy: Illumina or Gilead Sciences?","https://www.fool.com/investing/2017/02/13/better-buy-illumina-or-gilead-sciences.aspx","2017-02-13 13:00:00","Motley Fool","Illumina (NASDAQ:ILMN) and Gilead Sciences (NASDAQ:GILD) are healthcare goliaths that are disrupting their industries, and each of these companies has catalysts on deck that could reward investors in the future.","GILD"," Gilead"
"393","Why I Just Bought More Shares of Gilead Sciences, Inc.","https://www.fool.com/investing/2017/02/14/why-i-just-bought-more-shares-of-gilead-sciences-i.aspx","2017-02-14 08:18:45","Motley Fool","So you might be wondering why I was so quick to scoop up more shares of Gilead Sciences (NASDAQ:GILD) stock after its latest earnings report.","GILD"," Gilead"
"394","Gilead Will Free-Fall In Spite Of Carl Icahn","http://seekingalpha.com/article/4045702-gilead-will-free-fall-spite-carl-icahn","2017-02-14 09:15:00","Seeking Alpha","GILD's HCV sales (45% of product sales) are in free fall. HIV (47% of product sales) could be next. GSK and JNJ have a two-drug HIV combo that measured up to three and four-drug combos on efficacy.","GILD"," Gilead"
"395","The Zacks Analyst Blog Highlights: Gilead Sciences, Celgene, Fate Therapeutics ...","http://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-143002852.html","2017-02-14 10:18:50","Yahoo Finance","Biotech major, Gilead Sciences Inc. (NASDAQ: GILD- Free Report ), reported better-than-expected results for the fourth quarter of 2016 ","GILD"," Gilead"
"396","Gilead Sciences, Inc. (GILD): Bictegravir HIV Data Looks Good","https://www.smarteranalyst.com/2017/02/14/gilead-sciences-inc-gild-bictegravir-hiv-data-looks-good/","2017-02-14 10:45:00","Smarter Analyst","Gilead Sciences, Inc. (NASDAQ:GILD) announced yesterday positive phase 2 results for bictegravir vs. GSK/ViiV's dolutegravir (Tivicay) in combination with F/TAF in treatment naive HIV patients.","GILD"," Gilead"
"397","Gilead Sciences, Inc. (NASDAQ:GILD) Announces Preclinical Study Results Of HIV ...","http://www.financialstrend.com/gilead-sciences-inc-nasdaqgild-announces-preclinical-study-results-of-hiv-capsid-inhibitors-25743.html","2017-02-15 05:41:15","FinancialsTrend","On February 13th 2017, Gilead Sciences, Inc. (NASDAQ:GILD) announced the preclinical study results on HIV capsid inhibitors (CAI) evaluation as an antiretroviral treatment (ARV).","GILD"," Gilead"
"398","Will Gilead Buy Bristol-Myers Squibb?","http://seekingalpha.com/article/4046183-will-gilead-buy-bristol-myers-squibb","2017-02-15 09:26:15","Seeking Alpha","Gilead (NASDAQ:GILD) has hit new multi year lows after the company reported its fourth quarter results and provided guidance for the current year that sees revenues and earnings coming in well below what analysts have been estimating for 2017.","GILD"," Gilead"
"399","Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences","http://www.prnewswire.com/news-releases/amygdala-neurosciences-acquires-gs-6637-from-gilead-sciences-300408827.html","2017-02-16 10:00:00","PR Newswire (press release)"," Amygdala Neurosciences Inc., a biopharmaceutical company focused on the development and commercialization of first-in-class drug candidates for addiction disorders, has entered into an agreement with ...","GILD"," Gilead"
"400","AMYGDALA NEUROSCIENCES ACQUIRES GS-6637 FROM GILEAD SCIENCES","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3529598","2017-02-16 10:03:00","Reuters Key Development","AMYGDALA NEUROSCIENCES ACQUIRES GS-6637 FROM GILEAD SCIENCES","GILD"," Gilead"
"401","Robin L. Washington of Gilead Sciences, Inc. selected for Bay Area CFO of the ...","http://finance.yahoo.com/news/robin-l-washington-gilead-sciences-160000057.html","2017-02-16 11:05:35","Yahoo Finance","(Marketwired - February 16, 2017) - The independent selection panel of the 12th Annual Bay Area CFO of the Year Awards is proud to announce their 2017 Hall of Fame Lifetime Achievement Award winner: Robin L. Washington, ...","GILD"," Gilead"
"402","Gilead receives approval in Canada for Odefsey for treatment of HIV-1 infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3529632","2017-02-16 11:30:00","Reuters Key Development","Gilead receives approval in Canada for Odefsey for treatment of HIV-1 infection","GILD"," Gilead"
"403","Is AbbVie The Next Gilead?","http://seekingalpha.com/article/4046999-abbvie-next-gilead","2017-02-16 21:15:00","Seeking Alpha","AbbVie Inc. (NYSE:ABBV) and Gilead Sciences Inc. (NASDAQ:GILD) are both large-cap pharma companies with market caps of $98.84 billion and $91.44 billion, respectively.","GILD"," Gilead"
"404","Gilead&#39;s HCV Guidance Wasn&#39;t Sandbagged","http://seekingalpha.com/article/4047123-gileads-hcv-guidance-sandbagged","2017-02-17 09:22:50","Seeking Alpha","HCV revenue has seen sharp declines in the last year, and guidance suggests it won't be better for FY'17. Investors struggle to value effectively lumpy cash flow businesses due to the desire for steady cash flow generation and revenue growth ...","GILD"," Gilead"
"405","Why President Trump Should Buy Gilead Sciences","https://www.fool.com/investing/2017/02/17/why-president-trump-should-buy-gilead-sciences.aspx","2017-02-17 13:56:15","Motley Fool","Problem is, right now, not a lot of folks on Wall Street do think Gilead Sciences is a great deal. Thanks to the company's rapidly evaporating HCV franchise, analysts currently predict at least five straight years of precisely 0% profits growth at ...","GILD"," Gilead"
"406","Equity Perception: Analyst&#39;s Indicator Review for Gilead Sciences Inc. (GILD ...","http://theusacommerce.com/2017/02/20/equity-perception-analysts-indicator-review-for-gilead-sciences-inc-gild-starbucks-corporation-sbux/","2017-02-20 11:30:00","The USA Commerce","Shares of Gilead Sciences Inc. (NASDAQ:GILD) dropped -0.65% to $69.85. During the trading on 02/17/2017, Company's stock ranged from $69.71 to $70.79.","GILD"," Gilead"
"407","Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Announces $125 Deal with Gilead ...","http://stocknewsunion.com/sarepta-therapeutics-inc-nasdaqsrpt-announces-125-deal-with-gilead-sciences-inc-gild/1999/","2017-02-21 08:52:30","StockNewsUnion","Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced it has entered into an agreement with Gilead Sciences, Inc. (NASDAQ:GILD) to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $125 million.","GILD"," Gilead"
"408","Gilead: The Catalyst We Were Waiting For?","http://seekingalpha.com/article/4047853-gilead-catalyst-waiting","2017-02-21 11:52:30","Seeking Alpha","Gilead has recently tested the three-year low, due to a weak guidance for 2017 and declining HCV sales. The only way the company can unlock revenue growth is through diversification in other areas, such as NASH and IBD. There is a catalyst on the ...","GILD"," Gilead"
"409","Checking Out the Technicals for Gilead Sciences Inc. (GILD)","http://theusacommerce.com/2017/02/21/checking-out-the-technicals-for-gilead-sciences-inc-gild/","2017-02-21 14:52:30","The USA Commerce","We have gathered the technical data on Gilead Sciences Inc. (GILD), and see some interesting trends in the stock's behavior of late.","GILD"," Gilead"
"410","Form 4 GILEAD SCIENCES INC For: Feb 15 Filed by: Washington Robin L","http://www.streetinsider.com/SEC+Filings/Form+4+GILEAD+SCIENCES+INC+For%3A+Feb+15+Filed+by%3A+Washington+Robin+L/12575712.html","2017-02-21 21:15:00","StreetInsider.com","Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here. FORM 4, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.","GILD"," Gilead"
"411","Gilead&#39;s M&amp;A Growth Strategies Becoming Increasingly Limited","http://seekingalpha.com/article/4048212-gileads-m-growth-strategies-becoming-increasingly-limited","2017-02-22 08:41:15","Seeking Alpha","Shares of Gilead Sciences (NASDAQ:GILD) have underperformed the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks the total return performance of the Nasdaq Biotechnology Index (NASDAQ:NBI), by some 13 percentage points so far this year on ...","GILD"," Gilead"
"412","Gilead: Is Management The Issue?","http://seekingalpha.com/article/4048289-gilead-management-issue","2017-02-22 10:00:00","Seeking Alpha","It has been a rough two years for shareholders of Gilead Sciences (NASDAQ:GILD), although the stock's five-year performance is still rock solid.","GILD"," Gilead"
"413","Analytical Guide for Abbott Laboratories (ABT), Gilead Sciences Inc. (GILD ...","http://theusacommerce.com/2017/02/22/analytical-guide-for-abbott-laboratories-abt-gilead-sciences-inc-gild-stakeholders/","2017-02-22 10:56:15","The USA Commerce","Shares of Abbott Laboratories (NYSE:ABT) surged 0.72% to $45.01. During the trading on 02/21/2017, Company's stock ranged from $44.54 to $45.15.","GILD"," Gilead"
"414","Gilead Sciences Canada says Ontario to list Epclusa on public drug plan to treat all six genotypes of chronic Hepatitis C infection","http://www.reuters.com/finance/stocks/GILD.O/key-developments/article/3533070","2017-02-22 11:36:00","Reuters Key Development","Gilead Sciences Canada says Ontario to list Epclusa on public drug plan to treat all six genotypes of chronic Hepatitis C infection","GILD"," Gilead"
"415","Cramer&#39;s lightning round: Why Gilead could be a value trap","http://www.cnbc.com/2017/02/22/cramers-lightning-round-why-gilead-could-be-a-value-trap.html","2017-02-22 19:22:30","CNBC","Incyte Corporation: ""Let me give you some incite about Incyte, I think this company is incredibly undervalued because they have got a great pipeline and they actually make a lot of money.","GILD"," Gilead"
"416","Undervalued Gilead Sciences – FCF/EV Yield 30%, Shareholder Yield 17%","http://www.valuewalk.com/2017/02/undervalued-gilead-sciences-fcfev-yield-30-shareholder-yield-17/","2017-02-23 08:18:45","ValueWalk","One of the cheapest stocks in our all All Investable - Stock Screener is Gilead Sciences, Inc. (NASDAQ:GILD). Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company. The company focuses on the discovery, development and ...","GILD"," Gilead"
"417","The Technical Facts on Gilead Sciences Inc. (GILD)","http://theusacommerce.com/2017/02/23/the-technical-facts-on-gilead-sciences-inc-gild-3/","2017-02-23 13:45:00","The USA Commerce","We have gathered the technical data on Gilead Sciences Inc. (GILD), and see some interesting trends in the stock's behavior of late.","GILD"," Gilead"
"418","Gilead Sciences Inc. (GILD) Shouts Loudly With Its Technical Chart","http://nystocknews.com/2017/02/23/gilead-sciences-inc-gild-shouts-loudly-with-its-technical-chart/","2017-02-23 14:07:30","NY Stock News","The technicals for Gilead Sciences Inc. (GILD) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup.","GILD"," Gilead"
"419","Gilead&#39;s strategy to deal with the EU patent of TDF expiring is to switch ...","http://seekingalpha.com/article/4049323-gilead-hcv-problem","2017-02-24 09:06:21","Seeking Alpha","I can hear your sigh of relief, for this week, we'll explore Gilead's (NASDAQ:GILD) thriving HIV business rather than the dreadful HCV business we covered last week.","GILD"," Gilead"
"420","Latest Updates :Gilead Sciences Inc.&#39;s (GILD) stock price is Worth at $69.94 ...","http://www.hotstockspoint.com/latest-updates-gilead-sciences-inc-s-gild-stock-price-worth-69-94-analysts-mean-rating-score-stands-2-30/","2017-02-27 07:30:02","Hot Stocks Point","Gilead Sciences Inc.'s (GILD) stock price ended its day with a gain of 0.82% and finalized at the price of $69.94. During its last trading session, Stock traded with the total exchanged volume of 7.37 million shares.","GILD"," Gilead"
"421","Gilead seeks to overturn $2.54 bln verdict in hepatitis C drug case","http://www.reuters.com/article/health-gilead-idUSL2N1GC0DV","2017-02-27 07:45:00","Reuters","Gilead Sciences Inc has asked a federal judge to overturn a record $2.54 billion jury verdict in a patent infringement lawsuit by rival Merck & Co Inc over Gilead's blockbuster hepatitis C drugs Sovaldi and Harvoni.","GILD"," Gilead"
"422","Top Trending Stock: Gilead Sciences Inc.&#39;s (GILD) stock price ends at $69.94 ...","http://www.wsnews4investors.com/2017/02/27/top-trending-stock-gilead-sciences-inc-s-gild-stock-price-ends-at-69-94-with-performance-of-0-82-on-volume-of-7367038-shares/","2017-02-27 09:11:14","WsNews 4investors","Gilead Sciences Inc.'s (GILD ) stock price distance from twenty day simple moving average slumped at -0.14% while its distance from fifty day simple moving average declined -3.03% along with -9.36% below distance from two hundred simple moving ...","GILD"," Gilead"
"423","Investor Center: Tracking the Numbers for Gilead Sciences Inc. (NASDAQ:GILD)","https://rivesjournal.com/investor-center-tracking-the-numbers-for-gilead-sciences-inc-nasdaqgild/56066/","2017-02-27 10:12:08","Rives Journal","The 12 month stock volatility for Gilead Sciences Inc. (NASDAQ:GILD) is currently 26.482100. The 6 month volatility is 23.758200, and the 3 month is seen at 26.087200.","GILD"," Gilead"
"424","Top Stocks on the Move: Cousins Properties Incorporated (NYSE:CUZ), Gilead ...","http://theriponadvance.com/top-stocks-on-the-move-cousins-properties-incorporated-nysecuz-gilead-sciences-inc-nasdaqgild/12154510/","2017-02-27 11:21:02","TRA","Cousins Properties Incorporated (NYSE:CUZ) ended its previous trading session at $8.49 with the Loss of -0.24%. The company's market cap is $3.46 Billion, and the average volume is $4.35 Million. The 52-Week High range of the stock is $8.82, while the ...","GILD"," Gilead"
"425","Gilead Sciences Inc. (GILD) : How Do the Technicals Stack Up?","http://theusacommerce.com/2017/02/27/gilead-sciences-inc-gild-how-do-the-technicals-stack-up/","2017-02-27 12:55:18","The USA Commerce","We have gathered the technical data on Gilead Sciences Inc. (GILD), and see some interesting trends in the stock's behavior of late.","GILD"," Gilead"
"426","Gilead: Cure - The Killer Paradigm","http://seekingalpha.com/article/4050082-gilead-cure-killer-paradigm","2017-02-27 13:11:15","Seeking Alpha","Gilead's (NASDAQ:GILD) HCV franchise breaks entirely new ground. It challenges society's standards for incentivizing medical advancements that are too effective.","GILD"," Gilead"
"427","Analyst Research Roundup: Citizens Financial Group, Inc. (CFG), Gilead ...","http://thewellesleysnews.com/index.php/2017/02/27/analyst-research-roundup-citizens-financial-group-inc-cfg-gilead-sciences-inc-gild/","2017-02-27 13:34:37","TWN","Citizens Financial Group, Inc. (NYSE:CFG) tinted loss of -1.61% (-0.6 points) to US$36.65. The volume of 7.55 Million shares climbed up over an trading activity of 5.01 Million shares.","GILD"," Gilead"
"428","Numeric Investors Llc Buys Gilead Sciences, Microsoft, Baxter International ...","http://www.gurufocus.com/news/487558/numeric-investors-llc-buys-gilead-sciences-microsoft-baxter-international-sells-facebook-symantec-comcast","2017-02-27 15:37:30","GuruFocus.com","Boston, MA, based Investment company Numeric Investors Llc buys Gilead Sciences, Microsoft, Baxter International, Apple, NetApp, CVS Health, Lamb Weston Holdings, FirstEnergy, Synchrony Financial, Baker Hughes, sells Facebook, Symantec, Comcast, ...","GILD"," Gilead"
"429","Earnings Rolls on, Stock Update on Gilead Sciences, Inc. (NASDAQ:GILD)","http://winfieldreview.com/earnings-rolls-on-stock-update-on-gilead-sciences-inc-nasdaqgild/36071/","2017-02-27 19:55:50","Winfield Review","Gilead Sciences, Inc. (NASDAQ:GILD) most recently reported quarterly actual earnings per share of $2.64 for the period ending on 2016-12-31.","GILD"," Gilead"
"430","Sanofi and Regeneron announce 18-month results of ODYSSEY long term trial with praluent (alirocumab)","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3172755","2015-03-14 22:58:00","Reuters Key Development","Sanofi and Regeneron announce 18-month results of ODYSSEY long term trial with praluent (alirocumab)","SNY","Sanofi Genzyme"
"431","Sanofi affiliate Shantha to provide up to 37 million doses of Shan5","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3173716","2015-03-17 02:00:00","Reuters Key Development","Sanofi affiliate Shantha to provide up to 37 million doses of Shan5","SNY","Sanofi Genzyme"
"432","Sanofi SA announces top-line results for cardiovascular outcomes study of Lyxumia (lixisenatide)","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3175439","2015-03-19 02:11:00","Reuters Key Development","Sanofi SA announces top-line results for cardiovascular outcomes study of Lyxumia (lixisenatide)","SNY","Sanofi Genzyme"
"433","Evotec AG and Sanofi SA sign definitive agreement for major multi-component strategic alliance","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3176160","2015-03-19 20:11:00","Reuters Key Development","Evotec AG and Sanofi SA sign definitive agreement for major multi-component strategic alliance","SNY","Sanofi Genzyme"
"434","Sanofi SA&#39;s Sanofi Pasteur division announces FDA approval of Quadracel DTaP-IPV vaccine","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3180162","2015-03-25 12:15:00","Reuters Key Development","Sanofi SA's Sanofi Pasteur division announces FDA approval of Quadracel DTaP-IPV vaccine","SNY","Sanofi Genzyme"
"435","Sanofi&#39;s Sanofi Pasteur division&#39;s Gardasil 9 HPV vaccine gets positive opinion from EMA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3182321","2015-03-27 09:02:00","Reuters Key Development","Sanofi's Sanofi Pasteur division's Gardasil 9 HPV vaccine gets positive opinion from EMA","SNY","Sanofi Genzyme"
"436","Innate Pharma and Sanofi collaborate on antibody-drug conjugates","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3193180","2015-04-16 01:30:00","Reuters Key Development","Innate Pharma and Sanofi collaborate on antibody-drug conjugates","SNY","Sanofi Genzyme"
"437","Sanofi partnership with Ypsomed Group to include new project","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3199281","2015-04-23 20:00:00","Reuters Key Development","Sanofi partnership with Ypsomed Group to include new project","SNY","Sanofi Genzyme"
"438","Sanofi says Sanofi FDA grants fast track designation to Genzyme&#39;s therapy","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3201777","2015-04-28 01:03:00","Reuters Key Development","Sanofi says Sanofi FDA grants fast track designation to Genzyme's therapy","SNY","Sanofi Genzyme"
"439","Sanofi SA reaffirms FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3203648","2015-04-30 01:30:00","Reuters Key Development","Sanofi SA reaffirms FY 2015 EPS guidance","SNY","Sanofi Genzyme"
"440","Sanofi and Regeneron announce positive pivotal phase 2b dupilumab data in asthma","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3215042","2015-05-18 12:30:00","Reuters Key Development","Sanofi and Regeneron announce positive pivotal phase 2b dupilumab data in asthma","SNY","Sanofi Genzyme"
"441","Regeneron Pharmaceuticals Inc and Sanofi announce positive topline results from phase 3 studies with sarilumab in patients with rheumatoid arthritis","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3216367","2015-05-21 01:00:00","Reuters Key Development","Regeneron Pharmaceuticals Inc and Sanofi announce positive topline results from phase 3 studies with sarilumab in patients with rheumatoid arthritis","SNY","Sanofi Genzyme"
"442","Sanofi SA announces FDA grants breathrough therapy designation to Genzyme&#39;s Olipudase Alfa","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3224564","2015-06-04 01:00:00","Reuters Key Development","Sanofi SA announces FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa","SNY","Sanofi Genzyme"
"443","Sanofi SA announces positive results for Toujeo in Phase III study extension in Japanese people with uncontrolled diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3225459","2015-06-06 15:01:00","Reuters Key Development","Sanofi SA announces positive results for Toujeo in Phase III study extension in Japanese people with uncontrolled diabetes","SNY","Sanofi Genzyme"
"444","FDA Advisory Committee recommends approval of Sanofi SA and Regeneron Pharmaceuticals, Inc&#39;s Praluent (alirocumab) Injection for Patients with Hypercholesterolemia","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3226790","2015-06-09 18:41:00","Reuters Key Development","FDA Advisory Committee recommends approval of Sanofi SA and Regeneron Pharmaceuticals, Inc's Praluent (alirocumab) Injection for Patients with Hypercholesterolemia","SNY","Sanofi Genzyme"
"445","Public Citizen said it petitioned U.S. health regulators to withdraw approval of Sanofi SA&#39;s Seprafilm and order a recall - Reuters","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3241688","2015-07-06 20:00:00","Reuters Key Development","Public Citizen said it petitioned U.S. health regulators to withdraw approval of Sanofi SA's Seprafilm and order a recall - Reuters","SNY","Sanofi Genzyme"
"446","Sanofi , Regeneron&#39;s high cholesterol drug Praluent gets EMA nod","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3250218","2015-07-24 07:00:00","Reuters Key Development","Sanofi , Regeneron's high cholesterol drug Praluent gets EMA nod","SNY","Sanofi Genzyme"
"447","Regeneron and Sanofi announce FDA Approval of Praluent Injection","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3250352","2015-07-24 15:17:00","Reuters Key Development","Regeneron and Sanofi announce FDA Approval of Praluent Injection","SNY","Sanofi Genzyme"
"448","AstraZeneca to sell cancer medicine Caprelsa to Sanofi &#39;s Genzyme","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3250575","2015-07-27 02:00:00","Reuters Key Development","AstraZeneca to sell cancer medicine Caprelsa to Sanofi 's Genzyme","SNY","Sanofi Genzyme"
"449","Sanofi says new data analyses support its dengue vaccine","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3251584","2015-07-27 12:00:00","Reuters Key Development","Sanofi says new data analyses support its dengue vaccine","SNY","Sanofi Genzyme"
"450","Regeneron and Sanofi launch major new immuno-oncology collaboration","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3251587","2015-07-28 01:00:00","Reuters Key Development","Regeneron and Sanofi launch major new immuno-oncology collaboration","SNY","Sanofi Genzyme"
"451","Sanofi comments on FY 2015 Business EPS guidance","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3253010","2015-07-30 01:32:00","Reuters Key Development","Sanofi comments on FY 2015 Business EPS guidance","SNY","Sanofi Genzyme"
"452","Ligand enters into commercial license and supply agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3253559","2015-07-30 09:00:00","Reuters Key Development","Ligand enters into commercial license and supply agreement with Sanofi","SNY","Sanofi Genzyme"
"453","Sanofi SA, Evotec enter diabetes partnership","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3258114","2015-08-07 01:00:00","Reuters Key Development","Sanofi SA, Evotec enter diabetes partnership","SNY","Sanofi Genzyme"
"454","Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3258770","2015-08-10 01:00:00","Reuters Key Development","Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills","SNY","Sanofi Genzyme"
"455","Sanofi SA to collaborate with Google life sciences","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3268023","2015-08-31 09:00:00","Reuters Key Development","Sanofi SA to collaborate with Google life sciences","SNY","Sanofi Genzyme"
"456","Sanofi SA Genzyme pays $32.59 mln in criminal Seprafilm case - Reuters","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3269855","2015-09-02 20:00:00","Reuters Key Development","Sanofi SA Genzyme pays $32.59 mln in criminal Seprafilm case - Reuters","SNY","Sanofi Genzyme"
"457","PeptiDream announces collaboration agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3272537","2015-09-13 19:45:00","Reuters Key Development","PeptiDream announces collaboration agreement with Sanofi","SNY","Sanofi Genzyme"
"458","Sanofi reports positive top-line results in second pivotal LixiLan Phase III study","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3272791","2015-09-14 01:00:00","Reuters Key Development","Sanofi reports positive top-line results in second pivotal LixiLan Phase III study","SNY","Sanofi Genzyme"
"459","Regeneron Pharmaceuticals Inc and Sanofi SA Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in the European Union","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3277938","2015-09-28 01:00:00","Reuters Key Development","Regeneron Pharmaceuticals Inc and Sanofi SA Announce Approval of Praluent (alirocumab) for the Treatment of Hypercholesterolemia in the European Union","SNY","Sanofi Genzyme"
"460","Eli Lilly and Company and Sanofi reach settlement agreement in U.S. insulin glargine litigation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3278263","2015-09-28 09:33:00","Reuters Key Development","Eli Lilly and Company and Sanofi reach settlement agreement in U.S. insulin glargine litigation","SNY","Sanofi Genzyme"
"461","Sanofi SA reaches patent settlement on Lantus SoloSTAR with Eli Lilly and Co","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3278267","2015-09-28 09:34:00","Reuters Key Development","Sanofi SA reaches patent settlement on Lantus SoloSTAR with Eli Lilly and Co","SNY","Sanofi Genzyme"
"462","Sanofi SA New Drug Application for lixisenatide accepted for review by FDA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3278811","2015-09-29 08:00:00","Reuters Key Development","Sanofi SA New Drug Application for lixisenatide accepted for review by FDA","SNY","Sanofi Genzyme"
"463","Sanofi reports positive long-term data for Genzyme&#39;s Lemtrada clinical trials","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3282367","2015-10-08 01:00:00","Reuters Key Development","Sanofi reports positive long-term data for Genzyme's Lemtrada clinical trials","SNY","Sanofi Genzyme"
"464","Sanofi SA - Sanofi U.S. recalls Auvi-Q injections for severe allergy - Reuters","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3292271","2015-10-28 17:11:00","Reuters Key Development","Sanofi SA - Sanofi U.S. recalls Auvi-Q injections for severe allergy - Reuters","SNY","Sanofi Genzyme"
"465","Sanofi and Hanmi announce license agreement","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3296337","2015-11-05 01:02:00","Reuters Key Development","Sanofi and Hanmi announce license agreement","SNY","Sanofi Genzyme"
"466","Sanofi gives mid term outlook (2018-2020)","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3297021","2015-11-06 01:00:00","Reuters Key Development","Sanofi gives mid term outlook (2018-2020)","SNY","Sanofi Genzyme"
"467","Sanofi SA and Lexicon Pharmaceuticals to collaborate on Sotagliflozin","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3297020","2015-11-06 01:00:00","Reuters Key Development","Sanofi SA and Lexicon Pharmaceuticals to collaborate on Sotagliflozin","SNY","Sanofi Genzyme"
"468","Regeneron and Sanofi announce new Praluent (alirocumab) injection analyses presented at AHA scientific sessions 2015","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3298678","2015-11-10 18:00:00","Reuters Key Development","Regeneron and Sanofi announce new Praluent (alirocumab) injection analyses presented at AHA scientific sessions 2015","SNY","Sanofi Genzyme"
"469","Regeneron and Sanofi say Odyssey Outcomes Trial of Praluent injection fully enrolled","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3303529","2015-11-24 01:00:00","Reuters Key Development","Regeneron and Sanofi say Odyssey Outcomes Trial of Praluent injection fully enrolled","SNY","Sanofi Genzyme"
"470","Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3314589","2015-12-23 01:00:00","Reuters Key Development","Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide","SNY","Sanofi Genzyme"
"471","Sanofi Dengvaxia dengue vaccine approved in Brazil","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3315770","2015-12-28 05:31:00","Reuters Key Development","Sanofi Dengvaxia dengue vaccine approved in Brazil","SNY","Sanofi Genzyme"
"472","Sanofi and Innate Pharma collaborate on new bispecific NK cell engagers in immuno-oncology","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3318972","2016-01-10 21:00:00","Reuters Key Development","Sanofi and Innate Pharma collaborate on new bispecific NK cell engagers in immuno-oncology","SNY","Sanofi Genzyme"
"473","Sanofi says U.S. FDA accepts diabetes drug application","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3333646","2016-02-22 01:00:00","Reuters Key Development","Sanofi says U.S. FDA accepts diabetes drug application","SNY","Sanofi Genzyme"
"474","Sanofi Genzyme presents results from phase 1/2 study of therapy for pompe disease","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3338873","2016-03-03 17:00:00","Reuters Key Development","Sanofi Genzyme presents results from phase 1/2 study of therapy for pompe disease","SNY","Sanofi Genzyme"
"475","Sanofi and Regeneron announce results of study on sarilumab","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3341778","2016-03-11 01:00:00","Reuters Key Development","Sanofi and Regeneron announce results of study on sarilumab","SNY","Sanofi Genzyme"
"476","Sanofi SA (ADR) - DICE Deal To Replace Injectables With Oral Formulations","http://www.businessfinancenews.com/28244-sanofi-sa-adr-dice-deal-to-replace-injectables-with-oral-formulations/","2016-03-16 15:27:59","Business Finance News","Sanofi SA (ADR) (NYSE:SNY) has announced it has signed an agreement with DiCE Molecules, for the research and development of novel molecules that can replace injectables with oral formulations, for certain diseases.","SNY","Sanofi Genzyme"
"477","Who Will Acquire Medivation Inc; Sanofi SA (ADR), Gilead Sciences, Inc. or Others?","http://www.businessfinancenews.com/28554-who-will-acquire-medivation-inc-sanofi-sa-adr-gilead-sciences-inc-or-others/","2016-04-13 13:54:15","Business Finance News","On the other hand, Sanofi SA (NYSE:SNY) is also working with the financial advisers for a possible acquisition of the Medivation.","SNY","Sanofi Genzyme"
"478","Sanofi SA (ADR): SNY Pipeline Is Overflowing With Potential","http://investorplace.com/2016/04/sanofi-stock-sny-pipeline/","2016-04-14 12:18:45","Investorplace.com","France-based Sanofi SA (ADR) (SNY) is one of the world's largest pharmaceutical companies. I mentioned where it's headquartered because the company actually pre-dates much of America.","SNY","Sanofi Genzyme"
"479","Sanofi SA (ADR) (NYSE:SNY) Looking To Acquire Medivation Inc (NASDAQ:MDVN) For ...","http://marketexclusive.com/sanofi-sa-adr-nysesny-looking-acquire-medivation-inc-nasdaqmdvn-9-3-billion/6124/","2016-04-29 10:37:30","Market Exclusive","Sanofi SA (ADR) (NYSE:SNY) has made public its intention of acquiring Medivation Inc (NASDAQ:MDVN), having tabled a $9.3 billion takeover bid.","SNY","Sanofi Genzyme"
"480","Pfizer Inc, Sanofi SA (ADR), Novartis AG (ADR): Who Will Acquire Medivation Inc?","http://www.businessfinancenews.com/28846-pfizer-inc-sanofi-sa-adr-novartis-ag-adr-who-will-acquire-medivation-inc/","2016-05-04 14:25:40","Business Finance News","The drugmakers are looking for M&A to expand their drug portfolios in order to make their drug pipeline more robust and competitive.","SNY","Sanofi Genzyme"
"481","Inovio Pharmaceuticals Inc, Sanofi SA (ADR): Zika Virus Vaccine Failure is ...","http://www.businessfinancenews.com/28864-inovio-pharmaceuticals-inc-sanofi-sa-adr-zika-virus-vaccine-failure-is-into/","2016-05-05 14:09:46","Business Finance News","According to GlaxoSmithKline plc (ADR) (NYSE:GSK), a vaccine minimally takes 10-15 years to get approved by the regulatory agencies such as Food and Drug Administration (FDA) and European Union (EU).","SNY","Sanofi Genzyme"
"482","Medivation Inc Takeover Talk: Sanofi May Lose Out Despite Offer To Raise Bid","http://www.bidnessetc.com/68544-medivation-takeover-talk-sanofi-lose-offer-raise-bid/","2016-05-06 08:00:00","Bidness ETC","Last week, the French drug giant Sanofi SA (ADR) (NYSE:SNY) publicly offered to buy Medivation for $52.50 per share, almost a 50% premium over the company's average share price in the two months prior to takeover speculations.","SNY","Sanofi Genzyme"
"483","Sanofi files for Hart-Scott-Rodino notification regarding proposed acquisition of Medivation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3373437","2016-05-12 14:17:01","Reuters Key Development","Sanofi files for Hart-Scott-Rodino notification regarding proposed acquisition of Medivation","SNY","Sanofi Genzyme"
"484","Amgen Or Sanofi - Who is More Desperate for Medivation?","http://www.bidnessetc.com/68940-amgen-sanofi-desperate-medivation/","2016-05-13 08:00:00","Bidness ETC","So far, however, only Sanofi SA ADR (NYSE:SNY) has publically announced its acquisition proposal. The French drug maker has offered to buy Medivation at $52.50, which reflects a 50% premium over the target's average stock price of two months before the ...","SNY","Sanofi Genzyme"
"485","Sanofi seeking to replace entire Medivation board - CNBC","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3374639","2016-05-13 09:20:57","Reuters Key Development","Sanofi seeking to replace entire Medivation board - CNBC","SNY","Sanofi Genzyme"
"486","ALK-Abello names Carsten Hellmann new CEO","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3377205","2016-05-18 00:59:21","Reuters Key Development","ALK-Abello names Carsten Hellmann new CEO","SNY","Sanofi Genzyme"
"487","Sanofi says Pascale Witz, executive VP, diabetes &amp; cardiovascular, to leave company on June 1","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3379871","2016-05-23 08:19:03","Reuters Key Development","Sanofi says Pascale Witz, executive VP, diabetes & cardiovascular, to leave company on June 1","SNY","Sanofi Genzyme"
"488","Sanofi SA (ADR) and Diabetes: Things Are Not Working Out","http://www.businessfinancenews.com/29092-sanofi-sa-adr-and-diabetes-things-are-not-working-out/","2016-05-24 14:11:15","Business Finance News","Sanofi SA (NYSE:SNY) came into the spotlight after Food and Drug Administration (FDA) initiated a debate in association with its Diabetes Mellitus Type II combo drug LixiLan pointing out number of questions regarding the safety and clinical efficacy ...","SNY","Sanofi Genzyme"
"489","Sanofi seeking shareholder support for removal of Medivation board","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3381348","2016-05-25 06:25:00","Reuters Key Development","Sanofi seeking shareholder support for removal of Medivation board","SNY","Sanofi Genzyme"
"490","Is Sanofi SA (ADR) (SNY) Overvalued at Current Levels?","http://investcorrectly.com/20160525/is-sanofi-sa-adr-sny-overvalued-at-current-levels/","2016-05-25 08:33:45","InvestCorrectly","Sanofi SA (ADR) (NYSE:SNY) valuation is a point of concern on the street, given the headwinds the drug maker is facing.","SNY","Sanofi Genzyme"
"491","Sanofi sends letter to Medivation board of directors","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3381444","2016-05-25 08:43:55","Reuters Key Development","Sanofi sends letter to Medivation board of directors","SNY","Sanofi Genzyme"
"492","FDA recommends approval of Sanofi treatment for Type 2 Diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3381713","2016-05-25 18:50:00","Reuters Key Development","FDA recommends approval of Sanofi treatment for Type 2 Diabetes","SNY","Sanofi Genzyme"
"493","Parnell Pharmaceuticals says manufacturing deal with Merial","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3384640","2016-05-31 16:05:00","Reuters Key Development","Parnell Pharmaceuticals says manufacturing deal with Merial","SNY","Sanofi Genzyme"
"494","Sanofi expected to request record date from Medivation today - CNBC, citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3385339","2016-06-01 09:52:01","Reuters Key Development","Sanofi expected to request record date from Medivation today - CNBC, citing sources","SNY","Sanofi Genzyme"
"495","Sanofi requests record date for consent solicitation to remove and replace Medivation&#39;s board","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3385442","2016-06-01 14:15:00","Reuters Key Development","Sanofi requests record date for consent solicitation to remove and replace Medivation's board","SNY","Sanofi Genzyme"
"496","Medivation sets record date for Sanofi&#39;s proposed consent solicitation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3385522","2016-06-01 18:45:00","Reuters Key Development","Medivation sets record date for Sanofi's proposed consent solicitation","SNY","Sanofi Genzyme"
"497","Pfizer Inc, Sanofi SA (ADR) Could Eye Biogen&#39;s Hemophilia Franchise","http://www.bidnessetc.com/69916-pfizer-sanofi-sa-eye-biogens-hemophilia-franchise/","2016-06-03 11:05:21","Bidness ETC","Sanofi SA (ADR) could be one of the potential buyers interested in paying up for Biogen's hemophilia business. Having no approved and launched drugs for the treatment of the rare blood disorder, Sanofi might be interested in investigating a potential ...","SNY","Sanofi Genzyme"
"498","Sanofi, Regeneron Pharmaceuticals Inc. To Launch Blockbuster Molecule Really Soon","http://www.businessfinancenews.com/29222-sanofi-regeneron-pharmaceuticals-to-launch-blockbuster-molecule-really-soon/","2016-06-07 11:15:06","Business Finance News","Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) in collaboration with Sanofi (NYSE:SNY) has announced the positive results in relation to the clinical trials of the investigational molecule dupilumab indicated for the management and treatment rare skin ...","SNY","Sanofi Genzyme"
"499","Sanofi files investor presentation with SEC on proposed acquisition of Medivation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3388592","2016-06-08 06:32:19","Reuters Key Development","Sanofi files investor presentation with SEC on proposed acquisition of Medivation","SNY","Sanofi Genzyme"
"500","Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation&lt;MDVN.O&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3390853","2016-06-13 12:09:10","Reuters Key Development","Sanofi announces expiration of Hart-Scott-Rodino waiting period for proposed acquisition of Medivation<MDVN.O><SASY.PA>","SNY","Sanofi Genzyme"
"501","U.S. SEC accuses Christopher Plaford of insider trading, overstating fund&#39;s valuation&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3391640","2016-06-15 10:43:29","Reuters Key Development","U.S. SEC accuses Christopher Plaford of insider trading, overstating fund's valuation<SASY.PA>","SNY","Sanofi Genzyme"
"502","Can BioMarin Rumors be Sanofi&#39;s Ruse to Lure In Medivation?","http://www.bidnessetc.com/70526-biomarin-rumors-sanofis-ruse-lure-medivation/","2016-06-18 09:16:05","Bidness ETC","Note that while being attractive, BioMarin and its pipeline is not just overvalued for Sanofi S.A. (ADR) (NYSE:SNY), but also an unnecessary area of expansion.","SNY","Sanofi Genzyme"
"503","Sanofi May Try and Win Over Medivation With Past, Genzyme-Like Tactics","http://www.bidnessetc.com/70722-sanofi-try-win-medivation-genzymelike-tactics/","2016-06-23 07:51:43","Bidness ETC","Sanofi SA (ADR) (NYSE:SNY) is leaving no stone unturned to convince Medivation Inc. shareholders of the benefit in ousting their own board of directors.","SNY","Sanofi Genzyme"
"504","Medivation Inc Shareholders May Turn Down Sanofi&#39;s Bid","http://www.bidnessetc.com/70827-medivation-shareholders-turn-sanofis-bid/","2016-06-27 09:16:40","Bidness ETC","Medivation Inc (NASDAQ:MDVN), the most attractive acquisition target for large drug makers seeking high growth assets specifically in the area of oncology, faces a crucial decision at this point as Sanofi SA (ADR) (NYSE:SNY) advances with its takeover ...","SNY","Sanofi Genzyme"
"505","How the Asset Swap Deal Fits into Sanofi&#39;s Restructuring Plans","http://www.bidnessetc.com/70853-asset-swap-deal-fits-sanofis-restructuring-plans/","2016-06-27 14:43:34","Bidness ETC","Sanofi SA ADR (NYSE:SNY) has announced a $25.1 billion deal, (22.8 billion euro) under which the drug maker would be swapping certain assets with German drugmaker, Boehringer Ingelheim GmbH.","SNY","Sanofi Genzyme"
"506","Icagen acquires Sanofi&#39;s Oro Valley, Arizona research facility","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3396485","2016-06-27 16:00:00","Reuters Key Development","Icagen acquires Sanofi's Oro Valley, Arizona research facility","SNY","Sanofi Genzyme"
"507","Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3397100","2016-06-28 09:56:10","Reuters Key Development","Sanofi sounding out Medivation shareholders as it prepares to raise bid- CNBC","SNY","Sanofi Genzyme"
"508","Sanofi Genzyme says Saskatchewan has added Lemtrada to province&#39;s MS drugs program","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3400571","2016-07-05 08:00:00","Reuters Key Development","Sanofi Genzyme says Saskatchewan has added Lemtrada to province's MS drugs program","SNY","Sanofi Genzyme"
"509","Sanofi raises Medivation offer, enters confidentiality agreement","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3400756","2016-07-05 16:28:03","Reuters Key Development","Sanofi raises Medivation offer, enters confidentiality agreement","SNY","Sanofi Genzyme"
"510","Sanofi Genzyme begins pivotal phase 2/3 trial","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3401178","2016-07-06 08:00:00","Reuters Key Development","Sanofi Genzyme begins pivotal phase 2/3 trial","SNY","Sanofi Genzyme"
"511","Sanofi SA (ADR) (SNY) Confirmed Confidentiality Agreement with Medivation Inc ...","http://www.thecountrycaller.com/29559-sanofi-sa-adr-sny-confirmed-confidentiality-agreement-with-medivation-inc-mdvn","2016-07-06 09:07:30","TCC","As Medivation Inc (NASDAQ:MDVN) is headed towards a selloff, it is in talks with many parties who seek to buy the company. With Board of Directors consent, Medivation and Sanofi SA (ADR) (NYSE:SNY) have entered into confidentiality agreement.","SNY","Sanofi Genzyme"
"512","Sanofi Enzyme says Ontario adds LEMTRADA to exceptional access program for eligible patients","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3409200","2016-07-21 08:00:00","Reuters Key Development","Sanofi Enzyme says Ontario adds LEMTRADA to exceptional access program for eligible patients","SNY","Sanofi Genzyme"
"513","Sanofi India June-qtr profit up about 33 pct&lt;SANO.NS&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3409952","2016-07-22 06:37:43","Reuters Key Development","Sanofi India June-qtr profit up about 33 pct<SANO.NS><SASY.PA>","SNY","Sanofi Genzyme"
"514","Sanofi pasteur ships seasonal influenza vaccine doses in U.S.","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3411659","2016-07-26 08:00:00","Reuters Key Development","Sanofi pasteur ships seasonal influenza vaccine doses in U.S.","SNY","Sanofi Genzyme"
"515","Sanofi, Pfizer, Gilead &amp; Celgene interested in Medivation - CNBC citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3415470","2016-07-29 09:40:53","Reuters Key Development","Sanofi, Pfizer, Gilead & Celgene interested in Medivation - CNBC citing sources","SNY","Sanofi Genzyme"
"516","Can Sanofi Increased Hunger for Medivation Drive Out Competition?","http://www.bidnessetc.com/71850-sanofi-increased-hunger-medivation-drive-competition/","2016-07-30 10:48:45","Bidness ETC","After reporting poor second quarter financial data, Sanofi SA (ADR) (NYSE:SNY) is more persistent than ever to acquire US biotech Medivation Inc. Earnings and sales both fell in the quarter, despite a double-digit growth posted by its biotech division ...","SNY","Sanofi Genzyme"
"517","Sanofi SA (ADR) (SNY) and Regeneron Pharmaceuticals Inc (REGN) Ready to Enter ...","http://www.thecountrycaller.com/65737-sanofi-sa-adr-sny-and-regeneron-pharmaceuticals-inc-regn-ready-to-enter-european-therapeutic-markets","2016-08-02 08:22:30","TCC","Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that their human monoclonal antibody, sarilumab has been given green signal by the European Medicines Agency (EMA) for the marketing authorization ...","SNY","Sanofi Genzyme"
"518","Will Pluristem Therapeutics Inc. (NASDAQ:PSTI) Succeed in CLI Where Sanofi SA ...","http://marketexclusive.com/will-pluristem-therapeutics-inc-nasdawqpsti-succeed-cli-sanofi-sa-adr-nysesny-failed/24337/","2016-08-11 10:09:14","Market Exclusive","Back in 2010, Sanofi SA (ADR) (NYSE:SNY) failed a promising Phase III CLI study for its drug called NV1FGF, even after positive Phase II results that were unfortunately not successfully replicated in the larger pivotal trial.","SNY","Sanofi Genzyme"
"519","Headwinds Ahead Of Sanofi SA (ADR) (SNY) Diabetes Portfolio In 2017","http://www.thecountrycaller.com/43265-headwinds-ahead-of-sanofi-sa-adr-sny-diabetes-portfolio-in-2017","2016-08-15 15:41:15","TCC","Berenberg analyst, Alistair Campbell made no change in Sanofi SA (NYSE:SNY) Hold rating and $93.00 price target, following second quarter earnings release.","SNY","Sanofi Genzyme"
"520","Amgen, Sanofi and Regeneron&#39;s PCSK9 drugs need to be cheaper study says","http://www.bidnessetc.com/72349-amgen-sanofi-cut-cholesterol-molecules-prices/","2016-08-17 12:21:51","Bidness ETC","On Tuesday,the Journal of the American Medical Association in a study opined that Amgen, Inc. (NASDAQ:AMGN), Sanofi SA, and Regeneron's cholesterol-lowering molecules have to cut prices to more than two-third in order get momentum in the revenue ...","SNY","Sanofi Genzyme"
"521","Zealand Pharma announces new timelines for U.S. FDA decision on iglarlixi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3429751","2016-08-19 18:28:57","Reuters Key Development","Zealand Pharma announces new timelines for U.S. FDA decision on iglarlixi","SNY","Sanofi Genzyme"
"522","FDA&#39;s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi","http://www.insidermonkey.com/blog/fdas-sanofi-sa-adr-sny-delay-highlights-some-red-flags-with-iglarlixi-470046/","2016-08-22 11:56:15","Insider Monkey (blog)","We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)'s insulin combo candidate IGlarLixi.","SNY","Sanofi Genzyme"
"523","Sanofi, Regeneron&#39;s Praluent Gets Label Expansion","http://www.bidnessetc.com/72776-sanofi-regenerons-praluent-label-expansion/","2016-08-30 13:28:38","Bidness ETC","Praluent's growth has been shaky due to the hefty price tag of $14,000 annually and the insurers have restricted its access to the therapeutic market.","SNY","Sanofi Genzyme"
"524","Inside the FDA: Why Sanofi SA (ADR) (NYSE:SNY) IGlarLixi Was Delayed But Novo ...","https://marketexclusive.com/inside-fda-sanofi-sa-adr-nysesny-iglarlixi-delayed-novo-nordisk-adr-nysenvo-ideglira-wasnt/26122/","2016-09-02 09:49:41","Market Exclusive","The race between Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) combination diabetes therapies is now down to the wire, with Novo pulling ahead after a delay was slapped on Sanofi.","SNY","Sanofi Genzyme"
"525","Market Insights on Price Target: Sanofi SA (ADR) (NYSE:SNY)","http://postregistrar.com/2016/09/06/market-insights-on-price-target-sanofi-sa-adr-nysesny/","2016-09-06 11:08:29","Post Registrar","Sanofi SA (ADR) (NYSE:SNY) soared 2.00% during previous trade, a total of 1.28M shares exchanged hands compared with its average trading volume of 1.70M shares whereas its relative volume is 0.56.","SNY","Sanofi Genzyme"
"526","Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo ...","http://www.insidermonkey.com/blog/inside-the-fda-why-sanofi-sa-adr-sny-iglarlixi-was-delayed-but-novo-nordisk-as-adr-nvo-ideglira-wasnt-472620/","2016-09-06 13:37:30","Insider Monkey (blog)","The race between Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) combination diabetes therapies is now down to the wire, with Novo pulling ahead after a delay was slapped on Sanofi.","SNY","Sanofi Genzyme"
"527","Lexicon Pharmaceuticals, Inc, Sanofi SA Collab Sotagliflozin Outshines in ...","http://www.bidnessetc.com/72962-lexicon-pharmaceuticals-sanofi-sa-collab-sotagliflozin-outshines-pha/","2016-09-09 10:15:00","Bidness ETC","Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock jumped as high as 24.89% during the early trading hours today, after the company reported the results from its pivotal inTandem1 Phase 3 trial of Sotagliflozin, which is a treatment for diabetes.","SNY","Sanofi Genzyme"
"528","Sanofi SA (ADR) &amp; Alphabet Inc&#39;s Verily Life Sciences To Bet Big On Diabetes","http://www.thecountrycaller.com/47995-sanofi-sa-adr-alphabet-incs-verily-life-sciences-to-bet-big-on-diabetes","2016-09-12 07:48:45","TCC","According to a recent announcement, Sanofi SA (ADR) (NYSE:SNY) and Alphabet Inc's (NASDAQ:GOOGL) Verily Life Sciences are teaming up to spin out a collaborative venture, called Onduo.","SNY","Sanofi Genzyme"
"529","Sanofi files suit in U.S. to defend paten rights on Lantus and Lantus Solostar","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3442156","2016-09-19 01:00:42","Reuters Key Development","Sanofi files suit in U.S. to defend paten rights on Lantus and Lantus Solostar","SNY","Sanofi Genzyme"
"530","Sanofi SA (ADR) (SNY) Sues Merck &amp; Co., Inc. (MRK) Over Multiple Patent ...","http://investorplace.com/2016/09/sanofi-merck/","2016-09-19 12:18:45","Investorplace.com","Sanofi SA (ADR) (NYSE:SNY) is suing Merck & Co., Inc. (NYSE:MRK) for what it claims are several instances of patent infringement.","SNY","Sanofi Genzyme"
"531","Sanofi and Regeneron accepted for priority review by U.S. FDA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3444832","2016-09-26 01:00:45","Reuters Key Development","Sanofi and Regeneron accepted for priority review by U.S. FDA","SNY","Sanofi Genzyme"
"532","U.S. Department of health and human services says BARDA awards funding to Sanofi Pasteur for Zika vaccine","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3445252","2016-09-26 10:36:46","Reuters Key Development","U.S. Department of health and human services says BARDA awards funding to Sanofi Pasteur for Zika vaccine","SNY","Sanofi Genzyme"
"533","Sanofi says BARDA grants $43.2 million to Sanofi Pasteur for Zika","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3445249","2016-09-26 11:05:24","Reuters Key Development","Sanofi says BARDA grants $43.2 million to Sanofi Pasteur for Zika","SNY","Sanofi Genzyme"
"534","Immune Design Announces Advancement of First GLAAS-based Allergy Program into Clinical Development","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3446435","2016-09-28 08:00:00","Reuters Key Development","Immune Design Announces Advancement of First GLAAS-based Allergy Program into Clinical Development","SNY","Sanofi Genzyme"
"535","Will Sanofi SA (ADR) (SNY) Lead the Zika Vaccine Manufacturing?","http://smartstocknews.com/56760-will-sanofi-sa-adr-sny-lead-the-zika-vaccine-manufacturing/","2016-09-28 11:08:56","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Keeping in view the severity of the Zika virus, multiple companies are working on the research and development (R&D) to ascertain the vaccine for the virus.","SNY","Sanofi Genzyme"
"536","Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN) Ready to Launch ...","http://smartstocknews.com/63782-sanofi-sa-adr-sny-regeneron-pharmaceuticals-inc-regn-ready-to-launch-dermatology-molecule/","2016-10-03 10:37:30","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi SA (ADR) (NYSE:SNY) have announced that the clinical results from the LIBERTY AD SOLO 1 and SOLO 2 tests to check the vitality of the investigational molecule Dupixent® (dupilumab) have ...","SNY","Sanofi Genzyme"
"537","Sanofi reports open market purchase of 450,000 shares of Myokardia","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3449608","2016-10-05 09:00:00","Reuters Key Development","Sanofi reports open market purchase of 450,000 shares of Myokardia","SNY","Sanofi Genzyme"
"538","Sanofi SA (ADR) (NYSE:SNY), Alphabet Inc (NASDAQ:GOOGL) Verily Life Sciences ...","http://marketexclusive.com/sanofi-sa-adr-nysesny-alphabet-inc-nasdaqgoogl-verily-life-sciences-llc-forms-joint-venture/33617/","2016-10-11 09:18:45","Market Exclusive","The company will tap the expertise of Sanofi in clinical development and of Verily Life Sciences in analytics, miniaturization, and software development.","SNY","Sanofi Genzyme"
"539","Science 37 secures $31m series B funding","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3455848","2016-10-18 07:30:00","Reuters Key Development","Science 37 secures $31m series B funding","SNY","Sanofi Genzyme"
"540","Myriad RBM announces agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3460295","2016-10-25 07:05:00","Reuters Key Development","Myriad RBM announces agreement with Sanofi","SNY","Sanofi Genzyme"
"541","Earnings Whispers: Sanofi SA (ADR) (SNY) and Xerox Corp (XRX)","http://www.thecountrycaller.com/40702-earnings-whispers-sanofi-sa-adr-sny-and-xerox-corp-xrx","2016-10-27 12:07:30","TCC","Ahead of the third quarter earnings report of Sanofi SA (ADR) (NYSE:SNY) and Xerox Corp (NYSE:XRX) for the fiscal year 2016, The Country Caller discusses whisper numbers for both the companies.","SNY","Sanofi Genzyme"
"542","Sanofi CEO says share buyback doesn&#39;t preclude M&amp;A","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3463971","2016-10-28 01:40:50","Reuters Key Development","Sanofi CEO says share buyback doesn't preclude M&A","SNY","Sanofi Genzyme"
"543","Regeneron advised by Sanofi that manufacturing deficiencies have been raised by U.S. FDA","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3464548","2016-10-28 06:14:42","Reuters Key Development","Regeneron advised by Sanofi that manufacturing deficiencies have been raised by U.S. FDA","SNY","Sanofi Genzyme"
"544","Regeneron and Sanofi receive complete response letter from FDA for Sarilumab","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3464966","2016-10-28 14:35:00","Reuters Key Development","Regeneron and Sanofi receive complete response letter from FDA for Sarilumab","SNY","Sanofi Genzyme"
"545","Sanofi starts phase 3 trial of pompe disease treatment","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3470265","2016-11-04 08:00:00","Reuters Key Development","Sanofi starts phase 3 trial of pompe disease treatment","SNY","Sanofi Genzyme"
"546","Mannkind - Enters into settlement agreement with Sanofi-Aventis","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3473963","2016-11-09 17:47:37","Reuters Key Development","Mannkind - Enters into settlement agreement with Sanofi-Aventis","SNY","Sanofi Genzyme"
"547","Selecta Biosciences receives exclusive rights to peanut allergy and celiac disease programs","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3474848","2016-11-10 06:45:00","Reuters Key Development","Selecta Biosciences receives exclusive rights to peanut allergy and celiac disease programs","SNY","Sanofi Genzyme"
"548","Sanofi gets CHMP recommendation for approval of Suliqua in the EU","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3476256","2016-11-11 07:19:44","Reuters Key Development","Sanofi gets CHMP recommendation for approval of Suliqua in the EU","SNY","Sanofi Genzyme"
"549","Alnylam pharmaceuticals announces Sanofi Genzyme opt-in decision","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3477537","2016-11-14 08:00:00","Reuters Key Development","Alnylam pharmaceuticals announces Sanofi Genzyme opt-in decision","SNY","Sanofi Genzyme"
"550","Regeneron and Sanofi Present Results from late-stage Monarch study at American College of Rheumatology Annual Meeting","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3479949","2016-11-16 08:00:00","Reuters Key Development","Regeneron and Sanofi Present Results from late-stage Monarch study at American College of Rheumatology Annual Meeting","SNY","Sanofi Genzyme"
"551","Sanofi says Sarilumab phase 3 study shows positive results","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3479934","2016-11-16 08:00:23","Reuters Key Development","Sanofi says Sarilumab phase 3 study shows positive results","SNY","Sanofi Genzyme"
"552","Sanofi says receives FDA approval of Soliqua 100/33&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3482360","2016-11-21 18:20:58","Reuters Key Development","Sanofi says receives FDA approval of Soliqua 100/33<SASY.PA>","SNY","Sanofi Genzyme"
"553","Sanofi says receives FDA approval of Soliqua 100/33","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3482361","2016-11-21 19:06:41","Reuters Key Development","Sanofi says receives FDA approval of Soliqua 100/33","SNY","Sanofi Genzyme"
"554","Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3482456","2016-11-21 19:38:20","Reuters Key Development","Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes","SNY","Sanofi Genzyme"
"555","Natrix Separations announces collaboration agreements with Merck and Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3487623","2016-11-30 09:30:00","Reuters Key Development","Natrix Separations announces collaboration agreements with Merck and Sanofi","SNY","Sanofi Genzyme"
"556","Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters","http://www.insidermonkey.com/blog/sanofi-sa-adr-sny-facing-manufacturing-headache-on-two-blockbusters-495295/","2016-11-30 13:00:00","Insider Monkey (blog)","Manufacturing problems in France threaten to delay the release of Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s blockbuster drug, dupilumab, according to analysts at Leerink.","SNY","Sanofi Genzyme"
"557","China Resources Sanjiu Medical &amp; Pharma plans framework agreement with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3488647","2016-12-01 23:20:46","Reuters Key Development","China Resources Sanjiu Medical & Pharma plans framework agreement with Sanofi","SNY","Sanofi Genzyme"
"558","Is Sanofi SA (ADR) (SNY) a Good Stock To Buy?","http://www.insidermonkey.com/blog/is-sanofi-sa-adr-sny-a-good-stock-to-buy-492320/","2016-12-04 17:07:30","Insider Monkey (blog)","Is Sanofi SA (ADR) (NYSE:SNY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.","SNY","Sanofi Genzyme"
"559","Sanofi Genzyme says initiation of ICARIA-MM phase III trial of Isatuximab","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3490154","2016-12-05 12:50:00","Reuters Key Development","Sanofi Genzyme says initiation of ICARIA-MM phase III trial of Isatuximab","SNY","Sanofi Genzyme"
"560","Sanofi to explore counterbid for Actelion amid J&amp;J talks - Bloomberg, citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3490184","2016-12-05 16:25:37","Reuters Key Development","Sanofi to explore counterbid for Actelion amid J&J talks - Bloomberg, citing sources","SNY","Sanofi Genzyme"
"561","EMA Reviews Regeneron Pharmaceuticals Inc (NASDAQ:REGN), Sanofi SA (ADR) (NYSE ...","https://marketexclusive.com/ema-reviews-regeneron-pharmaceuticals-inc-nasdaqregn-sanofi-sa-adr-nysesny-dupixent-maa/44430/","2016-12-09 07:56:15","Market Exclusive","The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) for Dupixent (dupilumab) as a treatment for adult ...","SNY","Sanofi Genzyme"
"562","Sanofi SA (SNY) to Acquire the Largest European Biotech Company","http://www.thecountrycaller.com/74630-sanofi-sa-sny-to-acquire-the-largest-european-biotech-company","2016-12-15 09:48:45","TCC","According to the latest report by Wall Street Journal, Sanofi (NYSE:SNY), the French drug maker, has entered in talks to acquire Actelion Pharmaceuticals Ltd.","SNY","Sanofi Genzyme"
"563","Sanofi in advanced talks to buy Actelion- Bloomberg, citing sources","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3496182","2016-12-15 20:43:43","Reuters Key Development","Sanofi in advanced talks to buy Actelion- Bloomberg, citing sources","SNY","Sanofi Genzyme"
"564","M&amp;A Drama Inspires Rare Round of Sanofi SA (SNY) Call Trading","http://www.schaeffersresearch.com/content/options/2016/12/21/ma-drama-inspires-rare-round-of-sanofi-sa-sny-call-trading","2016-12-21 14:18:47","Schaeffers Research (blog)","Sanofi SA's (ADR) (NYSE:SNY) hopes of buying Actelion have been dealt a serious blow, after Johnson & Johnson (NYSE:JNJ) ","SNY","Sanofi Genzyme"
"565","Sanofi SA (NYSE:SNY) Files Suit Against Novo Nordisk A/S (ADR) (NYSE:NVO) Over ...","https://marketexclusive.com/sanofi-sa-nysesny-files-suit-novo-nordisk-adr-nysenvo-false-insulin-claims/53087/","2016-12-28 12:37:30","Market Exclusive","Novo Nordisk A/S (NYSE:NVO) has been sued by Sanofi SA (NYSE:SNY) for making false claims. In the lawsuit filed in the United States, the French company has accused Novo Nordisk of claiming that the insulin drugs manufactured and distributed by ...","SNY","Sanofi Genzyme"
"566","Regulator Demands Divestiture In Asset Swap Deal Between Boehringer, Sanofi SA ...","http://www.insidermonkey.com/blog/regulator-demands-divestiture-in-asset-swap-deal-between-boehringer-sanofi-sa-adr-sny-513737/","2016-12-30 08:52:30","Insider Monkey (blog)","In the proposed asset swap involving Sanofi SA (ADR) (NYSE:SNY) and Boeringer Ingelheim, the latter was to acquire the former's animal care subsidiary for $13.5 billion.","SNY","Sanofi Genzyme"
"567","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3502754","2017-01-02 02:05:14","Reuters Key Development","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","SNY","Sanofi Genzyme"
"568","Myokardia says Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3503366","2017-01-03 08:30:00","Reuters Key Development","Myokardia says Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration","SNY","Sanofi Genzyme"
"569","Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over ...","http://www.insidermonkey.com/blog/mylan-nv-myl-abbvie-inc-abbv-sanofi-sa-adr-sny-in-spotlight-over-price-hikes-514347/","2017-01-03 13:11:15","Insider Monkey (blog)","A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations. The bill seeks to shed more light on the world of prescription drug pricing, though as all prices are driven by supply and ...","SNY","Sanofi Genzyme"
"570","Sanofi announces Soliqua 100/33 now available in the U.S","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3503972","2017-01-04 08:00:00","Reuters Key Development","Sanofi announces Soliqua 100/33 now available in the U.S","SNY","Sanofi Genzyme"
"571","Sanofi SA (ADR) (SNY) Hit With Cease And Desist Order On Dengue Vaccine Ads In ...","http://www.insidermonkey.com/blog/sanofi-sa-adr-sny-hit-with-cease-and-desist-order-on-dengue-vaccine-ads-in-the-philippines-514553/","2017-01-04 11:07:30","Insider Monkey (blog)","The Philippines Food and Drug Administration has ordered Sanofi SA (ADR) (NYSE:SNY) to desist from advertising its dengue vaccine or face major consequences.","SNY","Sanofi Genzyme"
"572","Impax confirms patent challenge relating to generic Aubagio","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3505064","2017-01-06 08:30:00","Reuters Key Development","Impax confirms patent challenge relating to generic Aubagio","SNY","Sanofi Genzyme"
"573","Sanofi and Immunext enter into agreement to develop treatments for autoimmune diseases","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3505805","2017-01-09 08:00:00","Reuters Key Development","Sanofi and Immunext enter into agreement to develop treatments for autoimmune diseases","SNY","Sanofi Genzyme"
"574","Amgen Wins Over Sanofi &amp; Regeneron; Here&#39;s How","http://www.thecountrycaller.com/54168-amgen-wins-over-sanofi-regeneron-heres-how","2017-01-09 14:41:15","TCC","According to the latest announcement by Amgen, Inc. (NASDAQ:AMGN), Delaware based US District Court has approved of its patent infringement allegations on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY). As per ...","SNY","Sanofi Genzyme"
"575","Amgen comments on Delaware court&#39;s ruling on PCSK9 patent litigation&lt;AMGN.O&gt;&lt;REGN.O&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506103","2017-01-09 18:21:52","Reuters Key Development","Amgen comments on Delaware court's ruling on PCSK9 patent litigation<AMGN.O><REGN.O><SASY.PA>","SNY","Sanofi Genzyme"
"576","Regeneron says Sanofi plant used to fill drugs now deemed acceptable&lt;REGN.O&gt;&lt;SASY.PA&gt;","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506085","2017-01-09 18:49:25","Reuters Key Development","Regeneron says Sanofi plant used to fill drugs now deemed acceptable<REGN.O><SASY.PA>","SNY","Sanofi Genzyme"
"577","Regeneron says Sanofi plant used to fill drugs now deemed acceptable","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506087","2017-01-09 19:26:18","Reuters Key Development","Regeneron says Sanofi plant used to fill drugs now deemed acceptable","SNY","Sanofi Genzyme"
"578","Amgen comments on Delaware court&#39;s ruling on PCSK9 patent litigation","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3506101","2017-01-09 20:04:52","Reuters Key Development","Amgen comments on Delaware court's ruling on PCSK9 patent litigation","SNY","Sanofi Genzyme"
"579","Sanofi buys 87,298 shares of Regeneron&#39;s common stock on Jan 11","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3508508","2017-01-13 16:28:47","Reuters Key Development","Sanofi buys 87,298 shares of Regeneron's common stock on Jan 11","SNY","Sanofi Genzyme"
"580","Enteris Biopharma enters agreement with Sanofi to develop investigational oral therapeutic for type 2 diabetes","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3512764","2017-01-23 08:04:00","Reuters Key Development","Enteris Biopharma enters agreement with Sanofi to develop investigational oral therapeutic for type 2 diabetes","SNY","Sanofi Genzyme"
"581","Sanofi and Regeneron announce first approval of Kevzara","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3518398","2017-02-01 01:10:29","Reuters Key Development","Sanofi and Regeneron announce first approval of Kevzara","SNY","Sanofi Genzyme"
"582","Sanofi&#39;s Xyzal® Allergy 24HR approved for over-the-counter use in United States","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3518423","2017-02-01 01:35:10","Reuters Key Development","Sanofi's Xyzal® Allergy 24HR approved for over-the-counter use in United States","SNY","Sanofi Genzyme"
"583","Verizon revealed newly restructured business unit","http://www.benchmarkmonitor.com/2017/02/03/verizon-revealed-newly-restructured-business-unit/","2017-02-03 08:07:30","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) shares moved to $40.51 after starting the day at $40.55 on Thursday. The weekly volatility of SNY is 1.16% and monthly volatility is 1.24%.","SNY","Sanofi Genzyme"
"584","Why Biogen Inc (BIIB) Stock Is a Solid Long-Term Bet","http://www.nasdaq.com/article/why-biogen-inc-biib-stock-is-a-solid-long-term-bet-cm743150","2017-02-03 11:30:00","Nasdaq","The competition is also getting tougher - large pharma rivals such as Novartis AG (ADR) (NYSE: NVS ) and Sanofi SA(ADR) (NYSE: SNY ) offer competing MS drugs. Near-term, BIIB would like see further approval for Spinraza, for the treatment of spinal ...","SNY","Sanofi Genzyme"
"585","Stocks to watch this week: Gilead Sciences, Inc.(NASDAQ: GILD); The Coca-Cola ...","http://fxdailyreport.com/stocks-watch-week-gilead-sciences-inc-nasdaq-gild-coca-cola-conyse-ko-nippon-telegraph-telephone-corp-adrnyse-ntt-sanofi-sa-adrnyse-sny/","2017-02-06 10:33:45","FX Daily Report","Sanofi SA (ADR)(NYSE: SNY) has been granted by the European Commission, the marketing authorization in Europe for SuliquaTM, the once-daily titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist ...","SNY","Sanofi Genzyme"
"586","Sanofi appointed Hugo Fry as general manager of UK and Ireland business","http://www.kcregister.com/sanofi-appointed-hugo-fry-as-general-manager-of-uk-and-ireland-business/40080/","2017-02-06 11:18:45","KC Register","Sanofi SA (ADR) (NYSE:SNY) has appointed Hugo Fry as the new general manager of its UK and Ireland business. Fry brings over two decades of commercial, strategic and management experience to the Guildford-based branch, most recently from Sanofi ...","SNY","Sanofi Genzyme"
"587","Where Does GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Stand In The Race Of ...","http://mmjreporter.com/where-does-gw-pharmaceuticals-plc-adr-nasdaqgwph-stand-in-the-race-of-patent-filing-2381.html","2017-02-07 07:45:00","MMJ Reporter","... number of patents (35 in the U.S. and 2 pending) for its cannabinoid receptor ligands, followed by Bristol-Myers Squibb (21 U.S.","SNY","Sanofi Genzyme"
"588","Earnings Scheduled For February 8, 2017","https://www.benzinga.com/news/earnings/17/02/9009954/earnings-scheduled-for-february-8-2017","2017-02-08 04:41:34","Benzinga","Louisiana-Pacific Corporation (NYSE: LPX) is estimated to report its quarterly earnings at $0.19 per share on revenue of $534.56 million.","SNY","Sanofi Genzyme"
"589","Sanofi SA (ADR) (SNY) Releases Earnings Results, Beats Expectations By $0.02 EPS","https://www.highlandmirror.com/2017-02-08-sanofi-sa-adr-sny-releases-earnings-results-beats-expectations-by-0-02-eps","2017-02-08 05:52:30","Highland Mirror","Sanofi SA (ADR) (SNY) announced its most recent quarterly financial results on Wednesday, Feb-8-2017. SNY said it had a profit of $1.25 Earnings per Share for the quarter.","SNY","Sanofi Genzyme"
"590","Sanofi SA (ADR) (NYSE:SNY) Heffx Trading Outlook","http://www.livetradingnews.com/sanofi-sa-adr-nysesny-heffx-trading-outlook-29764.html","2017-02-08 07:22:30","Live Trading News","During the past 10 bars, there have been 4 white candles and 5 black candles for a net of 1 black candles. During the past 50 bars, there have been 20 white candles and 29 black candles for a net of 9 black candles.","SNY","Sanofi Genzyme"
"591","Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3523223","2017-02-08 17:30:00","Reuters Key Development","Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent","SNY","Sanofi Genzyme"
"592","Regeneron Pharmaceuticals Inc (NASDAQ:REGN) And Sanofi SA (ADR)(NYSE:SNY ...","https://marketexclusive.com/regeneron-pharmaceuticals-inc-nasdaqregnand-sanofi-sa-adrnysesny-loses-suit-blocking-amgen-inc-nasdaqamgn-selling-cholesterol-drug/71476/","2017-02-09 06:20:33","Market Exclusive","Sanofi SA (ADR)(NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) have lost an important court battle. The two were seeking to have Amgen, Inc. (NASDAQ:AMGN) blocked from selling their cholesterol-lowering drug Praluent in the U.S.","SNY","Sanofi Genzyme"
"593","Regeneron says price increases unrelated from innovation will be pushed back on","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3524093","2017-02-09 09:00:00","Reuters Key Development","Regeneron says price increases unrelated from innovation will be pushed back on","SNY","Sanofi Genzyme"
"594","Twitter, Cliffs Natural Resources, Regeneron Pharmaceuticals News Today","http://www.schaeffersresearch.com/content/news/2017/02/09/twitter-cliffs-natural-resources-regeneron-pharmaceuticals-news-today","2017-02-09 10:00:00","Schaeffers Research (blog)","REGN is 2.6% higher at $362.69, after a U.S. appeals court stayed an order that would have blocked REGN and Sanofi SA (ADR) (NYSE:SNY) from selling their cholesterol drug, Praluent, while appealing the patent infringement victory of rival Amgen, Inc.","SNY","Sanofi Genzyme"
"595","Sanofi nearing deal to sell some over-the-counter products to Ipsen for about 100 mln euros- Bloomberg, citing source","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3525417","2017-02-12 20:43:20","Reuters Key Development","Sanofi nearing deal to sell some over-the-counter products to Ipsen for about 100 mln euros- Bloomberg, citing source","SNY","Sanofi Genzyme"
"596","Ipsen acquires a portfolio of select consumer healthcare products from Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3525545","2017-02-13 01:52:25","Reuters Key Development","Ipsen acquires a portfolio of select consumer healthcare products from Sanofi","SNY","Sanofi Genzyme"
"597","Sanofi SA (ADR) (NYSE:SNY) expects appeals on injunction against sales of ...","http://www.benchmarkmonitor.com/2017/02/13/sanofi-sa-adr-nysesny-expects-appeals-on-injunction-against-sales-of-pcsk9-inhibitor-praluent/","2017-02-13 07:40:57","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) expects an appeals court ruling on an injunction against sales of its PCSK9 inhibitor Praluent (alirocumab) could come as soon as June, lawyers representing the French drugmaker said on a media call Friday.","SNY","Sanofi Genzyme"
"598","Morning Top Movers: Dollar General Corporation (NYSE:DG), Sanofi SA (ADR ...","http://www.benchmarkmonitor.com/2017/02/13/morning-top-movers-dollar-general-corporation-nysedg-sanofi-sa-adr-nysesny/","2017-02-13 08:30:00","Benchmark Monitor","At the movement Dollar General Corporation (NYSE:DG) is under coverage by number of analysts. Buy rating has been given by 7 analysts to the company stock whereas no analyst given UNDERPERFORM rating to stock and 17 analysts given HOLD rating.","SNY","Sanofi Genzyme"
"599","Sanofi SA (ADR) (NYSE:SNY) approaching agreement to sell products to Ipsen SA","http://www.benchmarkmonitor.com/2017/02/13/sanofi-sa-adr-nysesny-approaching-agreement-to-sell-products-to-ipsen-sa/","2017-02-13 09:30:29","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) is nearing an agreement to sell some over-the-counter products to Ipsen SA as it edges closer to completing a 22.8 billion-euro ($24.2 billion) asset swap with Boehringer Ingelheim GmbH, according to a person familiar with ...","SNY","Sanofi Genzyme"
"600","Sanofi initiates phase 2 clinical trial","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3527352","2017-02-14 08:00:00","Reuters Key Development","Sanofi initiates phase 2 clinical trial","SNY","Sanofi Genzyme"
"601","Today&#39;s Stock Alert: Sanofi SA (ADR) (NYSE:SNY), Xcerra Corporation (NASDAQ:XCRA)","http://www.benchmarkmonitor.com/2017/02/16/todays-stock-alert-sanofi-sa-adr-nysesny-xcerra-corporation-nasdaqxcra/","2017-02-16 06:15:34","Benchmark Monitor","At the movement Sanofi SA (ADR) (NYSE:SNY) is under coverage by number of analysts. Buy rating has been given by 2 analysts to the company stock whereas no analyst given UNDERPERFORM rating to stock and 1 analyst given HOLD rating.","SNY","Sanofi Genzyme"
"602","Should You Buy Amgen, Inc. (AMGN) Stock? 3 Pros, 3 Cons","http://investorplace.com/2017/02/should-you-buy-amgn-stock-pros-cons/","2017-02-16 12:33:45","Investorplace.com","That spiked AMGN stock, while sending Praluent owners Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) lower.","SNY","Sanofi Genzyme"
"603","Dividend Growth of Sanofi(SNY)","https://www.morningoutlook.com/02-17-2017/dividend-growth-of-sanofisny/","2017-02-17 06:52:19","Morning Outlook","Currently the company Insiders own 1% of Sanofi shares according to the proxy statements. Institutional Investors own 9.63% of Sanofi shares.","SNY","Sanofi Genzyme"
"604","Momentum Stocks Sanofi SA (ADR) (NYSE:SNY), Advance Auto Parts, Inc. (NYSE:AAP)","http://www.journalfinance.net/2017/02/momentum-stocks-sanofi-sa-adr-nysesny-advance-auto-parts-inc-nyseaap/","2017-02-21 12:11:02","Daily News Journal (press release)","On Friday, Sanofi SA (ADR) (NYSE:SNY) stock opened its trade at $43.12 and after floating in a range of $43.06 to $43.33, settled at $43.16.","SNY","Sanofi Genzyme"
"605","Icahn Takes Bristol-Myers Stake With M&amp;A In Mind; Who Could Be The Acquirer?","http://finance.yahoo.com/news/icahn-takes-bristol-myers-stake-214820857.html","2017-02-21 19:53:59","Yahoo Finance","Jefferies analyst Jeffrey Holford suggested in a recent note the company may appeal to Sanofi SA (ADR) (NYSE: SNY), Johnson & Johnson (NYSE: JNJ), Pfizer Inc. (NYSE: PFE) and Novartis AG (ADR) (NYSE: NVS) - but not likely Amgen, Inc. (NASDAQ: ...","SNY","Sanofi Genzyme"
"606","News Buzz – WisdomTree Investments, Inc. (NASDAQ:WETF), Sanofi SA (ADR) (NYSE:SNY)","http://www.journalfinance.net/2017/02/news-buzz-wisdomtree-investments-inc-nasdaqwetf-sanofi-sa-adr-nysesny/","2017-02-22 07:45:00","Daily News Journal (press release)","Sanofi SA (ADR) (NYSE:SNY) shares moved to $42.76 after opening the day at $42.21, on Tuesday. The stock floated in a price range of $42.08 to $42.78, with market capitalization of $108.43B.","SNY","Sanofi Genzyme"
"607","The Western Union Company (NYSE:WU) &amp; Sanofi SA (ADR) (NYSE:SNY) News Recap","http://www.journalfinance.net/2017/02/the-western-union-company-nysewu-sanofi-sa-adr-nysesny-news-recap/","2017-02-23 10:17:43","Daily News Journal (press release)","On Wednesday, Shares of The Western Union Company (NYSE:WU) gained 0.91% to $19.99. The share price is trading in a range of $19.75 - 20.14.","SNY","Sanofi Genzyme"
"608","Breaking Down The Multiple Sclerosis 2017 Formularies: &#39;Stability Fares Well ...","https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9087784/breaking-down-the-multiple-sclerosis-2017-formularies-st","2017-02-23 13:56:15","Benzinga","The injectable treatment option later expanded to Novartis AG (ADR) (NYSE: NVS)'s Extavia, Biogen's Plegridy and Glatopa, the generic version of Copaxone developed by Novartis' Sandoz unit.","SNY","Sanofi Genzyme"
"609","Carl Icahn&#39;s Track Record In Big Pharma","https://www.benzinga.com/general/biotech/17/02/9084990/carl-icahns-track-record-in-big-pharma","2017-02-24 09:37:30","Benzinga","Genzyme, which is a unit of Sanofi SA (ADR) (NYSE: SNY) came on Icahn's radar after the FDA delayed approval of one of its new drug and also found issues with its Massachusetts factory in 2009.","SNY","Sanofi Genzyme"
"610","FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi","http://www.reuters.com/finance/stocks/SNY/key-developments/article/3535475","2017-02-24 13:47:00","Reuters Key Development","FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi","SNY","Sanofi Genzyme"
"611","Shares of Sanofi (SNY) Plunge -1.07%","http://www.energyindexwatch.com/2017-02-27-shares-of-sanofi-sny-plunge-1-07","2017-02-27 07:38:50","Energy Index","Currently the company Insiders own 1% of Sanofi shares according to the proxy statements. Institutional Investors own 9.73% of Sanofi shares.","SNY","Sanofi Genzyme"
"612","Stocks to bet on- Manulife Financial Corporation (USA) (NYSE:MFC), Sanofi SA ...","http://www.wallstreetnews24.com/stocks-to-bet-on-manulife-financial-corporation-usa-nysemfc-sanofi-sa-adr-nysesny/","2017-02-27 08:52:56","Wall Street Times (press release)","Manulife Financial Corporation (USA) (NYSE:MFC) traded at a yearly high level of $19.52 during the last trading session. The last session's volume of 3.85 million shares was higher than its average volume of 2.65 million shares.","SNY","Sanofi Genzyme"
"613","Sanofi (NYSE:SNY) and Lonza enter into strategic partnership to establish ...","http://www.benchmarkmonitor.com/2017/02/27/sanofi-nysesny-and-lonza-enter-into-strategic-partnership-to-establish-biologics-production-facility-in-switzerland/","2017-02-27 10:22:30","Benchmark Monitor","Sanofi SA (ADR) (NYSE:SNY) shares edged up 0.45% to $42.70 on Friday. Sanofi SA (ADR) (NYSE:SNY) and Lonza Group AG, announced Monday that they have entered into a strategic partnership to establish a large-scale biologics production facility in ...","SNY","Sanofi Genzyme"
"614","Merck &amp; Co Inc&#39;s pivotal keynote-006 study in first-line treatment for advanced melanoma met co-primary endpoints and will be stopped early","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3179044","2015-03-24 08:30:00","Reuters Key Development","Merck & Co Inc's pivotal keynote-006 study in first-line treatment for advanced melanoma met co-primary endpoints and will be stopped early","MRK","Merck"
"615","Merck &amp; Co Inc announces new $10 billion share repurchase program","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3179306","2015-03-24 17:00:00","Reuters Key Development","Merck & Co Inc announces new $10 billion share repurchase program","MRK","Merck"
"616","Ablynx NV announces extension of ion channel research collaboration with Merck &amp; Co., Inc","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3180505","2015-03-26 02:10:00","Reuters Key Development","Ablynx NV announces extension of ion channel research collaboration with Merck & Co., Inc","MRK","Merck"
"617","China Animal Husbandry Industry signs MOU with subsidiary of Merck &amp; Co., Inc","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3182009","2015-03-26 20:00:00","Reuters Key Development","China Animal Husbandry Industry signs MOU with subsidiary of Merck & Co., Inc","MRK","Merck"
"618","Merck announces publication of pivotal data from phase 3 clinical studies of ZERBAXA","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3200759","2015-04-27 18:30:00","Reuters Key Development","Merck announces publication of pivotal data from phase 3 clinical studies of ZERBAXA","MRK","Merck"
"619","Merck &amp; Co Inc reaffirms FY 2015 guidance, raises EPS outlook","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3201649","2015-04-28 07:07:00","Reuters Key Development","Merck & Co Inc reaffirms FY 2015 guidance, raises EPS outlook","MRK","Merck"
"620","Plexxikon and Merck to collaborate on combination study evaluating investigational immuno-oncology regimen","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3208233","2015-05-07 08:30:00","Reuters Key Development","Plexxikon and Merck to collaborate on combination study evaluating investigational immuno-oncology regimen","MRK","Merck"
"621","Merck &amp; Co., Inc receives positive CHMP opinion for Pembrolizumab for treatment of advanced melanoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3217696","2015-05-22 07:12:00","Reuters Key Development","Merck & Co., Inc receives positive CHMP opinion for Pembrolizumab for treatment of advanced melanoma","MRK","Merck"
"622","Merck &amp; Co Inc announces Q3 2015 Dividend","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3219198","2015-05-26 13:31:00","Reuters Key Development","Merck & Co Inc announces Q3 2015 Dividend","MRK","Merck"
"623","Merck and NanoString Announce Clinical Research Collaboration","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3220680","2015-05-28 08:30:00","Reuters Key Development","Merck and NanoString Announce Clinical Research Collaboration","MRK","Merck"
"624","Merck submits U.S. New Drug Application for Grazoprevir/Elbasvir","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3220865","2015-05-28 16:30:00","Reuters Key Development","Merck submits U.S. New Drug Application for Grazoprevir/Elbasvir","MRK","Merck"
"625","Amgen And Merck Announce Expansion Of Collaboration","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3221511","2015-05-29 08:30:00","Reuters Key Development","Amgen And Merck Announce Expansion Of Collaboration","MRK","Merck"
"626","Merck &amp; Co Inc and Dynavax Technologies Corp announce new collaboration investigating combination of Immuno-Oncology Therapies","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3222444","2015-06-01 08:30:00","Reuters Key Development","Merck & Co Inc and Dynavax Technologies Corp announce new collaboration investigating combination of Immuno-Oncology Therapies","MRK","Merck"
"627","Merck &amp; Co Inc announces results from investigational IMPROVE-IT Study of VYTORIN published in New England Journal of Medicine","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3224228","2015-06-03 17:00:00","Reuters Key Development","Merck & Co Inc announces results from investigational IMPROVE-IT Study of VYTORIN published in New England Journal of Medicine","MRK","Merck"
"628","Merck &amp; Co Inc&#39;s Keytruda (pembrolizumab) receives conditional approval in Canada for treatment of Advanced Melanoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3225840","2015-06-08 07:00:00","Reuters Key Development","Merck & Co Inc's Keytruda (pembrolizumab) receives conditional approval in Canada for treatment of Advanced Melanoma","MRK","Merck"
"629","Merck &amp; Co Inc Cardiovascular safety trial of Januvia (Sitagliptin), met primary endpoint in patients with type 2 diabetes","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3227308","2015-06-10 07:00:00","Reuters Key Development","Merck & Co Inc Cardiovascular safety trial of Januvia (Sitagliptin), met primary endpoint in patients with type 2 diabetes","MRK","Merck"
"630","Merck announces phase 3 study of single-dose EMEND","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3236566","2015-06-29 08:30:00","Reuters Key Development","Merck announces phase 3 study of single-dose EMEND","MRK","Merck"
"631","Merck announces fourth-quarter 2015 dividend","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3248875","2015-07-22 13:28:00","Reuters Key Development","Merck announces fourth-quarter 2015 dividend","MRK","Merck"
"632","Merck &amp; Co Inc Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3250931","2015-07-27 08:30:00","Reuters Key Development","Merck & Co Inc Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA","MRK","Merck"
"633","Merck &amp; Co Inc announces U.S. FDA acceptance of NDA for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Genotypes 1, 4 and 6 Infection","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3251556","2015-07-28 06:30:00","Reuters Key Development","Merck & Co Inc announces U.S. FDA acceptance of NDA for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Genotypes 1, 4 and 6 Infection","MRK","Merck"
"634","Merck buys cCam Biotherapeutics for $95 mln upfront payment in cash","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3251655","2015-07-28 06:45:00","Reuters Key Development","Merck buys cCam Biotherapeutics for $95 mln upfront payment in cash","MRK","Merck"
"635","Merck &amp; Co Inc raises FY 2015 EPS outlook; raises low end of prior FY 2015 revenue guidance to a range in line with analysts&#39; estimates","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3251595","2015-07-28 07:00:00","Reuters Key Development","Merck & Co Inc raises FY 2015 EPS outlook; raises low end of prior FY 2015 revenue guidance to a range in line with analysts' estimates","MRK","Merck"
"636","Merck &amp; Co Inc announces approval of Brenzys in Korea","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3270830","2015-09-08 08:30:00","Reuters Key Development","Merck & Co Inc announces approval of Brenzys in Korea","MRK","Merck"
"637","Merck &amp; Co Inc says results of Phase 2 Study of Merck&#39;s Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3275352","2015-09-18 15:00:00","Reuters Key Development","Merck & Co Inc says results of Phase 2 Study of Merck's Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015","MRK","Merck"
"638","Merck &amp; Co Inc&#39;s MARIZEV (Omarigliptin), Merck&#39;s Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3278135","2015-09-28 07:30:00","Reuters Key Development","Merck & Co Inc's MARIZEV (Omarigliptin), Merck's Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes, Approved in Japan","MRK","Merck"
"639","Merck &amp; Co Inc and DNAtrix announce phase 2 immuno-oncology collaboration in patients with aggressive form of brain cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3280184","2015-10-01 08:00:00","Reuters Key Development","Merck & Co Inc and DNAtrix announce phase 2 immuno-oncology collaboration in patients with aggressive form of brain cancer","MRK","Merck"
"640","Merck &amp; Co Inc says FDA approves KEYTRUDA for treatment of patients with metastatic non-small cell lung cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3280757","2015-10-02 14:49:00","Reuters Key Development","Merck & Co Inc says FDA approves KEYTRUDA for treatment of patients with metastatic non-small cell lung cancer","MRK","Merck"
"641","OBI Pharma, Inc. enters exclusive agreement with Merck for rights to DIFICID (fidaxomicin) in Taiwan","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3280787","2015-10-04 05:58:00","Reuters Key Development","OBI Pharma, Inc. enters exclusive agreement with Merck for rights to DIFICID (fidaxomicin) in Taiwan","MRK","Merck"
"642","MacroGenics Inc and Merck to collaborate on Immuno-Oncology study","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3288628","2015-10-22 07:30:00","Reuters Key Development","MacroGenics Inc and Merck to collaborate on Immuno-Oncology study","MRK","Merck"
"643","Merck &amp; Co Inc says KEYTRUDA shows superior overall survival compared to chemotherapy in patients with previously treated advanced non-small cell lung cancer whose tumors express PD-l1","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3290092","2015-10-26 09:00:00","Reuters Key Development","Merck & Co Inc says KEYTRUDA shows superior overall survival compared to chemotherapy in patients with previously treated advanced non-small cell lung cancer whose tumors express PD-l1","MRK","Merck"
"644","Eli Lilly And Co and Merck &amp; Co Inc expand immuno-oncology collaboration with phase III nonsquamous non-small cell lung cancer trial","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3301983","2015-11-19 06:30:00","Reuters Key Development","Eli Lilly And Co and Merck & Co Inc expand immuno-oncology collaboration with phase III nonsquamous non-small cell lung cancer trial","MRK","Merck"
"645","Merck &amp; Co Inc announces increased quarterly dividend","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3303643","2015-11-24 12:35:00","Reuters Key Development","Merck & Co Inc announces increased quarterly dividend","MRK","Merck"
"646","Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin Lymphoma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3307408","2015-12-04 08:01:00","Reuters Key Development","Amgen And Merck Announce Cancer Immunotherapy Collaboration For Patients With Non-Hodgkin Lymphoma","MRK","Merck"
"647","Merck &amp; Co Inc - FDA panel rejects Merck claim Zetia/Vytorin cut heart risk - Reuters","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3312671","2015-12-14 16:28:00","Reuters Key Development","Merck & Co Inc - FDA panel rejects Merck claim Zetia/Vytorin cut heart risk - Reuters","MRK","Merck"
"648","Merck &amp; Co Inc says FDA approves expanded age indication for Gardasil 9 in males","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3311388","2015-12-15 17:07:00","Reuters Key Development","Merck & Co Inc says FDA approves expanded age indication for Gardasil 9 in males","MRK","Merck"
"649","Biocartis Group announces collaboration with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3318287","2016-01-07 02:00:00","Reuters Key Development","Biocartis Group announces collaboration with Merck","MRK","Merck"
"650","Merck &amp; Co Inc acquires IOmet Pharma","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3319291","2016-01-11 16:08:00","Reuters Key Development","Merck & Co Inc acquires IOmet Pharma","MRK","Merck"
"651","Merck announces FDA acceptance of Biologics License Application for Bezlotoxumab","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3324546","2016-01-27 08:30:00","Reuters Key Development","Merck announces FDA acceptance of Biologics License Application for Bezlotoxumab","MRK","Merck"
"652","Merck &amp; Co Inc gives FY 2016 guidance","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3328130","2016-02-03 06:45:00","Reuters Key Development","Merck & Co Inc gives FY 2016 guidance","MRK","Merck"
"653","Merck &amp; Co Inc&#39;s investigational once-daily formulation of ISENTRESS meets primary and secondary endpoints in pivotal phase 3 study","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3333704","2016-02-22 08:00:00","Reuters Key Development","Merck & Co Inc's investigational once-daily formulation of ISENTRESS meets primary and secondary endpoints in pivotal phase 3 study","MRK","Merck"
"654","Merck sets quarterly dividend of 46 cents per share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3380812","2016-05-24 14:35:00","Reuters Key Development","Merck sets quarterly dividend of 46 cents per share","MRK","Merck"
"655","Merck Global Health Innovation Fund hikes stake in OpGen to 37.5 pct from 11.8 pct","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3383227","2016-05-27 16:01:11","Reuters Key Development","Merck Global Health Innovation Fund hikes stake in OpGen to 37.5 pct from 11.8 pct","MRK","Merck"
"656","Merck to acquire Afferent Pharmaceuticals","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3389363","2016-06-09 17:07:00","Reuters Key Development","Merck to acquire Afferent Pharmaceuticals","MRK","Merck"
"657","Merck&#39;s Keytruda shows superior progression-free, overall survival in lung cancer patients","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3392163","2016-06-16 06:45:00","Reuters Key Development","Merck's Keytruda shows superior progression-free, overall survival in lung cancer patients","MRK","Merck"
"658","Merck, Premier Inc collaborate to improve care for osteoporosis patients","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3398666","2016-06-30 09:28:15","Reuters Key Development","Merck, Premier Inc collaborate to improve care for osteoporosis patients","MRK","Merck"
"659","Merck Animal Health to buy controlling interest in Vallée S.A","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3399527","2016-07-01 12:05:00","Reuters Key Development","Merck Animal Health to buy controlling interest in Vallée S.A","MRK","Merck"
"660","Merck&#39;s Healthcare invests majority stake in Staywell","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3403048","2016-07-11 07:00:00","Reuters Key Development","Merck's Healthcare invests majority stake in Staywell","MRK","Merck"
"661","Merck provides regulatory update on Biologics application","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3409440","2016-07-21 16:30:00","Reuters Key Development","Merck provides regulatory update on Biologics application","MRK","Merck"
"662","Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3410766","2016-07-25 08:00:00","Reuters Key Development","Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine","MRK","Merck"
"663","Enigma biomedical announces research collaboration agreement with Biogen Inc and Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3410983","2016-07-25 17:04:00","Reuters Key Development","Enigma biomedical announces research collaboration agreement with Biogen Inc and Merck","MRK","Merck"
"664","Merck sets quarterly dividend of $0.46 per share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3411869","2016-07-26 12:50:00","Reuters Key Development","Merck sets quarterly dividend of $0.46 per share","MRK","Merck"
"665","Merck plans to end partnership agreement with Alk Abello","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3412227","2016-07-27 01:25:37","Reuters Key Development","Merck plans to end partnership agreement with Alk Abello","MRK","Merck"
"666","Merck Q2 adjusted earnings per share $0.93","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3415225","2016-07-29 06:45:00","Reuters Key Development","Merck Q2 adjusted earnings per share $0.93","MRK","Merck"
"667","Biogen has drawn takeover interest from drug companies including Merck &amp; Co and Allergan - WSJ","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3417355","2016-08-02 14:47:32","Reuters Key Development","Biogen has drawn takeover interest from drug companies including Merck & Co and Allergan - WSJ","MRK","Merck"
"668","Merck announces U.S. FDA filing acceptance of new drug application (NDA) for mk-1293","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3420409","2016-08-05 08:00:00","Reuters Key Development","Merck announces U.S. FDA filing acceptance of new drug application (NDA) for mk-1293","MRK","Merck"
"669","Merck &amp; Co says FDA approves keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3420654","2016-08-05 19:30:00","Reuters Key Development","Merck & Co says FDA approves keytruda","MRK","Merck"
"670","BRIEF-Merck &amp; Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5)","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3421406","2016-08-08 11:43:34","Reuters Key Development","BRIEF-Merck & Co says FDA approves Keytruda for a type of head and neck cancer (Aug 5)","MRK","Merck"
"671","Biothera Pharmaceuticals expands relationship with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3431691","2016-08-24 11:25:00","Reuters Key Development","Biothera Pharmaceuticals expands relationship with Merck","MRK","Merck"
"672","Merck provides update on odanacatib development program","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3436751","2016-09-02 07:00:00","Reuters Key Development","Merck provides update on odanacatib development program","MRK","Merck"
"673","Merck says FDA grants breakthrough therapy designation to Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3438299","2016-09-07 06:45:00","Reuters Key Development","Merck says FDA grants breakthrough therapy designation to Keytruda","MRK","Merck"
"674","Merck Canada says BRENZYS approved in Canada","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3439878","2016-09-12 08:00:00","Reuters Key Development","Merck Canada says BRENZYS approved in Canada","MRK","Merck"
"675","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3441449","2016-09-15 08:31:00","Reuters Key Development","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","MRK","Merck"
"676","Merck&#39;s bladder cancer drug meets primary endpoint and stops early","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3458288","2016-10-21 06:45:00","Reuters Key Development","Merck's bladder cancer drug meets primary endpoint and stops early","MRK","Merck"
"677","Merck &amp; Co says FDA also approves a labeling update for Keytruda for treatment of patients with metastatic NSCLC","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3459589","2016-10-24 18:04:00","Reuters Key Development","Merck & Co says FDA also approves a labeling update for Keytruda for treatment of patients with metastatic NSCLC","MRK","Merck"
"678","Merck prices EUR 1 bln debt offering","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3461738","2016-10-26 13:31:00","Reuters Key Development","Merck prices EUR 1 bln debt offering","MRK","Merck"
"679","Adaptimmune announces collaboration with MSD to evaluate Keytruda (pembrolizumab)","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3463232","2016-10-27 10:16:05","Reuters Key Development","Adaptimmune announces collaboration with MSD to evaluate Keytruda (pembrolizumab)","MRK","Merck"
"680","Biothera Pharma&#39;s announces new preclinical data on its immunotherapy drug","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3476469","2016-11-11 11:59:00","Reuters Key Development","Biothera Pharma's announces new preclinical data on its immunotherapy drug","MRK","Merck"
"681","OpGen collaborates with Merck to develop rapid diagnostics and informatics tools to help combat antimicrobial resistance","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3477399","2016-11-14 07:00:00","Reuters Key Development","OpGen collaborates with Merck to develop rapid diagnostics and informatics tools to help combat antimicrobial resistance","MRK","Merck"
"682","Genexine entered into a clinical research collaboration with Merck &amp; Co","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3479954","2016-11-16 08:00:00","Reuters Key Development","Genexine entered into a clinical research collaboration with Merck & Co","MRK","Merck"
"683","Merck raises quarterly dividend to $0.47/share from $0.46/share","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3483029","2016-11-22 13:22:00","Reuters Key Development","Merck raises quarterly dividend to $0.47/share from $0.46/share","MRK","Merck"
"684","Natrix Separations announces collaboration agreements with Merck and Sanofi","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3487624","2016-11-30 09:30:00","Reuters Key Development","Natrix Separations announces collaboration agreements with Merck and Sanofi","MRK","Merck"
"685","Merck CEO says importing drugs from outside U.S. not possible","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3488430","2016-12-01 11:18:11","Reuters Key Development","Merck CEO says importing drugs from outside U.S. not possible","MRK","Merck"
"686","Biothera Pharmaceuticals and Merck further expand research collaboration","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3490086","2016-12-05 09:30:00","Reuters Key Development","Biothera Pharmaceuticals and Merck further expand research collaboration","MRK","Merck"
"687","Merck presents updated findings from Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3490122","2016-12-05 10:42:00","Reuters Key Development","Merck presents updated findings from Keytruda","MRK","Merck"
"688","Drugmakers trade group says government mandates wrong way to address drug costs","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3491584","2016-12-07 12:15:21","Reuters Key Development","Drugmakers trade group says government mandates wrong way to address drug costs","MRK","Merck"
"689","Europea&#39;s CHMP recommends Merck&#39;s Keytruda® for lung cancer treatment","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3496632","2016-12-16 07:26:00","Reuters Key Development","Europea's CHMP recommends Merck's Keytruda® for lung cancer treatment","MRK","Merck"
"690","Keytruda approved in japan for first-line treatment of patients with advanced non-small cell lung cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3497456","2016-12-19 07:00:00","Reuters Key Development","Keytruda approved in japan for first-line treatment of patients with advanced non-small cell lung cancer","MRK","Merck"
"691","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3502755","2017-01-02 02:05:14","Reuters Key Development","Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe","MRK","Merck"
"692","Cerveau Technologies signs license agreement with Merck for novel investigational Tau imaging agent","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3504677","2017-01-05 16:02:00","Reuters Key Development","Cerveau Technologies signs license agreement with Merck for novel investigational Tau imaging agent","MRK","Merck"
"693","Merck &amp; Co Inc gets FDA acceptance of supplemental biologics license application for Keytruda in combination with chemotherapy","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3506688","2017-01-10 16:06:00","Reuters Key Development","Merck & Co Inc gets FDA acceptance of supplemental biologics license application for Keytruda in combination with chemotherapy","MRK","Merck"
"694","Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3509610","2017-01-17 09:00:00","Reuters Key Development","Agenus Inc says collaboration with National Cancer Institute to evaluate combination of Pembrolizumab with prophage autologous vaccine","MRK","Merck"
"695","Bristol-Myers squibb and Ono pharmaceutical enters license agreement with Merck","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3511915","2017-01-20 16:01:00","Reuters Key Development","Bristol-Myers squibb and Ono pharmaceutical enters license agreement with Merck","MRK","Merck"
"696","Merck announces license agreement resolving Keytruda patent litigation","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3511913","2017-01-20 16:01:00","Reuters Key Development","Merck announces license agreement resolving Keytruda patent litigation","MRK","Merck"
"697","Pharma stocks to watch this week: Merck &amp; Co., Inc.(NYSE: MRK), Pfizer Inc ...","http://fxdailyreport.com/pharma-stocks-watch-week-merck-co-inc-nyse-mrk-pfizer-inc-nyse-pfe-amgen-inc-nasdaq-amgn/","2017-01-30 07:14:55","FX Daily Report","Merck & Co., Inc.(NYSE: MRK) will release the earnings on February 2nd, 2017. MRK in this quarter is expected to report the average revenues of $10.23 billion in the current quarter as per the analysts.","MRK","Merck"
"698","Hematogenix announces the recognition by Merck &amp; Co. as one of the national ...","http://www.prnewswire.com/news-releases/hematogenix-announces-the-recognition-by-merck--co-as-one-of-the-national-reference-laboratories-offering-pd-l1-testing-for-keytruda-300399221.html","2017-01-31 07:11:15","PR Newswire (press release)","... drug development, announces the inclusion by Merck & Co., Inc. as one of the national reference laboratories offering the U.S.","MRK","Merck"
"699","European Commission approves Keytruda for first-line treatment of patients with metastatic non-small cell lung cancer","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3518169","2017-01-31 16:00:00","Reuters Key Development","European Commission approves Keytruda for first-line treatment of patients with metastatic non-small cell lung cancer","MRK","Merck"
"700","Pharmaceutical Executives From Merck &amp; Co., Inc. (NYSE:MRK), Johnson &amp; Johnson ...","https://marketexclusive.com/pharmaceutical-executives-merck-co-inc-nysemrk-johnson-johnson-nysejnj-among-met-trump/70762/","2017-02-01 09:26:15","Market Exclusive","Trump was speaking to pharmaceutical executives from some of the well-known firms the likes of Merck & Co., Inc.","MRK","Merck"
"701","The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck &amp; Co., Inc ...","https://marketexclusive.com/european-medicines-agency-ema-recommends-keytruda-merck-co-inc-nysemrk/70761/","2017-02-01 09:26:15","Market Exclusive","The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK).","MRK","Merck"
"702","Earnings Forecast Research on Merck &amp; Company, Inc. (MRK)","https://www.highlandmirror.com/2017-02-01-earnings-forecast-research-on-merck-company-inc-mrk","2017-02-01 12:48:45","Highland Mirror","Merck & Company, Inc. has received $0.88 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 9 Financial Advisor in the Stock Trading Firms.","MRK","Merck"
"703","Merck Q4 adjusted earnings per share $0.89","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3519577","2017-02-02 06:53:10","Reuters Key Development","Merck Q4 adjusted earnings per share $0.89","MRK","Merck"
"704","Merck 2017 forecast reassuring; full-speed ahead with Keytruda","http://www.reuters.com/article/us-merck-co-results-idUSKBN15H19N","2017-02-02 07:02:10","Reuters","Merck & Co Inc (MRK.N), faced with patent expirations and increasing development costs for its high-profile Keytruda cancer immunotherapy, reassured investors on Thursday with a 2017 profit forecast roughly in line with Wall Street expectations.","MRK","Merck"
"705","Sirius XM Holdings Inc., Merck &amp; Co., Inc. Post Solid Fourth Quarter Results","http://www.valuewalk.com/2017/02/sirius-xm-merck-post-solid-fourth-quarter-results/","2017-02-02 08:18:45","ValueWalk","Sirius XM and Merck released their latest earnings reports before opening bell this morning. Sirius XM reported $1.3 billion in revenue, which was in line with the consensus estimate.","MRK","Merck"
"706","Merck CEO says business development a priority","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3519734","2017-02-02 09:11:01","Reuters Key Development","Merck CEO says business development a priority","MRK","Merck"
"707","Merck &amp; Co. (MRK) Q4 2016 Results - Earnings Call Transcript","http://seekingalpha.com/article/4042020-merck-and-co-mrk-q4-2016-results-earnings-call-transcript","2017-02-02 12:23:42","Seeking Alpha","Good morning. My name is Darla, and I will be your conference operator today. At this time, I'd like to welcome everyone to Merck's Q4 full-year 2016 sales and earnings conference call. All lines have been placed on mute to prevent any background noise.","MRK","Merck"
"708","FDA grants accelerated approval to Bristol-Myers Squibb&#39;s nivolumab","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3519859","2017-02-02 14:33:05","Reuters Key Development","FDA grants accelerated approval to Bristol-Myers Squibb's nivolumab","MRK","Merck"
"709","Merck says FDA accepts two SBLAs for Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3520358","2017-02-03 06:45:00","Reuters Key Development","Merck says FDA accepts two SBLAs for Keytruda","MRK","Merck"
"710","Merck &amp; Co., Inc. (MRK) Stock: The Long-Awaited Breakout?","http://investorplace.com/2017/02/merck-co-inc-mrk-stock-the-long-awaited-breakout/","2017-02-03 08:07:30","Investorplace.com","Shares of global pharmaceutical company Merck & Co., Inc. (NYSE:MRK) rallied 3.35% on Thursday on the back of its latest quarterly financial results.","MRK","Merck"
"711","Stock Returns: Merck &amp; Co. Inc (NYSE:MRK) is Beating Teva Pharmaceutical ...","http://news.cmlviz.com/2017/02/03/stock-returns-merck--co-inc-nyse-mrk--is-beating-teva-pharmaceutical-industries-limited-nyse-teva.html","2017-02-03 09:29:04","CML News","This is a snapshot to compare the stock returns for Merck & Co. Inc (NYSE:MRK) versus Teva Pharmaceutical Industries Limited (NYSE:TEVA) .","MRK","Merck"
"712","Merck Q4 Sales Slip, Promises Better 2017 (MRK)","http://www.investopedia.com/news/merck-q4-sales-slip-promises-better-2017-mrk/","2017-02-03 11:18:45","Investopedia","Merck & Co Inc.'s (MRK) announced fourth-quarter 2016 results on Thursday. The quarterly revenue missed market expectations by a whisker, as the company struggled with sales of its immuno-oncology (I/O) bestseller, Keytruda, along with limited sales of ...","MRK","Merck"
"713","Buy or Sell? Average Brokerage Ratings on Merck &amp; Co., Inc. (MRK), CVS Health ...","http://stocknewsjournal.com/2017/02/03/buy-or-sell-average-brokerage-ratings-on-merck-co-inc-mrk-cvs-health-corporation-cvs/","2017-02-03 12:48:45","StockNewsJournal","ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.","MRK","Merck"
"714","Merck: Analyzing 2016 Performance And Outlook For 2017","http://seekingalpha.com/article/4042752-merck-analyzing-2016-performance-outlook-2017","2017-02-05 09:48:45","Seeking Alpha","On February 2, Merck (NYSE:MRK) reported fourth-quarter results that met analyst forecasts on earnings, but missed on revenue.","MRK","Merck"
"715","Immunovaccine says Princess Margaret Cancer Centre to conduct Phase 2 clinical trial to evaluate use of co, Merck&#39;s combination of immunotherapies","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3521121","2017-02-06 07:05:00","Reuters Key Development","Immunovaccine says Princess Margaret Cancer Centre to conduct Phase 2 clinical trial to evaluate use of co, Merck's combination of immunotherapies","MRK","Merck"
"716","Better Buy: Merck &amp; Co. Inc. vs. GlaxoSmithKline","https://www.fool.com/investing/2017/02/07/better-buy-merck-co-inc-vs-glaxosmithkline.aspx","2017-02-07 07:00:00","Motley Fool","They're two of the biggest pharmaceutical companies in the world, but Merck (NYSE:MRK) and GlaxoSmithKline (NYSE:GSK) have had very different paths lately.","MRK","Merck"
"717","Drilling Down Into Merck &amp; Co., Inc. (MRK)","http://stocknewsjournal.com/2017/02/08/drilling-down-into-merck-co-inc-mrk/","2017-02-08 13:00:00","StockNewsJournal","Merck & Co., Inc. (MRK) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers - Major.","MRK","Merck"
"718","EOD Risers: Home Depot Inc, Intel Corporation, McDonald&#39;s Corporation, Merck ...","http://www.directorstalkinterviews.com/eod-risers-home-depot-inc-intel-corporation-mcdonalds-corporation-merck-co-inc/412723522","2017-02-09 05:25:56","DirectorsTalk Interviews","The trading price for Home Depot Inc found using EPIC: (NYSE:HD) a home improvement retailer, gained 0.94% or 1.28 points in yesterday's trading session.","MRK","Merck"
"719","What do Analysts suggest for: Merck &amp; Co., Inc. (NYSE:MRK)","https://www.newsoracle.com/2017/02/09/what-do-analysts-suggest-for-merck-co-inc-nysemrk-4/","2017-02-09 08:18:45","News Oracle","Merck & Co., Inc. (NYSE:MRK) will report its next earnings on 2-May-17. The company reported the earnings of $0.89/Share in the last quarter where the estimated EPS by analysts was $0.89/share.","MRK","Merck"
"720","Boehringer Ingelheim - To evaluate Afatinib in combination with PD-1 inhibitor pembrolizumab","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3524069","2017-02-09 08:30:00","Reuters Key Development","Boehringer Ingelheim - To evaluate Afatinib in combination with PD-1 inhibitor pembrolizumab","MRK","Merck"
"721","Merck &amp; Co., Inc. (NYSE:MRK) HPV Vaccine Gardasil Sales Impress, But For How Long?","https://marketexclusive.com/merck-co-inc-nysemrks-hpv-vaccine-gardasil-sales-impress-long/71592/","2017-02-10 09:48:45","Market Exclusive","Merck & Co., Inc. (NYSE:MRK)'s fourth quarter sales of its Human Papilloma Virus (HPV) vaccine, Gardasil, registered a 9% year-on-year rise in 4Q.","MRK","Merck"
"722","Capital World Investors reports 5.1 pct passive stake in Merck &amp; Co as on Dec 30 - SEC Filing","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3526396","2017-02-13 17:14:45","Reuters Key Development","Capital World Investors reports 5.1 pct passive stake in Merck & Co as on Dec 30 - SEC Filing","MRK","Merck"
"723","Merck &amp; Company Inc. (new) (MRK) Closes 0.97% Up on the Day for February 13","http://www.equities.com/news/merck-company-inc-new-mrk-closes-0-97-up-on-the-day-for-february-13","2017-02-13 17:30:00","Equities.com","Shares of Merck & Company Inc. (new) (MRK) ended the trading day Monday at $64.77, representing a move of 0.97%, or $0.62 per share, on volume of 7.14 million shares.","MRK","Merck"
"724","EOD Risers: Merck &amp; Co., Inc., Microsoft Corporation, Pfizer Inc., Procter ...","http://www.directorstalkinterviews.com/eod-risers-merck-co-inc-microsoft-corporation-pfizer-inc-procter-gamble-co-coca-cola-co/412723849","2017-02-14 05:08:20","DirectorsTalk Interviews","Shares of Merck & Co., Inc. with EPIC code: (NYSE:MRK) a global healthcare company, increased 0.97% or 0.62 points during the course of yesterday's session.","MRK","Merck"
"725","Merck&#39;s doravirine meets primary efficacy endpoint in pivotal phase 3 trial","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3527699","2017-02-14 16:05:00","Reuters Key Development","Merck's doravirine meets primary efficacy endpoint in pivotal phase 3 trial","MRK","Merck"
"726","Merck announces Epoch study of Verubecestat","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3527787","2017-02-14 17:00:00","Reuters Key Development","Merck announces Epoch study of Verubecestat","MRK","Merck"
"727","Merck &amp; Co., Inc. (MRK) : Checking the Chart","http://www.theusacommerce.com/2017/02/15/merck-co-inc-mrk-checking-the-chart-3/","2017-02-15 07:11:15","The USA Commerce","We have gathered the technical data on Merck & Co., Inc. (MRK), and see some interesting trends in the stock's behavior of late.","MRK","Merck"
"728","Checking Out the Technicals for Merck &amp; Co., Inc. (MRK)","http://theusacommerce.com/2017/02/17/checking-out-the-technicals-for-merck-co-inc-mrk-4/","2017-02-15 07:11:15","The USA Commerce","We have gathered the technical data on Merck & Co., Inc. (MRK), and see some interesting trends in the stock's behavior of late.","MRK","Merck"
"729","Impact of Brokerage Rating on Merck &amp; Company, Inc.(MRK)","https://www.highlandmirror.com/2017-02-15-impact-of-brokerage-rating-on-merck-company-inc-mrk","2017-02-15 08:18:45","Highland Mirror","Many Merck & Company, Inc.(MRK) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.","MRK","Merck"
"730","Merck Halts Study of Experimental Alzheimer&#39;s Treatment","http://www.nbcphiladelphia.com/news/local/Merck-Study-Experimental-Alzheimers-Treatment-413862113.html","2017-02-15 08:52:30","NBC 10 Philadelphia","Merck & Co. Inc. said it is stopping mid-stage clinical testing of an experimental treatment for mild-to-moderate Alzheimer's disease.","MRK","Merck"
"731","Comprehensive Stock Analysis of: Merck &amp; Co., Inc. (NYSE:MRK)","https://www.newsoracle.com/2017/02/16/comprehensive-stock-analysis-of-merck-co-inc-nysemrk-2/","2017-02-15 10:11:15","News Oracle","Merck & Co., Inc. (NYSE:MRK) will report its next earnings on 2-May-17. The company reported the earnings of $0.89/Share in the last quarter where the estimated EPS by analysts was $0.89/share.","MRK","Merck"
"732","Merck &amp; Company Inc. (new) (MRK) Closes 0.76% Down on the Day for February 15","https://www.equities.com/news/merck-company-inc-new-mrk-closes-0-76-down-on-the-day-for-february-15","2017-02-15 17:30:08","Equities.com","Shares of Merck & Company Inc. (new) (MRK) ended the trading day Wednesday at $65.16, representing a move of -0.76%, or $0.5 per share, on volume of 17.66 million shares.","MRK","Merck"
"733","Analyst&#39;s Indicator Review for Merck &amp; Co., Inc. (MRK), Applied Materials, Inc ...","http://theusacommerce.com/2017/02/16/analysts-indicator-review-for-merck-co-inc-mrk-applied-materials-inc-amat/","2017-02-16 10:33:45","The USA Commerce","Shares of Merck & Co., Inc. (NYSE:MRK) dropped -0.76% to $65.16. During the trading on 02/15/2017, Company's stock ranged from $64.85 to $65.87.","MRK","Merck"
"734","Merck HIV Drug Doravirine Posts Positive Results (MRK)","http://www.investopedia.com/news/merck-hiv-drug-doravirine-posts-positive-results-mrk/","2017-02-16 14:07:30","Investopedia","Merck & Co Inc. (MRK) announced positive results from its Phase 3 clinical trial evaluating the safety and efficacy of its HIV drug, doravirine (MK-1439).","MRK","Merck"
"735","Traders Sell Shares of Merck &amp; Company, Inc. (MRK) on Strength After Analyst ...","https://www.thecerbatgem.com/2017/02/16/traders-sell-shares-of-merck-company-inc-mrk-on-strength-after-analyst-downgrade.html","2017-02-16 18:48:45","The Cerbat Gem","Merck & Company logo Traders sold shares of Merck & Company, Inc. (NYSE:MRK) on strength during trading on Thursday after BMO Capital Markets lowered their price target on the stock from $72.00 to $70.00.","MRK","Merck"
"736","Cutler Investment Counsel LLC Buys 872 Shares of Merck &amp; Company, Inc. (MRK)","https://www.baseball-news-blog.com/cutler-investment-counsel-llc-buys-872-shares-of-merck-company-inc-mrk/","2017-02-17 05:52:30","BNB Daily (blog)","Merck & Company logo Cutler Investment Counsel LLC increased its position in shares of Merck & Company, Inc.","MRK","Merck"
"737","Stocks To Watch: WebMD Health Corp. (NASDAQ:WBMD), Merck &amp; Co., Inc. (NYSE:MRK ...","https://stockmarketdaily.co/2017/02/17/stocks-to-watch-webmd-health-corp-nasdaqwbmd-merck-co-inc-nysemrk-truecar-inc-nasdaqtrue-arista-networks-inc-nyseanet-and-a-few-more/","2017-02-17 06:06:16","Stock Market Daily","(NASDAQ:WBMD), Merck & Co., Inc. (NYSE:MRK), TrueCar Inc (NASDAQ:TRUE), and Arista Networks Inc (NYSE:ANET). These apart, there are few companies that lined up to announce their earnings results that are worth watching.","MRK","Merck"
"738","Featured Stock to Focus: Merck &amp; Co., Inc. (NYSE:MRK)","https://factsreporter.com/2017/02/17/featured-stock-to-focus-merck-co-inc-nysemrk/","2017-02-17 09:48:45","FactsReporter","Merck & Co., Inc. on 02/02/2017 reported its EPS as $0.89 with the analysts projecting the EPS of the stock as $0.89.","MRK","Merck"
"739","Merck &amp; Company, Inc. (MRK) Price Target Cut to $70.00","https://www.thecerbatgem.com/2017/02/17/merck-company-inc-mrk-price-target-cut-to-70-00.html","2017-02-17 09:48:45","The Cerbat Gem","Merck & Company logo Merck & Company, Inc. (NYSE:MRK) had its target price decreased by BMO Capital Markets from $72.00 to $70.00 in a research report issued to clients and investors on Wednesday.","MRK","Merck"
"740","Option Trading: Merck &amp; Co. Inc (NYSE:MRK) Powerful Short Put Spreads to ...","http://news.cmlviz.com/2017/02/17/option-trading-merck--co-inc-nyse-mrk--powerful-short-put-spreads-to-outperform-earnings.html","2017-02-17 10:56:15","CML News","We find a very powerful outcome examining short put spreads for Merck & Co. Inc when we use a clever earnings risk management approach.","MRK","Merck"
"741","Merck &amp; Company, Inc. (MRK) Position Lowered by Sentinel Trust Co. LBA","https://www.thecerbatgem.com/2017/02/19/merck-company-inc-mrk-position-lowered-by-sentinel-trust-co-lba.html","2017-02-19 07:45:00","The Cerbat Gem","Merck & Company logo Sentinel Trust Co. LBA reduced its position in shares of Merck & Company, Inc. (NYSE:MRK) by 5.2% during the fourth quarter, according to its most recent disclosure with the SEC.","MRK","Merck"
"742","Orbis Allan Gray Ltd Cuts Stake in Merck &amp; Company, Inc. (MRK)","https://www.thecerbatgem.com/2017/02/19/orbis-allan-gray-ltd-cuts-stake-in-merck-company-inc-mrk.html","2017-02-19 07:45:00","The Cerbat Gem","Merck & Company logo Orbis Allan Gray Ltd cut its position in Merck & Company, Inc. (NYSE:MRK) by 82.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).","MRK","Merck"
"743","Why Analysts put forward these two stocks: Merck &amp; Co., Inc. (MRK), VF ...","http://theusacommerce.com/2017/02/20/why-analysts-put-forward-these-two-stocks-merck-co-inc-mrk-v-f-corporation-vfc/","2017-02-20 11:18:45","The USA Commerce","Shares of Merck & Co., Inc. (NYSE:MRK) surged 0.20% to $65.39. During the trading on 02/17/2017, Company's stock ranged from $64.86 to $65.56.","MRK","Merck"
"744","EOD Risers: McDonald&#39;s Corporation, Merck &amp; Co., Inc., Microsoft Corporation ...","https://www.directorstalkinterviews.com/eod-risers-mcdonalds-corporation-merck-co-inc-microsoft-corporation-nike-inc/412724248","2017-02-21 05:32:43","DirectorsTalk Interviews","Shares in Merck & Co., Inc. ticker code: (NYSE:MRK) a global healthcare company, increased 0.2% or 0.13 points during yesterday's session.","MRK","Merck"
"745","Technicals in Focus for Merck &amp; Co., Inc. (MRK)","http://theusacommerce.com/2017/02/21/technicals-in-focus-for-merck-co-inc-mrk/","2017-02-21 14:52:30","The USA Commerce","We have gathered the technical data on Merck & Co., Inc. (MRK), and see some interesting trends in the stock's behavior of late.","MRK","Merck"
"746","EOD Risers: JPMorgan Chase &amp; Co., McDonald&#39;s Corporation, Merck &amp; Co., Inc ...","https://www.directorstalkinterviews.com/eod-risers-jpmorgan-chase-co-mcdonalds-corporation-merck-co-inc-nike-inc/412724335","2017-02-22 05:27:50","DirectorsTalk Interviews","Shares of Merck & Co., Inc. company symbol: (NYSE:MRK) a global healthcare company, rose 0.14% or 0.09 points during the course of yesterday's session.","MRK","Merck"
"747","Global Animal Antimicrobials Market 2017 Merck &amp; Co., Inc., Bayer AG, Sanofi ...","http://www.medgadget.com/2017/02/global-animal-antimicrobials-market-2017-merck-co-inc-bayer-ag-sanofi-ceva-sante-animale-virbac-vetoquinol-s-a.html","2017-02-22 07:29:24","Medgadget (blog)","The report, named “Global Animal Antimicrobials Market”, provides a Detailed overview of the Animal Antimicrobials market related to overall world.","MRK","Merck"
"748","Analysts Near-Term outlook: Mylan NV (MYL), Merck &amp; Co., Inc. (MRK)","http://theusacommerce.com/2017/02/22/analysts-near-term-outlook-mylan-n-v-myl-merck-co-inc-mrk/","2017-02-22 10:52:00","The USA Commerce","Shares of Mylan N.V. (NASDAQ:MYL) surged 0.59% to $42.30. During the trading on 02/21/2017, Company's stock ranged from $42.07 to $42.70.","MRK","Merck"
"749","Biothera Pharmaceuticals initiates patient dosing in phase 2 trial investigating Imprime PGG, Merck&#39;s Keytruda","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3534231","2017-02-23 09:00:00","Reuters Key Development","Biothera Pharmaceuticals initiates patient dosing in phase 2 trial investigating Imprime PGG, Merck's Keytruda","MRK","Merck"
"750","Earnings Clues on Merck &amp; Co., Inc. (MRK), KeyCorp (KEY) Analyst&#39;s Predictions","http://stocknewsjournal.com/2017/02/23/earnings-clues-on-merck-co-inc-mrk-keycorp-key-analysts-predictions/","2017-02-23 09:26:15","StockNewsJournal","ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.","MRK","Merck"
"751","Hot Healthcare Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Merck &amp; Co., Inc ...","http://thewellesleysnews.com/index.php/2017/02/23/hot-healthcare-stocks-gilead-sciences-inc-nasdaqgild-merck-co-inc-nysemrk/","2017-02-23 09:34:12","TWN","Gilead Sciences Inc. (NASDAQ:GILD) shares ended at $68.83 with 10.06 mln shares exchanging hands. That puts the market capitalization at $91.28 bln.","MRK","Merck"
"752","Merck &amp; Co., Inc.&#39;s (MRK) Potential Shot in the Arm Could be Painful for ...","http://smartstocknews.com/71593-merck-co-incs-mrk-potential-shot-in-the-arm-could-be-painful-for-pfizer-incs-pfe-prevnar/","2017-02-23 11:41:15","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Morgan Stanley believes that investors under-appreciate Merck & Co., Inc.'s (NYSE:MRK) opportunity to demonstrate proof of concept in 2H:17 for a vaccine that would compete with Pfizer Inc.'s (NYSE:PFE) Prevnar, the world's largest vaccine (2016 sales ...","MRK","Merck"
"753","Merck &amp; Co., Inc. (MRK): An Examination Of The Chart For Today&#39;s Session","http://nystocknews.com/2017/02/23/merck-co-inc-mrk-an-examination-of-the-chart-for-todays-session/","2017-02-23 13:22:30","NY Stock News","Merck & Co., Inc. (MRK) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.","MRK","Merck"
"754","Merck to record $2.9 bln impairment charge related to uprifosbuvir program - SEC filing","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3534597","2017-02-23 17:53:32","Reuters Key Development","Merck to record $2.9 bln impairment charge related to uprifosbuvir program - SEC filing","MRK","Merck"
"755","EOD Risers: McDonald&#39;s Corporation, Merck &amp; Co., Inc., Microsoft Corporation ...","https://www.directorstalkinterviews.com/eod-risers-mcdonalds-corporation-merck-co-inc-microsoft-corporation-pfizer-inc-coca-cola-co/412724500","2017-02-24 05:18:45","DirectorsTalk Interviews","Shares in Merck & Co., Inc. EPIC code: (NYSE:MRK) a global healthcare company, climbed 0.86% or 0.56 points during yesterday's session.","MRK","Merck"
"756","Technical Glance At Healthcare Stocks: Gilead Sciences Inc. (GILD), Merck &amp; Co ...","http://thewellesleysnews.com/index.php/2017/02/24/technical-glance-at-healthcare-stocks-gilead-sciences-inc-gild-merck-co-inc-mrk/","2017-02-24 09:03:45","TWN","Gilead Sciences Inc. (NASDAQ:GILD) shares ended at $69.37 with 7.52 mln shares exchanging hands. That puts the market capitalization at $91.99 bln.","MRK","Merck"
"757","Stocks Roundup: DENTSPLY International Inc. (NASDAQ:XRAY), Merck &amp; Co., Inc ...","http://theriponadvance.com/stocks-roundup-dentsply-international-inc-nasdaqxray-merck-co-inc-nysemrk/12153881/","2017-02-24 10:39:47","TRA","DENTSPLY International Inc. (NASDAQ:XRAY) ended its previous trading session at $62.45 with the Gain of 0.18%. The company's market cap is $14.38 Billion, and the average volume is $1.63 Million. The 52-Week High range of the stock is $65.83, while ...","MRK","Merck"
"758","Merck Antiviral Drug Reports Positive Data (MRK)","http://www.investopedia.com/news/merck-antiviral-drug-reports-positive-data-mrk/","2017-02-24 10:45:00","Investopedia","Merck & Co Inc. (MRK) said its experimental antiviral drug letermovir demonstrated positive results in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant.","MRK","Merck"
"759","In First Phase 3 Trial, Merck&#39;s Investigational Inactivated Varicella Zoster ...","http://www.businesswire.com/news/home/20170224005651/en/Phase-3-Trial-Merck%E2%80%99s-Investigational-Inactivated-Varicella","2017-02-24 16:00:00","Business Wire (press release)","Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first Phase 3 study results for V212, the company's investigational inactivated varicella zoster virus vaccine (VZV) for the ...","MRK","Merck"
"760","In first phase 3 trial Merck&#39;s virus vaccine (V2120 reduced the incidence of confirmed herpes zoster cases","http://www.reuters.com/finance/stocks/MRK/key-developments/article/3535487","2017-02-24 16:00:00","Reuters Key Development","In first phase 3 trial Merck's virus vaccine (V2120 reduced the incidence of confirmed herpes zoster cases","MRK","Merck"
"761","Successful Earnings Option Trading: Merck &amp; Co. Inc (NYSE:MRK)","http://news.cmlviz.com/2017/02/25/successful-earnings-option-trading-merck--co-inc-nyse-mrk.html","2017-02-25 20:12:42","CML News","As we look at Merck & Co. Inc we note that a short put is one of the most common implementations of an option strategy, but the analysis completed when employing the short put often times lacks the necessary rigor especially surrounding earnings.","MRK","Merck"
"762","Merck&#39;s Letermovir, an Investigational Antiviral Medicine for Prevention of ...","http://www.businesswire.com/news/home/20170226005071/en/Merck%E2%80%99s-Letermovir-Investigational-Antiviral-Medicine-Prevention-Cytomegalovirus","2017-02-26 12:26:15","Business Wire (press release)","Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, today announced results of the pivotal Phase 3 clinical study of letermovir, an investigational antiviral medicine for the prevention ...","MRK","Merck"
"763","Top Gainers Today: Merck &amp; Co., Inc. (NYSE:MRK)","http://news4j.com/top-gainers-today-merck-co-inc-nysemrk-4/","2017-02-26 18:26:08","The News Journal","The top gainer with a security that increased in price during today's trading was Merck & Co., Inc. (NYSE:MRK).","MRK","Merck"
"764","Morning Buzz: Merck &amp; Co., Inc. (NYSE:MRK), JC Penney Company Inc (NYSE:JCP)","http://www.benchmarkmonitor.com/2017/02/26/morning-buzz-merck-co-inc-nysemrk-j-c-penney-company-inc-nysejcp/","2017-02-26 23:41:15","Benchmark Monitor","Merck & Co., Inc. (NYSE:MRK) said it will book a pre-tax charge of $2.9 billion for a hepatitis C drug candidate.","MRK","Merck"
"765","Merck &amp; Co., Inc. (NYSE:MRK) announced first Phase 3 study results for V212","http://www.benchmarkmonitor.com/2017/02/27/merck-co-inc-nysemrk-announced-first-phase-3-study-results-for-v212/","2017-02-27 03:26:15","Benchmark Monitor","Merck & Co., Inc. (NYSE:MRK) announced the first Phase 3 study results for V212, the company's investigational inactivated varicella zoster virus vaccine (VZV) for the prevention of herpes zoster or HZ, also known as shingles, in immunocompromised ...","MRK","Merck"
"766","EOD Risers: Johnson &amp; Johnson, McDonald&#39;s Corporation, Merck &amp; Co., Inc., Nike Inc","https://www.directorstalkinterviews.com/eod-risers-johnson-johnson-mcdonalds-corporation-merck-co-inc-nike-inc/412724588","2017-02-27 06:15:03","DirectorsTalk Interviews","Shares of Johnson & Johnson ticker lookup code: (NYSE:JNJ) a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field, stepped up 1.51% or 1.83 points throughout Friday's ...","MRK","Merck"
"767","Stock List: Merck &amp; Co., Inc. (NYSE:MRK), Calumet Specialty Products Partners ...","http://www.benchmarkmonitor.com/2017/02/27/stock-list-merck-co-inc-nysemrk-calumet-specialty-products-partners-l-p-nasdaqclmt/","2017-02-27 07:33:45","Benchmark Monitor","Merck & Co., Inc. (NYSE:MRK) shares edged up 0.47% to $66.16 on Friday. Merck & Co., Inc. (NYSE:MRK) announced the first Phase 3 study results for V212, the company's investigational inactivated varicella zoster virus vaccine (VZV) for the prevention ...","MRK","Merck"
"768","Latest Updates :Merck &amp; Co., Inc.&#39;s (MRK) stock price is Worth at $66.16 while ...","http://www.hotstockspoint.com/latest-updates-merck-co-inc-s-mrk-stock-price-worth-66-16-analysts-mean-rating-score-stands-2-30/","2017-02-27 07:56:36","Hot Stocks Point","Merck & Co., Inc.'s (MRK) stock price ended its day with a gain of 0.47% and finalized at the price of $66.16.","MRK","Merck"
"769","Merck Restates 2016 Earnings, Takes $3B Charge (MRK)","http://www.investopedia.com/news/merck-restates-2016-earnings-takes-3b-charge-mrk/","2017-02-27 08:07:30","Investopedia","Merck acquired the proming uprifosbuvir as a part of its $3.9 billion acquisition of Idenix Pharmaceuticals Inc. in 2014, and had then recognized the asset to be worth $3.2 billion.","MRK","Merck"
"770","Momentum Stocks in Focus: Merck &amp; Company, Inc. (NYSE:MRK) , Mitsubishi UFJ ...","http://stockznews.com/momentum-stocks-in-focus-merck-company-inc-nysemrk-mitsubishi-ufj-financial-group-inc-nysemtu/","2017-02-27 09:51:46","NYSE Journal (press release)","On 2/24/2017, Shares of Merck & Company, Inc. (NYSE:MRK) closed at $66.16 in last trading day. After noting the initial trading entry at $65.65, it reached to a day's high of $66.16 and moved to a day's low of $65.63.","MRK","Merck"
"771","Analysts Estimates Reports on- Merck &amp; Co., Inc. (NYSE:MRK), Opko Health, Inc ...","http://www.senecaglobe.com/analysts-estimates-reports-on-merck-co-inc-nysemrk-opko-health-inc-nasdaqopk/371550/","2017-02-27 10:56:15","Seneca Globe","Shares of Merck & Co., Inc. (NYSE:MRK) swings by following news as it slightly up 0.47% to $66.16 in latest trading flood.","MRK","Merck"
"772","2 Movers of Yesterday: SeaDrill Limited (NYSE:SDRL), Merck &amp; Co., Inc. (NYSE:MRK)","http://theriponadvance.com/2-movers-of-yesterday-seadrill-limited-nysesdrl-merck-co-inc-nysemrk/12154483/","2017-02-27 10:56:15","TRA","SeaDrill Limited (NYSE:SDRL) ended its previous trading session at $1.98 with the Loss of -3.88%. The company's market cap is $1.05 Billion, and the average volume is $14.07 Million.","MRK","Merck"
"773","Drilling Down Into the Charts for Merck &amp; Co., Inc. (MRK)","http://theusacommerce.com/2017/02/27/drilling-down-into-the-charts-for-merck-co-inc-mrk-2/","2017-02-27 13:12:14","The USA Commerce","We have gathered the technical data on Merck & Co., Inc. (MRK), and see some interesting trends in the stock's behavior of late.","MRK","Merck"
"774","Analyst Research and Recommendations: Incyte Corporation (INCY), Merck &amp; Co ...","http://thewellesleysnews.com/index.php/2017/02/27/analyst-research-and-recommendations-incyte-corporation-incy-merck-co-inc-mrk/","2017-02-27 13:41:59","TWN","Incyte Corporation (NASDAQ:INCY) tinted gains of +7.59% (+9.26 points) to US$131.21. The volume of 9.23 Million shares climbed up over an trading activity of 1.33 Million shares.","MRK","Merck"
"775","Zostavax Shingles Vaccine Lawsuit Filed by Nevada Woman","https://dailyhornet.com/2017/zostavax-shingles-vaccine-lawsuit-filed-by-nevada-woman/","2017-02-27 16:42:41","Daily Hornet (satire) (press release) (registration) (blog)","Her lawyers accuse Merck & Co. of putting profits above public safety by downplaying the risk of Zostavax causing viral infections and other devastating complications.","MRK","Merck"
"776","Agenus (AGEN): What&#39;s Ahead for the Stock in Q4 Earnings?","https://www.zacks.com/stock/news/250953/agenus-agen-whats-ahead-for-the-stock-in-q4-earnings","2017-02-27 17:07:30","Zacks.com","We remind investors that Agenus' lead candidate and several backup antibodies were selected by Merck & Co., Inc. (MRK - Free Report) for an undisclosed checkpoint target. Under the terms of the agreement, Agenus is eligible to receive up to $100 ...","MRK","Merck"
"777","Merck &amp; Company Inc. (new) (MRK) Closes 0.47% Down on the Day for February 27","https://www.equities.com/news/merck-company-inc-new-mrk-closes-0-47-down-on-the-day-for-february-27","2017-02-27 17:30:05","Equities.com","Shares of Merck & Company Inc. (new) (MRK) ended the trading day Monday at $65.85, representing a move of -0.47%, or $0.31 per share, on volume of 7.13 million shares.","MRK","Merck"
"778","Most Active Runner As Share Volume Pops for Merck &amp; Co., Inc. (NYSE:MRK)","https://winfieldreview.com/most-active-runner-as-share-volume-pops-for-merck-co-inc-nysemrk/36021/","2017-02-27 19:59:51","Winfield Review","Session activity on Merck & Co., Inc.(NYSE:MRK) stock is placing it on today's most active list. After a recent spot-check, the stock has touched $65.77 which represents a change from the open of 0.02%.","MRK","Merck"
"779","Rogers Corp gives Q2 2015 revenue guidance below analysts&#39; estimates; gives EPS guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3203237","2015-04-29 16:01:00","Reuters Key Development","Rogers Corp gives Q2 2015 revenue guidance below analysts' estimates; gives EPS guidance","ROG","Roche"
"780","Rogers Corp lowers Q2 2015 guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3242345","2015-07-09 16:01:00","Reuters Key Development","Rogers Corp lowers Q2 2015 guidance","ROG","Roche"
"781","Rogers Corp gives Q3 2015 revenue guidance below analysts&#39; estimates","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3252701","2015-07-29 16:01:00","Reuters Key Development","Rogers Corp gives Q3 2015 revenue guidance below analysts' estimates","ROG","Roche"
"782","Rogers Corp engages PricewaterhouseCoopers as independent registered public accounting firm - Form 8-K","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3255589","2015-08-03 16:24:00","Reuters Key Development","Rogers Corp engages PricewaterhouseCoopers as independent registered public accounting firm - Form 8-K","ROG","Roche"
"783","Rogers Corp announces share repurchase program","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3257933","2015-08-06 16:59:00","Reuters Key Development","Rogers Corp announces share repurchase program","ROG","Roche"
"784","Rogers Corp gives Q4 2015 revenue guidance below analysts&#39; estimates","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3291955","2015-10-28 16:15:00","Reuters Key Development","Rogers Corp gives Q4 2015 revenue guidance below analysts' estimates","ROG","Roche"
"785","Rogers Corp&#39;s CFO Plans to Retire","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3291924","2015-10-28 16:20:00","Reuters Key Development","Rogers Corp's CFO Plans to Retire","ROG","Roche"
"786","Rogers Corp appoints Janice Stipp CFO","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3297652","2015-11-09 07:29:00","Reuters Key Development","Rogers Corp appoints Janice Stipp CFO","ROG","Roche"
"787","Rogers Corporation sells Polyimide and Thermoset Epoxy Laminate Operation","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3313780","2015-12-21 16:18:00","Reuters Key Development","Rogers Corporation sells Polyimide and Thermoset Epoxy Laminate Operation","ROG","Roche"
"788","CriticalPoint Capital acquires Electronic Materials Division from Rogers Corporation","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3314398","2015-12-22 16:36:00","Reuters Key Development","CriticalPoint Capital acquires Electronic Materials Division from Rogers Corporation","ROG","Roche"
"789","Rogers Corp gives Q1 2016 guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3334403","2016-02-22 16:20:00","Reuters Key Development","Rogers Corp gives Q1 2016 guidance","ROG","Roche"
"790","Rogers Corp gives Q2 2016 guidance","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3366806","2016-05-02 16:20:00","Reuters Key Development","Rogers Corp gives Q2 2016 guidance","ROG","Roche"
"791","Rogers Corp says to relocate global headquarters to Arizona","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3421592","2016-08-08 16:24:00","Reuters Key Development","Rogers Corp says to relocate global headquarters to Arizona","ROG","Roche"
"792","Rogers Corp. to move corporate headquarters out of Killingly","http://www.norwichbulletin.com/news/20160808/rogers-corp-to-move-corporate-headquarters-out-of-killingly","2016-08-08 20:22:25","Norwich Bulletin","KILLINGLY - Rogers Corporation announced Monday it plans to relocate its global headquarters from Killingly to Chandler, Ariz.","ROG","Roche"
"793","Rogers Corp. Moving Headquarters After 184 Years In Connecticut","http://www.courant.com/business/hc-rogers-arizona-20160809-story.html","2016-08-09 13:08:14","Hartford Courant","Rogers Corp., a 184-year-old Connecticut laminates and materials manufacturer, is moving its headquarters to Arizona to be closer to West Coast markets.","ROG","Roche"
"794","Rogers Corporation to move global headquarters to Chandler","http://azbusinessdaily.com/stories/510991598-rogers-corporation-to-move-global-headquarters-to-chandler","2016-08-12 12:41:15","Arizona Business Daily","“Rogers, Connecticut, will always be a place we call home and a strategic element of Rogers Corporation in the years ahead,” Hoechner said.","ROG","Roche"
"795","Rogers Corporation Relocating Global HQ To Arizona","http://businessfacilities.com/2016/08/rogers-corporation-relocating-global-hq-to-arizona/","2016-08-25 13:37:30","Business Facilities Magazine","Chandler Arizona Rogers Corporation, a global leader in engineered materials solutions, will relocate its global headquarters from Rogers, CT to Chandler, AZ.","ROG","Roche"
"796","Chandler could pay Rogers Corp. up to $238K for firm&#39;s move to city","http://www.azcentral.com/story/news/local/chandler/2016/10/13/chandler-could-pay-rogers-corp-up-238k-firms-move-city/91861762/","2016-10-13 08:56:15","azcentral.com","The money, taken from a city economic-development fund for attracting new business, is based on up to 190 new jobs Rogers Corp. could bring to Chandler over the next five years as part of the move and a planned expansion of its manufacturing plant, ...","ROG","Roche"
"797","Want to invest in Rogers Corporation (ROG) today? Read this before.","https://simplywall.st/news/2016/10/17/want-to-invest-in-rogers-corporation-rog-today-read-this-before/","2016-10-16 23:45:00","Simply Wall St","Rogers Corporation (NYSE:ROG) is a stock well positioned for future growth, but many investors are wondering whether its last closing price of $55.72 is based on unrealistic expectations.","ROG","Roche"
"798","Rogers sees Q4 earnings per share $0.61 to $0.71","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3468330","2016-11-02 16:20:00","Reuters Key Development","Rogers sees Q4 earnings per share $0.61 to $0.71","ROG","Roche"
"799","Rogers Corporation Reports Results for the 2016 Third Quarter","http://www.businesswire.com/news/home/20161102006617/en/Rogers-Corporation-Reports-Results-2016-Quarter","2016-11-02 16:20:27","Business Wire (press release)","Rogers Corporation (NYSE:ROG) today announced financial results for the 2016 third quarter.","ROG","Roche"
"800","Rogers Corp buys DeWAL Industries","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3483693","2016-11-23 13:06:00","Reuters Key Development","Rogers Corp buys DeWAL Industries","ROG","Roche"
"801","Rogers Corporation Price Volatility Hits An Unsually High Level","http://news.cmlviz.com/2017/01/27/rogers-corporation-price-volatility-hits-an-unsually-high-level.html","2016-12-01 12:15:00","CML News","This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Rogers Corporation (NYSE:ROG) . We examine the little used gem of daily stock volatility over a 20-day and ...","ROG","Roche"
"802","Rogers Corp. move will cost 50 jobs","http://www.norwichbulletin.com/news/20161203/rogers-corp-move-will-cost-50-jobs","2016-12-03 17:42:21","Norwich Bulletin","KILLINGLY - As part of its plan to relocate its corporate headquarters to Arizona, the Killingly-based Rogers Corp. will lay off 50 workers, according a state filing document.","ROG","Roche"
"803","Rogers to Participate in the Needham Growth Conference","http://www.businesswire.com/news/home/20170106005398/en/Rogers-Participate-Needham-Growth-Conference","2017-01-06 09:37:30","Business Wire (press release)","Rogers Corporation (NYSE:ROG) today announced Senior Vice President and CTO, Robert Daigle, and Vice President and CFO, Janice Stipp, will be presenting at the Nineteenth Annual Needham Growth Conference ...","ROG","Roche"
"804","Rogers acquires Diversified Silicone Products","http://seekingalpha.com/news/3233953-rogers-acquires-diversified-silicone-products","2017-01-06 13:00:00","Seeking Alpha","Rogers Corporation (NYSE:ROG) announced the acquisition of Diversified Silicone Products for an undisclosed term. “The acquisition of Diversified Silicone Products, Inc., in combination with our recent DeWAL acquisition, demonstrates continued ...","ROG","Roche"
"805","Rogers acquires Diversified Silicone Products","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3505250","2017-01-06 13:01:00","Reuters Key Development","Rogers acquires Diversified Silicone Products","ROG","Roche"
"806","In Volatile Markets Do Analysts Think You Should Buy Rogers Corporation (NYSE ...","http://www.desotoedge.com/stocks/in-volatile-markets-do-analysts-think-you-should-buy-rogers-corporation-nyserog-8/391523","2017-01-29 06:15:00","The De Soto Edge","Following U.S. election volatility some analysts have updated their recommended target prices on shares of Rogers Corporation (NYSE:ROG). According to the most recently released broker notes, 0 analysts have a rating of “strong buy” on the stock, ...","ROG","Roche"
"807","Option Trading: Rogers Corporation (NYSE:ROG) Powerful Short Put Spreads to ...","http://news.cmlviz.com/2017/02/06/option-trading-rogers-corporation-nyse-rog--powerful-short-put-spreads-to-outperform-earnings.html","2017-01-30 19:33:45","CML News","We find a very powerful outcome examining short put spreads for Rogers Corporation when we use a clever earnings risk management approach.","ROG","Roche"
"808","Rogers to Showcase Advanced Connectivity Material Solutions at IPC APEX EXPO 2017","http://pcb.iconnect007.com/index.php/article/102397/rogers-to-showcase-advanced-connectivity-material-solutions-at-ipc-apex-expo-2017/102400/?skin=pcb","2017-01-31 01:22:30","I-Connect007","Rogers Corporation and its Advanced Connectivity Solutions technical team will be presenting the latest developments in printed-circuit-board (PCB) materials for emerging high-frequency applications at the upcoming IPC APEX EXPO 2017, February 14-16, ...","ROG","Roche"
"809","Rogers Corporation (NYSE:ROG) investors have generally bought the stock after ...","http://postanalyst.com/rogers-corporation-nyserog-investors-have-generally-bought-the-stock-after-recent-earnings-reports/","2017-02-01 13:22:30","Post Analyst","Rogers Corporation (NYSE:ROG) is trading up on a volume of 0.09 million, or 0.64 times its standard daily volume. Shares have added 1.58% to $79.95.","ROG","Roche"
"810","Watch Mister Rogers Defend Public Programming In This Vintage Video","http://www.huffingtonpost.com/entry/watch-mister-rogers-defend-public-programming-in-this-vintage-video_us_58920f69e4b0c90eff01656c","2017-02-01 17:00:46","Huffington Post","After being elected in 1968, President Richard Nixon showed his support for cutting federal funding in half for the Corporation for Public Broadcasting (CPB). Rogers responded to the president's proposal in 1969 with a passionate speech in front of the ...","ROG","Roche"
"811","GP Strategies Acquires McKinney Rogers","http://www.prnewswire.com/news-releases/gp-strategies-acquires-mckinney-rogers-300401003.html","2017-02-02 06:37:30","PR Newswire (press release)"," Global performance improvement solutions provider GP Strategies Corporation(NYSE: GPX) announced today that it has completed the acquisition of certain assets and the business of McKinney Rogers, ...","ROG","Roche"
"812","The Zacks Analyst Blog Highlights: Best Buy, NCI Building Systems, Teck ...","http://www.nasdaq.com/article/the-zacks-analyst-blog-highlights-best-buy-nci-building-systems-teck-resources-childrens-place-and-rogers-cm742241","2017-02-02 10:36:03","Nasdaq","Rogers Corporation (NYSE: ROG - Free Report ) designs, develops, manufactures and sells engineered materials and components worldwide.","ROG","Roche"
"813","Global Conductive Adhesive Market 2016 – Henkel, Dow Corning, 3M, Fujikura ...","http://www.albaniantimes.com/2017/02/03/global-conductive-adhesive-market-2016/","2017-02-03 01:22:30","Albanian Times","Conductive Adhesive Market Global Conductive Adhesive Market 2016, presents a professional and in-depth study on the current state of the Conductive Adhesive market globally, providing basic overview of Conductive Adhesive market including definitions, ...","ROG","Roche"
"814","Would You Buy Rogers Corporation (NYSE:ROG) On These Analyst Ratings?","http://www.fiscalstandard.com/2017/02/06/would-you-buy-rogers-corporation-nyserog-on-these-analyst-ratings-3/","2017-02-04 22:00:00","Fiscal Standard","Recently analysts working for various investment brokerages have changed their ratings and price targets on shares of Rogers Corporation (NYSE:ROG). According to the the latest analyst ratings which have been released, 0 brokers have issued a rating of ...","ROG","Roche"
"815","Oxford Properties Limited selects RYCOM and Rogers to accelerate its Cisco ...","http://finance.yahoo.com/news/oxford-properties-limited-selects-rycom-140000139.html","2017-02-07 08:52:30","Yahoo Finance","TORONTO, Feb. 7, 2017 /CNW/ - Rogers Communications and RYCOM Corporation have engaged in a strategic collaboration to accelerate Oxford Properties' Smart and Connected Building strategy, based on Cisco technology infrastructure.","ROG","Roche"
"816","Mycio Wealth Partners Cuts Position in Rogers Corporation (ROG) by $4719369","https://www.highlandmirror.com/2017-02-07-mycio-wealth-partners-cuts-position-in-rogers-corporation-rog-by-4719369","2017-02-07 10:33:45","Highland Mirror","Mycio Wealth Partners reduced its stake in Rogers Corporation by 2.48% during the most recent quarter end. The institutional investor now holds a total of 59,029 shares of Rogers Corporation in its fund which is valued at $4,719,369 after selling 1,500 ...","ROG","Roche"
"817","Equiteq advises McKinney Rogers on its sale to GP Strategies Corp (NYSE: GPX)","http://www.realwire.com/releases/Equiteq-advises-McKinney-Rogers-on-its-sale-to-GP-Strategies-Corp","2017-02-07 11:18:45","RealWire (press release)","February, 2017 (New York, NY) - Equiteq, a global leader in providing strategic and M&A advisory services to knowledge-intensive services firms, is pleased to announce that it has advised McKinney Rogers (“McKinney Rogers” or “MR”), a results-driven ...","ROG","Roche"
"818","Rogers Corporation (ROG) and Rycom contracted to work with oxford properties","http://www.kcregister.com/rogers-corporation-rog-and-rycom-contracted-to-work-with-oxford-properties/40147/","2017-02-08 11:41:15","KC Register","Rogers Corporation (NYSE:ROG) and Rycom announced a contract to work with Oxford Properties on developing 'smart' buildings.","ROG","Roche"
"819","Rogers Public Library Hosts Event Featuring Author, David Baldacci","http://www.4029tv.com/article/rogers-public-library-hosts-event-featuring-author-david-baldacci/8703785","2017-02-09 06:37:30","4029tv","You may purchase tickets on our website at www.rplfoundation.org, in person at the Rogers Public Library, or you can contact rplfoundation@rplfoundation.","ROG","Roche"
"820","Chandler&#39;s Top 10 companies for job growth in 2016","http://www.azcentral.com/story/news/local/chandler/2017/02/09/chandler-top-10-companies-job-growth-2016/97351864/","2017-02-09 07:56:15","AZCentral.com","Other expansions will include the Rogers Corporation relocating its corporate headquarters from Connecticut to Chandler. The move is expected to add 200 corporate jobs this summer, and the company also is making a $20 million expansion to its building ...","ROG","Roche"
"821","Rogers Corporation: Rogers Schedules Q4 &amp; Full Year 2016 Earnings Call for Feb 21","https://www.twst.com/update/rogers-corporation-rogers-schedules-q4-full-year-2016-earnings-call-for-feb-21/","2017-02-10 10:45:00","The Wall Street Transcript","Rogers, Connecticut, February 10, 2017: Rogers Corporation (NYSE:ROG) plans to announce fourth quarter and full year 2016 results on February 20 after market close, which will be followed by a conference call on February 21 at 9 am ET.","ROG","Roche"
"822","Rogers Expands High-Speed Offering for Low-Income Households in Ottawa","https://www.cedmagazine.com/news/2017/02/rogers-expands-high-speed-offering-low-income-households-ottawa","2017-02-10 15:26:15","CED","“The City of Ottawa recognizes the importance of access to affordable internet for all residents, and I am pleased to see this collaboration between Ottawa Community Housing Corporation and Rogers,” Ottawa Mayor Jim Watson comments. “This collaboration ...","ROG","Roche"
"823","Thermoset Molding Compounds Market Expected to Reach $12298 Million by 2022 ...","http://finance.yahoo.com/news/thermoset-molding-compounds-market-expected-163000843.html","2017-02-13 11:30:00","Yahoo Finance","... include Ashland Global Holding Inc., BASF SE, Eastman Chemical Company, Evonik Industries AG, Hexion Inc., Huntsman Corporation, Kolon Industries Inc., Kyocera Chemical Corporation, Plastics Engineering Company (Plenco), Rogers Corporation.","ROG","Roche"
"824","Medical Foam Market : Analysis Detailed Profiles of Top Industry Players and ...","http://www.medgadget.com/2017/02/medical-foam-market-analysis-detailed-profiles-of-top-industry-players-and-their-segments-till-2025.html","2017-02-17 08:11:47","Medgadget (blog)","... global market for medical foam are the DOW Chemical Company, Bayer AG, Sekisui Chemical Co., Ltd., Huntsman Corporation, Trelleborg AB, S.à r.l.","ROG","Roche"
"825","Watch Mister Rogers defend public television to the US Senate in 1969","http://www.recode.net/2017/2/18/14657670/mister-rogers-public-television-senate-video","2017-02-18 11:30:00","Recode","Donald Trump is reportedly considering eliminating the U.S. Corporation for Public Broadcasting as part of his budget. This is hardly the first time that the future of public television has been at risk.","ROG","Roche"
"826","Rogers Corporation Reports Fourth Quarter 2016 and Full Year Results","http://www.businesswire.com/news/home/20170220005704/en/Rogers-Corporation-Reports-Fourth-Quarter-2016-Full","2017-02-20 16:45:00","Business Wire (press release)","Rogers Corporation (NYSE:ROG) is a global leader in engineered materials to power, protect, and connect our world. With more than 180 years of materials science experience, Rogers delivers high-performance solutions that enable clean energy, internet ...","ROG","Roche"
"827","Rogers Corp reports Q4 EPS $0.65","http://www.reuters.com/finance/stocks/ROG/key-developments/article/3531211","2017-02-20 16:47:00","Reuters Key Development","Rogers Corp reports Q4 EPS $0.65","ROG","Roche"
"828","Rogers Corporation (ROG) Moves Lower on Volume Spike for February 20","https://www.equities.com/news/rogers-corporation-rog-moves-lower-on-volume-spike-for-february-20","2017-02-20 17:30:05","Equities.com","Rogers Corporation (ROG) traded on unusually high volume on Feb. 20, as the stock lost 1.67% to close at $78.80. On the day, Rogers Corporation saw 181,551 shares trade hands on 2,046 trades. Considering that the stock averages only a daily volume of ...","ROG","Roche"
"829","How Rogers Corporation&#39;s (ROG) 7.1% ROE Fares Against The Industry?","https://simplywall.st/news/2017/02/21/how-rogers-corporations-rog-7-1-roe-fares-against-the-industry/","2017-02-20 19:22:30","Simply Wall St","Rogers Corporation (NYSE:ROG), with a ROE of 7.1% over the past twelve months, appeared relatively inefficient compared to the broader industry, which averaged 24.56% ROE.","ROG","Roche"
"830","Global High Density Microcellular Polyurethane Foam Market 2017-Evonik ...","http://registrardaily.com/2017/02/21/global-high-density-microcellular-polyurethane-foam-market-2017-3/","2017-02-21 07:49:10","Registrar Daily - Market Research News by Market.Biz (press release)","Global High Density Microcellular Polyurethane Foam Market “Global High Density Microcellular Polyurethane Foam Market 2017<U+2033> Research Report offers a complete and in-depth analysis of the growth rate of the High Density Microcellular Polyurethane ...","ROG","Roche"
"831","Rogers Park Target Gets $1.25 Million From CHA Despite Protests","https://www.dnainfo.com/chicago/20170221/rogers-park/rogers-park-target-gets-125m-from-cha-despite-protests","2017-02-21 12:55:15","DNAinfo","... mini-Target store slated for Sheridan Road and Devon Avenue in Rogers Park. The funds go toward a ""public-private partnership"" between the CHA and 1300 W. Devon Partners LLC - a corporation managed by Madison Construction CEO Robert Ferrino.","ROG","Roche"
"832","Rogers&#39; (ROG) CEO Bruce Hoechner on Q4 2016 Results - Earnings Call Transcript","http://seekingalpha.com/article/4047915-rogers-rog-ceo-bruce-hoechner-q4-2016-results-earnings-call-transcript","2017-02-21 13:45:00","Seeking Alpha","We also successfully executed internal restructuring, resulting in strategic redeployment of foreign cash, and we initiated plans to relocate our corporate headquarters to Chandler, Arizona. Please turn to slide five. In 2016, we refined our strategy ...","ROG","Roche"
"833","Nunavik organizations launch new green power corporation","http://www.nunatsiaqonline.ca/stories/article/65674nunavik_organizations_launch_new_green_power_corp/","2017-02-21 16:02:29","Nunatsiaq News","Makivik Corp. president Jobie Tukkiapik, left and Fédération des Coopératives du Nouveau-Québec president Aliva Tulugak sign a memorandum of understanding for their new joint-venture company, PowerCo, created to develop renewable energy stations ...","ROG","Roche"
"834","Rogers (ROG) Shows Strength: Stock Adds 9.8% in Session","http://finance.yahoo.com/news/rogers-rog-shows-strength-stock-132501462.html","2017-02-22 09:04:25","Yahoo Finance","Rogers Corporation ROG was a big mover last session, as its shares rose almost 10% on the day. The move came after the company announced robust fourth-quarter 2016 results.","ROG","Roche"
"835","Momentum Stocks: Tredegar Corporation (NYSE:TG), Rogers Corporation (NYSE:ROG)","http://www.benchmarkmonitor.com/2017/02/22/momentum-stocks-tredegar-corporation-nysetg-rogers-corporation-nyserog/","2017-02-22 10:15:58","Benchmark Monitor","At the movement Tredegar Corporation (NYSE:TG) is under coverage by number of analysts. 1 analyst given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Hold and their mean rating for the stock is 3.00 on scale of 1-5.","ROG","Roche"
"836","A New Kind of Stock Chart: Rogers Corporation (NYSE:ROG) Critical Pivot Points","http://news.cmlviz.com/2017/02/22/a-new-kind-of-stock-chart-rogers-corporation-nyse-rog--critical-pivot-points.html","2017-02-22 11:36:33","CML News","This is a real time view of the critical technical pivot points for Rogers Corporation (NYSE:ROG) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.","ROG","Roche"
"837","Ocular Therapeutix, Inc. (NASDAQ:OCUL) Announces FDA Acceptance of NDA ...","http://www.benchmarkmonitor.com/2017/02/23/ocular-therapeutix-inc-nasdaqocul-announces-fda-acceptance-of-nda-resubmission-for-dextenza/","2017-02-23 09:03:45","Benchmark Monitor","Rogers Corporation (NYSE:ROG) reported fourth-quarter net income of $11.9 million. The Rogers, Connecticut-based company said it had net income of 65 cents per share.","ROG","Roche"
"838","Worth Watching Stocks: OraSure Technologies, Inc. (NASDAQ:OSUR) , Rogers ...","http://stockznews.com/worth-watching-stocks-orasure-technologies-inc-nasdaqosur-rogers-corporation-nyserog/","2017-02-23 12:26:15","NYSE Journal (press release)","On 2/22/2017, Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) closed at $11.08 in last trading day. After noting the initial trading entry at $10.96, it reached to a day's high of $11.17 and moved to a day's low of $10.90.","ROG","Roche"
"839","Rogers Corporation (ROG) Moves Lower on Volume Spike for February 23","https://www.equities.com/news/rogers-corporation-rog-moves-lower-on-volume-spike-for-february-23","2017-02-23 17:30:04","Equities.com","Rogers Corporation (ROG) traded on unusually high volume on Feb. 23, as the stock lost 4.93% to close at $85.46. On the day, Rogers Corporation saw 237,092 shares trade hands on 2,487 trades. Considering that the stock averages only a daily volume of ...","ROG","Roche"
"840","Rogers Corporation&#39;s (ROG) stock price is Worth at $85.46 while finishes ...","https://www.hotstockspoint.com/rogers-corporations-rog-stock-price-is-worth-at-85-46-while-finishes-thursday-with-change-of-4-93-shares-in-the-trader-spot-light/","2017-02-24 09:42:40","Hot Stocks Point","Rogers Corporation's (ROG), a part of Technology sector and belongs to Diversified Electronics industry; ended its day with a loss of -4.93% and finalized at the price of $85.46.","ROG","Roche"
"841","Rogers Corporation Stock Volatility Hits A Notable High","http://news.cmlviz.com/2017/02/24/rogers-corporation-stock-volatility-hits-a-notable-high.html","2017-02-24 12:22:33","CML News","This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Rogers Corporation (NYSE:ROG) . We examine the little used gem of daily stock volatility over a 20-day and ...","ROG","Roche"
"842","NSA snoops told: Get your checkbooks and pens ready for a cyber-weapon ...","https://www.theregister.co.uk/2017/02/25/us_government_to_spend_more_on_online_weapons/","2017-02-24 19:33:45","The Register","NSA and US Cyber Command boss Mike Rogers has revealed the future direction of his two agencies - and for the private sector, this masterplan can be summarized in one word.","ROG","Roche"
"843","Tibshraney: State of the City still robust, vibrant and enduring","http://www.eastvalleytribune.com/opinion/tibshraney-state-of-the-city-still-robust-vibrant-and-enduring/article_69f5c4b8-f879-11e6-890a-eb0c6717949a.html","2017-02-25 08:05:45","East Valley Tribune","Rogers Corporation, one of Chandler's longest-running businesses, announced last summer it will move its headquarters here.","ROG","Roche"
"844","Week of Feb. 3 Real Estate Transactions","http://www.jconline.com/story/news/2017/02/26/week-feb-3-real-estate-transactions/98284752/","2017-02-26 07:04:23","Journal and Courier","Sheriff Barry G Richard, 1584 Crestwood Lane, Lafayette to PHH Mortage Corporation; $134,850. Sheriff Barry G Richard, 608 S. Fourth St., ... Prosper Property Group LLC, 2302 Rogers St., Lafayette to Jaesoon Lee; $68,000. William B Massengill, 4532 E.","ROG","Roche"
"845","The Lombard Odier &amp; Cie Canada Limited Partnership Raises Position in United ...","http://dailyquint.com/2017-02-26-lombard-odier-cie-canada-limited-partnership-raises-position-in-united-technologies-corporation-utx/","2017-02-26 11:32:13","DailyQuint","Lombard Odier & Cie Canada Limited Partnership boosted its position in shares of United Technologies Corporation (NYSE:UTX) by 3.6% during the third quarter, Holdings Channel reports.","ROG","Roche"
"846","Revenue Update on Huntsman Corporation(NYSE:HUN)","http://www.energyindexwatch.com/2017-02-26-revenue-update-on-huntsman-corporationnysehun","2017-02-26 11:43:32","Energy Index","On Jan 27, 2017, Robert Wade Rogers (Sr. VP, Human Resources) sold 44,265 shares at $21.50 per share price.Also, On Jan 27, 2017, Brian V Ridd (Sr.","ROG","Roche"
"847","Verizon buys Yahoo Internet business","http://www.itweb.co.za/index.php?option=com_content&view=article&id=159705","2017-02-27 01:44:58","ITWeb","Good quarterly numbers from Cotivity, Iron Mountain, Quanta Services (back in the black), Rogers Corporation and Sina. * Good year-end numbers from Atos.","ROG","Roche"
"848","On this day: February 27","http://www.ktvz.com/news/on-this-day-february-27/362757289","2017-02-27 02:07:30","KTVZ","2003: Children's television actor Fred Rogers, better known simply as Mister Rogers from his long-running show ""Mister Rogers' Neighborhood,"" dies of stomach cancer at the age of 74 in Pittsburgh, Pennsylvania. He's seen here in July 2002 after ...","ROG","Roche"
"849","Is the Bilbao effect over?","https://www.apollo-magazine.com/is-the-bilbao-effect-over-guggenheim/","2017-02-27 04:56:15","Apollo Magazine","But the Pompidou, designed by Richard Rogers and Renzo Piano (which opened in 1977), kicked the city into the contemporary age, transforming a moribund historic core into a place of possibilities.","ROG","Roche"
"850","Stock Focus: Checking the Chart on Shares of Rogers Corporation (NYSE:ROG)","https://6milestandard.com/stock-focus-checking-the-chart-on-shares-of-rogers-corporation-nyserog/23453/","2017-02-27 10:19:01","The Standard","Checking the Value Composite score for Rogers Corporation (NYSE:ROG), we see that the company has a rank of 51. This falls on a scale from 0 to 100 where a lower score indicated an undervalued company and a higher score would indicate an expensive ...","ROG","Roche"
"851","Stock Movements to Focus: Rogers Corporation&#39;s (ROG) is value at $84.30 per ...","http://www.streetupdates.com/2017/02/27/stock-movements-to-focus-rogers-corporations-rog-is-value-at-84-30-per-share-noted-a-price-change-of-1-36/","2017-02-27 10:37:39","Street Updates","Rogers Corporation's (ROG ) , a stock from Diversified Electronics Industry, has a value of $84.30 per share, noted a price change of -1.36% in recent trade close.","ROG","Roche"
"852","Skyline closing Mansfield manufactured-housing plant","http://www.star-telegram.com/news/local/community/mansfield-news-mirror/mnm-news/article135217034.html","2017-02-27 11:36:49","Fort Worth Star Telegram","Skyline Corp. plans to close its manufactured-housing plant in Mansfield this spring if it cannot find a buyer for the facility, which would leave 105 employees without a job.","ROG","Roche"
"853","Pending Alabama Tax Legislation (2017 Regular Session)","http://www.lexology.com/library/detail.aspx?g=b4c1794b-29a5-4f24-b1a8-e0943fe72b0f","2017-02-27 12:15:00","Lexology (registration)","H.B. 223 - Introduced by Rep. Rogers and Moore, this bill amends Section 65 of the Constitution of Alabama of 1901 to establish a lottery within the state and would form the Alabama Lottery Corporation. The bill permits both table and electronic gaming ...","ROG","Roche"
"854","Rogers Corporation (NYSE:ROG) Receives An Update From Brokers","http://www.desotoedge.com/stocks/rogers-corporation-nyserog-receives-an-update-from-brokers-8/517964","2017-02-27 12:33:20","The De Soto Edge","02/21/2017 - Rogers Corporation had its “” rating reiterated by analysts at Needham & Company. They now have a USD 91 price target on the stock.","ROG","Roche"
"855","Tyson Foods CEO to Headline Economic Development Lunch","http://www.arkansasbusiness.com/article/115750/tyson-ceo-to-headline-economic-development-lunch","2017-02-27 12:37:30","Arkansas Business Online","For luncheon sponsorship and ticket inquiries, contact Becky Rogers here or at (501) 377-4434. Hayes was appointed to the CEO post in December and previously led all operations and commercial functions as president of the company.","ROG","Roche"
"856","Duke Energy Corporation (NYSE:DUK) Analysts Recommendations and Insider Trading","http://theindependentrepublic.com/2017/02/27/duke-energy-corporation-nyseduk-analysts-recommendations-and-insider-trading-2/","2017-02-27 13:11:15","The Independent Republic","Executives hold 0.58 percent of the stock. James E. Rogers is one of the biggest insider owners in Duke Energy Corporation (NYSE:DUK), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 872,129 shares which have ...","ROG","Roche"
"857","Manulife unmasked as mystery bank fined $1.15 million for violations","http://www.nationalobserver.com/2017/02/27/news/manulife-confirms-its-mystery-bank-fined-115-million-fintrac","2017-02-27 14:11:56","National Observer","In a statement on Monday, Manulife Financial Corporation, which owns Manulife Bank, confirmed that it had received the $1.15 million fine, which it said was the result of “administrative lapses.","ROG","Roche"
"858","Global Polymeric Foams Industry","http://www.prnewswire.com/news-releases/global-polymeric-foams-industry-300414177.html","2017-02-27 15:07:32","PR Newswire (press release)"," rt analyzes the worldwide markets for Polymeric Foams in Metric Tons by the following Product Segments: Polyolefin Foams, Polystyrene Foams, Polyurethane Foams, PVC Foams, and Others.","ROG","Roche"
"859","Scientometrics Pioneer Eugene Garfield Dies","http://www.the-scientist.com/?articles.view/articleNo/48636/title/Scientometrics-Pioneer-Eugene-Garfield-Dies/","2017-02-27 17:18:45","The Scientist","“He was an amazing character whose influence on information science, writ large, can't be underestimated,” H. Carton Rogers III, vice provost and director of libraries at the University of Pennsylvania, where Garfield served as a member of the ...","ROG","Roche"
"860","Reliable stocks in today&#39;s share market: Rogers Communications Inc. (NYSE:RCI)","http://news4j.com/reliable-stocks-in-todays-share-market-rogers-communications-inc-nyserci-51/","2017-02-27 17:49:58","The News Journal","Rogers Communications Inc. (NYSE:RCI) exhibits a P/E ratio of 34.91 with a forward P/E of 12.52. At present, the PEG is valued at 5.35 alongside the P/S ratio of 2.15 and P/B ratio of 5.51.","ROG","Roche"
"861","The demise (we hope) of an ugly lawsuit","https://www.washingtonpost.com/opinions/the-demise-we-hope-of-an-ugly-lawsuit/2017/02/27/b0e34b0e-fa02-11e6-9845-576c69081518_story.html","2017-02-27 19:12:27","Washington Post","AMONG THE unfortunate consequences of Congress's failure to come up with a permanent replacement for the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, none carried more mischievous potential than the long-running ...","ROG","Roche"
"862","The Essex Financial Services Inc. Has $3757000 Stake in United Technologies ...","http://dailyquint.com/2017-02-28-essex-financial-services-inc-has-3757000-stake-in-united-technologies-corporation-utx/","2017-02-27 20:26:06","DailyQuint","Essex Financial Services Inc. boosted its position in United Technologies Corporation (NYSE:UTX) by 3.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.","ROG","Roche"
"863","Old Courthouse Square project takes shape in Santa Rosa","http://www.pressdemocrat.com/news/6705640-181/old-courthouse-square-project-takes","2017-02-27 20:55:32","Santa Rosa Press Democrat","The area has been framed with sections of the granite courthouse steps, most of which have been sitting in a city corporation yard for 50 years. Dozens of new sycamore trees have also recently been planted into ... The expected opening is now late ...","ROG","Roche"
"864","Zacks: Aceto Corporation (ACET) Given Average Rating of “Buy” by the Analysts","http://petroglobalnews24.com/2017-02-28-zacks-aceto-corporation-acet-given-average-rating-of-buy-by-analysts/","2017-02-27 22:30:51","Petro Global News 24","In other Aceto Corporation news, SVP Steven Rogers sold 2,400 shares of the business's stock in a transaction that occurred on Wednesday, November 23rd.","ROG","Roche"
"865","Pfizer receives European approval for new indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3165371","2015-03-03 08:35:00","Reuters Key Development","Pfizer receives European approval for new indication for Prevenar 13 for Prevention of Vaccine-Type Pneumococcal Pneumonia in Adults","PFE","Pfizer"
"866","Pfizer Inc and Eli Lilly and Co preparing to resume phase 3 chronic pain program for Tanezumab","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3177916","2015-03-23 08:00:00","Reuters Key Development","Pfizer Inc and Eli Lilly and Co preparing to resume phase 3 chronic pain program for Tanezumab","PFE","Pfizer"
"867","Pfizer Inc to shutter vaccines sales business in China - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3187308","2015-04-02 02:09:00","Reuters Key Development","Pfizer Inc to shutter vaccines sales business in China - Reuters","PFE","Pfizer"
"868","BIND Therapeutics Inc announces extension of global collaboration with Pfizer Inc to develop and commercialize multiple accurins","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3187083","2015-04-02 16:01:00","Reuters Key Development","BIND Therapeutics Inc announces extension of global collaboration with Pfizer Inc to develop and commercialize multiple accurins","PFE","Pfizer"
"869","Pfizer receives U.S. FDA breakthrough therapy designation For XALKORI","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3196325","2015-04-21 10:00:00","Reuters Key Development","Pfizer receives U.S. FDA breakthrough therapy designation For XALKORI","PFE","Pfizer"
"870","Pfizer Inc declares Q2 2015 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3198278","2015-04-23 14:07:00","Reuters Key Development","Pfizer Inc declares Q2 2015 dividend","PFE","Pfizer"
"871","Pfizer Inc lowers FY 2015 guidance","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3201648","2015-04-28 07:00:00","Reuters Key Development","Pfizer Inc lowers FY 2015 guidance","PFE","Pfizer"
"872","Pfizer Inc says Palbociclib more than doubled progression-free survival in phase 3 trial for patients with HR+, HER2- metastatic breast cancer whose disease has progressed following endocrine therapy","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3221779","2015-05-30 07:30:00","Reuters Key Development","Pfizer Inc says Palbociclib more than doubled progression-free survival in phase 3 trial for patients with HR+, HER2- metastatic breast cancer whose disease has progressed following endocrine therapy","PFE","Pfizer"
"873","Pfizer Inc reports top line results from a phase 3 study evaluating desvenlafaxine succinate sustained-release formulation in pediatric patients with major depressive disorder","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3228182","2015-06-11 15:00:00","Reuters Key Development","Pfizer Inc reports top line results from a phase 3 study evaluating desvenlafaxine succinate sustained-release formulation in pediatric patients with major depressive disorder","PFE","Pfizer"
"874","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3232667","2015-06-22 07:10:00","Reuters Key Development","Pfizer Inc to acquire Nimenrix And Mencevax from GlaxoSmithKline Plc","PFE","Pfizer"
"875","Pfizer Inc declares 28-cent third-quarter 2015 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3235107","2015-06-25 11:15:00","Reuters Key Development","Pfizer Inc declares 28-cent third-quarter 2015 dividend","PFE","Pfizer"
"876","Pfizer Inc Announces FDA acceptance for review of New Drug Application for a once-daily formulation of XELJANZ modified release tablets","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3239310","2015-07-02 16:30:00","Reuters Key Development","Pfizer Inc Announces FDA acceptance for review of New Drug Application for a once-daily formulation of XELJANZ modified release tablets","PFE","Pfizer"
"877","Pfizer Inc raises low end of prior FY 2015 revenue guidance and raises FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3251590","2015-07-28 07:00:00","Reuters Key Development","Pfizer Inc raises low end of prior FY 2015 revenue guidance and raises FY 2015 EPS guidance","PFE","Pfizer"
"878","Pfizer and synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3255131","2015-08-03 08:30:00","Reuters Key Development","Pfizer and synthon enter into U.S. commercialization agreement for potential generic treatment of multiple sclerosis","PFE","Pfizer"
"879","Gliknik licensee Pfizer Inc receives orphan drug designation from U.S.FDA for drug candidate directed towards rare neurological disorder","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3259240","2015-08-10 08:00:00","Reuters Key Development","Gliknik licensee Pfizer Inc receives orphan drug designation from U.S.FDA for drug candidate directed towards rare neurological disorder","PFE","Pfizer"
"880","Pfizer Inc gets Canadian Competition Bureau approval for Hospira acquisition","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3261946","2015-08-14 08:35:00","Reuters Key Development","Pfizer Inc gets Canadian Competition Bureau approval for Hospira acquisition","PFE","Pfizer"
"881","Pfizer announces positive topline results of two phase 3 studies of Trumenba","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3264475","2015-08-21 08:00:00","Reuters Key Development","Pfizer announces positive topline results of two phase 3 studies of Trumenba","PFE","Pfizer"
"882","Pfizer Inc receives clearance from U.S. Federal Trade Commission for Hospira acquisition","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3265010","2015-08-24 08:00:00","Reuters Key Development","Pfizer Inc receives clearance from U.S. Federal Trade Commission for Hospira acquisition","PFE","Pfizer"
"883","Alvogen to acquire product portfolio from Pfizer for the U.S. Market","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3266059","2015-08-26 06:12:00","Reuters Key Development","Alvogen to acquire product portfolio from Pfizer for the U.S. Market","PFE","Pfizer"
"884","Pfizer Inc completes acquisition of Hospira","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3269602","2015-09-03 09:00:00","Reuters Key Development","Pfizer Inc completes acquisition of Hospira","PFE","Pfizer"
"885","Pfizer announces positive top-line results from two phase 3 trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3275668","2015-09-21 08:00:00","Reuters Key Development","Pfizer announces positive top-line results from two phase 3 trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis","PFE","Pfizer"
"886","Merck and Pfizer announce FDA orphan drug designation for investigational immunotherapy avelumab in merkel cell carcinoma","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3277667","2015-09-25 07:00:00","Reuters Key Development","Merck and Pfizer announce FDA orphan drug designation for investigational immunotherapy avelumab in merkel cell carcinoma","PFE","Pfizer"
"887","Pfizer declares 28-Cent fourth-quarter 2015 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3277740","2015-09-25 10:10:00","Reuters Key Development","Pfizer declares 28-Cent fourth-quarter 2015 dividend","PFE","Pfizer"
"888","Pfizer Inc updates FY 2015 financial guidance solely to include Hospira operations in financial results from Sept. 3, 2015 through year-end 2015","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3279547","2015-09-30 08:30:00","Reuters Key Development","Pfizer Inc updates FY 2015 financial guidance solely to include Hospira operations in financial results from Sept. 3, 2015 through year-end 2015","PFE","Pfizer"
"889","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3280166","2015-10-01 08:00:00","Reuters Key Development","Pfizer Inc completes acquisition of nimenrix and mencevax from GlaxoSmithKline Plc","PFE","Pfizer"
"890","Pfizer receives complete response letter from FDA for Oral XELJANZ","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3284894","2015-10-14 17:00:00","Reuters Key Development","Pfizer receives complete response letter from FDA for Oral XELJANZ","PFE","Pfizer"
"891","Pfizer Inc enters multi-year collaboration with GSK on development of a next-generation equipment design","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3292623","2015-10-29 08:00:00","Reuters Key Development","Pfizer Inc enters multi-year collaboration with GSK on development of a next-generation equipment design","PFE","Pfizer"
"892","Merck kgaa, Darmstadt, Germany, and Pfizer Inc receive FDA breakthrough therapy designation for avelumab in metastatic merkel cell carcinoma","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3301540","2015-11-18 07:00:00","Reuters Key Development","Merck kgaa, Darmstadt, Germany, and Pfizer Inc receive FDA breakthrough therapy designation for avelumab in metastatic merkel cell carcinoma","PFE","Pfizer"
"893","Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3301593","2015-11-18 08:00:00","Reuters Key Development","Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer","PFE","Pfizer"
"894","Pfizer Inc - U.S. Treasury clamps down on corporate tax inversion deals - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3302390","2015-11-19 17:09:00","Reuters Key Development","Pfizer Inc - U.S. Treasury clamps down on corporate tax inversion deals - Reuters","PFE","Pfizer"
"895","Pfizer and Allergan to Combine","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3303022","2015-11-23 07:03:00","Reuters Key Development","Pfizer and Allergan to Combine","PFE","Pfizer"
"896","Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3304105","2015-11-25 08:00:00","Reuters Key Development","Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain","PFE","Pfizer"
"897","Pfizer Inc&#39;s Lyrica shows no relief from post-traumatic nerve pain - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3304660","2015-11-25 08:29:00","Reuters Key Development","Pfizer Inc's Lyrica shows no relief from post-traumatic nerve pain - Reuters","PFE","Pfizer"
"898","Pfizer Inc announces FDA acceptance of IBRANCE® (palbociclib) supplemental new drug application","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3309474","2015-12-10 08:00:00","Reuters Key Development","Pfizer Inc announces FDA acceptance of IBRANCE® (palbociclib) supplemental new drug application","PFE","Pfizer"
"899","Pfizer Inc approves increase in quarterly cash dividend to $0.30 per share","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3310747","2015-12-14 16:30:00","Reuters Key Development","Pfizer Inc approves increase in quarterly cash dividend to $0.30 per share","PFE","Pfizer"
"900","Pfizer Inc Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3313763","2015-12-21 16:00:00","Reuters Key Development","Pfizer Inc Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation","PFE","Pfizer"
"901","Pfizer Inc - SAC Capital to pay $10 million in investors&#39; insider trading lawsuit - Reuters","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3315991","2015-12-24 10:16:00","Reuters Key Development","Pfizer Inc - SAC Capital to pay $10 million in investors' insider trading lawsuit - Reuters","PFE","Pfizer"
"902","KineMed Inc enters collaboration with Pfizer Inc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3317230","2016-01-04 06:00:00","Reuters Key Development","KineMed Inc enters collaboration with Pfizer Inc","PFE","Pfizer"
"903","Merck KGaA,Darmstadt, Germany, Pfizer and Syndax announces collaboration to evaluate combination of avelumab and entinostat in ovarian cancer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3317281","2016-01-04 08:00:00","Reuters Key Development","Merck KGaA,Darmstadt, Germany, Pfizer and Syndax announces collaboration to evaluate combination of avelumab and entinostat in ovarian cancer","PFE","Pfizer"
"904","Pfizer Inc enters into translational research collaboration with Adaptive Biotechnologies","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3318816","2016-01-08 08:00:00","Reuters Key Development","Pfizer Inc enters into translational research collaboration with Adaptive Biotechnologies","PFE","Pfizer"
"905","HemoShear Therapeutics, LLC Announces Next Stage of Safety Collaboration with Pfizer Inc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3319166","2016-01-11 07:00:00","Reuters Key Development","HemoShear Therapeutics, LLC Announces Next Stage of Safety Collaboration with Pfizer Inc","PFE","Pfizer"
"906","Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3326789","2016-02-01 06:55:00","Reuters Key Development","Bristol-Myers Squibb and Pfizer sign collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan","PFE","Pfizer"
"907","Pfizer Inc gives FY 2016 guidance","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3327485","2016-02-02 06:45:00","Reuters Key Development","Pfizer Inc gives FY 2016 guidance","PFE","Pfizer"
"908","Pfizer Inc says Wyeth reaches agreement in principle to resolve medicaid drug rebate claims for 2001-2006 period for Protonix","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3332047","2016-02-16 06:45:00","Reuters Key Development","Pfizer Inc says Wyeth reaches agreement in principle to resolve medicaid drug rebate claims for 2001-2006 period for Protonix","PFE","Pfizer"
"909","Pfizer Inc receives expanded FDA approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3333361","2016-02-19 16:35:00","Reuters Key Development","Pfizer Inc receives expanded FDA approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer","PFE","Pfizer"
"910","Pfizer Inc announces FDA approval of XELJANZ","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3334878","2016-02-24 11:15:00","Reuters Key Development","Pfizer Inc announces FDA approval of XELJANZ","PFE","Pfizer"
"911","Pfizer Inc commences $5 bln accelerated share repurchase","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3340552","2016-03-09 06:45:00","Reuters Key Development","Pfizer Inc commences $5 bln accelerated share repurchase","PFE","Pfizer"
"912","Pfizer Inc says oral tofacitinib meets primary and key secondary endpoints in two ph 3 trials","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3345173","2016-03-18 11:00:00","Reuters Key Development","Pfizer Inc says oral tofacitinib meets primary and key secondary endpoints in two ph 3 trials","PFE","Pfizer"
"913","Pfizer Inc - New U.S. inversion rules threaten Pfizer-Allergan deal - Reuters News","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3353948","2016-04-04 23:06:00","Reuters Key Development","Pfizer Inc - New U.S. inversion rules threaten Pfizer-Allergan deal - Reuters News","PFE","Pfizer"
"914","Pfizer Inc must face revived Celebrex, Bextra safety lawsuit - Reuters News","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3356536","2016-04-12 22:59:00","Reuters Key Development","Pfizer Inc must face revived Celebrex, Bextra safety lawsuit - Reuters News","PFE","Pfizer"
"915","Pfizer Inc to pay $784.6 million to resolve Wyeth false claims lawsuit - Reuters News","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3365415","2016-04-27 21:35:00","Reuters Key Development","Pfizer Inc to pay $784.6 million to resolve Wyeth false claims lawsuit - Reuters News","PFE","Pfizer"
"916","First dosing of Pfizer DART candidate in phase 1 study triggers milestone payment to MacroGenics","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3370332","2016-05-10 07:30:00","Reuters Key Development","First dosing of Pfizer DART candidate in phase 1 study triggers milestone payment to MacroGenics","PFE","Pfizer"
"917","Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3370384","2016-05-10 08:29:45","Reuters Key Development","Pfizer Canada says Health Canada has given conditional approval of IBRANCE TM","PFE","Pfizer"
"918","Anacor-Pfizer merger agreement includes $180.8 mln termination fee - SEC filing","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3375748","2016-05-16 07:25:04","Reuters Key Development","Anacor-Pfizer merger agreement includes $180.8 mln termination fee - SEC filing","PFE","Pfizer"
"919","Moody&#39;s affirms Pfizer&#39;s A1/P-1 ratings","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3376091","2016-05-16 13:06:23","Reuters Key Development","Moody's affirms Pfizer's A1/P-1 ratings","PFE","Pfizer"
"920","Pfozer- Champix EU label updated to include new data from EAGLES clinical trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3379796","2016-05-23 07:00:00","Reuters Key Development","Pfozer- Champix EU label updated to include new data from EAGLES clinical trial","PFE","Pfizer"
"921","Biorap Technologies enters into an agreement with Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3384515","2016-05-31 09:00:00","Reuters Key Development","Biorap Technologies enters into an agreement with Pfizer","PFE","Pfizer"
"922","Pfizer prices $5.0 billion debt offering","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3384722","2016-05-31 19:05:00","Reuters Key Development","Pfizer prices $5.0 billion debt offering","PFE","Pfizer"
"923","Pfizer says takes 7.1 pct passive stake in Merus NV","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3387386","2016-06-06 17:39:01","Reuters Key Development","Pfizer says takes 7.1 pct passive stake in Merus NV","PFE","Pfizer"
"924","Mayne Pharma says FDA granted approval of its abbreviated new drug application&lt;MYX.AX&gt;&lt;PFE.N&gt;","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3387411","2016-06-06 18:29:57","Reuters Key Development","Mayne Pharma says FDA granted approval of its abbreviated new drug application<MYX.AX><PFE.N>","PFE","Pfizer"
"925","Pfizer announces positive top-line results from second Phase 3 oral Xeljanz trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3387838","2016-06-07 07:00:00","Reuters Key Development","Pfizer announces positive top-line results from second Phase 3 oral Xeljanz trial","PFE","Pfizer"
"926","Pfizer says FDA advisory committees&#39; recommend ALO-02 extended-release capsules for approval","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3388874","2016-06-08 19:15:00","Reuters Key Development","Pfizer says FDA advisory committees' recommend ALO-02 extended-release capsules for approval","PFE","Pfizer"
"927","DKSH and Pfizer expand collaboration in Thailand","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3388922","2016-06-09 00:51:06","Reuters Key Development","DKSH and Pfizer expand collaboration in Thailand","PFE","Pfizer"
"928","ICON signed new three-year agreement with Pfizer Inc.","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3389649","2016-06-10 06:00:00","Reuters Key Development","ICON signed new three-year agreement with Pfizer Inc.","PFE","Pfizer"
"929","Icon announces service agreement with Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3389631","2016-06-10 06:00:00","Reuters Key Development","Icon announces service agreement with Pfizer","PFE","Pfizer"
"930","Shire to license investigational gastric drug from Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3390852","2016-06-14 07:00:52","Reuters Key Development","Shire to license investigational gastric drug from Pfizer","PFE","Pfizer"
"931","Hospira says Inflectra has been approved by Health Canada for 3 additional indications","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3391032","2016-06-14 15:01:00","Reuters Key Development","Hospira says Inflectra has been approved by Health Canada for 3 additional indications","PFE","Pfizer"
"932","Merck KGaA says plans to apply for authorization for Avelumab in H2","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3393359","2016-06-20 05:00:00","Reuters Key Development","Merck KGaA says plans to apply for authorization for Avelumab in H2","PFE","Pfizer"
"933","Pfizer declares Q3 2016 $0.30 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3395370","2016-06-23 16:00:00","Reuters Key Development","Pfizer declares Q3 2016 $0.30 dividend","PFE","Pfizer"
"934","Pfizer completes acquisition of Anacor","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3395848","2016-06-24 09:00:00","Reuters Key Development","Pfizer completes acquisition of Anacor","PFE","Pfizer"
"935","Bind Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3399564","2016-07-01 17:30:00","Reuters Key Development","Bind Therapeutics files motion for sale of assets after accepting stalking horse bid from Pfizer","PFE","Pfizer"
"936","Pfizer and Merck initiate phase III trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3401180","2016-07-06 08:00:00","Reuters Key Development","Pfizer and Merck initiate phase III trial","PFE","Pfizer"
"937","BRIEF-Pfizer and Germany&#39;s Merck KGaA initiate phase III trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3401863","2016-07-07 11:56:45","Reuters Key Development","BRIEF-Pfizer and Germany's Merck KGaA initiate phase III trial","PFE","Pfizer"
"938","Pfizer announces positive top-line results from phase 3 S-TRAC trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3402404","2016-07-08 08:00:00","Reuters Key Development","Pfizer announces positive top-line results from phase 3 S-TRAC trial","PFE","Pfizer"
"939","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3406901","2016-07-18 06:16:10","Reuters Key Development","ARIA study shows superior efficacy of Triumeq for treatment-naïve women with HIV","PFE","Pfizer"
"940","Pfizer gets WHO prequalification for multi-dose vial presentation of Prevenar 13","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3407718","2016-07-19 08:00:00","Reuters Key Development","Pfizer gets WHO prequalification for multi-dose vial presentation of Prevenar 13","PFE","Pfizer"
"941","Bind Therapeutics says two bidders join Pfizer&#39;s stalking horse bid","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3410673","2016-07-25 07:00:00","Reuters Key Development","Bind Therapeutics says two bidders join Pfizer's stalking horse bid","PFE","Pfizer"
"942","Bind Therapeutics determines Pfizer&#39;s $40 mln bid highest","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3412044","2016-07-26 17:27:00","Reuters Key Development","Bind Therapeutics determines Pfizer's $40 mln bid highest","PFE","Pfizer"
"943","Pfizer and Western Oncolytics announce immuno-oncology research collaboration","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3414145","2016-07-28 10:00:00","Reuters Key Development","Pfizer and Western Oncolytics announce immuno-oncology research collaboration","PFE","Pfizer"
"944","Bind Therapeutics says it entered into an asset purchase agreement with Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3414375","2016-07-28 16:07:47","Reuters Key Development","Bind Therapeutics says it entered into an asset purchase agreement with Pfizer","PFE","Pfizer"
"945","Pfizer says it has reached $486 million settlement of litigation over Celebrex, Bextra&lt;PFE.N&gt;","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3417194","2016-08-02 07:30:00","Reuters Key Development","Pfizer says it has reached $486 million settlement of litigation over Celebrex, Bextra<PFE.N>","PFE","Pfizer"
"946","Pfenex will regain full rights to PF582","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3421200","2016-08-08 08:03:18","Reuters Key Development","Pfenex will regain full rights to PF582","PFE","Pfizer"
"947","Pfizer says as of July 3 offsetting foreign currency exposures was $31.5 bln","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3424796","2016-08-11 17:58:00","Reuters Key Development","Pfizer says as of July 3 offsetting foreign currency exposures was $31.5 bln","PFE","Pfizer"
"948","FDA approves Pfizer&#39;s TROXYCA ER extended-release capsules CII for pain management","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3429750","2016-08-19 18:21:00","Reuters Key Development","FDA approves Pfizer's TROXYCA ER extended-release capsules CII for pain management","PFE","Pfizer"
"949","Medivation to pay fee of $510 mln, upon Pfizer deal termination","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3430246","2016-08-22 08:30:01","Reuters Key Development","Medivation to pay fee of $510 mln, upon Pfizer deal termination","PFE","Pfizer"
"950","Moody&#39;s affirms Pfizer at A1/P-1; outlook remains negative","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3430372","2016-08-22 13:46:03","Reuters Key Development","Moody's affirms Pfizer at A1/P-1; outlook remains negative","PFE","Pfizer"
"951","Fitch: Pfizer deal highlights US Pharma trend for targeted M&amp;A","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3430991","2016-08-23 11:03:21","Reuters Key Development","Fitch: Pfizer deal highlights US Pharma trend for targeted M&A","PFE","Pfizer"
"952","Clovis enters into first amendment to license agreement between Clovis and pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3434931","2016-08-30 16:15:13","Reuters Key Development","Clovis enters into first amendment to license agreement between Clovis and pfizer","PFE","Pfizer"
"953","Pfizer appoints Chief Scientific Officer for Neuroscience Research","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3438319","2016-09-07 08:00:00","Reuters Key Development","Pfizer appoints Chief Scientific Officer for Neuroscience Research","PFE","Pfizer"
"954","Medivation and Pfizer file premerger notification","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3439325","2016-09-09 07:22:19","Reuters Key Development","Medivation and Pfizer file premerger notification","PFE","Pfizer"
"955","FDA staff say neuropsychiatric risk with Pfizer&#39;s quit-smoking drug varies in studies, trial design has limitations","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3439924","2016-09-12 09:22:09","Reuters Key Development","FDA staff say neuropsychiatric risk with Pfizer's quit-smoking drug varies in studies, trial design has limitations","PFE","Pfizer"
"956","U.S. FDA panel votes in favor of removing boxed warning on Pfizer&#39;s quit-smoking drug Chantix","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3441119","2016-09-14 16:15:00","Reuters Key Development","U.S. FDA panel votes in favor of removing boxed warning on Pfizer's quit-smoking drug Chantix","PFE","Pfizer"
"957","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3441448","2016-09-15 08:31:00","Reuters Key Development","Merck, Pfizer say investigational Ertugliflozin met primary endpoint","PFE","Pfizer"
"958","Oncoimmune announces option and license agreement with Pfizer Inc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3441468","2016-09-15 09:00:00","Reuters Key Development","Oncoimmune announces option and license agreement with Pfizer Inc","PFE","Pfizer"
"959","Pfizer declares 30-cent fourth-quarter 2016 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3444159","2016-09-22 11:56:00","Reuters Key Development","Pfizer declares 30-cent fourth-quarter 2016 dividend","PFE","Pfizer"
"960","Pfizer says it will not pursue splitting into two separate publicly traded companies","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3445096","2016-09-26 06:45:00","Reuters Key Development","Pfizer says it will not pursue splitting into two separate publicly traded companies","PFE","Pfizer"
"961","Moody&#39;s changes outlook on Pfizer&#39;s to stable from negative, affirms ratings","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3445301","2016-09-26 13:08:15","Reuters Key Development","Moody's changes outlook on Pfizer's to stable from negative, affirms ratings","PFE","Pfizer"
"962","Fitch says Pfizer&#39;s scrapped split decision will not affect ratings","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3445869","2016-09-27 10:52:23","Reuters Key Development","Fitch says Pfizer's scrapped split decision will not affect ratings","PFE","Pfizer"
"963","ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3450083","2016-10-06 07:52:59","Reuters Key Development","ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock","PFE","Pfizer"
"964","Pfizer announces results from Phase 3 S-TRAC clinical trial","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3450969","2016-10-10 02:15:00","Reuters Key Development","Pfizer announces results from Phase 3 S-TRAC clinical trial","PFE","Pfizer"
"965","Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3453528","2016-10-13 17:52:00","Reuters Key Development","Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer","PFE","Pfizer"
"966","Pfizer says company to begin shipping Inflectra to wholesalers in late November","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3455320","2016-10-17 16:05:00","Reuters Key Development","Pfizer says company to begin shipping Inflectra to wholesalers in late November","PFE","Pfizer"
"967","Pfizer awarded grant to evaluate vaccine for newborns","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3456590","2016-10-19 08:00:00","Reuters Key Development","Pfizer awarded grant to evaluate vaccine for newborns","PFE","Pfizer"
"968","CDC&#39;s ACIP votes to recommend new dosing schedule for vaccination with Pfizer&#39;s trumenba","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3456882","2016-10-19 18:02:00","Reuters Key Development","CDC's ACIP votes to recommend new dosing schedule for vaccination with Pfizer's trumenba","PFE","Pfizer"
"969","Debiopharm reports clinical collaboration with Merck KGaA and Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3457491","2016-10-20 08:00:00","Reuters Key Development","Debiopharm reports clinical collaboration with Merck KGaA and Pfizer","PFE","Pfizer"
"970","Merck and Pfizer say EMA validated Avelumab for MMA review","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3465523","2016-10-31 03:08:10","Reuters Key Development","Merck and Pfizer say EMA validated Avelumab for MMA review","PFE","Pfizer"
"971","Pfizer Q3 worldwide Ibrance revenue $550 mln vs.$230 mln last year","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3466807","2016-11-01 06:45:00","Reuters Key Development","Pfizer Q3 worldwide Ibrance revenue $550 mln vs.$230 mln last year","PFE","Pfizer"
"972","Pfizer Q3 adjusted EPS $0.61","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3466763","2016-11-01 06:45:00","Reuters Key Development","Pfizer Q3 adjusted EPS $0.61","PFE","Pfizer"
"973","Pfizer discontinues global development of Bococizumab, its investigational pcsk9 inhibitor","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3466754","2016-11-01 06:45:00","Reuters Key Development","Pfizer discontinues global development of Bococizumab, its investigational pcsk9 inhibitor","PFE","Pfizer"
"974","EMA says CHMP recommends approving Afstyla","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3476217","2016-11-11 07:11:27","Reuters Key Development","EMA says CHMP recommends approving Afstyla","PFE","Pfizer"
"975","Pfizer to collaborate with National Cancer Institute","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3477530","2016-11-14 08:00:00","Reuters Key Development","Pfizer to collaborate with National Cancer Institute","PFE","Pfizer"
"976","Pfizer says announces tender offer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3477650","2016-11-14 08:47:00","Reuters Key Development","Pfizer says announces tender offer","PFE","Pfizer"
"977","Paulson &amp; Co cuts share stake in Pfizer, raises share stake in Facebook","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3478208","2016-11-14 17:35:31","Reuters Key Development","Paulson & Co cuts share stake in Pfizer, raises share stake in Facebook","PFE","Pfizer"
"978","Pfizer prices $6 billion debt offering&lt;PFE.N&gt;","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3478278","2016-11-14 18:55:00","Reuters Key Development","Pfizer prices $6 billion debt offering<PFE.N>","PFE","Pfizer"
"979","Pfizer prices $6 billion debt offering","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3478279","2016-11-14 19:37:40","Reuters Key Development","Pfizer prices $6 billion debt offering","PFE","Pfizer"
"980","Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3481614","2016-11-18 14:55:00","Reuters Key Development","Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019","PFE","Pfizer"
"981","Pfizer says Pfizer Global Supply President to retire","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3482212","2016-11-21 10:11:00","Reuters Key Development","Pfizer says Pfizer Global Supply President to retire","PFE","Pfizer"
"982","FDA accepts the Biologics&#39; license application for Avelumab for priority review","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3486669","2016-11-29 08:17:00","Reuters Key Development","FDA accepts the Biologics' license application for Avelumab for priority review","PFE","Pfizer"
"983","Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3488323","2016-12-01 08:00:00","Reuters Key Development","Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery","PFE","Pfizer"
"984","UK&#39;s CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3491150","2016-12-07 02:18:33","Reuters Key Development","UK's CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike","PFE","Pfizer"
"985","Pfizer to appeal all aspects of decision by UK&#39;s CMA","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3491162","2016-12-07 02:27:34","Reuters Key Development","Pfizer to appeal all aspects of decision by UK's CMA","PFE","Pfizer"
"986","Drugmakers trade group says government mandates wrong way to address drug costs","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3491583","2016-12-07 12:15:21","Reuters Key Development","Drugmakers trade group says government mandates wrong way to address drug costs","PFE","Pfizer"
"987","Pfizer declares first-quarter 2017 dividend","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3493661","2016-12-12 11:57:27","Reuters Key Development","Pfizer declares first-quarter 2017 dividend","PFE","Pfizer"
"988","Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3494411","2016-12-13 13:03:00","Reuters Key Development","Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies","PFE","Pfizer"
"989","U.S. FDA approves Eucrisa for eczema","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3495181","2016-12-14 13:10:39","Reuters Key Development","U.S. FDA approves Eucrisa for eczema","PFE","Pfizer"
"990","Catalyst Biosciences entered into agreement with Wyeth Llc","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3495231","2016-12-14 16:18:23","Reuters Key Development","Catalyst Biosciences entered into agreement with Wyeth Llc","PFE","Pfizer"
"991","EMA recommends approval of Pfizer&#39;s lifmior drug","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3496637","2016-12-16 07:39:54","Reuters Key Development","EMA recommends approval of Pfizer's lifmior drug","PFE","Pfizer"
"992","Pfizer says FDA drops black box warning on anti-smoking drug Chantix","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3496828","2016-12-16 14:09:00","Reuters Key Development","Pfizer says FDA drops black box warning on anti-smoking drug Chantix","PFE","Pfizer"
"993","Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3497499","2016-12-19 08:00:00","Reuters Key Development","Portola Pharmaceuticals enters loan agreement with Bristol-Myers Squibb and Pfizer","PFE","Pfizer"
"994","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3500133","2016-12-23 02:05:00","Reuters Key Development","Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca","PFE","Pfizer"
"995","ICU Medical updates on Hospira Infusion Systems deal","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3504672","2017-01-05 16:05:00","Reuters Key Development","ICU Medical updates on Hospira Infusion Systems deal","PFE","Pfizer"
"996","Pfizer reports positive top-line results from phase 2 study of investigational clostridium difficile vaccine","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3515892","2017-01-26 08:00:00","Reuters Key Development","Pfizer reports positive top-line results from phase 2 study of investigational clostridium difficile vaccine","PFE","Pfizer"
"997","Pfizer Inc Risk Points versus Health Care","http://news.cmlviz.com/2017/02/09/pfizer-inc-risk-points-versus-health-care.html","2017-01-28 18:15:00","CML News","This is a scatter plot analysis of the critical risk points from the option market for Pfizer Inc (NYSE:PFE) compared to its own past and the Health Care ETF.","PFE","Pfizer"
"998","Pfizer guidance could be light - BMO","http://seekingalpha.com/news/3238604-pfizer-guidance-light-bmo","2017-01-30 06:48:45","Seeking Alpha","Pfizer's (NYSE:PFE) consensus doesn't leave much room for upside surprise for 2017 guidance, ""and we are 2-3% below,"" BMO writes.","PFE","Pfizer"
"999","Ex-Dividend Reminder: DR Horton, CMS Energy Corp and Pfizer","http://www.nasdaq.com/article/ex-dividend-reminder-dr-horton-cms-energy-corp-and-pfizer-cm740152","2017-01-30 10:33:42","Nasdaq","Looking at the universe of stocks we cover at Dividend Channel , on 2/1/17, D.R. Horton Inc. (Symbol: DHI), CMS Energy Corp (Symbol: CMS), and Pfizer Inc (Symbol: PFE) will all trade ex-dividend for their respective upcoming dividends. D.R. Horton Inc ...","PFE","Pfizer"
"1000","A Mixed Bag of Earnings Ahead: Eli Lilly, Pfizer, Exxon Mobil, And Under Armour","https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8965539/a-mixed-bag-of-earnings-ahead-eli-lilly-pfizer-exxon-mob","2017-01-30 11:41:15","Benzinga","Pharmaceutical giants Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) are both expected to report results before the markets open on Tuesday.","PFE","Pfizer"
"1001","Big Pre-Earnings Options Bets On Exxon Mobil Corporation and Pfizer Inc.","http://www.schaeffersresearch.com/content/analysis/2017/01/30/big-pre-earnings-options-bets-on-exxon-mobil-corporation-and-pfizer-inc","2017-01-30 14:56:46","Schaeffers Research (blog)","Dow stocks Exxon Mobil Corporation (NYSE:XOM) and Pfizer Inc. (NYSE:PFE) will head to the earnings confessional tomorrow morning.","PFE","Pfizer"
"1002","Better Buy: AbbVie Inc. vs. Pfizer","https://www.fool.com/investing/2017/01/30/better-buy-abbvie-inc-vs-pfizer.aspx","2017-01-30 16:11:15","Motley Fool","New products should help Pfizer's overall results improve. The company bought Medivation last year, picking up fast-growing prostate cancer drug Xtandi.","PFE","Pfizer"
"1003","Earnings Reaction History: Pfizer Inc, 45.5% Follow-Through Indicator, 1.3 ...","http://www.nasdaq.com/article/earnings-reaction-history-pfizer-inc-455-follow-through-indicator-13-sensitive-cm740599","2017-01-31 06:26:15","Nasdaq","Pfizer Inc ( PFE ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement.","PFE","Pfizer"
"1004","Pfizer Inc reports Q4 reported diluted EPS of $0.13","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3517905","2017-01-31 06:45:00","Reuters Key Development","Pfizer Inc reports Q4 reported diluted EPS of $0.13","PFE","Pfizer"
"1005","Pfizer Inc. Q4 Profit Retreats 13%","http://www.nasdaq.com/article/pfizer-inc-q4-profit-retreats-13-20170131-00305","2017-01-31 06:48:25","Nasdaq","(RTTNews.com) - Pfizer Inc. ( PFE ) announced earnings for fourth quarter that decreased compared to the same period last year.","PFE","Pfizer"
"1006","BRIEF-Pfizer Inc reports Q4 reported diluted EPS of $0.13","http://www.reuters.com/article/idUSL5N1FL3MO","2017-01-31 07:11:15","Reuters","BRIEF-Pfizer Inc reports Q4 reported diluted EPS of $0.13. Jan 31 Pfizer Inc : * Pfizer reports fourth-quarter and full-year 2016 results.","PFE","Pfizer"
"1007","Pfizer swings to 4Q profit after rough year, hikes 2017 view","http://www.seattletimes.com/business/pfizer-misses-4q-profit-forecasts/","2017-01-31 07:16:10","The Seattle Times","FILE - In this Monday, Nov. 23, 2015, file photo, a woman passes Pfizer's world headquarters, in New York. Pfizer Inc. (PFE) on Tuesday, Jan. 31, 2017, reported fourth-quarter net income of $775 million, after reporting a loss in the same period a year ...","PFE","Pfizer"
"1008","Pfizer&#39;s Q4 Lyrica IH revenue was $1.06 bln vs $955 mln yr ago","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3517901","2017-01-31 07:16:13","Reuters Key Development","Pfizer's Q4 Lyrica IH revenue was $1.06 bln vs $955 mln yr ago","PFE","Pfizer"
"1009","Pfizer Revenue Falls As Full-Year Sales Seen Below Wall Street Estimates","http://www.wsj.com/articles/pfizer-revenue-falls-full-year-sales-seen-below-wall-street-expectations-1485868955","2017-01-31 08:23:16","Wall Street Journal","Pfizer Inc. revenue declined in the latest quarter as sales of its top-selling product dropped, while the company's sales outlook for this year fell below Wall Street's expectations.","PFE","Pfizer"
"1010","Edelris Announces Research Collaboration Agreement with Pfizer Inc.","http://www.pharmpro.com/news/2017/01/edelris-announces-research-collaboration-agreement-pfizer-inc","2017-01-31 10:00:00","Pharmaceutical Processing","Edelris s.a.s., a medicinal chemistry company focused on applying its Edelris Discovery Engine (EDEN) technology toward the generation of innovative small molecule leads, announced the signing of a research collaboration agreement with Pfizer Inc.","PFE","Pfizer"
"1011","Pfizer sees 2017 Prevnar sales flat to slightly down","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3518084","2017-01-31 11:42:43","Reuters Key Development","Pfizer sees 2017 Prevnar sales flat to slightly down","PFE","Pfizer"
"1012","Pfizer&#39;s 3 Fastest-Growing Drugs","https://www.fool.com/investing/2017/01/31/pfizers-3-fastest-growing-drugs.aspx","2017-01-31 16:11:15","Motley Fool","... by its research and development team. Specifically, the company's notching significant sales growth from cancer drug Ibrance, anticoagulant Eliquis, and rheumatoid arthritis drug Xeljanz.","PFE","Pfizer"
"1013","Pfizer Needs to Keep Dealing","https://www.bloomberg.com/gadfly/articles/2017-01-31/pfizer-earnings-more-deals-needed","2017-01-31 16:37:41","Bloomberg","Pfizer Inc. did the second-biggest biotech deal of 2016, a $14 billion take-out Medivation, after the Treasury Department slapped it away from the biggest merger in pharma history.","PFE","Pfizer"
"1014","Pfizer said to hire JPMorgan to weigh $2 bln portfolio sale - Bloomberg, citing sources","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3519827","2017-02-02 12:27:33","Reuters Key Development","Pfizer said to hire JPMorgan to weigh $2 bln portfolio sale - Bloomberg, citing sources","PFE","Pfizer"
"1015","Pfizer commences $5 billion accelerated share repurchase","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3520455","2017-02-03 08:10:00","Reuters Key Development","Pfizer commences $5 billion accelerated share repurchase","PFE","Pfizer"
"1016","Form 8-K PFIZER INC For: Feb 02","http://www.streetinsider.com/SEC+Filings/Form+8-K+PFIZER+INC+For%3A+Feb+02/12495526.html","2017-02-03 08:52:30","StreetInsider.com","On February 2, 2017, Pfizer Inc. (""Pfizer"") entered into an accelerated share repurchase agreement with Citibank N.A.","PFE","Pfizer"
"1017","Pfizer May Be Another IBM","http://seekingalpha.com/article/4042443-pfizer-may-another-ibm","2017-02-03 10:11:15","Seeking Alpha","The stock trades near 30X earnings as if it were about to rebound with great growth. Yet, instead it just may be a lumbering giant making weak decisions not designed to provide rapid organic growth.","PFE","Pfizer"
"1018","Pfizer&#39;s Ibrance too pricey for Britain&#39;s NICE","http://seekingalpha.com/news/3240502-pfizers-ibrance-pricey-britains-nice","2017-02-03 10:11:15","Seeking Alpha","The UK's National Institute for Health and Care Excellence (NICE), an advisor to the National Health Service (NHS) on costs and care quality, gives a thumbs down to Pfizer's (PFE +1.3%) breast cancer med Ibrance (palbociclib) saying its ""cost is too ...","PFE","Pfizer"
"1019","Lanny&#39;s Recent Stock Purchase - Pfizer","http://seekingalpha.com/article/4043201-lannys-recent-stock-purchase-pfizer","2017-02-07 05:52:30","Seeking Alpha","Well, times have changed, their dividend has grown every year since then and the ""blue"" pilled company has been very strong as of late.","PFE","Pfizer"
"1020","Pfizer: Another Reason To Stay Long","http://seekingalpha.com/article/4044336-pfizer-another-reason-stay-long","2017-02-09 11:07:30","Seeking Alpha","There were already plenty of reasons like Pfizer (NYSE:PFE) as a long-term investment but management just gave investors another reason to add to that list when it was recently announced that the company entered into a $5b accelerated share repurchase ...","PFE","Pfizer"
"1021","Pfizer Inc.: Invest For Attractive Valuation And The 4% Dividend Yield","http://seekingalpha.com/article/4044441-pfizer-inc-invest-attractive-valuation-4-percent-dividend-yield","2017-02-09 14:16:18","Seeking Alpha","Pfizer Inc. (NYSE:PFE) is one of the world's largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.","PFE","Pfizer"
"1022","BRIEF-Pfizer Inc reports 16.4 pct stake in ICU Medical","http://www.reuters.com/article/idUSFWN1FY10H","2017-02-13 16:45:00","Reuters","Feb 13 ICU Medical Inc : * Pfizer Inc reports 16.4 pct stake in ICU Medical Inc as of Feb. 3 Source text: (bit.ly/2kpY8il) Further company coverage: Next In Market News.","PFE","Pfizer"
"1023","Pfizer Inc. (PFE) Closes 0.8% Up on the Day for February 13","https://www.equities.com/news/pfizer-inc-pfe-closes-0-8-up-on-the-day-for-february-13","2017-02-13 17:30:00","Equities.com","Shares of Pfizer Inc. (PFE) ended the trading day Monday at $32.61, representing a move of 0.8%, or $0.26 per share, on volume of 20.57 million shares.","PFE","Pfizer"
"1024","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3526433","2017-02-13 18:55:53","Reuters Key Development","ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine","PFE","Pfizer"
"1025","What are Analyst&#39;s Indicators for Microsoft Corporation (MSFT), Pfizer Inc. (PFE)","http://theusacommerce.com/2017/02/14/what-are-analysts-indicators-for-microsoft-corporation-msft-pfizer-inc-pfe/","2017-02-14 13:00:00","The USA Commerce","Shares of Microsoft Corporation (NASDAQ:MSFT) surged 1.13% to $64.72. During the trading on 02/13/2017, Company's stock ranged from $64.13 to $64.86.","PFE","Pfizer"
"1026","Appaloosa LP dissolves share stake in Citigroup, Bank of America - SEC Filing","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3527762","2017-02-14 16:47:43","Reuters Key Development","Appaloosa LP dissolves share stake in Citigroup, Bank of America - SEC Filing","PFE","Pfizer"
"1027","Paulson &amp; Co ups share stake in Pfizer","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3527812","2017-02-14 18:23:24","Reuters Key Development","Paulson & Co ups share stake in Pfizer","PFE","Pfizer"
"1028","EOD Risers: Microsoft Corporation, Nike Inc, Pfizer Inc., Travelers Companies Inc","http://www.directorstalkinterviews.com/eod-risers-microsoft-corporation-nike-inc-pfizer-inc-travelers-companies-inc/412723906","2017-02-15 04:56:15","DirectorsTalk Interviews","Shares of Microsoft Corporation ticker code: (NASDAQ:MSFT) a technology company, rose 0.37% or 0.24 points at the end of yesterday's session.","PFE","Pfizer"
"1029","Pfizer Inc. (PFE) Moves Higher on Volume Spike for February 15","https://www.equities.com/news/pfizer-inc-pfe-moves-higher-on-volume-spike-for-february-15","2017-02-15 17:30:08","Equities.com","Pfizer Inc. (PFE) traded on unusually high volume on Feb. 15, as the stock gained 2.32% to close at $33.51. On the day, Pfizer Inc. saw 45.3 million shares trade hands on 111,454 trades. Considering that the stock averages only a daily volume of 25.68 ...","PFE","Pfizer"
"1030","EOD Risers: Nike Inc, Pfizer Inc., Procter &amp; Gamble Co, Travelers Companies Inc","http://www.directorstalkinterviews.com/eod-risers-nike-inc-pfizer-inc-procter-gamble-co-travelers-companies-inc/412723978","2017-02-16 05:14:03","DirectorsTalk Interviews","The share price for Pfizer Inc. company symbol: (NYSE:PFE) a research-based global biopharmaceutical company, rose 2.32% or 0.76 points throughout yesterday's trading day.","PFE","Pfizer"
"1031","Pfizer announces top-line results from oral strategy trial of Xeljanz compared to Humira","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3529501","2017-02-16 08:00:00","Reuters Key Development","Pfizer announces top-line results from oral strategy trial of Xeljanz compared to Humira","PFE","Pfizer"
"1032","EOD Risers: Pfizer Inc., The Coca-Cola Co, Travelers Companies Inc, United ...","http://www.directorstalkinterviews.com/eod-risers-pfizer-inc-coca-cola-co-travelers-companies-inc-united-technologies-corporation/412724046","2017-02-17 05:13:53","DirectorsTalk Interviews","Shares of Pfizer Inc. company symbol: (NYSE:PFE) a research-based global biopharmaceutical company, increased 0.33% or 0.11 points throughout yesterday's trading day.","PFE","Pfizer"
"1033","Pfizer Inc: Active Stock","http://fsmnews.com/Articles/Pfizer-Inc-Active-Stock/article.aspx?Article=1446","2017-02-17 08:34:04","FSM News (registration) (blog)","Pfizer Inc. has been included in the investors' watch list in the Healthcare space, which focused on Drug Manufacturers.","PFE","Pfizer"
"1034","Why Investors remained confident on MGM Resorts International (MGM), Pfizer ...","http://stocknewsjournal.com/2017/02/17/why-investors-remained-confident-on-mgm-resorts-international-mgm-pfizer-inc-pfe/","2017-02-17 09:26:15","StockNewsJournal","Pfizer Inc. (NYSE:PFE), maintained return on investment for the last twelve months at 4.34, higher than what Reuters data shows regarding industry's average.","PFE","Pfizer"
"1035","Pfizer Inc. (PFE) : How Do the Technicals Stack Up?","http://www.theusacommerce.com/2017/02/21/pfizer-inc-pfe-how-do-the-technicals-stack-up-3/","2017-02-17 11:30:00","The USA Commerce","We have gathered the technical data on Pfizer Inc. (PFE), and see some interesting trends in the stock's behavior of late.","PFE","Pfizer"
"1036","Momenta Pharmaceuticals announces FDA warning letter to contracted Glatopa","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3530506","2017-02-17 19:02:15","Reuters Key Development","Momenta Pharmaceuticals announces FDA warning letter to contracted Glatopa","PFE","Pfizer"
"1037","Pfizer Near A Technical Breakout","http://seekingalpha.com/article/4047384-pfizer-near-technical-breakout","2017-02-18 18:17:19","Seeking Alpha","Pfizer's share price won't go to the moon but I believe there is strong downside protection here mainly due to the company's sheer size and diversification. I think what dividend investors need to take into account here is that there are companies ...","PFE","Pfizer"
"1038","Pfizer Is A Solid Buy In 2017","http://seekingalpha.com/article/4047486-pfizer-solid-buy-2017","2017-02-20 00:48:45","Seeking Alpha","Besides having a solid and well-diversified drug portfolio, Pfizer also boasts of having some of the most promising investigational therapies in its research pipeline.","PFE","Pfizer"
"1039","Pfizer, Inc. (PFE) Given a $39.00 Price Target at Berenberg Bank","https://www.thecerbatgem.com/2017/02/20/pfizer-inc-pfe-given-a-39-00-price-target-at-berenberg-bank.html","2017-02-20 12:37:30","The Cerbat Gem","Pfizer, Inc. logo Berenberg Bank set a $39.00 price target on Pfizer, Inc. (NYSE:PFE) in a research report report published on Friday.","PFE","Pfizer"
"1040","Pfizer Inc. (PFE) Closes Flat on the Day for February 20","https://www.equities.com/news/pfizer-inc-pfe-closes-flat-on-the-day-for-february-20","2017-02-20 17:30:00","Equities.com","Shares of Pfizer Inc. (PFE) ended the trading day Monday at $33.62, representing a move of 0%, or $0 per share, on volume of 34.99 million shares.","PFE","Pfizer"
"1041","EOD Risers: Pfizer Inc., Procter &amp; Gamble Co, The Coca-Cola Co, Travelers ...","https://www.directorstalkinterviews.com/eod-risers-pfizer-inc-procter-gamble-co-coca-cola-co-travelers-companies-inc/412724249","2017-02-21 05:32:43","DirectorsTalk Interviews","The stock price for Pfizer Inc. with EPIC code: (NYSE:PFE) a research-based global biopharmaceutical company, moved up 0.01% during yesterday's session.","PFE","Pfizer"
"1042","Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin ...","http://www.businesswire.com/news/home/20170221005530/en/Pfizer-Announces-Acceptance-Regulatory-Submission-Inotuzumab-Ozogamicin","2017-02-21 07:56:15","Business Wire (press release)","Pfizer Inc. (NYSE:PFE) today announced that a Biologics License Application (BLA) for inotuzumab ozogamicin has been accepted for filing and granted Priority Review by the U.S.","PFE","Pfizer"
"1043","Pfizer says U.S. FDA accepts regulatory submission for inotuzumab ozogamicin","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3531823","2017-02-21 08:00:00","Reuters Key Development","Pfizer says U.S. FDA accepts regulatory submission for inotuzumab ozogamicin","PFE","Pfizer"
"1044","Why Investors remained confident on Advanced Micro Devices, Inc. (AMD), Pfizer ...","http://stocknewsjournal.com/2017/02/21/why-investors-remained-confident-on-advanced-micro-devices-inc-amd-pfizer-inc-pfe/","2017-02-21 10:46:40","StockNewsJournal","Pfizer Inc. (NYSE:PFE), maintained return on investment for the last twelve months at 4.34, higher than what Reuters data shows regarding industry's average.","PFE","Pfizer"
"1045","Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes","https://www.benzinga.com/news/17/02/9074793/boeing-pfizer-and-others-band-together-to-ask-congress-for-more-taxes","2017-02-21 13:22:30","Benzinga","The coalition includes Merck & Co., Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), Boeing Co (NYSE: BA), Caterpillar Inc. (NYSE: CAT), General Electric Company (NYSE: GE), Dow Chemical Co (NYSE: DOW) and United Technologies Corporation (NYSE: UTX).","PFE","Pfizer"
"1046","Pfizer said SIX swiss exchange approved delisting of its shares","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3532434","2017-02-22 01:05:48","Reuters Key Development","Pfizer said SIX swiss exchange approved delisting of its shares","PFE","Pfizer"
"1047","Pfizer to cancel listing in the United Kingdom","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3532612","2017-02-22 02:00:07","Reuters Key Development","Pfizer to cancel listing in the United Kingdom","PFE","Pfizer"
"1048","SIX Exchange Regulation Publishes Decision With Grounds Regarding Delisting Of ...","http://www.mondovisione.com/media-and-resources/news/six-exchange-regulation-publishes-decision-with-grounds-regarding-delisting-of/","2017-02-22 02:30:00","Exchange News Direct","Pfizer Inc. has announced, that all of its secondary listed shares (Swiss Security Number 962'004 /ISIN US71170811035) with a nominal value of USD 0.05 will be delisted from SIX Swiss Exchange.","PFE","Pfizer"
"1049","Investors: Option reports for Advanced Micro Devices, Macy&#39;s Incorporated ...","http://www.prnewswire.com/news-releases/investors-option-reports-for-advanced-micro-devices-macys-incorporated-nike-pfizer-inc-and-vipshop-holdings-300411579.html","2017-02-22 09:32:15","PR Newswire (press release)"," InvestorsObserver issues critical PriceWatch Alerts for AMD, M, NKE, PFE, and VIPS. To see the high-return covered-call trades uncovered by InvestorsObserver's analysts, read the InvestorsObserver's PriceWatch ...","PFE","Pfizer"
"1050","Manufacturing Delay Of Generic Drug From Pfizer Inc. (NYSE:PFE) A Relief For ...","https://marketexclusive.com/a-manufacturing-delay-of-a-generic-drug-from-pfizer-inc-nysepfe-and-momenta-is-a-relief-for-teva-pharmaceutical-industries-ltd-adr-nyseteva/74090/","2017-02-22 09:37:30","Market Exclusive","Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories.","PFE","Pfizer"
"1051","Large Outflow of Money Witnessed in Pfizer, Inc.","http://www.moneyflowtrends.com/2017-02-22-large-outflow-of-money-witnessed-in-pfizer-inc","2017-02-22 11:00:38","Money Flow Index & Trends","Pfizer, Inc. (PFE) managed to stay afloat and traded higher with an addition of 0.07 point or 0.19% at $33.69. The money flow data is a negative $(-28.88) million with $69.42 million in upticks and $98.3 million in downticks.","PFE","Pfizer"
"1052","Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield","http://www.insidermonkey.com/blog/pfizer-inc-pfe-invest-for-attractive-valuation-and-the-4-dividend-yield-561556/","2017-02-22 16:41:26","Insider Monkey (blog)","Pfizer Inc. (NYSE:PFE) is one of the world's largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.","PFE","Pfizer"
"1053","Is Pfizer&#39;s Research Pipeline Truly Undervalued?","http://seekingalpha.com/article/4048823-pfizers-research-pipeline-truly-undervalued","2017-02-23 10:33:45","Seeking Alpha","I have also given a detailed account of the major cancer drugs in Pfizer's portfolio, considered to be the key growth drivers for the company in 2017. In addition to a robust drug portfolio, I strongly believe that Pfizer also has one seriously ...","PFE","Pfizer"
"1054","Forward Earnings Estimate of Pfizer, Inc.(PFE)","https://www.highlandmirror.com/2017-02-23-forward-earnings-estimate-of-pfizer-inc-pfe","2017-02-23 12:15:00","Highland Mirror","Pfizer, Inc.(PFE): For the most recent quarter end, Pfizer, Inc. reported Annual Earnings of $0.47. Based on the filings, last years Annual Earnings was, $2.4.","PFE","Pfizer"
"1055","The Technical Case for and Against Pfizer Inc. (PFE)","http://theusacommerce.com/2017/02/23/the-technical-case-for-and-against-pfizer-inc-pfe-2/","2017-02-23 13:56:15","The USA Commerce","We have gathered the technical data on Pfizer Inc. (PFE), and see some interesting trends in the stock's behavior of late.","PFE","Pfizer"
"1056","Johnson &amp; Johnson, Pfizer Lead DJIA Higher on Thursday","http://247wallst.com/investing/2017/02/23/johnson-johnson-pfizer-lead-djia-higher-on-thursday/","2017-02-23 16:00:00","24/7 Wall St.","Pfizer Inc. (NYSE: PFE) traded up 1.47% at $34.08. The stock's 52-week range is $28.74 to $37.39. Volume was about 10% below the daily average of around 25.5 million shares.","PFE","Pfizer"
"1057","Ronald E. Blaylock Elected to Pfizer&#39;s Board of Directors","http://www.businesswire.com/news/home/20170223006654/en/Ronald-E.-Blaylock-Elected-Pfizer%E2%80%99s-Board-Directors","2017-02-23 16:11:15","Business Wire (press release)","Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately.","PFE","Pfizer"
"1058","Ronald Blaylock elected to Pfizer&#39;s board of directors","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3534484","2017-02-23 16:15:00","Reuters Key Development","Ronald Blaylock elected to Pfizer's board of directors","PFE","Pfizer"
"1059","Pfizer says monitoring potential impact related to any changes to ACA","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3534594","2017-02-23 17:49:11","Reuters Key Development","Pfizer says monitoring potential impact related to any changes to ACA","PFE","Pfizer"
"1060","EOD Risers: McDonald&#39;s Corporation, Merck &amp; Co., Inc., Microsoft Corporation ...","https://www.directorstalkinterviews.com/eod-risers-mcdonalds-corporation-merck-co-inc-microsoft-corporation-pfizer-inc-coca-cola-co/412724500","2017-02-24 05:18:45","DirectorsTalk Interviews","The share price for McDonald's Corporation EPIC code: (NYSE:MCD) a company that operates and franchises McDonald's restaurants, moved up 0.33% or 0.42 points at the end of yesterday's session.","PFE","Pfizer"
"1061","Mix Momentum Stocks in Recom- Pfizer Inc. (NYSE:PFE), bluebird bio, Inc ...","http://www.senecaglobe.com/mix-momentum-stocks-recom-pfizer-inc-nysepfe-bluebird-bio-inc-nasdaqblue/370734/","2017-02-24 08:08:34","Seneca Globe","Pfizer Inc. (NYSE:PFE) [Trend Analysis] pretends to be active mover, stock build up around 1.40% to traded at $34.06. The stock got a shaky start early morning on analyst's remarks.","PFE","Pfizer"
"1062","Analyst&#39;s Review on: Bloomin&#39; Brands, Inc. (NASDAQ:BLMN), Pfizer Inc. (NYSE:PFE)","http://theriponadvance.com/analysts-review-on-bloomin-brands-inc-nasdaqblmn-pfizer-inc-nysepfe/12153888/","2017-02-24 10:22:30","TRA","Bloomin' Brands, Inc. (NASDAQ:BLMN) ended its previous trading session at $17.09 with the Loss of -4.42%. The company's market cap is $1.79 Billion, and the average volume is $1.38 Million. The 52-Week High range of the stock is $19.99, while the ...","PFE","Pfizer"
"1063","Pfizer Inc. (PFE), General Electric Company (GE) Stock Eyes Ahead of Earnings","http://theusacommerce.com/2017/02/24/pfizer-inc-pfe-general-electric-company-ge-stock-eyes-ahead-of-earnings/","2017-02-24 11:41:15","The USA Commerce","Shares of Pfizer Inc. (NYSE:PFE) surged 1.40% to $34.06. During the trading on 02/23/2017, Company's stock ranged from $33.58 to $34.12.","PFE","Pfizer"
"1064","Pfizer Prices $1065000000 Debt Offering","http://www.businesswire.com/news/home/20170224005660/en/Pfizer-Prices-1065000000-Debt-Offering","2017-02-24 13:00:00","Business Wire (press release)","Pfizer Inc. (NYSE: PFE) today announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047.","PFE","Pfizer"
"1065","Pfizer announces pricing of $1.07 bln debt offering","http://www.reuters.com/finance/stocks/PFE/key-developments/article/3535471","2017-02-24 13:12:25","Reuters Key Development","Pfizer announces pricing of $1.07 bln debt offering","PFE","Pfizer"
"1066","SNS Financial Group, LLC Buys Pfizer, Facebook, CH ...","http://www.nasdaq.com/article/sns-financial-group-llc-buys-pfizer-facebook-ch-cm753195","2017-02-24 14:30:00","Nasdaq","SNS Financial Group, LLC initiated holdings in C.H. Robinson Worldwide Inc. The purchase prices were between $67.3 and $77.47, with an estimated average price of $72.35.","PFE","Pfizer"
"1067","Pfizer subpoenaed in US over patient assistance plans","http://www.reuters.com/article/us-pfizer-subpoena-idUSKBN1632M3","2017-02-24 18:47:47","Reuters","Pfizer Inc said it received subpoenas from the U.S. Attorney's Office for the District of Massachusetts related to its support for organizations that provide financial help to Medicare patients.","PFE","Pfizer"
"1068","EOD Risers: Pfizer Inc., The Coca-Cola Co, United Technologies Corporation ...","https://www.directorstalkinterviews.com/eod-risers-pfizer-inc-coca-cola-co-united-technologies-corporation-unitedhealth-group-inc/412724589","2017-02-27 06:15:00","DirectorsTalk Interviews","Shares of Pfizer Inc. with EPIC code: (NYSE:PFE) a research-based global biopharmaceutical company, gained 0.59% or 0.2 points during the course of Friday's session.","PFE","Pfizer"
"1069","Hot Analysts Coverage: Pfizer Inc. (NYSE:PFE), Tesla Motors Inc (NASDAQ:TSLA)","http://www.benchmarkmonitor.com/2017/02/27/hot-analysts-coverage-pfizer-inc-nysepfe-tesla-motors-inc-nasdaqtsla/","2017-02-27 07:11:15","Benchmark Monitor","Pfizer Inc. (NYSE:PFE) shares edged up 0.59% to $34.26 on Friday. Pfizer Inc. (NYSE:PFE) said it received subpoenas from the U.S.","PFE","Pfizer"
"1070","Volume Buzzer Inside Investors Review: Pfizer Inc.&#39;s (PFE) stock price ...","http://www.wsnews4investors.com/2017/02/27/volume-buzzer-inside-investors-review-pfizer-inc-s-pfe-stock-price-finalizes-at-34-26-with-recent-daily-performance-of-0-59-on-volume-of-24657006-shares/","2017-02-27 07:33:45","WsNews 4investors","Pfizer Inc.'s (PFE ) stock price escalated 0.59% to finalize at $34.26 throughout previous buying and selling session. A total of 24.66 million shares exchanged at hands and its average trading volume is standing at 25.64 million shares.","PFE","Pfizer"
"1071","analysts Recommendations: Pfizer Inc. (NYSE:PFE)","https://www.newsoracle.com/2017/02/27/analysts-recommendations-pfizer-inc-nysepfe-3/","2017-02-27 08:41:15","News Oracle","Pfizer Inc. (NYSE:PFE) will report its next earnings on May 1 - May 5 (Est.). The company reported the earnings of $0.47/Share in the last quarter where the estimated EPS by analysts was $0.5/share.","PFE","Pfizer"
"1072","Mix Cap Volatile Mover: Merck &amp; Co. (NYSE:MRK), Pfizer Inc. (NYSE:PFE)","http://streetwisereport.com/mix-cap-volatile-mover-merck-co-nysemrk-pfizer-inc-nysepfe/3445421/","2017-02-27 12:03:45","Street Wise Report (blog)","Merck & Co., Inc. (NYSE:MRK) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 0.47% to $66.16.","PFE","Pfizer"
"1073","Upbeat Stocks in Focus- Pfizer Inc. (NYSE:PFE), Rowan Companies (NYSE:RDC ...","http://www.senecaglobe.com/upbeat-stocks-in-focus-pfizer-inc-nysepfe-rowan-companies-nyserdc-chevron-nysecvx/371636/","2017-02-27 12:04:39","Seneca Globe","Pfizer Inc. (NYSE:PFE) eased up turns in hot stance in regular session as it 0.23% to $34.34 in the session with shares volume of 7.5 Million.","PFE","Pfizer"
"1074","Bulls and Bear in Spotlight- Cempra, Inc. (NASDAQ:CEMP), Vale SA (NYSE:VALE ...","http://www.senecaglobe.com/bulls-and-bear-in-spotlight-cempra-inc-nasdaqcemp-vale-s-a-nysevale-pfizer-inc-nysepfe/371670/","2017-02-27 12:15:00","Seneca Globe","Shares of Cempra, Inc. (NASDAQ:CEMP) has price volatility of 10.85% in last 5 days trading session, as shares of firm closed at $4.15 by knocking up of 2.47% in last session.","PFE","Pfizer"
"1075","Pfizer Inc. (PFE): Essential Chart Information","http://nystocknews.com/2017/02/27/pfizer-inc-pfe-essential-chart-information/","2017-02-27 13:33:45","NY Stock News","Pfizer Inc. (PFE) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.","PFE","Pfizer"
"1076","Drilling Down Into the Charts for Pfizer Inc. (PFE)","http://www.theusacommerce.com/2017/02/27/drilling-down-into-the-charts-for-pfizer-inc-pfe/","2017-02-27 13:54:46","The USA Commerce","We have gathered the technical data on Pfizer Inc. (PFE), and see some interesting trends in the stock's behavior of late.","PFE","Pfizer"
"1077","Active Stocks&#39; Concerns Wondering in Street- Pfizer Inc. (NYSE:PFE), Mylan NV ...","http://www.senecaglobe.com/active-stocks-concerns-wondering-in-street-pfizer-inc-nysepfe-mylan-n-v-nasdaqmyl/371770/","2017-02-27 14:07:30","Seneca Globe","Pfizer Inc. (NYSE:PFE) [Trend Analysis] swings ardently in active trading session, it eases up of 0.23% to close at $34.34.","PFE","Pfizer"
"1078","Pfizer Reports Top-Line Results for Rheumatoid Arthritis Treatment Study","http://www.gurufocus.com/news/487513/pfizer-reports-topline-results-for-rheumatoid-arthritis-treatment-study","2017-02-27 16:45:00","GuruFocus.com","The top-line results from the Oral Strategy trial of Xeljanz were announced Feb. 16 by Pfizer Inc. (NYSE:PFE) through the Business Wire.","PFE","Pfizer"
"1079","Pfizer Inc. (PFE) Closes 0.06% Up on the Day for February 27","https://www.equities.com/news/pfizer-inc-pfe-closes-0-06-up-on-the-day-for-february-27","2017-02-27 17:30:05","Equities.com","Shares of Pfizer Inc. (PFE) ended the trading day Monday at $34.28, representing a move of 0.06%, or $0.02 per share, on volume of 21.75 million shares.","PFE","Pfizer"
"1080","Eli Lilly, Pfizer Urge Fed. Circ. To Undo Sanofi IP Ruling","https://www.law360.com/ip/articles/895265/eli-lilly-pfizer-urge-fed-circ-to-undo-sanofi-ip-ruling-","2017-02-27 18:13:09","Law360 (subscription)"," Eli Lilly and Co. and Pfizer Inc. have thrown their support behind Sanofi SA and its partner Regeneron Pharmaceuticals in a Federal Circuit case over patents for a cholesterol-lowering drug, saying ...","PFE","Pfizer"
"1081","Traders Jumping in on Action as Pfizer Inc. (NYSE:PFE) Makes Most Active List","https://winfieldreview.com/traders-jumping-in-on-action-as-pfizer-inc-nysepfe-makes-most-active-list/36006/","2017-02-27 19:55:50","Winfield Review","Recent session action on shares of Pfizer Inc. (NYSE:PFE) puts the stock on today's active list. Since the open, shares have moved 0.16% after recently hitting the $34.28 mark.","PFE","Pfizer"
"1082","Novartis AG announces completion of transactions with GSK","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3164129","2015-03-02 01:00:00","Reuters Key Development","Novartis AG announces completion of transactions with GSK","NVS","Novartis"
"1083","Novartis AG receives EU approval for Jakavi in polycythemia vera","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3173900","2015-03-17 02:15:00","Reuters Key Development","Novartis AG receives EU approval for Jakavi in polycythemia vera","NVS","Novartis"
"1084","Novartis AG&#39;s Cosentyx two-year data shows sustained effect and favorable safety profile in psoriasis patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3177338","2015-03-21 07:00:00","Reuters Key Development","Novartis AG's Cosentyx two-year data shows sustained effect and favorable safety profile in psoriasis patients","NVS","Novartis"
"1085","Aduro Biotech Inc establishes collaboration with Novartis AG for global research, development and commercialization of immuno-oncology products derived from STING-targeted CDN platform technology","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3182841","2015-03-30 01:15:00","Reuters Key Development","Aduro Biotech Inc establishes collaboration with Novartis AG for global research, development and commercialization of immuno-oncology products derived from STING-targeted CDN platform technology","NVS","Novartis"
"1086","Novartis AG announces FDA approval for Jadenu to simplify treatment administration for patients with chronic iron overload","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3183839","2015-03-30 19:03:00","Reuters Key Development","Novartis AG announces FDA approval for Jadenu to simplify treatment administration for patients with chronic iron overload","NVS","Novartis"
"1087","Novartis AG says Alcon receives FDA approval of new multifocal intraocular lens to treat cataract patients in United States","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3193600","2015-04-16 01:15:00","Reuters Key Development","Novartis AG says Alcon receives FDA approval of new multifocal intraocular lens to treat cataract patients in United States","NVS","Novartis"
"1088","Novartis AG confirms FY 2015 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3197912","2015-04-23 01:01:00","Reuters Key Development","Novartis AG confirms FY 2015 outlook","NVS","Novartis"
"1089","Novartis AG says leukaemia drug Arzerra meets main goal in trial","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3201723","2015-04-26 20:00:00","Reuters Key Development","Novartis AG says leukaemia drug Arzerra meets main goal in trial","NVS","Novartis"
"1090","Novartis says lung cancer drug Zykadia gains EU approval","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3209214","2015-05-08 01:15:00","Reuters Key Development","Novartis says lung cancer drug Zykadia gains EU approval","NVS","Novartis"
"1091","Novartis announces two positive U.S. phase III programs in COPD for QVA149 and NVA237","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3216147","2015-05-20 11:30:00","Reuters Key Development","Novartis announces two positive U.S. phase III programs in COPD for QVA149 and NVA237","NVS","Novartis"
"1092","Novartis drug Afinitor extended progression-free survival in Phase III trial in advanced gastrointestinal or lung neuroendocrine tumors","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3216709","2015-05-21 01:16:00","Reuters Key Development","Novartis drug Afinitor extended progression-free survival in Phase III trial in advanced gastrointestinal or lung neuroendocrine tumors","NVS","Novartis"
"1093","Novartis AG says drugs show survival benefit for metastatic melanoma patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3221820","2015-05-31 10:46:00","Reuters Key Development","Novartis AG says drugs show survival benefit for metastatic melanoma patients","NVS","Novartis"
"1094","Novartis says data shows drug relieves inflammatory disease AS","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3223227","2015-06-02 01:15:00","Reuters Key Development","Novartis says data shows drug relieves inflammatory disease AS","NVS","Novartis"
"1095","Novartis AG gains FDA approval for Promacta providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3228213","2015-06-11 18:31:00","Reuters Key Development","Novartis AG gains FDA approval for Promacta providing new option for children, ages 6 and older, with chronic ITP, a rare blood disorder","NVS","Novartis"
"1096","Novartis AG announces data show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3228951","2015-06-13 05:45:00","Reuters Key Development","Novartis AG announces data show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control","NVS","Novartis"
"1097","Novartis AG says Alcon receives European approval for PanOptix","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3230166","2015-06-16 01:15:00","Reuters Key Development","Novartis AG says Alcon receives European approval for PanOptix","NVS","Novartis"
"1098","Novartis AG says Farydak recommended by CHMP for EU approval","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3235789","2015-06-25 20:00:00","Reuters Key Development","Novartis AG says Farydak recommended by CHMP for EU approval","NVS","Novartis"
"1099","Novartis AG&#39;s Otrivin nasal spray withdrawn in UAE - Emirates247.com","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3239277","2015-06-29 20:00:00","Reuters Key Development","Novartis AG's Otrivin nasal spray withdrawn in UAE - Emirates247.com","NVS","Novartis"
"1100","Novartis says Alcon receives EU approval for lens in cataract patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3238234","2015-07-01 01:15:00","Reuters Key Development","Novartis says Alcon receives EU approval for lens in cataract patients","NVS","Novartis"
"1101","Novartis AG blocked from selling Neupogen copycat until Sept. 2 - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3248210","2015-07-20 20:00:00","Reuters Key Development","Novartis AG blocked from selling Neupogen copycat until Sept. 2 - Reuters","NVS","Novartis"
"1102","Novartis AG reconfirms FY 2015 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3248029","2015-07-21 01:01:00","Reuters Key Development","Novartis AG reconfirms FY 2015 outlook","NVS","Novartis"
"1103","Novartis drug Revolade recommended by CHMP for EU approval to treat patients with severe aplastic anemia","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3250234","2015-07-24 07:12:00","Reuters Key Development","Novartis drug Revolade recommended by CHMP for EU approval to treat patients with severe aplastic anemia","NVS","Novartis"
"1104","Novartis says FDA approves Odomzo to treat form of skin cancer","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3250325","2015-07-24 10:54:00","Reuters Key Development","Novartis says FDA approves Odomzo to treat form of skin cancer","NVS","Novartis"
"1105","Novartis AG completes divestiture of influenza vaccines business to CSL Limited for $275 million","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3255140","2015-08-02 18:30:00","Reuters Key Development","Novartis AG completes divestiture of influenza vaccines business to CSL Limited for $275 million","NVS","Novartis"
"1106","Novartis gains EU approval for Odomzo","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3263955","2015-08-20 01:15:00","Reuters Key Development","Novartis gains EU approval for Odomzo","NVS","Novartis"
"1107","Novartis buys remaining rights to GSK treatment","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3264456","2015-08-21 01:25:00","Reuters Key Development","Novartis buys remaining rights to GSK treatment","NVS","Novartis"
"1108","Novartis AG wins EU approval for tafinlar and mekinist, combination for melanoma","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3268694","2015-08-31 20:00:00","Reuters Key Development","Novartis AG wins EU approval for tafinlar and mekinist, combination for melanoma","NVS","Novartis"
"1109","Novartis wins EU approval for new Revolade use as therapy for patients with severe aplastic anemia","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3269089","2015-09-01 20:00:00","Reuters Key Development","Novartis wins EU approval for new Revolade use as therapy for patients with severe aplastic anemia","NVS","Novartis"
"1110","Novartis launches portfolio for low- and low-middle-income countries","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3277266","2015-09-24 01:16:00","Reuters Key Development","Novartis launches portfolio for low- and low-middle-income countries","NVS","Novartis"
"1111","Novartis says heart drug Entresto backed by EU regulator","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3277721","2015-09-25 01:15:00","Reuters Key Development","Novartis says heart drug Entresto backed by EU regulator","NVS","Novartis"
"1112","Novartis AG announces NEJM publication of secukinumab phase III data confirming significant efficacy in patients with Psoriatic Arthritis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3279755","2015-09-30 17:05:00","Reuters Key Development","Novartis AG announces NEJM publication of secukinumab phase III data confirming significant efficacy in patients with Psoriatic Arthritis","NVS","Novartis"
"1113","Novartis says long-term efficacy of Gilenya reinforced by 7-year data","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3282502","2015-10-08 01:15:00","Reuters Key Development","Novartis says long-term efficacy of Gilenya reinforced by 7-year data","NVS","Novartis"
"1114","Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3288030","2015-10-21 01:15:00","Reuters Key Development","Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts","NVS","Novartis"
"1115","Novartis AG confirms FY 2015 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3291013","2015-10-27 02:00:00","Reuters Key Development","Novartis AG confirms FY 2015 outlook","NVS","Novartis"
"1116","Novartis gets two EU approvals for Cosentyx","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3302969","2015-11-23 01:15:00","Reuters Key Development","Novartis gets two EU approvals for Cosentyx","NVS","Novartis"
"1117","Novartis &#39;s Entresto drug approved by European Commission","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3303480","2015-11-24 01:15:00","Reuters Key Development","Novartis 's Entresto drug approved by European Commission","NVS","Novartis"
"1118","Novartis AG - Research raises questions over ADHD drug effects - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3304430","2015-11-24 19:01:00","Reuters Key Development","Novartis AG - Research raises questions over ADHD drug effects - Reuters","NVS","Novartis"
"1119","Novartis announces positive results from the global Phase III RATIFY clinical trial","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3307861","2015-12-05 19:00:00","Reuters Key Development","Novartis announces positive results from the global Phase III RATIFY clinical trial","NVS","Novartis"
"1120","Novartis AG: phase III data shows Sandoz&#39; pegfilgrastim has similar safety and efficacy as reference product","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3307980","2015-12-07 10:45:00","Reuters Key Development","Novartis AG: phase III data shows Sandoz' pegfilgrastim has similar safety and efficacy as reference product","NVS","Novartis"
"1121","Novartis says advances biosimilars program with EMA acceptance of regulatory submission","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3308388","2015-12-08 01:15:00","Reuters Key Development","Novartis says advances biosimilars program with EMA acceptance of regulatory submission","NVS","Novartis"
"1122","Novartis announces collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc.","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3318041","2016-01-04 19:00:00","Reuters Key Development","Novartis announces collaboration with Qualcomm Incorporated through its subsidiary, Qualcomm Life, Inc.","NVS","Novartis"
"1123","Novartis AG sets immuno-oncology licensing deal with Surface","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3319219","2016-01-11 01:15:00","Reuters Key Development","Novartis AG sets immuno-oncology licensing deal with Surface","NVS","Novartis"
"1124","Novartis gets FDA approvals for cosentyx for ankylosing spondylitis, psoriatic arthritis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3321225","2016-01-15 17:28:00","Reuters Key Development","Novartis gets FDA approvals for cosentyx for ankylosing spondylitis, psoriatic arthritis","NVS","Novartis"
"1125","Novartis comments on FY 2016 outlook, proposes FY 2015 dividend","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3324492","2016-01-27 01:00:00","Reuters Key Development","Novartis comments on FY 2016 outlook, proposes FY 2015 dividend","NVS","Novartis"
"1126","Novartis says EMA accepts Sandoz application for pegfilgrastim biosimilar","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3330783","2016-02-11 01:15:00","Reuters Key Development","Novartis says EMA accepts Sandoz application for pegfilgrastim biosimilar","NVS","Novartis"
"1127","Novartis says Alcon entered into agreement to acquire Transcend Medical, Inc.","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3332783","2016-02-18 01:00:00","Reuters Key Development","Novartis says Alcon entered into agreement to acquire Transcend Medical, Inc.","NVS","Novartis"
"1128","Novartis drug PKC412 (midostaurin) receives Breakthrough Therapy","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3333296","2016-02-19 01:15:00","Reuters Key Development","Novartis drug PKC412 (midostaurin) receives Breakthrough Therapy","NVS","Novartis"
"1129","Novartis AG - Prosecutors raid Novartis Korea over alleged rebates - Yonhap - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3334719","2016-02-23 22:22:00","Reuters Key Development","Novartis AG - Prosecutors raid Novartis Korea over alleged rebates - Yonhap - Reuters","NVS","Novartis"
"1130","Novartis AG settles charges alleging bribery in China - SEC - Reuters News","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3347484","2016-03-23 16:25:00","Reuters Key Development","Novartis AG settles charges alleging bribery in China - SEC - Reuters News","NVS","Novartis"
"1131","Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations","http://marketexclusive.com/novartis-ag-adr-nysenvs-to-pay-25-million-over-bribery-allegations/4749/","2016-03-25 08:45:00","Market Exclusive","Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.","NVS","Novartis"
"1132","Novartis AG (ADR) (NVS) Under Investigation for &#39;Sham&#39; Events","http://investorplace.com/2016/03/novartis-sham-nvs/","2016-03-28 13:37:30","Investorplace.com","Novartis AG (ADR) (NVS) is under investigation for alleged sham events it held for doctors. Novartis, NVS The U.S is seeking information regarding what it claims were 80,000 sham events.","NVS","Novartis"
"1133","Novartis AG investigating $85 mln bribery allegations in Turkey - Reuters News","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3350235","2016-03-29 11:17:00","Reuters Key Development","Novartis AG investigating $85 mln bribery allegations in Turkey - Reuters News","NVS","Novartis"
"1134","Novartis comments on FY 2016 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3351685","2016-03-30 20:00:00","Reuters Key Development","Novartis comments on FY 2016 outlook","NVS","Novartis"
"1135","Novartis AG - Turkish health ministry says investigating drugmaker over bribe allegations - Reuters News","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3351939","2016-03-31 00:13:00","Reuters Key Development","Novartis AG - Turkish health ministry says investigating drugmaker over bribe allegations - Reuters News","NVS","Novartis"
"1136","Novartis receives positive EMA CHMP opinon on Neparvis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3352706","2016-03-31 20:00:00","Reuters Key Development","Novartis receives positive EMA CHMP opinon on Neparvis","NVS","Novartis"
"1137","Novartis receives EU approval for Revolade for children with chronic ITP","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3354084","2016-04-07 01:15:00","Reuters Key Development","Novartis receives EU approval for Revolade for children with chronic ITP","NVS","Novartis"
"1138","Novartis AG&#39; Sandoz unit receives EC approval for biosimilar Binocrit&#39;s nephrology indication","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3354626","2016-04-08 01:00:00","Reuters Key Development","Novartis AG' Sandoz unit receives EC approval for biosimilar Binocrit's nephrology indication","NVS","Novartis"
"1139","Novartis confirms FY 2016 outlook","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3359602","2016-04-21 01:00:00","Reuters Key Development","Novartis confirms FY 2016 outlook","NVS","Novartis"
"1140","Novartis AG discussing Roche stake sale, but not imminent -sources - Reuters","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3360970","2016-04-25 04:50:00","Reuters Key Development","Novartis AG discussing Roche stake sale, but not imminent -sources - Reuters","NVS","Novartis"
"1141","Novartis AG receives three FDA breakthrough therapy designations for Ilaris","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3363653","2016-04-27 01:15:00","Reuters Key Development","Novartis AG receives three FDA breakthrough therapy designations for Ilaris","NVS","Novartis"
"1142","Novartis AG says Afinitor gets nod in EU for some GI, lung neuroendocrine tumors","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3365650","2016-04-29 07:50:00","Reuters Key Development","Novartis AG says Afinitor gets nod in EU for some GI, lung neuroendocrine tumors","NVS","Novartis"
"1143","Genmab - PDUFA target action date of September 10 for Ofatumumab","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3377061","2016-05-17 16:03:45","Reuters Key Development","Genmab - PDUFA target action date of September 10 for Ofatumumab","NVS","Novartis"
"1144","China NT Pharma says co entered into asset purchase agreement with Novartis&lt;1011.HK&gt;&lt;NOVN.S&gt;","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3377712","2016-05-18 10:39:08","Reuters Key Development","China NT Pharma says co entered into asset purchase agreement with Novartis<1011.HK><NOVN.S>","NVS","Novartis"
"1145","Can Novartis AG (ADR) Reach Financial Stability via Restructuring?","http://www.businessfinancenews.com/29047-can-novartis-ag-adr-reach-financial-stability-via-restructuring/","2016-05-20 09:02:14","Business Finance News","As Novartis AG (ADR) (NYSE:NVS) head of pharmaceuticals, David Epstein, announced his departure from the company, it initiated the process of restructuring the business portfolios.","NVS","Novartis"
"1146","Novartis: Sandoz&#39; biosimilar rituximab regulatory submission accepted by European Medicines Agency","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3380206","2016-05-24 01:15:14","Reuters Key Development","Novartis: Sandoz' biosimilar rituximab regulatory submission accepted by European Medicines Agency","NVS","Novartis"
"1147","Novartis CEO: Willing to sell Roche stake without premium","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3381158","2016-05-25 03:28:00","Reuters Key Development","Novartis CEO: Willing to sell Roche stake without premium","NVS","Novartis"
"1148","Sandoz broadens pharma portfolio with addition of Euro-Pharm product line","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3384713","2016-05-31 10:00:00","Reuters Key Development","Sandoz broadens pharma portfolio with addition of Euro-Pharm product line","NVS","Novartis"
"1149","Eisai and Novartis enter deal to co-promote Lenvima with Everolimus in U.S.","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3386155","2016-06-02 16:15:00","Reuters Key Development","Eisai and Novartis enter deal to co-promote Lenvima with Everolimus in U.S.","NVS","Novartis"
"1150","Novartis reports 13.6 pct passive stake in Merus NV as of May 24, 2016","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3386633","2016-06-03 08:02:00","Reuters Key Development","Novartis reports 13.6 pct passive stake in Merus NV as of May 24, 2016","NVS","Novartis"
"1151","Mereo Biopharma to list on London&#39;s AIM","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3386875","2016-06-06 02:10:46","Reuters Key Development","Mereo Biopharma to list on London's AIM","NVS","Novartis"
"1152","Spectrum Pharmaceuticals&#39; unit, Allos Therapeutics and Sandoz enter settlement agreement","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3389083","2016-06-09 06:15:14","Reuters Key Development","Spectrum Pharmaceuticals' unit, Allos Therapeutics and Sandoz enter settlement agreement","NVS","Novartis"
"1153","Novartis AG (ADR) Aiming to Target Biosimilar Market by 2020","http://www.businessfinancenews.com/29356-novartis-ag-adr-aiming-to-target-biosimilar-market-by-2020/","2016-06-20 11:57:23","Business Finance News","By 2020, Novartis AG (NYSE:NVS) plans to launch a number of biosimilar versions of the blockbuster drugs in order to enter multiple therapeutic markets.","NVS","Novartis"
"1154","How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?","http://marketexclusive.com/many-heart-failure-deaths-can-novartis-ag-adr-nysenvss-entresto-reduce/8331/","2016-06-23 07:25:30","Market Exclusive","A fresh analysis of Novartis AG (ADR) (NYSE:NVS) drug Entresto has shown that it can significantly reduce heart failure deaths.","NVS","Novartis"
"1155","Xencor enteres into collaboration and license agreement with Novartis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3396645","2016-06-28 01:15:00","Reuters Key Development","Xencor enteres into collaboration and license agreement with Novartis","NVS","Novartis"
"1156","Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...","http://smallcapexclusive.com/xencor-inc-nasdaqxncr-collaborate-pharma-giant-novartis/","2016-06-29 00:47:37","Small Cap Exclusive (press release)","Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...","NVS","Novartis"
"1157","Novartis AG and Xencor Inc; Geared up to Stamp Out Hematological Ailments","http://www.businessfinancenews.com/29502-novartis-ag-and-xencor-inc-geared-up-to-stamp-out-hematological-ailments/","2016-07-03 06:32:22","Business Finance News","Swiss pharmaceutical company, Novartis AG (NYSE:NVS) has finalized mutual collaboration with Xencor for $2.41 billion. Both the companies will work on the research and development of molecules for the management and treatment of blood cancer.","NVS","Novartis"
"1158","FDA approves Roche&#39;s Xolair for allergic asthma in children","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3401939","2016-07-07 16:40:00","Reuters Key Development","FDA approves Roche's Xolair for allergic asthma in children","NVS","Novartis"
"1159","Novartis AG Enbrel Biosimilar Receives FDA Approval","http://www.businessfinancenews.com/29571-novartis-ag-enbrel-biosimilar-receives-fda-approval/","2016-07-14 14:45:36","Business Finance News","The US Food and Drug Administration (FDA) Advisory Committee has approved Novartis AG's (ADR) (NYSE:NVS) GP2015, a biosimilar version of Enbrel.","NVS","Novartis"
"1160","Novartis to spend extra $200 mln to push Entresto - CEO","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3407333","2016-07-19 01:55:12","Reuters Key Development","Novartis to spend extra $200 mln to push Entresto - CEO","NVS","Novartis"
"1161","Genvec says FDA lifts hold on clinical trial of hearing loss treatment","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3410760","2016-07-25 07:30:00","Reuters Key Development","Genvec says FDA lifts hold on clinical trial of hearing loss treatment","NVS","Novartis"
"1162","Can Novartis AG Acquire AstraZeneca plc?","http://www.bidnessetc.com/71816-novartis-ag-acquire-astrazeneca/","2016-07-29 09:30:56","Bidness ETC","AstraZeneca plc (ADR) (NYSE:AZN) shares spiked up in Thursday's trade after market buzzed with speculation that the UK-based pharma giant may attract takeover interest from the Swiss company, Novartis AG. While rumors were not confirmed by either ...","NVS","Novartis"
"1163","Can Novartis Endure After Patents Expire?","http://www.businessfinancenews.com/29729-can-novartis-endure-after-patents-expire/","2016-08-03 13:26:15","Business Finance News","Novartis AG (NYSE:NVS) is going through a transitory era of stiff competition due to the patent expiration of its blockbuster drugs.","NVS","Novartis"
"1164","Will Novartis AG (ADR) (NVS) Clinch Biosimilar Market by 2020?","http://www.thecountrycaller.com/37301-will-novartis-ag-adr-nvs-clinch-biosimilar-market-by-2020","2016-08-08 09:07:30","TCC","Novartis AG's (ADR)(NYSE:NVS) biosimilar and generic division, Sandoz is working for the development of novel biosimilars versions of the blockbuster drugs to patch up the revenue loss of its blockbuster drugs' patents.","NVS","Novartis"
"1165","Novartis Ready to Launch Game Changer Molecule for Asthma Treatment","http://www.bidnessetc.com/72080-novartis-ready-launch-game-changer-molecule-asthma-treatment/","2016-08-09 06:07:30","Bidness ETC","Novartis AG (ADR) (NYSE:NVS) is finally said to be in the final stages for the development of a game-changing molecule to treat asthma.","NVS","Novartis"
"1166","Jacobs wins contract for Novartis Biotechnology Center expansion","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3424399","2016-08-11 07:45:00","Reuters Key Development","Jacobs wins contract for Novartis Biotechnology Center expansion","NVS","Novartis"
"1167","Will Novartis AG (ADR) (NVS) be Forbidden in Korea after Bribe Charges?","http://www.thecountrycaller.com/69268-will-novartis-ag-adr-nvs-be-forbidden-in-korea-after-bribe-charges","2016-08-16 13:15:00","TCC","Novartis AG (ADR) (NYSE:NVS) is hit by bad news of involvement of its six senior officials under the charges of corruption.","NVS","Novartis"
"1168","Novartis AG MS Drug Yields Unexpected Positive: Big WIn?","http://www.bidnessetc.com/72676-novartis-ag-ms-drug-yields-unexpected-positive-big-win/","2016-08-26 14:03:35","Bidness ETC","Novartis AG (ADR) (NYSE:NVS) is heading towards another victory to add to its new drugs successes. Its MS drug candidate, BAF312, has met the primary endpoint in a late stage study for treating a severe form of multiple sclerosis, known as secondary ...","NVS","Novartis"
"1169","Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words","https://marketexclusive.com/novartis-ag-adr-nysenvs-says-picture-worth-thousand-words/25054/","2016-08-30 07:03:45","Market Exclusive","Novartis feels that much is still not known about melanoma, especially the gene mutation that causes the disease. As such, the company has taken the initiative to use photographs to show the world something more about the disease and how it can be ...","NVS","Novartis"
"1170","U.S. FDA approves Erelzi, a biosimilar to Enbrel","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3434925","2016-08-30 16:25:36","Reuters Key Development","U.S. FDA approves Erelzi, a biosimilar to Enbrel","NVS","Novartis"
"1171","The Biosimilar of Amgen&#39;s Enbrel, by Novartis AG (ADR) (NYSE:NVS), has been ...","http://www.thecountrycaller.com/61841-the-biosimilar-of-amgens-enbrel-by-novartis-ag-adr-has-been-approved-by-fda","2016-08-31 07:10:40","TCC","In a latest development, the Food and Drug Administration (FDA) has announced the approval of Novartis AG's (NYSE:NVS) Erelzi, which is a biosimilar version of Amgen's blockbuster drug Enbrel.","NVS","Novartis"
"1172","Genvec says Novartis informed co that it remains engaged on CGF166 program","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3436154","2016-09-01 06:54:48","Reuters Key Development","Genvec says Novartis informed co that it remains engaged on CGF166 program","NVS","Novartis"
"1173","Novartis AG (ADR): How to Deal With the Alcon Crises","http://www.bidnessetc.com/73075-novartis-ag-deal-alcon-crises/","2016-09-16 12:18:45","Bidness ETC","Novartis AG (ADR) (NYSE:NVS) may have not completely written off a potential sale of its second-largest division, Alcon.","NVS","Novartis"
"1174","Can Novartis AG (ADR) (NVS) Survive with Alcon Crisis?","http://smartstocknews.com/50247-can-novartis-ag-adr-nvs-survive-with-alcon-crises/","2016-09-19 09:53:06","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Novartis AG (ADR) (NYSE:NVS) is considering the sale of its eye care division, Alcon, due to its revenue decline in the last two years.","NVS","Novartis"
"1175","Novartis AG (ADR) (NVS) Multiple Sclerosis Molecule: Ray of Hope","http://www.thecountrycaller.com/36958-novartis-ag-adr-nvs-multiple-sclerosis-molecule-ray-of-hope","2016-09-19 10:37:30","TCC","Novartis AG (ADR) (NYSE:NVS) investigational molecule for the treatment and management of multiple sclerosis has shown remarkable reduction in the disease progression up to 21%.","NVS","Novartis"
"1176","Will Novartis AG (ADR) (NVS) Cosentyx Lead Psoriasis Therapeutic Market?","http://smartstocknews.com/45892-will-novartis-ag-adr-nvs-cosentyx-lead-psoriasis-therapeutic-market/","2016-10-05 08:22:30","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Keeping in view fierce competition in the future as well as the patent cliff side effects, Novartis AG (ADR) (NYSE:NVS) is working on its blockbuster molecule Cosentyx to be the market leader in the management and treatment of psoriasis.","NVS","Novartis"
"1177","Pfizer, Inc.&#39;s (PFE) Ibrance Need Not Fear Novartis AG (ADR) (NVS) In Breast ...","http://www.voiceobserver.com/71883-pfizer-incs-pfe-ibrance-need-not-fear-novartis-ag-adr-nvs-in-breast-cancer/","2016-10-10 10:44:44","The Voice Observer","Novartis AG (ADR) (NYSE:NVS) presented Phase 3 data of its experimental drug, ribociclib, for the treatment of a certain type of advanced breast cancer this weekend.","NVS","Novartis"
"1178","Novartis AG (ADR) (NVS) Q3 Earnings: What Leerink Expects","http://smartstocknews.com/40519-novartis-ag-adr-nvs-q3-earnings-what-leerink-expects/","2016-10-20 14:37:23","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Novartis AG (ADR) (NYSE:NVS) is expected to report its third quarter financial results on October 25. Leerink Partners analyst Seamus Fernandez expects data to be broadly in line with his estimates and consensus.","NVS","Novartis"
"1179","Novartis says Entresto sales force&#39;s impact to come in 2017","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3459820","2016-10-25 02:14:40","Reuters Key Development","Novartis says Entresto sales force's impact to come in 2017","NVS","Novartis"
"1180","Novartis: Peak Patent Exposure Offers Opportunity","http://seekingalpha.com/article/4015929-novartis-peak-patent-exposure-offers-opportunity","2016-10-27 16:03:39","Seeking Alpha","Novartis AG (NYSE:NVS) is a large pharmaceutical firm based in Switzerland. Its shares trade on the NYSE as an American Depository Receipt, or ADR. The company was created by the merger of Sandoz AG and Ciba-Geigy AG in December 1996.","NVS","Novartis"
"1181","Novartis says LEE011 (ribociclib) granted FDA priority review","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3466912","2016-11-01 07:30:00","Reuters Key Development","Novartis says LEE011 (ribociclib) granted FDA priority review","NVS","Novartis"
"1182","Novartis AG (NVS) May Fancy AstraZeneca plc (AZN) for Takoever: Reports","http://smartstocknews.com/56404-novartis-ag-nvs-may-fancy-astrazeneca-plc-azn-for-takoever-reports/","2016-11-12 09:48:45","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","The American depository receipts of AstraZeneca plc (ADR) (NYSE:AZN) traded up over 1% on the New York exchange Friday, after a report suggested that the company may attract a takeover interest from Novartis AG (ADR) (NYSE:NVS). Novartis' ADRs ...","NVS","Novartis"
"1183","Novartis drug PKC412 granted FDA priority review for newly-diagnosed flt3-mutated aml and advanced systemic mastocytosis","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3477467","2016-11-14 07:30:00","Reuters Key Development","Novartis drug PKC412 granted FDA priority review for newly-diagnosed flt3-mutated aml and advanced systemic mastocytosis","NVS","Novartis"
"1184","Novartis AG (NVS) Seeks M&amp;A as It Mulls Possible Alcon Sale","http://smartstocknews.com/50539-novartis-ag-adr-nvs-seeks-ma-as-it-mulls-possible-alcon-sale/","2016-11-15 08:28:00","Sm<U+0430>rt St<U+043E>ck N<U+0435>ws","Novartis AG (ADR) (NYSE:NVS) is planning to enter into mergers and acquisitions as it continues to weigh options for the long-struggling eye-care business Alcon.","NVS","Novartis"
"1185","Novartis AG Ready to Capture Leukemia Therapeutic Market","http://www.thecountrycaller.com/65514-novartis-ag-ready-to-capture-leukemia-therapeutic-market","2016-11-15 10:11:15","TCC","Novartis AG (ADR) (NYSE:NVS) is putting efforts to capture the lucrative market of immuno-oncology with its investigational molecules covering multiple therapeutic areas.","NVS","Novartis"
"1186","BioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3482104","2016-11-21 07:00:00","Reuters Key Development","BioLine RX in-licenses novel anti-inflammatory treatment for dry eye syndrome under strategic collaboration with major global pharmaceutical company","NVS","Novartis"
"1187","Novartis AG (ADR) (NVS) Acquires Selexys Pharmaceuticals Corp.","http://www.insidermonkey.com/blog/novartis-ag-adr-nvs-acquires-selexys-pharmaceuticals-corp-489542/","2016-11-22 10:33:45","Insider Monkey (blog)","Novartis AG (ADR) (NYSE:NVS) has recently acquired Selexys Pharmaceuticals Corp. after receiving results from the SUSTAIN clinical trial, a Phase II clinical trial evaluating SelG1 for the reduction of vaso-occlusive pain among sickle cell disease (SCD ...","NVS","Novartis"
"1188","Novartis Stock Is Worth $90 A Share","http://seekingalpha.com/article/4026472-novartis-stock-worth-90-share","2016-11-27 14:30:00","Seeking Alpha","Novartis AG (ADR) (NYSE:NVS) is now trading over 30% off its 2015 highs. The market has taken the last two earnings reports negatively and has penalized the share price accordingly.","NVS","Novartis"
"1189","Analyst Review Alert on Price Target: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2016/12/09/analyst-review-alert-on-price-target-novartis-ag-adr-nysenvs/","2016-12-09 09:15:00","Post Registrar","Novartis AG (ADR) (NYSE:NVS) plunged -1.50% during previous trade, a total of 5.42M shares exchanged hands compared with its average trading volume of 3.39M shares whereas its relative volume is 1.96.","NVS","Novartis"
"1190","Meganesuper and Alcon Japan to buy MEGANE HOUSE for 300 mln yen","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3495360","2016-12-14 22:02:33","Reuters Key Development","Meganesuper and Alcon Japan to buy MEGANE HOUSE for 300 mln yen","NVS","Novartis"
"1191","Novartis says Votubia recommended by CHMP for TSC patients","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3496619","2016-12-16 07:26:25","Reuters Key Development","Novartis says Votubia recommended by CHMP for TSC patients","NVS","Novartis"
"1192","Novartis gets positive CHMP nod for Ilaris for periodic fever syndromes","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3496628","2016-12-16 07:31:14","Reuters Key Development","Novartis gets positive CHMP nod for Ilaris for periodic fever syndromes","NVS","Novartis"
"1193","Novartis signs licensing deal with Sunovion Pharma","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3498950","2016-12-21 08:00:00","Reuters Key Development","Novartis signs licensing deal with Sunovion Pharma","NVS","Novartis"
"1194","Sun Pharma to buy Novartis&#39; cancer drug Odomzo","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3499223","2016-12-21 22:01:10","Reuters Key Development","Sun Pharma to buy Novartis' cancer drug Odomzo","NVS","Novartis"
"1195","Alcon receives U.S. FDA approval for acrysof® iq restor® +3.0d multifocal toric intraocular lens","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3499926","2016-12-22 18:00:00","Reuters Key Development","Alcon receives U.S. FDA approval for acrysof® iq restor® +3.0d multifocal toric intraocular lens","NVS","Novartis"
"1196","Analyst Viewpoints on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2016/12/28/analyst-viewpoints-on-price-reaction-history-novartis-ag-adr-nysenvs-2/","2016-12-28 08:07:30","Post Registrar","Novartis AG (ADR) (NYSE:NVS) soared 0.24% during previous trade, a total of 1.86M shares exchanged hands compared with its average trading volume of 3.16M shares whereas its relative volume is 0.60.","NVS","Novartis"
"1197","Novartis AG (NVS) To Buy Intercept Pharmaceuticals Inc (ICPT) in Mid-Jan?","http://www.thecountrycaller.com/48757-novartis-ag-nvs-to-buy-intercept-pharmaceuticals-inc-icpt-in-mid-jan","2016-12-29 07:11:15","TCC","Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares soared as much as 9.34% in Wednesday's trading session amid speculations that Novartis AG (ADR) (NYSE:NVS) is interested in acquiring the company. The deal could be announced in mid-January, ...","NVS","Novartis"
"1198","Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG ...","https://www.smarteranalyst.com/2017/01/06/ionis-pharmaceuticals-inc-ions-akcea-strike-favorable-deal-novartis-ag-adr-nvs-cowen-top-analyst/","2017-01-06 12:26:15","Smarter Analyst","Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an exclusive cardiovascular disease treatment collaborative agreement with Novartis AG ...","NVS","Novartis"
"1199","Novartis AG (ADR) (NVS) is Downgraded by Credit Suisse to Neutral","https://www.highlandmirror.com/2017-01-11-novartis-ag-adr-nvs-is-downgraded-by-credit-suisse-to-neutral","2017-01-11 07:11:15","Highland Mirror","On the company's financial health, Novartis AG (ADR) reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 25, 2016.","NVS","Novartis"
"1200","Novartis AG (ADR) (NVS) is Downgraded by Berenberg to Hold","https://www.highlandmirror.com/2017-01-17-novartis-ag-adr-nvs-is-downgraded-by-berenberg-to-hold","2017-01-17 07:56:15","Highland Mirror","On the company's financial health, Novartis AG (ADR) reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 25, 2016.","NVS","Novartis"
"1201","Novartis CEO says sees downward pressure on pharma prices -CNBC","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3510059","2017-01-18 03:13:42","Reuters Key Development","Novartis CEO says sees downward pressure on pharma prices -CNBC","NVS","Novartis"
"1202","Analyst Views on Price Target: Novartis AG (ADR) (NYSE:NVS)","http://postregistrar.com/2017/01/18/analyst-views-on-price-target-novartis-ag-adr-nysenvs/","2017-01-18 09:15:00","Post Registrar","Novartis AG (ADR) (NYSE:NVS) plunged -0.57% during previous trade, a total of 7.41M shares exchanged hands compared with its average trading volume of 3.15M shares whereas its relative volume is 2.25.","NVS","Novartis"
"1203","Shares of Novartis AG (NYSE:NVS) Sees Large Inflow of Net Money Flow","https://www.highlandmirror.com/2017-01-24-shares-of-novartis-ag-nysenvs-sees-large-inflow-of-net-money-flow-2","2017-01-24 00:26:15","Highland Mirror","Novartis AG (ADR) Last issued its quarterly earnings results on Oct 25, 2016. The company reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06.","NVS","Novartis"
"1204","Novartis proposes raising dividend to 2.75 Sfr/share","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514236","2017-01-25 01:09:39","Reuters Key Development","Novartis proposes raising dividend to 2.75 Sfr/share","NVS","Novartis"
"1205","Novartis CEO: All options for alcon on table, &quot;we have not ruled anything out&quot;","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514281","2017-01-25 01:35:07","Reuters Key Development","Novartis CEO: All options for alcon on table, ""we have not ruled anything out""","NVS","Novartis"
"1206","Novartis Considering Sale Of Alcon Unit After Mixed Q4 Results And Outlook","http://etfdailynews.com/2017/01/25/novartis-considering-sale-of-alcon-unit-after-mixed-q4-results-and-outlook/","2017-01-25 06:26:15","ETF Daily News (blog)","In perhaps the biggest news stemming from the report, Novartis noted is considering strategic options for the consumer eye care Alcon Division.","NVS","Novartis"
"1207","Novartis CEO plans to meet with US President Trump, no date set","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514804","2017-01-25 07:06:54","Reuters Key Development","Novartis CEO plans to meet with US President Trump, no date set","NVS","Novartis"
"1208","Novartis&#39;s Alcon head expects op. profit to hit trough in 2017","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514894","2017-01-25 08:36:56","Reuters Key Development","Novartis's Alcon head expects op. profit to hit trough in 2017","NVS","Novartis"
"1209","Novartis expects CART therapy CTL019 to exceed $1 bln in annual sales","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3514898","2017-01-25 08:50:05","Reuters Key Development","Novartis expects CART therapy CTL019 to exceed $1 bln in annual sales","NVS","Novartis"
"1210","Why Novartis AG (ADR) (NYSE: NVS) and Boeing Co (NYSE: BA) are rising today","http://fxdailyreport.com/novartis-ag-adr-nyse-nvs-boeing-co-nyse-ba-rising-today/","2017-01-25 10:11:15","FX Daily Report","Novartis AG (ADR) (NYSE: NVS) stock opened positive this morning and rose over 1.5% on January 25th, 2017 (as of 10:00 AM EST; Source: Google finance).","NVS","Novartis"
"1211","Analysts&#39; Recommendations Stocks to Watch: Halliburton Company (NYSE:HAL ...","http://www.newsismoney.com/2017/01/25/analysts-recommendations-stocks-to-watch-halliburton-company-nysehal-novartis-ag-adr-nysenvs/","2017-01-25 10:26:33","Money News","On Tuesday, Shares of Halliburton Company (NYSE:HAL) gained 3.32% to $56.62. The share price is trading in a range of $55.09 - 56.79.","NVS","Novartis"
"1212","Novartis says Alcon launches new lens for astigmatism","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3515379","2017-01-26 01:00:15","Reuters Key Development","Novartis says Alcon launches new lens for astigmatism","NVS","Novartis"
"1213","Trending Stocks Frontier Communications Corp (NASDAQ:FTR), Novartis AG (ADR ...","http://wallstrt24.com/trending-stocks-frontier-communications-corp-nasdaqftr-novartis-ag-adr-nysenvs/2427893/","2017-01-27 10:56:15","Wall Street 24","Shares of Novartis AG (ADR) (NYSE:NVS) declined -0.35% to $71.91. Stock exchanged hands with the total volume of 4.89 Million shares, as contrast to its average volume of 3.55 Million shares.","NVS","Novartis"
"1214","2 Movers to Watch for Chesapeake Energy Corporation (NYSE:CHK), Novartis AG ...","http://wallstrt24.com/2-movers-to-watch-for-chesapeake-energy-corporation-nysechk-novartis-ag-adr-nysenvs/2427974/","2017-01-30 09:03:45","Wall Street 24","On Friday, Chesapeake Energy Corporation (NYSE:CHK) stock opened its trade at $7.02 and after floating in a range of $6.86 to $7.09, settled at $6.92.","NVS","Novartis"
"1215","The Only 3 Vanguard Funds You Need to Build a Portfolio","http://www.satprnews.com/2017/01/31/the-only-3-vanguard-funds-you-need-to-build-a-portfolio/","2017-01-30 17:30:00","Satellite PR News (press release)","The fund consists primarily of large-cap stocks like Royal Dutch Shell plc (ADR) (NYSE: RDS.B , NYSE: RDS.A ), Nestle SA (ADR) (OTCMKTS: NSRGF ), and Novartis AG (ADR) (NYSE: NVS ), but it also holds international mid- and small-cap stocks.","NVS","Novartis"
"1216","Steady Stocks Johnson &amp; Johnson (NYSE:JNJ), Novartis AG (ADR) (NYSE:NVS)","http://wallstrt24.com/steady-stocks-johnson-johnson-nysejnj-novartis-ag-adr-nysenvs/2428321/","2017-01-31 09:03:45","Wall Street 24","Shares of Novartis AG (ADR) (NYSE:NVS) inclined 0.12% to $72.30. Stock exchanged hands with the total volume of 4.10 Million shares, as contrast to its average volume of 3.65 Million shares.","NVS","Novartis"
"1217","A District Court&#39;s Ruling Against Teva Pharma Opens The Door For Generics","https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8971958/a-district-courts-ruling-against-teva-pharma-opens-the-d","2017-01-31 14:52:18","Benzinga","Analysts believe that Novartis AG (ADR) (NYSE: NVS)'s Sandoz division/Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) as the most likely generic to receive approval, as the only pharmaceutical company to successfully develop a Copaxone 20mg generic ...","NVS","Novartis"
"1218","Amgen, Inc. (AMGN) Q4 Earnings Preview","http://investorplace.com/2017/02/amgen-inc-amgn-q4-earnings-preview/","2017-02-01 10:11:15","Investorplace.com","As it's customary with Amgen, Inc. (NASDAQ:AMGN), the biotech giant topped analysts' expectation in each of the first three quarters of 2016.","NVS","Novartis"
"1219","Nabriva Therapeutics AG – ADR (NBRV) is Reiterated by Wedbush to “Outperform”","https://www.highlandmirror.com/2017-02-01-nabriva-therapeutics-ag-adr-nbrv-is-reiterated-by-wedbush-to-outperform","2017-02-01 16:11:15","Highland Mirror","Nabriva Therapeutics AG - ADR (NBRV) was Reiterated by Wedbush to “Outperform” and the brokerage firm has set the Price Target at $13.","NVS","Novartis"
"1220","Novartis Has Bright Future","http://finance.yahoo.com/news/novartis-bright-future-222046258.html","2017-02-01 17:29:28","Yahoo Finance","Novartis is a large pharmaceutical firm based in Switzerland. Its shares trade on the New York Stock Exchange (NYSE) as an American Depositary Receipt (ADR). The company was created by the merger of Sandoz AG and Ciba-Geigy AG in December 1996.","NVS","Novartis"
"1221","Stock&#39;s Buzzers Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Novartis AG (ADR ...","http://wallstrt24.com/stocks-buzzers-ariad-pharmaceuticals-inc-nasdaqaria-novartis-ag-adr-nysenvs/2428507/","2017-02-02 08:41:15","Wall Street 24","On Wednesday, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened its trade at $23.81 and after floating in a range of $23.74 to $23.84, settled at $23.79.","NVS","Novartis"
"1222","Pfizer Inc&#39;s (NYSE:PFE) Breast Cancer Drug Too Expensive: Says NICE","https://marketexclusive.com/pfizer-incs-nysepfe-breast-cancer-drug-expensive-says-nice/71026/","2017-02-03 09:38:08","Market Exclusive","The drug was in competition with a rival treatment from Novartis AG (ADR)(NYSE:NVS); the ribociclib. Both drugs are meant to be used in combination with existing drugs in the treatment of tumors growing in response to oestrogen.","NVS","Novartis"
"1223","Why Biogen Inc (BIIB) Stock Is a Solid Long-Term Bet","http://www.nasdaq.com/article/why-biogen-inc-biib-stock-is-a-solid-long-term-bet-cm743150","2017-02-03 11:30:00","Nasdaq","The competition is also getting tougher - large pharma rivals such as Novartis AG (ADR) (NYSE: NVS ) and Sanofi SA(ADR) (NYSE: SNY ) offer competing MS drugs.","NVS","Novartis"
"1224","Shares of Novartis AG (NVS) Sees Large Outflow of Money","https://www.highlandmirror.com/2017-02-08-shares-of-novartis-ag-nvs-sees-large-outflow-of-money","2017-02-08 03:37:30","Highland Mirror","Novartis AG (ADR) was Downgraded by Credit Suisse to Neutral on Jan 11, 2017. Novartis AG (ADR) was Upgraded by Argus to Buy on Nov 10, 2016.","NVS","Novartis"
"1225","Novartis AG (ADR) (NVS) Greater Use Of Technology In Transforming Medical ...","http://www.insidermonkey.com/blog/novartis-ag-adr-nvs-greater-use-of-technology-in-transforming-medical-education-551756/","2017-02-14 11:07:30","Insider Monkey (blog)","Novartis AG (ADR) (NYSE:NVS) is quickly entering into an engagement with the use of digital technology. The idea is to enhance and increase interaction with healthcare professionals.","NVS","Novartis"
"1226","3 European Mutual Funds to Buy as Economy Revives","http://www.nasdaq.com/article/3-european-mutual-funds-to-buy-as-economy-revives-cm748194","2017-02-15 08:41:15","Nasdaq","Further, as of the last filing, Koninklijke Philips, Enel SPA and Novartis AG ADR were the top holdings for TEMIX. Invesco European Small Company Y ESMYX seeks appreciation of capital for the long run.","NVS","Novartis"
"1227","Deutsche Bank Casts Doubt On Pfizer&#39;s Rumored Takeover Approach To Bristol-Myers","https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9054293/deutsche-bank-casts-doubt-on-pfizers-rumored-takeover-ap","2017-02-15 14:32:34","Benzinga","The brokerage issued the comment after Street Insider said Roche Holding Ltd. (ADR) (OTC: RHHBY), Novartis AG (ADR) (NYSE: NVS)and Pfizer could be interested in buying Bristol-Myers, while Gilead Sciences, Inc. (NASDAQ: GILD) is also seen as a ...","NVS","Novartis"
"1228","Thursday&#39;s Vital Data: Apple Inc. (AAPL), Groupon Inc (GRPN) and Bristol-Myers ...","http://www.nasdaq.com/article/thursdays-vital-data-apple-inc-aapl-groupon-inc-grpn-and-bristol-myers-squibb-co-bmy-cm749139","2017-02-16 09:03:45","Nasdaq","U.S. stock futures are feeling the heat this morning, and Wall Street is set to take a breather following the longest record-setting winning streak in nearly 25 years.","NVS","Novartis"
"1229","Stocks News Update – Cousins Properties Inc (NYSE:CUZ), Novartis AG (ADR ...","http://www.journalfinance.net/2017/02/stocks-news-update-cousins-properties-inc-nysecuz-novartis-ag-adr-nysenvs/","2017-02-16 09:08:57","Daily News Journal (press release)","Novartis AG (ADR) (NYSE:NVS) shares moved to $75.83 after opening the day at $74.90, on Wednesday. The stock floated in a price range of $74.86 to $75.91, with market capitalization of $197.34B.","NVS","Novartis"
"1230","Top 10 Dividend ETFs to Invest in For 2017","https://www.incomeinvestors.com/top-10-dividend-etfs-invest-2017/14805/","2017-02-16 10:30:24","Income Investors","The other half of the portfolio is invested in companies based abroad, including Novartis AG (VTX:NOVN) and Total SA (ADR) (NYSE:TOT). The VT ETF is a great method for getting exposed to many companies with a global presence at a very low cost.","NVS","Novartis"
"1231","Traders Watch list Novartis AG (ADR) (NYSE:NVS), IHS Markit Ltd (NASDAQ:INFO)","http://www.journalfinance.net/2017/02/traders-watch-list-novartis-ag-adr-nysenvs-ihs-markit-ltd-nasdaqinfo/","2017-02-20 09:37:27","Daily News Journal (press release)","On Friday, Novartis AG (ADR) (NYSE:NVS) stock opened its trade at $76.27 and after floating in a range of $76.23 to $77.21, settled at $77.20.","NVS","Novartis"
"1232","Stock Price of Novartis AG (NVS) Increases 2.65%","http://www.energyindexwatch.com/2017-02-21-stock-price-of-novartis-ag-nvs-increases-2-65","2017-02-21 03:55:20","Energy Index","Novartis AG (ADR) Last issued its quarterly earnings results on Jan 25, 2017. The company reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.02.","NVS","Novartis"
"1233","Vodafone Group Plc (ADR) (NASDAQ:VOD) has decided to offer its SuperHour","http://www.benchmarkmonitor.com/2017/02/21/vodafone-group-plc-adr-nasdaqvod-has-decided-to-offer-its-superhour/","2017-02-21 08:32:48","Benchmark Monitor","Novartis AG (NYSE:NVS) said that, People living in Ayrshire and Arran who have some of the most common forms of avoidable sight loss will now be able to benefit from a new facility designed specifically for the eye service through a partnership between ...","NVS","Novartis"
"1234","Icahn Takes Bristol-Myers Stake With M&amp;A In Mind; Who Could Be The Acquirer?","http://finance.yahoo.com/news/icahn-takes-bristol-myers-stake-214820857.html","2017-02-21 19:53:59","Yahoo Finance","Jefferies analyst Jeffrey Holford suggested in a recent note the company may appeal to Sanofi SA (ADR) (NYSE: SNY), Johnson & Johnson (NYSE: JNJ), Pfizer Inc. (NYSE: PFE) and Novartis AG (ADR) (NYSE: NVS) - but not likely Amgen, Inc. (NASDAQ: ...","NVS","Novartis"
"1235","Manufacturing Delay Of Generic Drug From Pfizer Inc. (NYSE:PFE) A Relief For ...","https://marketexclusive.com/a-manufacturing-delay-of-a-generic-drug-from-pfizer-inc-nysepfe-and-momenta-is-a-relief-for-teva-pharmaceutical-industries-ltd-adr-nyseteva/74090/","2017-02-22 09:37:30","Market Exclusive","This will also have an impact on the Cambridge, Massachusetts-based Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), which is seeking collaboration with Novartis AG (ADR) (NYSE:NVS) subsidiary Sandoz on the generic drug. Of course, the news will ...","NVS","Novartis"
"1236","Novartis says Zykadia drug gets FDA priority review","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3533475","2017-02-23 01:18:15","Reuters Key Development","Novartis says Zykadia drug gets FDA priority review","NVS","Novartis"
"1237","Forward Earnings Estimate of Novartis AG(NVS)","https://www.highlandmirror.com/2017-02-23-forward-earnings-estimate-of-novartis-agnvs","2017-02-23 02:41:15","Highland Mirror","Novartis AG has received $1.15 as the consensus Earnings Estimate for the Quarter ending on Mar 2017 ,According to the estimate provided by 1 Financial Advisor in the Stock Trading Firms.","NVS","Novartis"
"1238","Novartis says Zykadia drug receives FDA priority review","http://www.reuters.com/finance/stocks/NVS/key-developments/article/3534139","2017-02-23 07:30:00","Reuters Key Development","Novartis says Zykadia drug receives FDA priority review","NVS","Novartis"
"1239","Stocks Buzz Novartis AG (ADR) (NYSE:NVS), Lincoln National Corporation (NYSE:LNC)","http://www.journalfinance.net/2017/02/stocks-buzz-novartis-ag-adr-nysenvs-lincoln-national-corporation-nyselnc/","2017-02-23 09:03:45","Daily News Journal (press release)","On Wednesday, Novartis AG (ADR) (NYSE:NVS) stock opened its trade at $76.50 and after floating in a range of $76.48 to $77.11, settled at $76.85.","NVS","Novartis"
"1240","Why President Trump Wants To Transform The FDA – And What It Could Mean For ...","http://www.insidermonkey.com/blog/why-president-trump-wants-to-transform-the-fda-and-what-it-could-mean-for-biotech-stocks-561604/","2017-02-23 10:00:00","Insider Monkey (blog)","“We're also going to be streamlining the process,” Trump told CEOs from Pharmaceutical Research and Manufacturers of America (PhRMA), Merck & Co.","NVS","Novartis"
"1241","Breaking Down The Multiple Sclerosis 2017 Formularies: &#39;Stability Fares Well ...","https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9087784/breaking-down-the-multiple-sclerosis-2017-formularies-st","2017-02-23 13:56:15","Benzinga","The injectable treatment option later expanded to Novartis AG (ADR) (NYSE: NVS)'s Extavia, Biogen's Plegridy and Glatopa, the generic version of Copaxone developed by Novartis' Sandoz unit.","NVS","Novartis"
"1242","Carl Icahn&#39;s Track Record In Big Pharma","https://www.benzinga.com/general/biotech/17/02/9084990/carl-icahns-track-record-in-big-pharma","2017-02-24 09:37:30","Benzinga","The names doing the round include Pfizer Inc. (NYSE: PFE), Roche Holding Ltd. (ADR) (OTC: RHHBY) and Novartis AG (ADR) (NYSE: NVS). Of these companies, Pfizer, which has had a failed attempt in the recent past, might be the most likely one to give ...","NVS","Novartis"
"1243","Stocks Alert Banco Bradesco SA (ADR) (NYSE:BBD), Novartis AG (ADR) (NYSE:NVS)","http://www.journalfinance.net/2017/02/stocks-alert-banco-bradesco-sa-adr-nysebbd-novartis-ag-adr-nysenvs/","2017-02-27 09:08:21","Daily News Journal (press release)","On Friday,Banco Bradesco SA (ADR) (NYSE:BBD)stock opened its trade at $10.69 and after floating in a range of $10.68 to $10.86, settled at $10.72.","NVS","Novartis"
"1244","Company Shares of Novartis AG (NVS) Rally 0.1%","https://www.highlandmirror.com/2017-02-27-company-shares-of-novartis-ag-nvs-rally-0-1","2017-02-27 09:40:39","Highland Mirror","Institutional Investors own 10.36% of Novartis AG shares. Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.","NVS","Novartis"
"1246","Bristol Bay Native Corporation plans to acquire Katmailand","http://www.alaskapublic.org/2016/04/25/bristol-bay-native-corporation-plans-to-acquire-katmialand/","2016-04-25 19:47:20","Alaska Public Radio Network","BBNC is a local company, it's owned by people who live out in Bristol Bay. I think it's a good fit, and I'm proud to be selling to them.","BAYN","Bayer"
"1247","Wisconsin&#39;s Mike Gallagher Runs for the House","http://www.nationalreview.com/article/438993/mike-gallaghers-wisconsin-congressional-race-former-marine-runs-congress","2016-08-15 15:34:06","National Review Online","In Congress, Gallagher wants to push for effective trade policies built for the era of the micro multi-national corporation, but TPP, he says, has too many deficiencies to pass Congress. “I don't think it's going anywhere. It's dead and Obama has ...","BAYN","Bayer"
"1248","In Biscayne National Park, South Florida Communities Mix with Pristine Wildlife","http://wlrn.org/post/biscayne-national-park-south-florida-communities-mix-pristine-wildlife-0","2016-08-24 20:29:18","WLRN","And for many like Robert O'Bryant, who heads the Mahogany Youth Corporation that seeks to introduce urban youth to the national park, keeping the fish population healthy is crucial to making sure future generations will be able to fish in the bay too.","BAYN","Bayer"
"1249","Is the national anthem even necessary?","http://www.sfchronicle.com/49ers/article/Is-the-national-anthem-even-necessary-9191779.php","2016-08-29 21:36:15","San Francisco Chronicle","Didn't we just do that, with the nasty, ill-advised criticism of gymnast Gabby Douglas, who was skewered for not putting her hand over her heart during the national anthem? She wasn't doing it out of protest, but it seemed that we had some discourse ...","BAYN","Bayer"
"1250","13 Whitefish Bay High School Students Named National Merit Scholarship Semi ...","http://patch.com/wisconsin/whitefishbay/13-whitefish-bay-high-school-students-named-national-merit-scholarship-semi","2016-09-14 13:37:30","Patch.com"," On Tuesday officials of the National Merit Scholarship Corporation (NMSC) announced the names of approximately 16,000 Semifinalists in the 62nd annual National Merit Scholarship Program. “These academically talented high school ...","BAYN","Bayer"
"1251","Access National, Middleburg Financial announce merger","http://www.bizjournals.com/washington/news/2016/10/24/access-national-middleburg-financial-announce.html","2016-10-24 08:55:26","Washington Business Journal","Shareholders in Access National, the parent company of Access National Bank, will own 53.5 percent of the new company, which will keep the name Access National Corporation. Middleburg shareholders will own 46.5 percent. So far Access National Bank ...","BAYN","Bayer"
"1252","Mike Evans: Tampa Bay Buccaneers WR apologizes for sitting during national anthem","http://www.upi.com/Sports_News/NFL/2016/11/15/Mike-Evans-Tampa-Bay-Buccaneers-WR-apologizes-for-sitting-during-national-anthem/8451479246470/","2016-11-15 16:51:40","UPI.com","Tampa Bay Buccaneers wide receiver Mike Evans issued an apology and will no longer sit during the national anthem, as he did before last Sunday's game against the Chicago Bears.","BAYN","Bayer"
"1253","ICYMI: US Volunteers Provide $184 Billion in Service; How Tampa Bay Stacks Up","http://patch.com/florida/stpete/u-s-volunteers-provide-184-billion-service-how-tampa-bay-stacks","2016-11-17 14:18:45","Patch.com","Throughout the Tampa Bay area, folks also rolled up their sleeves to lend a helping hand, according to data released by the federal government Wednesday.","BAYN","Bayer"
"1254","Alaska Native corporation acquires oil and gas leases in Arctic waters","http://www.alaskapublic.org/2016/11/17/alaska-native-corporation-acquires-leases-arctic-waters/","2016-11-17 19:53:41","Alaska Public Radio Network","He announced Wednesday that the corporation has acquired Shell's leases in Camden Bay, just off the coast of the Arctic National Wildlife Refuge. After spending billions on an unsuccessful exploration campaign, Shell halted its efforts to drill in the ...","BAYN","Bayer"
"1255","Regulators turn up heat on &#39;illegal&#39; North Bay Corp. recycling site","http://www.pressdemocrat.com/news/6426729-181/regulators-turn-up-heat-on","2016-12-12 22:08:28","Santa Rosa Press Democrat","Regulators appear to be losing patience with Sonoma County's largest garbage hauler for its continued use of unpermitted Santa Rosa recycling facilities, hiking fines on the company and referring it to the Sonoma County District Attorney's Office for ...","BAYN","Bayer"
"1256","Oneida tribal corporation sues city over revoked waste-to-energy plant","http://wbay.com/2016/12/23/oneida-tribal-corporation-sues-city-over-revoked-waste-to-energy-plant/","2016-12-23 14:52:30","WBAY","In 2010, the Oneida Seven Generations Corporation worked with the city to develop plans for the facility, which the tribe says would provide an alternate energy source.","BAYN","Bayer"
"1257","Oneida Tribal Corporation Suing Green Bay Over Failed Power Plant","http://www.wpr.org/oneida-tribal-corporation-suing-green-bay-over-failed-power-plant","2016-12-27 16:39:27","Wisconsin Public Radio News","Wisconsin's Oneida Tribe of Indians is suing the city of Green Bay over a failed energy project. The tribal corporation, Oneida Seven Generations Corp., received go-ahead from the city in 2010 to build an energy plant, but, after construction began ...","BAYN","Bayer"
"1258","National Championship To Draw Up To 100000 Visitors To Tampa Bay Area","http://wusfnews.wusf.usf.edu/post/national-championship-draw-100000-visitors-tampa-bay-area","2016-12-28 05:21:00","WUSF News","It all means money for the local economy, said Rob Higgins, executive director of the Tampa Bay Sports Commission. When the National Championship was held in Dallas and in Phoenix, officials there reported $300 million flowed into their local economies.","BAYN","Bayer"
"1259","Ratto Group selling North Bay garbage empire","http://www.petaluma360.com/news/6606024-181/ratto-group-selling-north-bay","2017-01-29 10:11:15","Petaluma Argus Courier","The Ratto Group, the umbrella business, and North Bay Corp., one of its controlling entities, face nearly $14 million in fines from Santa Rosa from alleged violations of its contract with the city.","BAYN","Bayer"
"1260","Canopy Growth to Trade as WEED on the TSX","http://www.newswire.ca/news-releases/canopy-growth-to-trade-as-weed-on-the-tsx-612341993.html","2017-01-31 18:15:00","Canada NewsWire (press release)","31, 2017 /CNW/ - Canopy Growth Corporation (TSX: CGC) (""Canopy Growth"" or ""the Company"") is pleased to announce that its share ticker will change to TSX:WEED upon the commencement of trading on the Toronto Stock Exchange (""TSX"") on February 1, 2017 ...","BAYN","Bayer"
"1261","Historic Bay City bank building has a contractor, architect and a restaurant","http://www.mlive.com/news/bay-city/index.ssf/2017/02/the_legacy_bay_city_historic.html","2017-02-03 05:38:51","MLive.com","In September, officials from the National Park Service gave Acosta permission to remove the metal facade from the building and put the structure on its National Register of Historic Places. Because the metal facade was installed on the building more ...","BAYN","Bayer"
"1262","Bioremediation of sludge begins","http://www.thehindu.com/news/national/tamil-nadu/Bioremediation-of-sludge-begins/article17186921.ece","2017-02-03 14:46:00","The Hindu","The bioremediation of oil sludge collected from the Bay of Bengal near Ernavur began at the Kamarajar Port Ltd in Ennore on Friday.","BAYN","Bayer"
"1263","Man in 50s suffers back and neck injuries in cliff fall","http://www.stuff.co.nz/national/89133569/man-in-50s-suffers-back-and-neck-injuries-in-cliff-fall","2017-02-06 02:52:30","Stuff.co.nz","... Bay has been taken to hospital with back and neck injuries. The man, in his 50s, was found by rescue helicopter crews clinging to a flax bush so that he didn't slip farther down the steep hillside, a Lowe Corporation Rescue Helicopter spokeswoman said.","BAYN","Bayer"
"1264","King&#39;s Bay Acquires 100% Interest in Three Additional Cobalt Properties in Quebec","https://www.juniorminingnetwork.com/junior-miner-news/press-releases/1930-tsx-venture/kbg/28982-king-s-bay-acquires-100-interest-in-three-additional-cobalt-properties-in-quebec.html","2017-02-06 03:26:15","Junior Mining Network","Vancouver, British Columbia (FSCwire) - King's Bay Gold Corporation (TSX.V: KBG), (FSE: KGB1), operating as “King's Bay”, a mining exploration and development company based in Vancouver, is pleased to announce the 100% acquisition of three cobalt ...","BAYN","Bayer"
"1265","Blum and Doom","http://www.bohemian.com/northbay/blum-and-doom/Content?oid=3152669","2017-02-08 04:10:03","North Bay Bohemian","The U.S. Department of Education's decision in August to ban a troubled for-profit college corporation from taking federal student aid funds made national headlines. But what went largely unnoticed was the damage the move did to the family fortune of a ...","BAYN","Bayer"
"1266","Clearwater lawmaker files bill to protect franchise owners","http://www.bizjournals.com/tampabay/news/2017/02/09/clearwater-lawmaker-files-bill-to-protect.html","2017-02-09 14:07:30","Tampa Bay Business Journal","“Currently these small businessmen and women have no real protection if the national corporation drops them as a franchise holder,” Latvala said.","BAYN","Bayer"
"1267","North Bay commercial real estate transactions: Feb. 13, 2017","http://www.northbaybusinessjournal.com/events/6647671-181/north-bay-commercial-real-estate","2017-02-13 09:48:45","North Bay Business Journal","3,175sf at 899 Northgate Drive, #210, San Rafael; office, sublease; Van Dermyden Maddux Law Corporation; na; Seagate Northgate Associates, LLC (lessor) & Two Harbors Investment Corp. (sublessor); Haden Ongaro & Mark Carrington of NC&C; Nov.","BAYN","Bayer"
"1268","Grant program lights spark in Bay Area students to learn art of welding","http://caeconomy.org/reporting/entry/grant-provides-bay-area-students-with-tools-to-learn-the-art-of-welding","2017-02-13 10:00:00","California Economy Reporting","A program at community colleges throughout the San Francisco Bay Area uses funding from a Career Technical Education Enhancement Fund grant in order to the develop industry-approved curriculum and purchase new equipment for welding students.","BAYN","Bayer"
"1269","California Climate Investments Provides Funding to Deploy 20 New Flyer Fuel ...","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170213C8291&filter=5611","2017-02-13 18:48:45","Montreal Gazette","Program support also includes sponsorship from the Bay Area Air Quality Management District and South Coast Air Quality Management District.","BAYN","Bayer"
"1270","TVI&#39;s 30.66% owned TVIRD Awaits Formal Notice of MPSA Cancelation","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170215C3339&filter=5611","2017-02-15 07:00:00","Montreal Gazette","CALGARY, Feb. 15, 2017 /CNW/ - TVI Pacific Inc. (TSX-V: TVI) (OTC Pink: TVIPF) (""TVI"" or ""the Company"") announces that TVI Resource Development (Phils.","BAYN","Bayer"
"1271","H&amp;R REIT Announces Fourth Quarter and 2016 Annual Results","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170215C2559&filter=5611","2017-02-15 12:37:30","Montreal Gazette","In August 2016, H&R acquired a 31.7% non-managing interest in 38.4 acres of land located in Hercules, California, adjacent to the San Pablo Bay, northeast of San Francisco, (""Hercules Project"") for the future development of multi-family residential units.","BAYN","Bayer"
"1272","Early Warning Press Release in Accordance with National Instrument 62-103","http://www.baystreet.ca/viewarticle.aspx?id=455244","2017-02-15 13:22:30","Baystreet.ca","CALGARY, AB / ACCESSWIRE / February 15, 2017 / Mr. Clarence Wagenaar issues this press release pursuant to Part 3 - Early Warning Requirements of National Instrument 62-103 with respect to Emerald Bay Energy Inc. On February 19, 2016, ... The Common ...","BAYN","Bayer"
"1273","Increased focus on work safety for award-winning Bay of Plenty companies","http://www.nzherald.co.nz/bay-of-plenty-times/news/article.cfm?c_id=1503343&objectid=11801307","2017-02-15 21:37:30","New Zealand Herald","The trust was a finalist last year in the Accident Compensation Corporation Workplace Safety category at the Westpac Tauranga Business Awards, which was won by Z Energy Retail Operations for the Bay of Plenty. Mr Thurlow said the Waipuna Hospice trust ...","BAYN","Bayer"
"1274","Midland Announces a New Strategic Alliance for Gold in the James Bay Region ...","http://www.marketwired.com/press-release/midland-announces-new-strategic-alliance-gold-james-bay-region-with-altius-minerals-tsx-venture-md-2196523.htm","2017-02-16 08:30:00","Marketwired (press release)","Midland is proud to count on reputable partners such as Altius Minerals Corp., Agnico Eagle Mines Limited, Teck Resources Limited, SOQUEM INC.","BAYN","Bayer"
"1275","All-New 2017 Kia Cadenza Makes Canadian Debut in Toronto","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170216C4834&filter=5611","2017-02-16 16:00:00","Montreal Gazette","In their pursuit of building the safest cars on sale today, Kia's engineers set their sights on achieving a five-star rating from the National Highway Traffic and Safety Administration and a Top Safety Pick+ designation from the Insurance Institute for ...","BAYN","Bayer"
"1276","Landore Resources Limited - Maiden Mineral Resource estimate and report BAM ...","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170217C3496&filter=5611","2017-02-17 01:56:15","Montreal Gazette","This Technical Report is compliant with the requirements of National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101).","BAYN","Bayer"
"1277","Adelyn Rae enters Canadian market","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170217C6032&filter=5611","2017-02-17 06:03:45","Montreal Gazette","The popular women's dress designer now offers their fashion collections to Canadians through retailers such as Hudson's Bay, Nordstrom, Le Chateau, and Mendocino. ""SCI made it very ... Trusted by clients in the retail, e-commerce, technology, and ...","BAYN","Bayer"
"1278","TVO&#39;s 8 over-the-air transmitters will continue to send signals","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170217C3048&filter=5611","2017-02-17 11:41:15","Montreal Gazette","17, 2017 /CNW/ - TVO has announced it will continue to transmit free broadcast signals across 8 over-the-air transmitters in Ottawa, Belleville, Thunder Bay, Chatham, Cloyne, Kitchener, London, and Windsor. Based on feedback from these communities ...","BAYN","Bayer"
"1279","FDC Audited Accounts Tabled After 11 Years","https://www.winnfm.com/news/local/20723-fdc-audited-accounts-tabled-after-11-years","2017-02-17 12:26:15","WINN FM","St. Kitts and Nevis (WINN); Three years of audited financial statements for the Frigate Bay Development Corporation have been tabled in parliament, the first time in 11 years.","BAYN","Bayer"
"1280","Spin Master Sets Standard for the Leading Edge of Play with 2017 Portfolio","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170217C8854&filter=5611","2017-02-17 13:11:15","Montreal Gazette","17, 2017 /CNW/ - Spin Master Corp., (""Spin Master"") (TSX: TOY) - a leading global children's entertainment company - is set to reveal its most diverse portfolio of toys, games and entertainment properties to date at the North American International Toy ...","BAYN","Bayer"
"1281","Island Princess to set sail in May 2018","http://www.rustourismnews.com/2017/02/18/island-princess-to-set-sail-in-may-2018/","2017-02-17 13:45:00","RusTourismNews","Unveiled by Carnival Corporation CEO Arnold Donald during his opening keynote last month at CES 2017, Princess Cruises is the first Carnival Corporation brand to debut this groundbreaking innovation. The Ocean Medallion is ... The Medallion Class ...","BAYN","Bayer"
"1282","Princess Cruises Announces Fourth Ship to Debut Medallion Class Ocean Vacations","http://finance.yahoo.com/news/princess-cruises-announces-fourth-ship-184600590.html","2017-02-17 13:53:44","Yahoo Finance","Unveiled by Carnival Corporation CEO Arnold Donald during his opening keynote last month at CES 2017, Princess Cruises is the first Carnival Corporation brand to debut this groundbreaking innovation. The Ocean Medallion is ... The Medallion Class ...","BAYN","Bayer"
"1283","Maple Leaf Short Duration 2017 Flow-Through Limited Partnership NATIONAL ...","http://www.baystreet.ca/viewarticle.aspx?id=455453","2017-02-17 14:18:45","Baystreet.ca","The syndicate of agents for the offering is being led by Scotiabank, BMO Capital Markets, CIBC and National Bank Financial Inc. and includes Canaccord Genuity Corp., Desjardins Securities Inc., Manulife Securities Incorporated, Raymond James Ltd., ...","BAYN","Bayer"
"1284","Government relents: nine ServiceOntario centres to stay open","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170217C4156&filter=5611","2017-02-17 17:30:00","Montreal Gazette","The announcement comes nine months after the Ministry of Government and Consumer Services said it would permanently shutter ServiceOntario offices in Mississauga, Terrace Bay, Guelph, Milton, Minden, Embrun, Morrisburg, Blind River, and Kemptville.","BAYN","Bayer"
"1285","Byron Williams: With Flynn no longer in, Trump faces big test","http://www.eastbaytimes.com/2017/02/18/byron-williams-with-flynn-no-longer-in-trump-faces-big-test/","2017-02-18 12:07:16","East Bay Times","Michael Flynn resigned as national security adviser. We also know in December, Flynn was in conversation with Russian Ambassador Sergey Kislyak regarding the sanctions that President Barack Obama placed on Russia in response for interfering in the ...","BAYN","Bayer"
"1286","Prime Minister Breaks Ground for $132 Million Sewerage Project in Bay Farm Villa","http://jis.gov.jm/new-us1-03-million-sewerage-facility-bay-farm-villa/","2017-02-18 20:11:41","Government of Jamaica, Jamaica Information Service","Andrew Holness (2nd left), is briefed on developments related to the $131.9 million (US$1.03 million) Bay Farm Villa Sewerage Project in West Central St. Andrew, by National Water Commission (NWC) President, Mark Barnett (right), during Friday's ... Dr ...","BAYN","Bayer"
"1287","Japan eager to invest in Walvis Bay logistics hub","https://economist.com.na/22673/general-news/japan-eager-to-invest-in-walvis-bay-logistic-hub/","2017-02-20 10:02:03","Namibia Economist","On 23 Februaury, the mission meets with the Minister of Mines and Energy and attend a mining seminar organized by Japan Oil, Gas and Metals National Corporation as well as a reception for the business community to network with members of the Namibia ...","BAYN","Bayer"
"1288","India&#39;s gas hydrates","http://www.ogfj.com/articles/print/volume-14/issue-2/features/india-s-gas-hydrates.html","2017-02-20 12:32:06","Oil & Gas Financial Journal","THE UNITED STATES GEOLOGICAL SURVEY (USGS), which is involved in natural gas hydrate (NGH) research in India and Japan, has assisted the Indian Oil Ministry in discovering highly enriched accumulations of NGH in the Bay of Bengal. .... National ...","BAYN","Bayer"
"1289","Princess Cruises announces the fourth ship to debut Medallion Class Ocean ...","http://www.rustourismnews.com/2017/02/22/princess-cruises-announces-the-fourth-ship-to-debut-medallion-class-ocean-vacations/","2017-02-20 13:00:00","RusTourismNews","Princess Cruises has announced that Island Princess will be the fourth cruise ship in its fleet to feature the exciting new Ocean Medallion™, debuting on the ship in Alaska in May 2018.","BAYN","Bayer"
"1290","South Coast strike team deployed to northern fire front","http://www.edenmagnet.com.au/story/4482945/strike-team-deployed-to-northern-fires/","2017-02-21 00:03:45","Eden Magnet","South Coast strike team deployed to northern fire frontA strike team of 17 Forestry Corporation firefighters from Eden, Narooma and Batemans Bay has returned home after being deployed as part of the emergency response to wild fires on the North Coast.","BAYN","Bayer"
"1291","Azimut commences geophysical survey over high-grade chromite zone on its ...","http://www.montrealgazette.com/business/cnw/release.html?rkey=20170221C3064&filter=5611","2017-02-21 09:03:45","Montreal Gazette","21, 2017 /CNW Telbec/ - Azimut Exploration Inc. (""Azimut"") (TSXV: AZM) is pleased to announce that a ground-based gravity survey will commence on its 100%-owned Eastmain West Property in the James Bay region of Quebec. The objective is to better ...","BAYN","Bayer"
"1292","LSI Industries Inc. Acquires Atlas Lighting Products, Inc.","http://www.econotimes.com/LSI-Industries-Inc-Acquires-Atlas-Lighting-Products-Inc-550654","2017-02-21 09:47:54","EconoTimes","Boyce Brannock Joins Boards of First National Corporation and First Bank ... “Atlas' line of quick-ship standard products, including floods, wallpacks, linear, pole mount, and high bay fixtures, complement LSI's custom product lines with minimal ...","BAYN","Bayer"
"1293","Ocean Medallion will debut on Princess Cruises&#39; Island Princess during Alaska ...","http://www.travelweek.ca/news/ocean-medallion-will-debut-princess-cruises-island-princess-alaska-2018-season/","2017-02-21 10:11:15","Travelweek","SANTA CLARITA - Carnival Corporation's Ocean Medallion is gaining steam across its fleet, with the announcement that the wearable device will soon be available on Princess Cruises' Island Princess.","BAYN","Bayer"
"1294","Packers franchise certificate won in auction: Priceless","http://www.packers.com/news-and-events/article-cliffs-notes/article-1/Packers-franchise-certificate-won-in-auction-Priceless/b91e78aa-027e-4e86-9ad2-764bcb1727b4","2017-02-23 11:39:03","Packers.com","The original description when the item was first posted at Hunt's website read, “Historically significant 1921 Green Bay Packers National Football League Charter Certificate. A momentous offering of the original hand calligraphed(sic) charter ...","BAYN","Bayer"
"1295","Gordhan warns against blaming external factors for SA&#39;s economic woes","http://www.sabc.co.za/news/a/6ba48580402d94589014fbf8e0b8bbd7/Gordhan-warns-against-blaming-external-factors-for-SAs-economic-woes-20170223","2017-02-23 16:56:15","South African Broadcasting Corporation","Gordhan and senior officials from the Treasury were unpacking some crucial aspects of the budget, ahead of next week's debate and its adoption in the National Assembly. Some of the issues which legislators wanted clarity on include the ... However ...","BAYN","Bayer"
"1296","Brexit prompts ship insurers to open new EU outposts","http://business.mb.com.ph/2017/02/27/brexit-prompts-ship-insurers-to-open-new-eu-outposts/","2017-02-24 09:48:45","Manila Bulletin","A spokeswoman for Luxembourg for Finance - the national financial development agency - said numerous UKcompanies including insurers were currently considering Luxembourg for their post-Brexit set-up.","BAYN","Bayer"
"1297","What to do about NVIDIA (NVDA)","http://www.baystreet.ca/articles.aspx?id=37168","2017-02-24 13:56:15","Baystreet.ca","We noted NVIDIA Corporation at $19 a year and a half ago and added it to Top Picks for $32. The company remains a Spotlight Top Pick, but the stock has hit a wall.","BAYN","Bayer"
"1298","Learning from Patchogue: Can Riverhead achieve its &#39;sister&#39; town&#39;s success?","http://riverheadlocal.com/2017/02/24/learning-patchogue-can-riverhead-achieve-sister-towns-success/","2017-02-24 19:00:00","RiverheadLOCAL","By the time the family-owned Swezey's gave up its fight to compete with national discount chains, closing its doors in 2003, Patchogue's Main Street was but a shadow of its former self.","BAYN","Bayer"
"1299","Origin of Spooky Meteor Noises Examined by Researchers","http://www.netnewsledger.com/2017/02/25/origin-spooky-meteor-noises-examined-researchers/","2017-02-25 07:47:42","Net Newsledger","Sandia National Laboratories is a multimission laboratory operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corp., for the U.S. Department of Energy's National Nuclear Security Administration. With main facilities in ...","BAYN","Bayer"
"1300","Roseville leaders work with Sacramento-based group to sell region","http://www.thepresstribune.com/article/2/23/17/roseville-leaders-work-sacramento-based-group-sell-region","2017-02-25 09:03:45","Press Tribune Newspaper","Chris Robles knows the challenge Roseville faces in attempting to attract business to the area. The city's economic development director, Robles and his staff offer a few encouraging statistics for Roseville: a median household income of $80,000 ...","BAYN","Bayer"
"1301","“He knows he can&#39;t beat anybody.” Pat Perez&#39;s comments about Tiger Woods go ...","http://www.denverpost.com/2017/02/25/pat-perez-talks-tiger-woods-pga-tour/","2017-02-25 13:22:30","The Denver Post","“He's got this new corporation that he started, so he's got to keep his name relevant to keep the corporation going. So he's going to show up to a few events… he's going to try to play. ... Perez went on to talk about whether Woods is going to play ...","BAYN","Bayer"
"1302","Dick Spotswood: When national politics are tangled in local decisions","http://www.marinij.com/article/NO/20170225/LOCAL1/170229901","2017-02-25 15:48:45","Marin Independent Journal","The North Bay's Public Broadcasting Service outlet, KRCB-TV Channel 22, is one of the few media on any platform designed to cross county lines and link Sonoma, Marin, Napa and Southern Mendocino counties.","BAYN","Bayer"
"1303","Editorial: Don&#39;t cut funding for arts and public broadcasting","http://www.stltoday.com/news/opinion/columns/the-platform/editorial-don-t-cut-funding-for-arts-and-public-broadcasting/article_40f21fc1-7ede-59f0-aded-9732f1e3e426.html","2017-02-26 13:00:00","STLtoday.com","In an attempt to hold Trump at bay, cultural groups are emphasizing the enormous bang that taxpayers get for their bucks. They say the arts are a $704 billion industry that adds more to the gross domestic product than ... Conservatives have spent more ...","BAYN","Bayer"
"1304","Burrup Peninsula Aboriginal rock art could be given World Heritage status","http://www.watoday.com.au/wa-news/burrup-peninsula-aboriginal-rock-art-could-be-given-world-heritage-status-20170227-gulzsw.html","2017-02-26 22:06:51","WAtoday","One of Australia's most significant heritage sites - the Burrup Peninsula Aboriginal rock art in the state's north west - could soon be given World Heritage status.","BAYN","Bayer"
"1305","Four students named as 2017 Barnes Scholarship winners","http://www.tampabay.com/news/education/four-students-named-as-2017-barnes-scholarship-winners/2314421","2017-02-26 23:13:40","Tampabay.com","Four winners were named recipients of the 2017 Barnes Scholarship, an annual award sponsored by the Tampa Bay Times Fund named after Andrew Barnes, the former chairman and CEO of the newspaper's parent company, Times Publishing Co.","BAYN","Bayer"
"1306","Government starts ground breaking for new NHT housing schemes","http://www.jamaicaobserver.com/news/Government-starts-ground-breaking-for-new-NHT-housing-schemes_90820","2017-02-27 00:15:00","Jamaica Observer","He is joined by (from left): Mayor of Montego Bay Homer Davis; tourism minister and Member of Parliament for St James East Central Edmund Bartlett; attorney general and Member of Parliament for St James West Central Marlene Malahoo Forte; hairman of ...","BAYN","Bayer"
"1307","Is the Bilbao effect over?","https://www.apollo-magazine.com/is-the-bilbao-effect-over-guggenheim/","2017-02-27 04:56:15","Apollo Magazine","Or of Singapore, where the skyline was radically redefined by the sci-fi scale of Moshe Safdie's Marina Bay Sands, a city image bodied in a casino - a gamble - which is a neat metaphor for the attempt to commission a landmark to be the symbol of a city ...","BAYN","Bayer"
"1308","Foran Follows Up on Spectacular Drill Results to Build a Resource at Bigstone","https://www.juniorminingnetwork.com/junior-miner-news/press-releases/466-tsx-venture/fom/29717-foran-follows-up-on-spectacular-drill-results-to-build-a-resource-at-bigstone.html","2017-02-27 08:28:54","Junior Mining Network","(Marketwired - February 27, 2017) - Foran Mining Corporation (TSX VENTURE: FOM) (""Foran"" or the ""Company"") is pleased to announce that it is planning to initiate a drill program focused on the historic Bigstone deposit1, on its 100 ...","BAYN","Bayer"
"1309","Sunbelt Business Brokers Open New Office in Kansas City, Missouri","http://www.baystreet.ca/viewarticle.aspx?id=456034","2017-02-27 09:41:45","Baystreet.ca","A third-quarter 2016 national business growth survey report released by the Wendover Corporation, cited Kansas City as topping the nation with its business growth index score of 23.8 percent.","BAYN","Bayer"
"1310","MONDAY MAN: The man behind winning St James park","http://www.nationnews.com/nationnews/news/94007/monday-winning-st-james-park","2017-02-27 10:56:15","Nation News","Having conquered the national competition in 1978, as well as 1979, he went on to make strides as a bodybuilder, winning Mr St James in 1982 and Mr West Coast the next year.","BAYN","Bayer"
"1311","Real estate shopping for nuclear waste in Northwest Russia in a time of ...","http://bellona.org/news/nuclear-issues/2017-02-real-estate-shopping-for-nuclear-waste-in-northwest-russia","2017-02-27 15:48:45","Bellona","The acting director of a Russian national park has made the surprising suggestion of packing the country's nuclear waste into a high arctic archipelago where the Soviets used to test atomic bombs.","BAYN","Bayer"
"1312","Silver Bay Realty Trust Corp. Announces Agreement to Be Acquired by Tricon ...","http://www.businesswire.com/news/home/20170227006533/en/Silver-Bay-Realty-Trust-Corp.-Announces-Agreement","2017-02-27 16:00:00","Business Wire (press release)","Silver Bay Realty Trust Corp. is an internally managed Maryland corporation focused on the acquisition, renovation, leasing and management of single-family properties for rental income and long-term capital appreciation.","BAYN","Bayer"
"1313","Discovery Harbour Enters Extension to the Agreement to Purchase 100% Ownership ...","http://www.baystreet.ca/viewarticle.aspx?id=456117","2017-02-27 16:37:44","Baystreet.ca","(TSX-V: DHR) (""DHR"" or the ""Company"") is pleased to announce that it has reached an agreement with Genesis Gold Corporation (""GGC"") to extend the term of the Exploration License and Option To Purchase Agreement (the ""Agreement or Option"") to acquire a ...","BAYN","Bayer"
"1314","Case by case, legal aid attorneys battle displacement in the Bay Area","http://kalw.org/post/case-case-legal-aid-attorneys-battle-displacement-bay-area","2017-02-27 20:23:24","KALW","But, the reality is, the majority of owners that Colangelo faces are corporations. Investment companies bought up huge swaths of low rent housing in the East Bay after the foreclosure crisis. And they tend to evict more often than mom and pops ...","BAYN","Bayer"
"1316","Cardinal Health to Acquire Johnson &amp; Johnson&#39;s Cordis business","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3164279","2015-03-02 07:30:00","Reuters Key Development","Cardinal Health to Acquire Johnson & Johnson's Cordis business","JNJ","Johnson & Johnson"
"1317","GlaxosmithKline Plc and Johnson &amp; Johnson settle U.S. lawsuit over allergy ads - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3184361","2015-03-30 22:21:00","Reuters Key Development","GlaxosmithKline Plc and Johnson & Johnson settle U.S. lawsuit over allergy ads - Reuters","JNJ","Johnson & Johnson"
"1318","Johnson &amp; Johnson updates FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3191998","2015-04-14 08:00:00","Reuters Key Development","Johnson & Johnson updates FY 2015 EPS guidance","JNJ","Johnson & Johnson"
"1319","Johnson &amp; Johnson announces dividend increase of 7.1 pct","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3198222","2015-04-23 10:59:00","Reuters Key Development","Johnson & Johnson announces dividend increase of 7.1 pct","JNJ","Johnson & Johnson"
"1320","Johnson &amp; Johnson announces acceptance of binding offer from cardinal health to acquire cordis","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3220651","2015-05-28 08:00:00","Reuters Key Development","Johnson & Johnson announces acceptance of binding offer from cardinal health to acquire cordis","JNJ","Johnson & Johnson"
"1321","Carna Biosciences announces collaboration with Johnson &amp; Johnson innovation","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3228041","2015-06-11 08:00:00","Reuters Key Development","Carna Biosciences announces collaboration with Johnson & Johnson innovation","JNJ","Johnson & Johnson"
"1322","Johnson &amp; Johnson increases FY 2015 EPS guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3244262","2015-07-14 07:45:00","Reuters Key Development","Johnson & Johnson increases FY 2015 EPS guidance","JNJ","Johnson & Johnson"
"1323","Johnson &amp; Johnson announces quarterly dividend for third quarter 2015","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3247524","2015-07-20 11:40:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for third quarter 2015","JNJ","Johnson & Johnson"
"1324","Johnson &amp; Johnson gets partial win against Covidien in surgical patent case - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3258641","2015-08-06 20:00:00","Reuters Key Development","Johnson & Johnson gets partial win against Covidien in surgical patent case - Reuters","JNJ","Johnson & Johnson"
"1325","Johnson &amp; Johnson starts Clinical Trial of Ebola Vaccine Regimen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3282835","2015-10-09 02:00:00","Reuters Key Development","Johnson & Johnson starts Clinical Trial of Ebola Vaccine Regimen","JNJ","Johnson & Johnson"
"1326","Johnson &amp; Johnson - Surgical funder ordered to turn over information on hip surgeries - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3285451","2015-10-13 20:00:00","Reuters Key Development","Johnson & Johnson - Surgical funder ordered to turn over information on hip surgeries - Reuters","JNJ","Johnson & Johnson"
"1327","Johnson &amp; Johnson defeats first lawsuit on Tylenol&#39;s link to liver damage - Bloomberg - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3286676","2015-10-15 20:00:00","Reuters Key Development","Johnson & Johnson defeats first lawsuit on Tylenol's link to liver damage - Bloomberg - Reuters","JNJ","Johnson & Johnson"
"1328","Johnson &amp; Johnson announces quarterly dividend for fourth quarter","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3288829","2015-10-22 13:26:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for fourth quarter","JNJ","Johnson & Johnson"
"1329","Johnson &amp; Johnson announces agreement to acquire Novira Therapeutics Inc","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3295869","2015-11-04 12:01:00","Reuters Key Development","Johnson & Johnson announces agreement to acquire Novira Therapeutics Inc","JNJ","Johnson & Johnson"
"1330","Johnson &amp; Johnson - Court revives Oregon suit over &#39;phantom recall&#39; of Motrin - AP","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3306837","2015-11-25 18:32:00","Reuters Key Development","Johnson & Johnson - Court revives Oregon suit over 'phantom recall' of Motrin - AP","JNJ","Johnson & Johnson"
"1331","Johnson &amp; Johnson announces completion of Novira Therapeutics, Inc. acquisition","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3307492","2015-12-04 16:30:00","Reuters Key Development","Johnson & Johnson announces completion of Novira Therapeutics, Inc. acquisition","JNJ","Johnson & Johnson"
"1332","Johnson &amp; Johnson announces formation of verb surgical inc., in collaboration with verily","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3309520","2015-12-10 09:00:00","Reuters Key Development","Johnson & Johnson announces formation of verb surgical inc., in collaboration with verily","JNJ","Johnson & Johnson"
"1333","Johnson &amp; Johnson - Kentucky reaches $39.5 mln settlement with Purdue, Johnson &amp; Johnson - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3315120","2015-12-23 17:41:00","Reuters Key Development","Johnson & Johnson - Kentucky reaches $39.5 mln settlement with Purdue, Johnson & Johnson - Reuters","JNJ","Johnson & Johnson"
"1334","Johnson &amp; Johnson announces quarterly dividend for first quarter 2016","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3317247","2016-01-04 06:45:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for first quarter 2016","JNJ","Johnson & Johnson"
"1335","Johnson &amp; Johnson gives FY 2016 guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3323919","2016-01-26 06:41:00","Reuters Key Development","Johnson & Johnson gives FY 2016 guidance","JNJ","Johnson & Johnson"
"1336","Johnson &amp; Johnson must pay $72 million for cancer death linked to talcum powder: lawyers - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3334478","2016-02-23 06:47:00","Reuters Key Development","Johnson & Johnson must pay $72 million for cancer death linked to talcum powder: lawyers - Reuters","JNJ","Johnson & Johnson"
"1337","Johnson &amp; Johnson - UK cost agency rejects leukaemia drug from J&amp;J and AbbVie - Reuters","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3338183","2016-03-01 14:01:00","Reuters Key Development","Johnson & Johnson - UK cost agency rejects leukaemia drug from J&J and AbbVie - Reuters","JNJ","Johnson & Johnson"
"1338","Johnson &amp; Johnson hit with $500 mln verdict in hip implant trial - Reuters News","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3344731","2016-03-17 16:18:00","Reuters Key Development","Johnson & Johnson hit with $500 mln verdict in hip implant trial - Reuters News","JNJ","Johnson & Johnson"
"1339","Johnson &amp; Johnson updates FY 2016 sales guidance; increases EPS guidance","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3358527","2016-04-19 06:40:00","Reuters Key Development","Johnson & Johnson updates FY 2016 sales guidance; increases EPS guidance","JNJ","Johnson & Johnson"
"1340","Johnson &amp; Johnson announces dividend","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3364796","2016-04-28 10:30:00","Reuters Key Development","Johnson & Johnson announces dividend","JNJ","Johnson & Johnson"
"1341","J&amp;J says Janssen received civil investigative demand from U.S. Attorney’s office on contractual relationships with pharmacy benefit managers","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3370184","2016-05-10 06:02:47","Reuters Key Development","J&J says Janssen received civil investigative demand from U.S. Attorney’s office on contractual relationships with pharmacy benefit managers","JNJ","Johnson & Johnson"
"1342","Johnson &amp; Johnson says Janssen unit received civil investigative demand from U.S. Attorney’s office for Southern district of New York","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3370195","2016-05-10 06:40:37","Reuters Key Development","Johnson & Johnson says Janssen unit received civil investigative demand from U.S. Attorney’s office for Southern district of New York","JNJ","Johnson & Johnson"
"1343","Manitex Capital declares a dividend-in-kind","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3370881","2016-05-10 16:51:00","Reuters Key Development","Manitex Capital declares a dividend-in-kind","JNJ","Johnson & Johnson"
"1344","Johnson &amp; Johnson says collaborating with HP Inc&#39;s unit","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3376875","2016-05-17 08:52:23","Reuters Key Development","Johnson & Johnson says collaborating with HP Inc's unit","JNJ","Johnson & Johnson"
"1345","European Commission approves Johnson &amp; Johnson&#39;s TREVICTA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3384404","2016-05-31 07:00:00","Reuters Key Development","European Commission approves Johnson & Johnson's TREVICTA","JNJ","Johnson & Johnson"
"1346","Janssen Pharmaceutica NV says Idylla ebola virus test granted emergency use authorization by U.S. FDA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3385111","2016-06-01 01:00:00","Reuters Key Development","Janssen Pharmaceutica NV says Idylla ebola virus test granted emergency use authorization by U.S. FDA","JNJ","Johnson & Johnson"
"1347","Johnson &amp; Johnson to acquire Vogue International for about $3.3 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3385893","2016-06-02 06:45:00","Reuters Key Development","Johnson & Johnson to acquire Vogue International for about $3.3 bln","JNJ","Johnson & Johnson"
"1348","Amyris announces collaboration with Johnson &amp; Johnson Innovation","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3387209","2016-06-06 08:30:00","Reuters Key Development","Amyris announces collaboration with Johnson & Johnson Innovation","JNJ","Johnson & Johnson"
"1349","Janssen announces data from Phase 3 MMY3003 (POLLUX) trial","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3389676","2016-06-10 07:00:00","Reuters Key Development","Janssen announces data from Phase 3 MMY3003 (POLLUX) trial","JNJ","Johnson & Johnson"
"1350","UK&#39;s CMA says Reckitt Benckiser licensed K-Y brand to Thornton &amp; Ross","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3393462","2016-06-20 09:10:32","Reuters Key Development","UK's CMA says Reckitt Benckiser licensed K-Y brand to Thornton & Ross","JNJ","Johnson & Johnson"
"1351","Gilead says European Commission grants marketing authorization for Odefsey®","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3395262","2016-06-23 07:53:00","Reuters Key Development","Gilead says European Commission grants marketing authorization for Odefsey®","JNJ","Johnson & Johnson"
"1352","Abbvie announces fourth breakthrough therapy designation granted by FDA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3397728","2016-06-29 07:30:00","Reuters Key Development","Abbvie announces fourth breakthrough therapy designation granted by FDA","JNJ","Johnson & Johnson"
"1353","Fitch affirms Johnson &amp; Johnson&#39;s IDR at &#39;AAA&#39;; outlook stable","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3398741","2016-06-30 10:03:51","Reuters Key Development","Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable","JNJ","Johnson & Johnson"
"1354","Adjuvant Cosme Japan forms business and capital alliance with JNJ&#39;s units","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3402812","2016-07-11 02:53:47","Reuters Key Development","Adjuvant Cosme Japan forms business and capital alliance with JNJ's units","JNJ","Johnson & Johnson"
"1355","Johnson &amp; Johnson to buy 20 pct stake in CI:Z Holdings Co - Nikkei","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3403242","2016-07-11 14:02:38","Reuters Key Development","Johnson & Johnson to buy 20 pct stake in CI:Z Holdings Co - Nikkei","JNJ","Johnson & Johnson"
"1356","Johnson &amp; Johnson sets quarterly cash dividend of $0.80 per share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3407131","2016-07-18 14:30:00","Reuters Key Development","Johnson & Johnson sets quarterly cash dividend of $0.80 per share","JNJ","Johnson & Johnson"
"1357","Ionis Pharmaceuticals licenses oral antisense drug to Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3407678","2016-07-19 07:00:00","Reuters Key Development","Ionis Pharmaceuticals licenses oral antisense drug to Janssen","JNJ","Johnson & Johnson"
"1358","Johnson &amp; Johnson posts Q2 earnings of $1.43/share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3407648","2016-07-19 07:00:00","Reuters Key Development","Johnson & Johnson posts Q2 earnings of $1.43/share","JNJ","Johnson & Johnson"
"1359","Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3408324","2016-07-20 07:00:00","Reuters Key Development","Health Canada approves INVOKAMET for treatment of adults with type 2 diabetes","JNJ","Johnson & Johnson"
"1360","Janssen says Health Canada approves Imbruvica for treatment of chronic lymphocytic leukemia","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3408351","2016-07-20 08:00:00","Reuters Key Development","Janssen says Health Canada approves Imbruvica for treatment of chronic lymphocytic leukemia","JNJ","Johnson & Johnson"
"1361","Bristol-Myers Squibb collaborates with Johnson and Johnson for lung cancer research","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3411570","2016-07-26 06:59:00","Reuters Key Development","Bristol-Myers Squibb collaborates with Johnson and Johnson for lung cancer research","JNJ","Johnson & Johnson"
"1362","Johnson &amp; Johnson announces ruling related to Remicade","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3428215","2016-08-17 13:54:00","Reuters Key Development","Johnson & Johnson announces ruling related to Remicade","JNJ","Johnson & Johnson"
"1363","Janssen submits application to U.S. FDA to expand indication for daratumumab","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3428228","2016-08-17 15:25:00","Reuters Key Development","Janssen submits application to U.S. FDA to expand indication for daratumumab","JNJ","Johnson & Johnson"
"1364","Genmab to receive $15 mln in milestone payments from Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3428238","2016-08-17 15:40:32","Reuters Key Development","Genmab to receive $15 mln in milestone payments from Janssen","JNJ","Johnson & Johnson"
"1365","Johnson &amp; Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3429614","2016-08-19 10:31:23","Reuters Key Development","Johnson & Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing","JNJ","Johnson & Johnson"
"1366","J&amp;J wins dismissal of New Jersey lawsuits over talc claims - Bloomberg","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3436903","2016-09-02 16:04:47","Reuters Key Development","J&J wins dismissal of New Jersey lawsuits over talc claims - Bloomberg","JNJ","Johnson & Johnson"
"1367","Janssen receives CHMP positive opinion for Stelara (Ustekinumab)","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3441983","2016-09-16 09:45:00","Reuters Key Development","Janssen receives CHMP positive opinion for Stelara (Ustekinumab)","JNJ","Johnson & Johnson"
"1368","Johnson &amp; Johnson to buy Abbott Medical Optics for $4.325 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3442035","2016-09-16 15:00:00","Reuters Key Development","Johnson & Johnson to buy Abbott Medical Optics for $4.325 bln","JNJ","Johnson & Johnson"
"1369","Abbott to sell Abbott Medical Optics to Johnson &amp; Johnson for $4.325 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3442037","2016-09-16 15:00:00","Reuters Key Development","Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 bln","JNJ","Johnson & Johnson"
"1370","Argentum Pharmaceuticals succeeds in starting patent cancellation trial against Janssen&#39;s Zytiga","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3442492","2016-09-19 11:00:00","Reuters Key Development","Argentum Pharmaceuticals succeeds in starting patent cancellation trial against Janssen's Zytiga","JNJ","Johnson & Johnson"
"1371","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3444644","2016-09-23 08:00:00","Reuters Key Development","Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis","JNJ","Johnson & Johnson"
"1372","Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson &amp; Johnson Innovation – JJDC Inc","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3446434","2016-09-28 08:00:00","Reuters Key Development","Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation – JJDC Inc","JNJ","Johnson & Johnson"
"1373","U.S. FDA warns about the risk of Hepatitis B","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3449271","2016-10-04 17:31:00","Reuters Key Development","U.S. FDA warns about the risk of Hepatitis B","JNJ","Johnson & Johnson"
"1374","U.S. Department of Homeland Security warns on vulnerabilities in J&amp;J insulin pumps","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3449677","2016-10-05 12:39:54","Reuters Key Development","U.S. Department of Homeland Security warns on vulnerabilities in J&J insulin pumps","JNJ","Johnson & Johnson"
"1375","Astrazeneca divests rights to Rhinocort Aqua outside US","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3450406","2016-10-07 02:00:08","Reuters Key Development","Astrazeneca divests rights to Rhinocort Aqua outside US","JNJ","Johnson & Johnson"
"1376","Genmab says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3450803","2016-10-07 18:07:30","Reuters Key Development","Genmab says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma","JNJ","Johnson & Johnson"
"1377","Johnson &amp; Johnson reports Q3 EPS $1.53","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3455810","2016-10-18 06:59:07","Reuters Key Development","Johnson & Johnson reports Q3 EPS $1.53","JNJ","Johnson & Johnson"
"1378","J&amp;J sets quarterly cash dividend of $0.80 per share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3457739","2016-10-20 16:10:00","Reuters Key Development","J&J sets quarterly cash dividend of $0.80 per share","JNJ","Johnson & Johnson"
"1379","Janssen Therapeutics receives funding from a special RFA","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3460447","2016-10-25 08:00:00","Reuters Key Development","Janssen Therapeutics receives funding from a special RFA","JNJ","Johnson & Johnson"
"1380","BRIEF-Janssen Therapeutics announces recipients of funding from special RFA (Oct 25)","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3461681","2016-10-26 11:43:56","Reuters Key Development","BRIEF-Janssen Therapeutics announces recipients of funding from special RFA (Oct 25)","JNJ","Johnson & Johnson"
"1381","Johnson &amp; Johnson reports 6.4 pct passive stake in Tracon Pharmaceuticals","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3466168","2016-10-31 15:25:17","Reuters Key Development","Johnson & Johnson reports 6.4 pct passive stake in Tracon Pharmaceuticals","JNJ","Johnson & Johnson"
"1382","British artificial intelligence firm announces license agreement with Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3472185","2016-11-08 06:03:00","Reuters Key Development","British artificial intelligence firm announces license agreement with Janssen","JNJ","Johnson & Johnson"
"1383","Genmab says combination of drugs from J&amp;J, Amgen will be tested in study","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3475062","2016-11-10 08:27:42","Reuters Key Development","Genmab says combination of drugs from J&J, Amgen will be tested in study","JNJ","Johnson & Johnson"
"1384","Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3475067","2016-11-10 08:34:00","Reuters Key Development","Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib","JNJ","Johnson & Johnson"
"1385","Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3477816","2016-11-14 11:45:00","Reuters Key Development","Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal","JNJ","Johnson & Johnson"
"1386","Paulson &amp; Co cuts share stake in Alexion Pharmaceuticals, Johnson &amp; Johnson","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3478214","2016-11-14 17:38:35","Reuters Key Development","Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson & Johnson","JNJ","Johnson & Johnson"
"1387","Janssen&#39;s Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3479127","2016-11-15 08:00:00","Reuters Key Development","Janssen's Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial","JNJ","Johnson & Johnson"
"1388","Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3480805","2016-11-17 08:00:00","Reuters Key Development","Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab","JNJ","Johnson & Johnson"
"1389","Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3482264","2016-11-21 15:46:31","Reuters Key Development","Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma","JNJ","Johnson & Johnson"
"1390","J&amp;J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3484690","2016-11-24 13:55:31","Reuters Key Development","J&J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg","JNJ","Johnson & Johnson"
"1391","Actelion has given J&amp;J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3486775","2016-11-29 11:05:08","Reuters Key Development","Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources","JNJ","Johnson & Johnson"
"1392","Johnson &amp; Johnson says it has ended discussions with Actelion","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3494524","2016-12-13 18:38:00","Reuters Key Development","Johnson & Johnson says it has ended discussions with Actelion","JNJ","Johnson & Johnson"
"1393","Actelion says in discussions with another party regarding possible strategic transaction","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3494544","2016-12-13 20:11:07","Reuters Key Development","Actelion says in discussions with another party regarding possible strategic transaction","JNJ","Johnson & Johnson"
"1394","FDA clears wireless integration for WellDoc, Lifescan project","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3495084","2016-12-14 09:24:00","Reuters Key Development","FDA clears wireless integration for WellDoc, Lifescan project","JNJ","Johnson & Johnson"
"1395","Ionis Pharmaceuticals says earned $5 mln milestone payment from Janssen Biotech","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3499641","2016-12-22 07:00:00","Reuters Key Development","Ionis Pharmaceuticals says earned $5 mln milestone payment from Janssen Biotech","JNJ","Johnson & Johnson"
"1396","Mylan launches generic Concerta tablets","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3502192","2016-12-29 16:23:00","Reuters Key Development","Mylan launches generic Concerta tablets","JNJ","Johnson & Johnson"
"1397","Johnson &amp; Johnson announces quarterly dividend for Q1 2017","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3503289","2017-01-03 06:40:00","Reuters Key Development","Johnson & Johnson announces quarterly dividend for Q1 2017","JNJ","Johnson & Johnson"
"1398","J&amp;J&#39;s DePuy Synthes acquires technology from Interventional Spine Inc","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3503532","2017-01-03 13:09:29","Reuters Key Development","J&J's DePuy Synthes acquires technology from Interventional Spine Inc","JNJ","Johnson & Johnson"
"1399","Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase 2","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3507178","2017-01-11 08:00:00","Reuters Key Development","Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase 2","JNJ","Johnson & Johnson"
"1400","Orthocell announces collaboration with Johnson &amp; Johnson&lt;JNJ.N&gt;&lt;OCC.AX&gt;","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3507342","2017-01-11 17:58:34","Reuters Key Development","Orthocell announces collaboration with Johnson & Johnson<JNJ.N><OCC.AX>","JNJ","Johnson & Johnson"
"1401","Orthocell announces collaboration with Johnson &amp; Johnson","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3507344","2017-01-11 19:21:10","Reuters Key Development","Orthocell announces collaboration with Johnson & Johnson","JNJ","Johnson & Johnson"
"1402","Johnson &amp; Johnson reports 7.4 pct stake in Merus NV as of Dec 31, 2016","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3510520","2017-01-18 17:59:24","Reuters Key Development","Johnson & Johnson reports 7.4 pct stake in Merus NV as of Dec 31, 2016","JNJ","Johnson & Johnson"
"1403","Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3511818","2017-01-20 08:30:00","Reuters Key Development","Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products","JNJ","Johnson & Johnson"
"1404","Johnson &amp; Johnson reports Q4 adj. earnings $1.58 per share","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3513588","2017-01-24 05:32:03","Reuters Key Development","Johnson & Johnson reports Q4 adj. earnings $1.58 per share","JNJ","Johnson & Johnson"
"1405","J&amp;J sees 2017 effective tax rate 19-20 percent","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3513757","2017-01-24 10:07:09","Reuters Key Development","J&J sees 2017 effective tax rate 19-20 percent","JNJ","Johnson & Johnson"
"1406","Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3514858","2017-01-25 07:30:00","Reuters Key Development","Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics","JNJ","Johnson & Johnson"
"1407","Jupiter says J&amp;J purchase of Actelion &quot;very good outcome&quot;","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515745","2017-01-26 06:00:00","Reuters Key Development","Jupiter says J&J purchase of Actelion ""very good outcome""","JNJ","Johnson & Johnson"
"1408","Actelion CEO hopes new R&amp;D business to collaborate with J&amp;J on products","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515877","2017-01-26 08:04:27","Reuters Key Development","Actelion CEO hopes new R&D business to collaborate with J&J on products","JNJ","Johnson & Johnson"
"1409","J&amp;J has two-year agreement on stake in R&amp;D company","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515936","2017-01-26 09:04:23","Reuters Key Development","J&J has two-year agreement on stake in R&D company","JNJ","Johnson & Johnson"
"1410","DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3515976","2017-01-26 10:00:00","Reuters Key Development","DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems","JNJ","Johnson & Johnson"
"1411","Fitch affirms Johnson &amp; Johnson&#39;s IDR at &#39;AAA&#39;; outlook stable","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3516799","2017-01-27 15:42:33","Reuters Key Development","Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable","JNJ","Johnson & Johnson"
"1412","Johnson &amp; Johnson Plus Actelion: A Good Combination?","http://seekingalpha.com/article/4040652-johnson-and-johnson-plus-actelion-good-combination","2017-01-30 10:41:20","Seeking Alpha","Johnson & Johnson's (NYSE:JNJ) acquisition of Actelion (OTCPK:ALIOY) makes a lot of sense on a number of levels. There have been some concerns about the price being paid by the company, which is understandable as I also believe it is on the richer ...","JNJ","Johnson & Johnson"
"1413","Johnson &amp; Johnson&#39;s Q4 Earnings: What You Need to Know","https://www.fool.com/investing/2017/01/31/johnson-johnsons-q4-earnings-what-you-need-to-know.aspx","2017-01-31 08:41:15","Motley Fool","This week, healthcare giant Johnson & Johnson (NYSE:JNJ) kicked off healthcare earnings by reporting a quarter that was mostly in line with expectations.","JNJ","Johnson & Johnson"
"1414","ChemDiv announces multi-year hit identification collaboration with Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3518013","2017-01-31 09:00:00","Reuters Key Development","ChemDiv announces multi-year hit identification collaboration with Janssen","JNJ","Johnson & Johnson"
"1415","Johnson &amp; Johnson names new head for Texas Medical Center program","http://www.bizjournals.com/houston/news/2017/01/31/johnson-johnson-names-new-head-for-texas-medical.html","2017-01-31 10:00:00","Houston Business Journal","New Jersey-based Johnson & Johnson Inc. (NYSE: JNJ) has named a new leader for its JLabs @ TMC incubator program. Tom Luby, formerly Johnson & Johnson's senior director of new ventures for the J&J's Boston Innovation Center, now leads the ...","JNJ","Johnson & Johnson"
"1416","Pharmaceutical Executives From Merck &amp; Co., Inc. (NYSE:MRK), Johnson &amp; Johnson ...","https://marketexclusive.com/pharmaceutical-executives-merck-co-inc-nysemrk-johnson-johnson-nysejnj-among-met-trump/70762/","2017-02-01 09:26:15","Market Exclusive","Trump was speaking to pharmaceutical executives from some of the well-known firms the likes of Merck & Co., Inc.(NYSE:MRK), and Johnson & Johnson (NYSE:JNJ) in a meeting at the White House. He also called on them to cut prices but he also gave a ...","JNJ","Johnson & Johnson"
"1417","Johnson &amp; Johnson Loses Venue Fight for Missouri Talc Lawsuits","http://www.insurancejournal.com/news/midwest/2017/02/01/440583.htm","2017-02-01 12:26:15","Insurance Journal","The Missouri Supreme Court has denied Johnson & Johnson's bid to move out of a St. Louis state court thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.","JNJ","Johnson & Johnson"
"1418","3 Pharmaceutical Stocks With Bigger Dividends Than Johnson &amp; Johnson","https://www.fool.com/investing/2017/02/01/3-pharmaceutical-stocks-with-bigger-dividends-than.aspx","2017-02-01 15:37:30","Motley Fool","If there were such a thing as the dividend stock hall of fame, Johnson & Johnson (NYSE:JNJ) would be in it. After all, the company increased its dividend for a whopping 54 years in a row.","JNJ","Johnson & Johnson"
"1419","BRIEF-J&amp;J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3519128","2017-02-01 16:05:00","Reuters Key Development","BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee","JNJ","Johnson & Johnson"
"1420","Actelion, Specializing in PAH Treatments, to Be Purchased by Johnson &amp; Johnson ...","https://pulmonaryhypertensionnews.com/2017/02/02/biopharma-actelion-to-be-purchased-by-johnson-johnson-30-billion-dollars/","2017-02-02 08:57:21","Pulmonary Hypertension News","Actelion, which manufactures treatments for conditions like pulmonary arterial hypertension (PAH), will be acquired by Johnson & Johnson for $30 billion. The board of directors of both companies agreed to the transaction, said Alex Gorsky, chairman and ...","JNJ","Johnson & Johnson"
"1421","The Zacks Analyst Blog Highlights: Johnson &amp; Johnson, PayPal, Thermo Fisher ...","http://finance.yahoo.com/news/zacks-analyst-blog-highlights-johnson-143002154.html","2017-02-02 10:04:50","Yahoo Finance","Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson ( NYSE:JNJ - Free Report ), PayPal ( NASDAQ:PYPL - Free Report ) ...","JNJ","Johnson & Johnson"
"1422","Johnson &amp; Johnson Adds Hospital Medical Devices to Sandra Peterson ...","http://finance.yahoo.com/news/johnson-johnson-adds-hospital-medical-170000720.html","2017-02-02 12:08:00","Yahoo Finance"," Johnson & Johnson (JNJ) today announced that in addition to her current responsibilities, Sandra Peterson, Group Worldwide Chair, will assume leadership of its Hospital Medical Device business, effective June 1, when Gary Pruden ...","JNJ","Johnson & Johnson"
"1423","Johnson &amp; Johnson medical device chief Pruden to step down","http://www.massdevice.com/johnson-johnson-medical-device-chief-pruden-step/","2017-02-02 12:37:30","Mass Device","“Since joining the company more than four years ago, Sandi has been a valuable partner and has played a critical role in positioning Johnson & Johnson to thrive in a rapidly changing environment,” chairman & CEO Alex Gorsky said in prepared remarks.","JNJ","Johnson & Johnson"
"1424","Johnson &amp; Johnson Is Becoming a Far Riskier Investment","https://www.fool.com/investing/2017/02/03/johnson-johnson-is-becoming-a-far-riskier-investme.aspx","2017-02-03 12:03:45","Motley Fool","Also, until the quick rise and fall of hepatitis C drug Olysio, Johnson & Johnson had a better than three-decade-long streak of increasing its adjusted earnings per share on a year-over-year basis.","JNJ","Johnson & Johnson"
"1425","Johnson &amp; Johnson Unit Sued Over Leaking Breast Implants","https://www.bloomberg.com/news/articles/2017-02-03/johnson-johnson-unit-sued-over-leaking-breast-implants","2017-02-03 17:18:45","Bloomberg","A Johnson & Johnson unit is allegedly selling defective breast implants that are causing health problems for some women, including muscle pain and nausea, according to the first state-court lawsuit in California over the devices.","JNJ","Johnson & Johnson"
"1426","Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3521234","2017-02-06 11:00:00","Reuters Key Development","Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen","JNJ","Johnson & Johnson"
"1427","Johnson &amp; Johnson: A vision for automation","http://www.mmh.com/article/johnson_johnson_a_vision_for_automation","2017-02-06 13:56:15","Modern Materials Handling","At first glance, you may not think a company like Johnson & Johnson Vision Care, which supplies eye care specialists with contact lenses and vision care products, would be concerned about disruption or competition from the likes of Amazon.","JNJ","Johnson & Johnson"
"1428","Better Buy: Kimberly-Clark Corporation vs. Johnson &amp; Johnson","https://www.fool.com/investing/2017/02/07/better-buy-kimberly-clark-corporation-vs-johnson-j.aspx","2017-02-07 12:48:45","Motley Fool","As long-term investments, it's hard not to like dividend giants Kimberly-Clark (NYSE:KMB) and Johnson & Johnson (NYSE:JNJ).","JNJ","Johnson & Johnson"
"1429","Johnson &amp; Johnson Needs To Paint A Heartening Picture With Canvas","http://seekingalpha.com/article/4043439-johnson-and-johnson-needs-paint-heartening-picture-canvas","2017-02-07 13:33:45","Seeking Alpha","Johnson & Johnson's (NYSE:JNJ) diabetes therapy Invokana needs a strong result in its cardiovascular outcomes trials this year if it is to hold off the threat of Lilly (NYSE:LLY) and Boehringer Ingelheim's rival SGLT2 inhibitor Jardiance (see table ...","JNJ","Johnson & Johnson"
"1430","Johnson &amp; Johnson To Acquire Actelion","http://seekingalpha.com/article/4043696-johnson-and-johnson-acquire-actelion","2017-02-08 05:30:00","Seeking Alpha","Acquirer Johnson & Johnson (NYSE:JNJ) has a market cap of about $309B and the target Actelion (OTCPK:ALIOY) (OTCPK:ALIOF) of about $28B.","JNJ","Johnson & Johnson"
"1431","Johnson &amp; Johnson: Betting On Growth","http://seekingalpha.com/article/4043920-johnson-and-johnson-betting-growth","2017-02-08 14:07:30","Seeking Alpha","Johnson & Johnson (NYSE:JNJ) has pulled the trigger on buying up Actelion (OTCPK:ALIOY) for $30 billion, an effort to boost its drug discovery capabilities.","JNJ","Johnson & Johnson"
"1432","Johnson &amp; Johnson To Acquire Actelion For $30 Billion: Is This A Smart Move?","http://seekingalpha.com/article/4044172-johnson-and-johnson-acquire-actelion-30-billion-smart-move","2017-02-09 04:00:00","Seeking Alpha","Johnson & Johnson (NYSE:JNJ) recently announced that it would acquire Swiss firm Actelion (OTCPK:ALIOY) (OTCPK:ALIOF) for $30 billion and then split off part of it into a new firm called the NewCo.","JNJ","Johnson & Johnson"
"1433","Goldthrip v. Johnson &amp; Johnson: Alter Ego Personal Jurisdiction Arguments Rejected","http://www.natlawreview.com/article/goldthrip-v-johnson-johnson-alter-ego-personal-jurisdiction-arguments-rejected","2017-02-09 12:48:45","The National Law Review","A recent case, Goldthrip v. Johnson & Johnson, provides an excellent roadmap to follow when representing out of state corporate parents who have been dragged into court on an alter ego theory of personal jurisdiction based on the local activities of a ...","JNJ","Johnson & Johnson"
"1434","3 Reasons Johnson &amp; Johnson&#39;s Actelion Deal Might Not Be Totally Crazy","https://www.fool.com/investing/2017/02/12/3-reasons-johnson-johnsons-actelion-deal-might-not.aspx","2017-02-12 07:22:30","Motley Fool","There's no question that Johnson & Johnson (NYSE:JNJ) has been one of the most stable companies around. You don't survive and thrive for over 130 years and increase earnings and dividends every year for decades without being rock-solid.","JNJ","Johnson & Johnson"
"1435","Akebia to pay Janssen to access come intellectual property","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3526002","2017-02-13 07:00:00","Reuters Key Development","Akebia to pay Janssen to access come intellectual property","JNJ","Johnson & Johnson"
"1436","Akebia Therapeutics provides update on Janssen deal","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3526028","2017-02-13 07:24:04","Reuters Key Development","Akebia Therapeutics provides update on Janssen deal","JNJ","Johnson & Johnson"
"1437","Akebia in HIF compounds play with Johnson &amp; Johnson","http://www.fiercebiotech.com/biotech/akebia-hif-compounds-play-johnson-johnson","2017-02-13 08:56:58","FierceBiotech","Johnson & Johnson has outlicensed its portfolio of hypoxia-inducible factor (HIF) to Cambridge MA-based Akebia as the biotech boosts its early-stage pipeline.","JNJ","Johnson & Johnson"
"1438","Johnson &amp; Johnson: What Will The 55th Dividend Increase Be?","http://seekingalpha.com/article/4045388-johnson-and-johnson-will-55th-dividend-increase","2017-02-13 12:26:15","Seeking Alpha","Johnson & Johnson Has increased its dividend for 54 years and presently has a yield of 2.8% which is above average with the last increase declared in April 2016.","JNJ","Johnson & Johnson"
"1439","Johnson &amp; Johnson ditch plastic cotton buds to save oceans","http://www.telegraph.co.uk/science/2017/02/13/johnson-johnson-ditch-plastic-cotton-buds-save-oceans/","2017-02-13 13:35:04","Telegraph.co.uk","Cotton buds made by the pharmaceutical company Johnson & Johnson will no longer have plastic handles to prevent toxic waste reaching waterways and seas.","JNJ","Johnson & Johnson"
"1440","Jim Simons Buys Gilead Sciences, Johnson &amp; Johnson, Monsanto Co, Sells Bristol ...","http://www.nasdaq.com/article/jim-simons-buys-gilead-sciences-johnson-johnson-monsanto-co-sells-bristol-myers-squibb-cm747882","2017-02-13 19:11:15","Nasdaq","Jim Simons initiated holdings in Broadcom Ltd. The purchase prices were between $162.79 and $182.31, with an estimated average price of $173.24.","JNJ","Johnson & Johnson"
"1441","Johnson &amp; Johnson to ditch harmful plastic","http://www.nzherald.co.nz/business/news/article.cfm?c_id=3&objectid=11800378","2017-02-14 23:07:30","New Zealand Herald","Cotton buds made by the pharmaceutical company Johnson & Johnson will no longer have plastic handles to prevent toxic waste reaching waterways and seas.","JNJ","Johnson & Johnson"
"1442","Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson &amp; Johnson for $1.045 bln","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528463","2017-02-15 07:00:00","Reuters Key Development","Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson for $1.045 bln","JNJ","Johnson & Johnson"
"1443","Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528510","2017-02-15 08:03:00","Reuters Key Development","Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal","JNJ","Johnson & Johnson"
"1444","No Joke: Johnson &amp; Johnson Could Grow Sales by 5% (or More) Annually Over the ...","https://www.fool.com/investing/2017/02/15/no-joke-johnson-johnson-could-grow-sales-by-5-or-m.aspx","2017-02-15 08:07:30","Motley Fool","For many investors, Johnson & Johnson (NYSE:JNJ) is the quintessential set-it-and-forget-it investment in the healthcare arena.","JNJ","Johnson & Johnson"
"1445","X-Chem expands collaboration with Janssen in inflammatory diseases","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528514","2017-02-15 08:15:00","Reuters Key Development","X-Chem expands collaboration with Janssen in inflammatory diseases","JNJ","Johnson & Johnson"
"1446","Integra Bids $1.05 Billion for Johnson &amp; Johnson Neurosurgery Business","https://www.wsj.com/articles/integra-bids-1-05-billion-for-johnson-johnson-neurosurgery-business-1487166240","2017-02-15 08:41:15","Wall Street Journal (subscription)","Integra LifeSciences Holdings Corp. said Wednesday that it made an offer to buy Johnson & Johnson's Codman Neurosurgery business for about $1.05 billion in cash.","JNJ","Johnson & Johnson"
"1447","Trianni signs licensing agreement with Janssen","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3528545","2017-02-15 09:00:00","Reuters Key Development","Trianni signs licensing agreement with Janssen","JNJ","Johnson & Johnson"
"1448","Johnson &amp; Johnson Shares Cross Above 200 DMA","http://www.nasdaq.com/article/johnson-johnson-shares-cross-above-200-dma-cm748612","2017-02-15 16:58:37","Nasdaq","In trading on Wednesday, shares of Johnson & Johnson (Symbol: JNJ) crossed above their 200 day moving average of $117.03, changing hands as high as $117.46 per share.","JNJ","Johnson & Johnson"
"1449","Johnson &amp; Johnson Is Not Cheap, And It Never Will Be","http://seekingalpha.com/article/4046477-johnson-and-johnson-cheap-never-will","2017-02-15 19:22:30","Seeking Alpha","Forward looking P/E is at a historically attractive level for one of the highest-quality companies on earth. Investors can expect 55th consecutive annual dividend increase in April.","JNJ","Johnson & Johnson"
"1450","Swiss Takeover Commission OKs J&amp;J offer for Actelion","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3529235","2017-02-16 03:01:07","Reuters Key Development","Swiss Takeover Commission OKs J&J offer for Actelion","JNJ","Johnson & Johnson"
"1451","Johnson &amp; Johnson (JNJ) Stock Breaks Higher","http://investorplace.com/2017/02/johnson-johnson-jnj-breaking-higher/","2017-02-16 15:15:00","Investorplace.com","Case in point is Johnson & Johnson (NYSE:JNJ), which is rising up and over its four-month trading range to return to levels not seen since November.","JNJ","Johnson & Johnson"
"1452","Glg Llc Buys Midstates Petroleum Co, Apple, Johnson &amp; Johnson, Sells Teva ...","http://www.gurufocus.com/news/484511/glg-llc-buys-midstates-petroleum-co-apple-johnson--johnson-sells-teva-pharmaceutical-industries-facebook-amazoncom","2017-02-16 15:47:07","GuruFocus.com","New York, NY, based Investment company Glg Llc buys Midstates Petroleum Co, Apple, Johnson & Johnson, Genesee & Wyoming, Innoviva, Exxon Mobil, Costco Wholesale, Procter & Gamble Co, Intel, Boeing Co, sells Teva Pharmaceutical Industries, ...","JNJ","Johnson & Johnson"
"1453","Ethicon announces agreement to acquire Torax Medical","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3530414","2017-02-17 10:00:00","Reuters Key Development","Ethicon announces agreement to acquire Torax Medical","JNJ","Johnson & Johnson"
"1454","Exclusive: Following Up Akebia, Johnson &amp; Johnson&#39;s Research And License Agreement","https://www.benzinga.com/general/biotech/17/02/9061564/exclusive-following-up-akebia-johnson-johnsons-research-and-license-ag","2017-02-17 10:11:15","Benzinga","On Monday, Akebia Therapeutics Inc (NASDAQ: AKBA) signed a $1 million research and license agreement with Johnson & Johnson (NYSE: JNJ) to access hundreds of hypoxia inducible factor (HIF)-targeted compounds. This access includes a coveted ...","JNJ","Johnson & Johnson"
"1455","Johnson &amp; Johnson&#39;s half-hearted switch from plastic to paper cotton buds isn ...","http://www.treehugger.com/corporate-responsibility/johnson-johnsons-switch-plastic-paper-cotton-buds-pathetically-half-hearted.html","2017-02-17 14:01:09","Treehugger","It's only happening in half the world. The rest of us can keep using plastic sticks. (Don't they know about ocean currents?","JNJ","Johnson & Johnson"
"1456","Why You Should Surround Yourself With Great People","http://fortune.com/2017/02/17/brainstorm-health-02-17-intro/","2017-02-17 14:37:25","Fortune","And maybe I'm playing favorites—well, sure I'm playing favorites—but I was especially partial to the conversation I had with Sandi Peterson, Johnson & Johnson's Group Worldwide Chairman. (J&J is the lead sponsor of the forum, which is now in its ...","JNJ","Johnson & Johnson"
"1457","Better Buy: Eli Lilly and Company vs. Johnson &amp; Johnson","https://www.fool.com/investing/2017/02/18/better-buy-eli-lilly-and-company-vs-johnson-johnso.aspx","2017-02-18 07:11:15","Motley Fool","However, there's plenty to like about Johnson & Johnson. For one thing, the situation with its consumer and medical devices segments isn't really all that bad.","JNJ","Johnson & Johnson"
"1458","Johnson &amp; Johnson&#39;s Ethicon buys Torax Medical","http://seekingalpha.com/news/3244568-johnson-and-johnsons-ethicon-buys-torax-medical","2017-02-18 16:00:00","Seeking Alpha","Johnson & Johnson's (NYSE:JNJ) Ethicon unit acquires privately held St. Paul, MN-based Torax Medical for an undisclosed sum.","JNJ","Johnson & Johnson"
"1459","Johnson &amp; Johnson subsidiary buys Torax Medical","http://www.startribune.com/johnson-amp-johnson-subsidiary-buys-torax-medical/414280943/","2017-02-20 17:18:45","Minneapolis Star Tribune","Shoreview medical device maker Torax Medical is being acquired by a subsidiary of health care giant Johnson & Johnson Co.","JNJ","Johnson & Johnson"
"1460","Torax Medical agrees to sell to Johnson &amp; Johnson subsidiary","http://www.bizjournals.com/twincities/news/2017/02/21/torax-medical-agrees-to-sell-to-johnson-johnson.html","2017-02-21 08:00:30","Minneapolis / St. Paul Business Journal","Torax Medical Inc., which makes a ring-shaped device that treats acid-reflux disease, is being bought by a surgical-tools subsidiary of Johnson & Johnson Co. The health-care giant, which invested in Torax last year, will fold the company into Ethicon ...","JNJ","Johnson & Johnson"
"1461","The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals ...","http://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-143002469.html","2017-02-21 10:08:22","Yahoo Finance","Stocks recently featured in the blog include Merck & Co. (NYSE: MRK - Free Report ), Valeant Pharmaceuticals International ( VRX - Free Report ), Allergan (AGN - Free Report ), AstraZeneca (NYSE: AZN - Free Report ) and Johnson & Johnson (NYSE: JNJ ...","JNJ","Johnson & Johnson"
"1462","Johnson &amp; Johnson Leads 164 Stocks Going Ex-Dividend This Week","http://www.dividend.com/news/2017/02/21/johnson-johnson-leads-164-stocks-going-ex-dividend-this-week/","2017-02-21 11:55:16","Dividend.com","There are 162 stocks going ex-dividend this week starting Tuesday, Feb. 21. For income investors looking to generate more income as part of a dividend capture strategy, a stock must be purchased one day before the ex-dividend date to capture the ...","JNJ","Johnson & Johnson"
"1463","9 Reasons To Own Johnson &amp; Johnson","http://seekingalpha.com/article/4048254-9-reasons-johnson-and-johnson","2017-02-22 09:37:30","Seeking Alpha","Back in 2015, Johnson & Johnson (NYSE:JNJ) stated they expect 10 new drugs to be filed by 2019, all with potential to exceed $1 billion in sales.","JNJ","Johnson & Johnson"
"1464","Ex-Dividend Reminder: Brookfield Infrastructure Partners LP, NextEra Energy ...","http://www.nasdaq.com/article/ex-dividend-reminder-brookfield-infrastructure-partners-lp-nextera-energy-and-johnson-johnson-cm751210","2017-02-22 10:10:59","Nasdaq","Looking at the universe of stocks we cover at Dividend Channel , on 2/24/17, Brookfield Infrastructure Partners LP (Symbol: BIP), NextEra Energy Inc (Symbol: NEE), and Johnson & Johnson (Symbol: JNJ) will all trade ex-dividend for their respective ...","JNJ","Johnson & Johnson"
"1465","Johnson &amp; Johnson tops its peers in the &#39;most-admired&#39; department—again","http://www.fiercepharma.com/marketing/johnson-johnson-most-admired-pharma-company-fortune-list-again","2017-02-22 10:11:15","FiercePharma","Other pharmas? Not so much, though in an industry-specific ranking, of Novartis and Roche tied for second behind J&J. Johnson & Johnson led pharma in Fortune's annual corporate poll of the most admired companies in the world for the fourth year in a row.","JNJ","Johnson & Johnson"
"1466","Forward Earnings Estimate of Johnson &amp; Johnson(JNJ)","https://www.highlandmirror.com/2017-02-23-forward-earnings-estimate-of-johnson-johnsonjnj","2017-02-23 04:45:00","Highland Mirror","Johnson & Johnson(JNJ): For the most recent quarter end, Johnson & Johnson reported Annual Earnings of $1.58.","JNJ","Johnson & Johnson"
"1467","Johnson &amp; Johnson (JNJ) Ex-Dividend Date Scheduled for February 24, 2017","http://www.nasdaq.com/article/johnson-johnson-jnj-ex-dividend-date-scheduled-for-february-24-2017-cm751843","2017-02-23 09:03:45","Nasdaq","Johnson & Johnson ( JNJ ) will begin trading ex-dividend on February 24, 2017. A cash dividend payment of $0.8 per share is scheduled to be paid on March 14, 2017.","JNJ","Johnson & Johnson"
"1468","Why I Doubled Down On Johnson &amp; Johnson","http://seekingalpha.com/article/4048892-doubled-johnson-and-johnson","2017-02-23 12:03:45","Seeking Alpha","As I noted in my recent portfolio update, I added a new position in Johnson & Johnson (NYSE:JNJ) in January. I'm not quite to the point that I have huge sums of money to invest each month yet, so I'm not able to buy in blocks of hundreds of shares ...","JNJ","Johnson & Johnson"
"1469","Johnson &amp; Johnson, Pfizer Lead DJIA Higher on Thursday","http://finance.yahoo.com/news/johnson-johnson-pfizer-lead-djia-210135625.html","2017-02-23 16:00:00","Yahoo Finance","The DJIA stock posting the largest daily percentage gain ahead of the close Thursday was Johnson & Johnson (JNJ) which traded up 1.77% at $121.64.","JNJ","Johnson & Johnson"
"1470","Johnson &amp; Johnson Therapeutic Pipeline Market Review, H2 2017","http://www.medgadget.com/2017/02/johnson-johnson-therapeutic-pipeline-market-review-h2-2017.html","2017-02-24 07:00:00","Medgadget (blog)","The report provides comprehensive information on the therapeutics under development by Johnson & Johnson, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.","JNJ","Johnson & Johnson"
"1471","Johnson &amp; Johnson (JNJ) Up 6% Since Earnings Report: Can It Continue?","http://finance.yahoo.com/news/johnson-johnson-jnj-6-since-112011930.html","2017-02-24 07:10:31","Yahoo Finance","A month has gone by since the last earnings report for Johnson & Johnson JNJ. Shares have added about 5.6% in that time frame, outperforming the market.","JNJ","Johnson & Johnson"
"1472","Option Trading: Johnson &amp; Johnson (NYSE:JNJ) Powerful Short Put Spreads to ...","http://news.cmlviz.com/2017/02/24/option-trading-johnson--johnson-nyse-jnj--powerful-short-put-spreads-to-outperform-earnings.html","2017-02-24 09:05:26","CML News","We find a very powerful outcome examining short put spreads for Johnson & Johnson when we use a clever earnings risk management approach.","JNJ","Johnson & Johnson"
"1473","Plaintiff Experts Endure Withering Cross-Examination By Johnson &amp; Johnson As ...","http://blog.cvn.com/plaintiff-experts-endure-withering-cross-examination-by-johnson-johnson-as-talc-powder-trial-continues","2017-02-24 10:30:03","CVN News (blog)","St. Louis - Expert witnesses retained by attorneys for a woman accusing Johnson & Johnson of withholding the cancer risks of talc powder-based hygiene products from the public recently underwent intense questioning by the company's high-powered legal ...","JNJ","Johnson & Johnson"
"1474","Johnson &amp; Johnson May Already Have Its Remicade Replacement Well in Hand","https://www.fool.com/investing/2017/02/24/johnson-johnson-may-already-have-its-remicade-repl.aspx","2017-02-24 18:37:30","Motley Fool","When it comes to safe stocks, there may be none safer than healthcare conglomerate Johnson & Johnson (NYSE:JNJ). Johnson & Johnson is often a staple holding for income seekers, conservative investors, and even value investors. It has a 54-year streak ...","JNJ","Johnson & Johnson"
"1475","Dan Nathan&#39;s Bearish Johnson &amp; Johnson Trade","https://www.benzinga.com/media/cnbc/17/02/9097135/dan-nathans-bearish-johnson-johnson-trade","2017-02-26 15:26:15","Benzinga","Nathan said that Johnson & Johnson is trading at its resistance from November and he is concerned about the impact of strong dollar on its revenues.","JNJ","Johnson & Johnson"
"1476","Global Fluticasone Furoate Market 2017 Sanofi, GlaxoSmithKline, Pfizer ...","http://www.medgadget.com/2017/02/global-fluticasone-furoate-market-2017-sanofi-glaxosmithkline-pfizer-johnson-johnson.html","2017-02-27 03:15:00","Medgadget (blog)","The report, named “Global Fluticasone Furoate Market”, provides a Detailed overview of the Fluticasone Furoate market related to overall world.","JNJ","Johnson & Johnson"
"1477","EOD Risers: Johnson &amp; Johnson, McDonald&#39;s Corporation, Merck &amp; Co., Inc., Nike Inc","https://www.directorstalkinterviews.com/eod-risers-johnson-johnson-mcdonalds-corporation-merck-co-inc-nike-inc/412724588","2017-02-27 06:15:03","DirectorsTalk Interviews","Shares of Johnson & Johnson ticker lookup code: (NYSE:JNJ) a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field, stepped up 1.51% or 1.83 points throughout Friday's ...","JNJ","Johnson & Johnson"
"1478","Johnson &amp; Johnson Completes Acquisition of Abbott Medical Optics","http://www.prnewswire.com/news-releases/johnson--johnson-completes-acquisition-of-abbott-medical-optics-300413727.html","2017-02-27 07:11:15","PR Newswire (press release)"," Johnson & Johnson (NYSE: JNJ) today announced it has completed the acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott.","JNJ","Johnson & Johnson"
"1479","Concerns Warier in Focus- Johnson &amp; Johnson (NYSE:JNJ), Palatin Technologies ...","http://www.senecaglobe.com/concerns-warier-in-focus-johnson-johnson-nysejnj-palatin-technologies-nyseptn/371240/","2017-02-27 07:22:30","Seneca Globe","Johnson & Johnson (NYSE:JNJ) [Trend Analysis] pretends to be active mover, stock surged around 0.85% to close at $122.73.","JNJ","Johnson & Johnson"
"1480","Global Insulin pump Accessories Market Research Report 2017 Medtronic, Johnson ...","http://www.medgadget.com/2017/02/global-insulin-pump-accessories-market-research-report-2017-medtronic-johnson-johnson-roche-sooil.html","2017-02-27 08:18:45","Medgadget (blog)","Qy Research Reports Brings You The Latest Report Title Insulin pump Accessories Which The In-House Expert Analysts Have Prognosticated To Considerably Grow At A Fairly Large Cagr Over The Forecast Period.","JNJ","Johnson & Johnson"
"1481","Analysts mean rating score stands at 2.50 while Johnson &amp; Johnson&#39;s (JNJ ...","http://www.hotstockspoint.com/analysts-mean-rating-score-stands-2-50-johnson-johnsons-jnj-stock-price-worth-122-73-investors-alert/","2017-02-27 08:37:22","Hot Stocks Point","Johnson & Johnson's (JNJ) stock price ended its day with a gain of 0.85% and finalized at the price of $122.73. During its last trading session, Stock traded with the total exchanged volume of 10.8 million shares.","JNJ","Johnson & Johnson"
"1482","Wall Street Active Spotlight: Johnson &amp; Johnson&#39;s (JNJ) stock price settles at ...","http://www.wsnews4investors.com/2017/02/27/wall-street-active-spotlight-johnson-johnsons-jnj-stock-price-settles-at-122-73-with-movement-of-0-85/","2017-02-27 08:52:30","WsNews 4investors","Johnson & Johnson's (JNJ ) stock price escalated 0.85% to finalize at $122.73 throughout previous buying and selling session.","JNJ","Johnson & Johnson"
"1483","Better Buy: PDL BioPharma, Inc. vs. Johnson &amp; Johnson","https://www.fool.com/investing/2017/02/27/better-buy-pdl-biopharma-inc-vs-johnson-johnson.aspx","2017-02-27 09:37:30","Motley Fool","Over the same period, Johnson & Johnson (NYSE:JNJ) stock has kept pace with the buoyant broad-market S&P 500 index.","JNJ","Johnson & Johnson"
"1484","Johnson &amp; Johnson (JNJ) Stake Raised by First Interstate Bank","https://www.chaffeybreeze.com/2017/02/27/johnson-johnson-jnj-stake-raised-by-first-interstate-bank.html","2017-02-27 10:00:00","Chaffey Breeze","Johnson & Johnson logo First Interstate Bank raised its stake in Johnson & Johnson (NYSE:JNJ) by 5.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).","JNJ","Johnson & Johnson"
"1485","Analysts Taking Ride on Hard Facts For- Johnson &amp; Johnson (NYSE:JNJ), Sarepta ...","http://www.senecaglobe.com/analysts-taking-ride-on-hard-facts-for-johnson-johnson-nysejnj-sarepta-therapeutics-inc-nasdaqsrpt/371530/","2017-02-27 10:33:45","Seneca Globe","Shares of Johnson & Johnson (NYSE:JNJ) raised 0.85% to finish at $122.73 in last run as Finally, we can see dark clouds emerging over JNJ.","JNJ","Johnson & Johnson"
"1486","Johnson &amp; Johnson pursues empathy in an age of &#39;anxiety and mistrust&#39;","http://www.campaignlive.co.uk/article/johnson-johnson-pursues-empathy-age-anxiety-mistrust/1425530","2017-02-27 11:07:30","CampaignLive","In order to address the issues of sleep Johnson & Johnson developed a ""clinically proven routine"" to help babies sleep better, which includes practices such as giving the baby a warm bath.","JNJ","Johnson & Johnson"
"1487","The Technical Case for and Against Johnson &amp; Johnson (JNJ)","http://theusacommerce.com/2017/02/27/the-technical-case-for-and-against-johnson-johnson-jnj-2/","2017-02-27 13:23:02","The USA Commerce","We have gathered the technical data on Johnson & Johnson (JNJ), and see some interesting trends in the stock's behavior of late.","JNJ","Johnson & Johnson"
"1488","Analyst Stock Recommendations For Comcast Corporation (CMCSA), Johnson ...","http://thewellesleysnews.com/index.php/2017/02/27/analyst-stock-recommendations-for-comcast-corporation-cmcsa-johnson-johnson-jnj/","2017-02-27 13:45:00","TWN","Comcast Corporation (NASDAQ:CMCSA) tinted gains of +0.64% (+0.24 points) to US$37.89. The volume of 11.51 Million shares climbed down over an trading activity of 9.73 Million shares.","JNJ","Johnson & Johnson"
"1489","Drugmakers pledge restraint, but prices will still soar","http://www.chicagotribune.com/business/ct-drug-prices-drugmakers-20170227-story.html","2017-02-27 14:41:15","Chicago Tribune","The latest drugmaker move came Monday, when Johnson & Johnson, the world's biggest maker of health care products, issued its first public report on price increases for its drugs.","JNJ","Johnson & Johnson"
"1490","Johnson &amp; Johnson Prescription Unit List Prices Rose 8.5% Last Year","https://www.wsj.com/articles/johnson-johnson-prescription-unit-list-prices-rose-8-5-last-year-1488226977","2017-02-27 15:23:11","Wall Street Journal (subscription)","Johnson & Johnson said it raised the list price of its prescription medicines by an average of 8.5% last year—and 3.5% after discounts—in the health-products company's first effort to address criticism about the high cost of medicines by opening up ...","JNJ","Johnson & Johnson"
"1491","Johnson &amp; Johnson says received a subpoena in Feb. from the U.S. attorney&#39;s office for the District of Massachusetts","http://www.reuters.com/finance/stocks/JNJ/key-developments/article/3536672","2017-02-27 16:59:23","Reuters Key Development","Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts","JNJ","Johnson & Johnson"
"1492","BRIEF-Johnson &amp; Johnson says received a subpoena in Feb. from the US attorney ...","http://www.reuters.com/article/brief-johnson-johnson-says-received-a-su-idUSFWN1GC14G","2017-02-27 17:18:45","Reuters","BRIEF-Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts.","JNJ","Johnson & Johnson"
